
<html lang="en"     class="pb-page"  data-request-id="c3f313ad-96bf-4a8d-b2a4-7e84bdc6cc8e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm801026e;issue:issue:10.1021/jmcmar.2009.52.issue-8;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 4-(Benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(Pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4" /></meta><meta name="dc.Creator" content="Hwei-Ru  Tsou" /></meta><meta name="dc.Creator" content="Xiaoxiang  Liu" /></meta><meta name="dc.Creator" content="Gary  Birnberg" /></meta><meta name="dc.Creator" content="Joshua  Kaplan" /></meta><meta name="dc.Creator" content="Mercy  Otteng" /></meta><meta name="dc.Creator" content="Tritin  Tran" /></meta><meta name="dc.Creator" content="Kristina  Kutterer" /></meta><meta name="dc.Creator" content="Zhilian  Tang" /></meta><meta name="dc.Creator" content="Ron  Suayan" /></meta><meta name="dc.Creator" content="Arie  Zask" /></meta><meta name="dc.Creator" content="Malini  Ravi" /></meta><meta name="dc.Creator" content="Angela  Bretz" /></meta><meta name="dc.Creator" content="Mary  Grillo" /></meta><meta name="dc.Creator" content="John P.  McGinnis" /></meta><meta name="dc.Creator" content="Sridhar K.  Rabindran" /></meta><meta name="dc.Creator" content="Semiramis  Ayral-Kaloustian" /></meta><meta name="dc.Creator" content="Tarek S.  Mansour" /></meta><meta name="dc.Description" content="The series of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-dione and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-dione derivatives reported here represents a novel class of potent..." /></meta><meta name="Description" content="The series of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-dione and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-dione derivatives reported here represents a novel class of potent..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 24, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm801026e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm801026e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm801026e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm801026e" /></link>
        
    
    

<title>Discovery of 4-(Benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(Pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm801026e" /></meta><meta property="og:title" content="Discovery of 4-(Benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(Pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0017.jpeg" /></meta><meta property="og:description" content=" The series of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-dione and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-dione derivatives reported here represents a novel class of potential antitumor agents, which potently and selectively inhibit CDK4 over CDK2 and CDK1. In the benzylamino headpiece, a 3-OH substituent is required on the phenyl ring for CDK4 inhibitory activity, which is further enhanced when an iodo, aryl, heteroaryl, t-butyl, or cyclopentyl substituent is introduced at the C-6 position of the isoquinoline-1,3-dione core. To circumvent the metabolic liability associated with the phenolic OH group on the 4-substituted 3-OH phenyl headpiece, we take two approaches: first, introduce a nitrogen o- or p- to the 3-OH group in the phenyl ring; second, replace the phenyl headpiece with N-substituted 2-pyridones. We present here the synthesis, SAR data, metabolic stability data, and a CDK4 mimic model that explains the binding, potency, and selectivity of our CDK4 selective inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm801026e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm801026e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm801026e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm801026e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm801026e&amp;href=/doi/10.1021/jm801026e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 2289-2310</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm801016j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm801060h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 4-(Benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones and 4-[(Pyridylmethyl)aminomethylene]isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hwei-Ru++Tsou">Hwei-Ru Tsou</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoxiang++Liu">Xiaoxiang Liu</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Birnberg">Gary Birnberg</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joshua++Kaplan">Joshua Kaplan</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mercy++Otteng">Mercy Otteng</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tritin++Tran">Tritin Tran</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristina++Kutterer">Kristina Kutterer</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhilian++Tang">Zhilian Tang</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ron++Suayan">Ron Suayan</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arie++Zask">Arie Zask</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Malini++Ravi">Malini Ravi</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Bretz">Angela Bretz</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary++Grillo">Mary Grillo</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+P.++McGinnis">John P. McGinnis</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sridhar+K.++Rabindran">Sridhar K. Rabindran</a></span><span class="author-xref-symbol "><sup>‡</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Semiramis++Ayral-Kaloustian">Semiramis Ayral-Kaloustian</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tarek+S.++Mansour">Tarek S. Mansour</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: (845) 602-4712. Fax: (845) 602-5561. E-mail: <a href="/cdn-cgi/l/email-protection#b6c2c5d9c3def6c1cfd3c2de98d5d9db"><span class="__cf_email__" data-cfemail="07737468726f47707e62736f2964686a">[email protected]</span></a></div><div class="corresp-fn" id="afn2">†Chemical and Screening Sciences.</div><div class="corresp-fn" id="afn3">‡Oncology Research.</div><div class="corresp-fn" id="afn1">§Current address: GlaxoSmithKline, 1250 S. Collegeville Road, UP1450, Collegeville, PA 19426.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm801026e&amp;href=/doi/10.1021%2Fjm801026e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 2289–2310</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 24, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 August 2008</li><li><span class="item_label"><b>Published</b> online</span>24 March 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 April 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm801026e" title="DOI URL">https://doi.org/10.1021/jm801026e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2289%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHwei-Ru%2BTsou%252C%2BXiaoxiang%2BLiu%252C%2BGary%2BBirnberg%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D8%26contentID%3Djm801026e%26title%3DDiscovery%2Bof%2B4-%2528Benzylaminomethylene%2529isoquinoline-1%252C3-%25282H%252C4H%2529-diones%2Band%2B4-%255B%2528Pyridylmethyl%2529aminomethylene%255Disoquinoline-1%252C3-%25282H%252C4H%2529-diones%2Bas%2BPotent%2Band%2BSelective%2BInhibitors%2Bof%2Bthe%2BCyclin-Dependent%2BKinase%2B4%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2310%26publicationDate%3DApril%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm801026e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5167</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">49</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm801026e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 4-(Benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(Pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hwei-Ru&quot;,&quot;last_name&quot;:&quot;Tsou&quot;},{&quot;first_name&quot;:&quot;Xiaoxiang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Birnberg&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;Kaplan&quot;},{&quot;first_name&quot;:&quot;Mercy&quot;,&quot;last_name&quot;:&quot;Otteng&quot;},{&quot;first_name&quot;:&quot;Tritin&quot;,&quot;last_name&quot;:&quot;Tran&quot;},{&quot;first_name&quot;:&quot;Kristina&quot;,&quot;last_name&quot;:&quot;Kutterer&quot;},{&quot;first_name&quot;:&quot;Zhilian&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Ron&quot;,&quot;last_name&quot;:&quot;Suayan&quot;},{&quot;first_name&quot;:&quot;Arie&quot;,&quot;last_name&quot;:&quot;Zask&quot;},{&quot;first_name&quot;:&quot;Malini&quot;,&quot;last_name&quot;:&quot;Ravi&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Bretz&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Grillo&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;P. McGinnis&quot;},{&quot;first_name&quot;:&quot;Sridhar&quot;,&quot;last_name&quot;:&quot;K. Rabindran&quot;},{&quot;first_name&quot;:&quot;Semiramis&quot;,&quot;last_name&quot;:&quot;Ayral-Kaloustian&quot;},{&quot;first_name&quot;:&quot;Tarek&quot;,&quot;last_name&quot;:&quot;S. Mansour&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;2289-2310&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm801026e&quot;},&quot;abstract&quot;:&quot;The series of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-dione and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-dione derivatives reported here represents a novel class of potential antitumor agents, which potently and selectively inhibit CDK4 over CDK2 and CDK1. In the benzylamino headpiece, a 3-OH substituent is required on the phenyl ring for CDK4 inhibitory activity, which is further enhanced when an iodo, aryl, heteroaryl, t-butyl, or cyclopentyl substituent is introduced at the C-6 position of the isoquinoline-1,3-dione core. To circumvent the metabolic liability associated with the phenolic OH group on the 4-substituted 3-OH phenyl headpiece, we take two approaches: first, introduce a nitrogen o- or p- to the 3-OH group in the phenyl ring; second, replace the phenyl headpiece with N-substituted 2-pyridones. We present here the synthesis, SAR data, metabolic stability data, and a CDK4 mimic model that explains the binding, potency, and selectivity of our CDK4 selective inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801026e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801026e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801026e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801026e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801026e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801026e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm801026e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801026e&amp;href=/doi/10.1021/jm801026e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm801026e" /></input><a href="/doi/pdf/10.1021/jm801026e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (614 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm801026e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm801026e%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DTsou%26date%3D2009%26atitle%3DDiscovery%2Bof%2B4-%2528Benzylaminomethylene%2529isoquinoline-1%252C3-%25282H%252C4H%2529-diones%2Band%2B4-%255B%2528Pyridylmethyl%2529aminomethylene%255Disoquinoline-1%252C3-%25282H%252C4H%2529-diones%2Bas%2BPotent%2Band%2BSelective%2BInhibitors%2Bof%2Bthe%2BCyclin-Dependent%2BKinase%2B4%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D8%26spage%3D2289%26epage%3D2310%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The series of 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-dione and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-dione derivatives reported here represents a novel class of potential antitumor agents, which potently and selectively inhibit CDK4 over CDK2 and CDK1. In the benzylamino headpiece, a 3-OH substituent is required on the phenyl ring for CDK4 inhibitory activity, which is further enhanced when an iodo, aryl, heteroaryl, <i>t</i>-butyl, or cyclopentyl substituent is introduced at the C-6 position of the isoquinoline-1,3-dione core. To circumvent the metabolic liability associated with the phenolic OH group on the 4-substituted 3-OH phenyl headpiece, we take two approaches: first, introduce a nitrogen <i>o</i>- or <i>p</i>- to the 3-OH group in the phenyl ring; second, replace the phenyl headpiece with N-substituted 2-pyridones. We present here the synthesis, SAR data, metabolic stability data, and a CDK4 mimic model that explains the binding, potency, and selectivity of our CDK4 selective inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Progression of cells through the cell division cycle is regulated by a family of serine/threonine kinases (CDKs<a class="ref internalNav" href="#fn1" aria-label="a">a</a>) and their activating partners, the cyclins.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Different combinations of cyclin/CDK complexes regulate each of the cell cycle transitions. In the G1-S phase transition, the D-type cyclins (D1, D2, or D3) in complex with CDK4 (or CDK6 in hematopoietic cells), along with cyclin E/CDK2 complexes, cooperatively phosphorylate the retinoblastoma susceptibility gene family of proteins (Rb).<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Phosphorylation of Rb converts it from a repressor to an activator of the E2F transcription factors, leading to the transcription of genes required for DNA synthesis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The expression/activity of G1 cyclin/CDK complexes are positively regulated by the mitogenic signaling pathways and negatively regulated by the cyclin-dependent kinase inhibitors (CKIs), which include p16<sup>INK4a</sup>, p15<sup>INK4b</sup>, p21<sup>CIP1</sup>, and p27<sup>KIP1</sup>.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This coordinated regulation facilitates sequential activation of the G1 cyclin/CDK complexes required for orderly transition into S-phase.</div><div class="NLM_p"><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: CDK, cyclin-dependent kinase.</p></div></div><div class="NLM_p">Aberrant control of cell proliferation is a hallmark of cancer,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and the p16<sup>INK4a</sup>-cyclin D1/CDK4-Rb axis has been implicated in this dysregulation.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> CDK4 mutants that are resistant to p16 have been indentified in melanoma, while loss of p16 activity due to mutations, deletions, or gene silencing has been observed in glioblastoma, pancreatic cancers, and NSCLC.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Cyclin D1 is deregulated by chromosomal translocation in B-cell lymphoma and parathyroid adenomas, and is overexpressed in breast, esophagus, head and neck, and colon cancers.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> CDK4 is overexpressed in osteosarcomas, and Rb is mutated in retinoblastomas and SCLC.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> We recently reported that the inhibition of endogenous cyclin D1 or CDK4 expression by RNA interference in MCF-7 breast cancer cells resulted in the inhibition of cell growth, hypophosphorylation of Rb, and accumulation of cells in the G1 phase.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This result supports the view that pharmacological inhibition of cyclin D1/CDK4 complexes is a useful strategy to inhibit the growth of tumors. Consistent with this, microinjection of cyclin D1 antibodies or antisense oligonucleotides in cells caused G1/S arrest and decreased tumorigenesis in nude mice.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9-12)</a> The importance of deregulated cyclin D/CDK4 complexes in tumorigenesis is underscored by the observation that both cyclin D1 and CDK4 knockout mice are resistant to ErbB-2 induced tumorigenesis.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Importantly, this effect is mediated by the catalytic activity of CDK4 since mice expressing a mutant cyclin D1 that binds to, but cannot activate CDK4/6, are resistant to ErbB-2-mediated tumorigenesis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">In the past few years, several small-molecule CDK inhibitors have been identified, but none have been approved for clinical use.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Flavopiridol and CYC-202 (Seliciclib), which inhibit multiple CDKs, are in clinical trials but have only shown modest activity.<a onclick="showRef(event, 'cit16a'); return false;" href="javascript:void(0);" class="ref cit16a">(16a)</a> Until recently, flavopiridol was reported to demonstrate a marked clinical efficacy in treating patients with chronic lymphocytic leukemia by using a pharmacologically derived schedule for drug administration.<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> Among the second generation of CDK inhibitors, a pyridopyrimidine (PD-0332991),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> a 3-aminothioacridone,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> a triaminopyrimidine derivative (CINK4),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> a diarylurea,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and 3-(α-heteroarylaminobenzylidene)-2-indolinones<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> are reported to be selective for CDK4/6, as compared with other CDKs. Recently, we reported a novel series of 4-(phenylaminomethylene)isoquinoline-1,3-diones as potent and selective inhibitors of CDK4.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In that series, substitution with an <i>N</i>-methylpiperazine or a piperidinylmethyl group at the para position of the aniline headpiece is essential for CDK4 potency. Here, we report a new series, 4-[(3-hydroxybenzylamino)-methylene]-4<i>H</i>-isoquinoline-1,3-diones, as highly potent and selective CDK4 inhibitors. Compared to our earlier series where the headpiece was a substituted aniline, this new series carried a substituted 3-hydroxybenzylamino headpiece and exhibited higher potency for CDK4 and higher activity in inhibiting cell proliferation. We describe the details of our optimization efforts and the structure−activity relationships relevant to the substituents at the C-4, C-5, and C-6 positions of the isoquinoline-1,3-dione core. Furthermore, we show a closely related new series, where the benzylamino headpiece was replaced with the pyridylmethylamino headpieces, to enhance metabolic stability while maintaining potency as CDK4 selective inhibitors. We also present one of our inhibitors docked in the ATP binding domain of the CDK4 mimic model, to show the critical hydrogen bond interactions that may explain the CDK4 selectivity as well as potency.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Chemistry</h3><div class="NLM_p">As shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, 4-(methoxymethylene)isoquinoline-1,3-dione (<b>1</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was reacted with 3,4-dihydroxyaniline (<b>2a</b>) or 3,4-dihydroxyphenethylamine (<b>2f</b>) to give the corresponding aniline derivative (<b>3a</b>) and phenethylamine derivative (<b>3f</b>), respectively, similar to the protocol used in our earlier paper.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The corresponding benzylamine derivatives (<b>3b</b>−<b>e</b>) were obtained from the reaction of <b>1</b> and benzylamines (<b>2b</b>−<b>e</b>). The early lead compound <b>3e</b> has a (3-hydroxy-4-methoxybenzyl)aminomethylene substituent at the C-4 of the isoquinoline-1,3-dione core, with no substituents on the rest of the core. We began to explore analogues carrying substituents at either the C-5 or the C-6 position. The 5-bromo and 6-halogen analogues, namely, <b>5c</b> and <b>5a</b>,<b>b</b>,<b>d</b>,<b>e</b>, were prepared from the corresponding 5-bromo intermediate (<b>4c</b>) and 6-halogen intermediates (<b>4a</b>,<b>b</b>,<b>d</b>,<b>e</b>),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> respectively, as depicted in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Similarly, the 6-methoxy derivative (<b>5f</b>), 6-(<i>N</i>-pyrrolyl) derivative (<b>5g</b>), 6-(3-thienyl) derivative (<b>5h</b>), and 6-(3-furyl) derivative (<b>5i</b>) were prepared from the corresponding 6-methoxy, 6-(<i>N</i>-pyrrolyl), 6-(3-thienyl), and 6-(3-furyl) intermediates, namely, <b>4f</b>−<b>i</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> respectively. The 6-bromo derivative (<b>5d</b>) was further reacted with phenylboronic acid, under Suzuki coupling conditions, to yield the 6-phenyl derivative (<b>5j</b>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0008.jpeg" id="gs1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0009.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <b>2e</b>, DMF, Et<sub>3</sub>N, room temperature; (ii) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DMF, microwave, 150 °C.</p></p></figure><div class="NLM_p">The linker group at C-4 of <b>5d</b> was varied by introducing a methyl group at the methylene or the nitrogen of the benzylamine, namely, <b>11</b> and <b>13</b>, as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The hydroxyl group of 3-hydroxy-4-methoxybenzaldehyde (<b>6</b>) was protected as the benzyl ether, and then methyllithium was added to the aldehyde group of <b>7</b> to form the secondary alcohol <b>8</b>. The alcohol <b>8</b> was treated with (PhO)<sub>2</sub>P(O)N<sub>3</sub> and DBU in toluene to yield the corresponding azide (<b>9</b>), which was reduced and debenzylated to yield the amine hydrochloride salt <b>10</b>. Coupling of <b>4d</b> with <b>10</b> afforded <b>11</b>. Derivative <b>13</b> was prepared by reacting <b>4d</b> with <i>N</i>-methyl-3-hydroxy-4-methoxybenzylamine (<b>12</b>), which was prepared by reductive amination of <b>6</b> with methylamine.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0010.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) PhCH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, room temperature; (ii) THF, MeLi in ethyl ether, −78 °C; (iii) (PhO)<sub>2</sub>P(O)N<sub>3</sub>, toluene, DBU, 0 °C; (iv) Pd/C, H<sub>2</sub>, EtOH, HCl; (v) <b>4d</b>, DMF, Et<sub>3</sub>N, room temperature; (vi) MeNH<sub>2</sub>, EtOH, room temperature; then NaBH<sub>4</sub>, MeOH; (vii) <b>4d</b>, THF, room temperature.</p></p></figure><div class="NLM_p">Early on, we observed that moving the OH group from C-3 (<b>3d</b>) to C-4 (<b>3c</b>) on the benzylamine, resulted in a dramatic loss of potency. Additional analogues also supported the importance of the OH group, at the C-3 position of benzylamine, for activity. Therefore, in the majority of our analoguing efforts, we kept this unique structural feature unchanged. We turned our attention to study the effect of the methoxy group at C-4 of the benzylamine in <b>5d</b>, by replacing it with a variety of other functional groups, as depicted in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Treatment of 3,4-dihydroxybenzaldehyde (<b>14</b>) and potasium carbonate in DMF, with 1-bromopropane, or 2-bromoethyl methyl ether, provided the corresponding 3-hydroxy-4-alkoxybenzaldehydes <b>15b</b>,<b>c</b>, after purification by column chromatography. Subsequent reaction of <b>15a</b>−<b>c</b> with methoxyamine hydrochloride in pyridine to form <i>O</i>-methyl-oximes, followed by catalytic hydrogenation, yielded the corresponding benzylamine hydrochlorides <b>16a</b>−<b>c</b>. Treatment of <b>4d</b> with <b>16a</b>−<b>c</b> gave the desired 4-alkoxy derivatives <b>17a</b>−<b>c</b>, respectively. Further reaction of <b>17a</b> with iodoethane and potassium carbonate in DMF yielded the ethoxy derivative <b>17d</b> after purification by high performance liquid chromatography. The 3-hydroxy-4,5-dimethoxy derivative <b>18</b> was prepared in a similar way from <b>4d</b> and 3-hydroxy-4,5-dimethoxybenzylamine. An additional analogue of <b>5d</b>, where the 4-methoxy group was replaced with an amine, was prepared starting from 3-hydroxy-4-nitrobenzaldehyde <b>19</b>. Hydrogenation of the oxime of <b>19</b> followed by reaction with <b>4d</b> provided the desired 4-amino analogue <b>21</b>.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0011.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) RBr, K<sub>2</sub>CO<sub>3</sub>, or Na<sub>2</sub>CO<sub>3</sub>, DMF, room temperature or 65 °C; (ii) MeONH<sub>2</sub> · HCl, pyridine, room temperature; then Pd/C, H<sub>2</sub>, EtOH, HCl; (iii) <b>4d</b>, DMF, room temperature; (iv) EtI, K<sub>2</sub>CO<sub>3</sub>, DMF, 65 °C.</p></p></figure><div class="NLM_p">Other methoxy replacements at C-4 of the benzylamine headpiece in <b>5d</b> included methyl and phenyl groups. Their preparations (<b>25</b> and <b>34</b>) are shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. 3-Hydroxy-4-methylbenzoic acid <b>22</b>, was converted to the corresponding benzoyl chloride <b>23</b>, followed by the addition of ammonium hydroxide, to provide 3-hydroxy-4-methylbenzamide <b>24</b>. Reduction of <b>24</b> gave the desired 3-hydroxy-4-methylbenzylamine <b>25</b>. 3-Hydroxy-4-phenylbenzylamine <b>34</b> was prepared from 3-hydroxy-4-aminobenzoic acid <b>26</b>. After <b>26</b> was esterified, it was converted to the diazonium salt, and the latter was treated with potassium iodide to yield 3-hydroxy-4-iodobenzoate <b>28</b>. The 3-hydroxy group of <b>28</b> was protected as the methyl ether, then the resulting <b>29</b> was treated with phenylboronic acid under Suzuki coupling conditions to yield 3-methoxy-4-phenylbenzoate <b>30</b>. The benzoate group of <b>30</b> was reduced to the benzyl alcohol <b>31</b>,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> which was then activated as the benzyl chloride <b>32</b>. Demethylation of <b>32</b> with boron tribromide, followed by treatment with sodium azide, yielded 3-hydroxy-4-phenylbenzylazide <b>33</b>, which was converted to the desired 3-hydroxy-4-phenylbenzylamine <b>34</b> under Staudinger reaction conditions.</div><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0012.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) (COCl)<sub>2</sub>, 60 °C; (ii) NH<sub>4</sub>OH, 0 °C to room temperature; (iii) BH<sub>3</sub>, THF, 0 °C; (iv) HCl, MeOH, reflux; (v) H<sub>2</sub>O, HCl, NaNO<sub>2</sub>, 0 °C; then KI, H<sub>2</sub>O, room temperature; (vi) NaH, DMF, then Mel, 0 °C; (vii) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (viii) LiAlH<sub>4</sub>, Et<sub>2</sub>O; (ix) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (x) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C; then NaN<sub>3</sub>, DMF, room temperature; (xi) PPh<sub>3</sub>, THF, H<sub>2</sub>O, room temperature; (xii) NH<sub>4</sub>OH, then I<sub>2</sub>, KI, H<sub>2</sub>O; (xiii) Et<sub>3</sub>N, THF, isobutylchloroformate, 0 °C; then NH<sub>3</sub> in THF, room temperature; (xiv) SOCl<sub>2</sub>, toluene, reflux; (xv) BH<sub>3</sub>, THF, room temperature; (xvi) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 2-furylSnBu<sub>3</sub>, CuI, DMF, 100 °C; (xvii) NaH, MOMCl, DMF, 0 °C; (xviii) (for <b>43a</b>) 3-furanboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (for <b>43b</b>−<b>d</b>) XSnBu<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, DMF, 100 °C.</p></p></figure><div class="NLM_p">In addition, heteroaryl groups were introduced as methoxy replacements at the C-4 of the benzylamine headpiece in <b>5d</b>. Compounds <b>41</b> and <b>45a</b>−<b>d</b> were prepared via a common intermediate, 3-hydroxy-4-iodobenzonitrile <b>38</b>, which was readily synthesized from 3-hydroxybenzoic acid <b>35</b> using a procedure modified from Sagi’s route.<a onclick="showRef(event, 'cit24a'); return false;" href="javascript:void(0);" class="ref cit24a">(24a)</a> Treatment of <b>38</b> with 2-furyltributyltin under Stille coupling conditions, followed by borane reduction, gave 3-hydroxy-4-(2-furyl)benzylamine <b>41</b>. The corresponding 3-furyl derivative <b>45a</b> was prepared in a different way. The hydroxyl group of <b>38</b> was protected with MOMCl to provide <b>42</b>. The latter intermediate was then coupled with 3-furylboronic acid, followed by reduction of the nitrile group with lithium aluminum hydride, to yield 3-methoxymethoxy-4-(3-furyl)benzylamine <b>44a</b>. Refluxing of <b>44a</b> in methanolic hydrochloric acid removed the MOM group to give the desired 3-hydroxy-4-(3-furyl)benzylamine <b>45a</b>. The corresponding three 4-pyridyl regioisomers <b>45b</b>−<b>d</b> were prepared in a similar fashion, except that the introductions of the pyridyl groups were carried out via Stille coupling procedures instead of Suzuki coupling conditions.</div><div class="NLM_p">We then explored ways in our designs of new analogues to minimize the potential metabolic liability of the 3-OH group in the benzylamine headpiece while maintaining the potency and selectivity in the series. One way was to replace the phenyl ring of the 3-hydroxy-4-methoxybenzylamine headpiece with pyrimidine ring <b>51</b>, as shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Substituted acetonitrile <b>46</b><a onclick="showRef(event, 'cit24b'); return false;" href="javascript:void(0);" class="ref cit24b">(24b)</a> was treated with hydrochloric acid in dioxane to form acetimidate hydrochloride <b>47</b>. Subsequent treatment of <b>47</b> with ammonia gave the tricyclic iminium salt <b>48</b>, which was then coupled with the sodium salt of 3-hydroxy-2-methoxy-acrylic acid methyl ester <b>49</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> to produce the pyrimidinol derivative <b>50</b>. Hydrazinolysis of <b>50</b> deprotected the phthalimide to yield the desired 2-aminomethyl-5-methoxy-pyrimidin-4-ol, <b>51</b>.</div><figure id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0013.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) HCl, dioxane, MeOH, room temperature; (ii) NH<sub>3</sub> in MeOH, 0 °C; (iii) MeOH, reflux; (iv) EtOH, NH<sub>2</sub>NH<sub>2</sub>; (v) NaOMe, MeOH, dioxane; (vi) RaNi, H<sub>2</sub>, NH<sub>3</sub>, MeOH; (vii) aq. HCl, reflux; (viii) O(CO<sub>2</sub>-<i>t</i>-Bu)<sub>2</sub>, dioxane, NaOH, room temperature; (ix) Me<sub>3</sub>SnPh, Cu(OAc)<sub>2</sub>, <i>n</i>-Bu<sub>4</sub>NF in THF, CH<sub>2</sub>Cl<sub>2</sub>, room temperature; (x) 4 N HCl in dioxane; (xi) (3-furyl)Br, Cul, K<sub>2</sub>CO<sub>3</sub>, DMF, 180 °C, microwave, or 150 °C; (xii) (Me<sub>2</sub>N)<sub>2</sub>CH(O-<i>t</i>-Bu), DMF, 100−150 °C; (xiii) NaIO<sub>4</sub>, aq. THF, room temperature; (xiv) MeONH<sub>2</sub> HCl, pyridine, room temperature; (xv) Zn, HOAc,100 °C.</p></p></figure><div class="NLM_p">Other attempts to enhance metabolic stability of the phenolic OH in the headpiece involved the preparation of the corresponding 2-pyridinol <b>55</b>. Nucleophilic displacement of the chloro group of 2-chloro-4-cyanopyridine, <b>52</b>, with sodium methoxide,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> followed by hydrogenation of the nitrile group of <b>53</b> with Raney Ni, in the presence of ammonia<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> gave 4-(2-methoxypyridyl)methylamine, <b>54</b>. Acid hydrolysis of the methoxy group of <b>54</b> provided the desired 2-pyridinol derivative <b>55</b>. To evaluate the contribution of potency from the 2-pyridinol headpiece <b>55</b>, where N-1 is unsubstituted, we prepared the N-1 substituted 2-pyridones <b>58</b> and <b>65</b>, which no longer carry an OH group. Boc protection of the primary amine of <b>55</b> set the stage for installation of a phenyl substituent on N-1 of the pyridinol <b>56</b>, via treatment with trimethylphenyl tin in the presence of cupric acetate and <i>n</i>-tetrabutylammonium fluoride to generate the Boc protected 1-phenyl-2-pyridone derivative <b>57</b>. Acid treatment of <b>57</b> produced the desired 4-aminomethyl-1-phenyl-2-pyridone <b>58</b>. An alternate synthetic approach was used to synthesize the corresponding 1-(3-furyl)-2-pyridone derivative, <b>65</b>. 2-Hydroxy-4-methylpyridine <b>59</b> was N-arylated with 3-bromofuran via the copper-catalyzed Ullmann condensation<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> to yield 1-(3-furyl)-4-methyl-pyridone <b>60</b>. The 4-methyl group of <b>60</b> was extended to <i>N</i>,<i>N</i>-dimethylenamine <b>61</b>, which upon periodate oxidation produced the aldehyde <b>62</b>. The aldehyde <b>62</b> was then converted into its oxime <b>63</b>, which upon reduction with zinc in acetic acid yielded the desired, but impure, amine <b>65</b>. Because of the difficulty in purifying the free amine, we converted <b>65</b> into its Boc protected derivative <b>64</b>, which allowed easy purification. Final deprotection of the Boc group of <b>64</b> yielded pure 4-aminomethyl-1-(3-furyl)-2-pyridone, <b>65</b>.</div><div class="NLM_p">Additional headpieces, such as substituted 4-pyrones <b>70a</b>−<b>b</b>, 4-pyridinols <b>74a</b>−<b>b</b>, <b>81a</b>−<b>b</b>, and 6-pyridinol <b>88</b>, were prepared as shown in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. Kojic acid <b>66</b> was alkylated,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and then the OH group was transformed into the NH<sub>2</sub> functionality,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> under the same conditions used to prepare <b>34</b>, to yield the desired 2-aminomethyl-5-alkoxy-4-pyrones <b>70a</b>−<b>b</b>. The corresponding pyridinols <b>74a</b>−<b>b</b> were prepared starting from the 4-pyrone intermediates <b>67a</b>−<b>b</b>. Treatment of <b>67a</b>−<b>b</b> with ammonia<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> in a sealed tube generated the corresponding 2-hydroxymethyl-5-alkoxy-4-pyridinols <b>71a</b>−<b>b</b>, which were then converted into <b>74a</b>−<b>b</b>, under the conditions described for the preparation of <b>70a</b>−<b>b</b>. Additional analogues of <b>74a</b>−<b>b</b> where the alkoxy group was replaced by aryl and heteroaryl groups were also prepared. 4-Pyrone-5-triflate <b>75</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> was coupled with phenylboronic acid or furan-3-boronic acid under Suzuki coupling conditions, followed by the removal of the silyl protecting group to yield 5-phenyl-4-pyrone derivative <b>77a</b> and 5-(3-furyl)-4-pyrone derivative <b>77b</b>, respectively. The pyrones <b>77a</b>−<b>b</b> were then converted into pyridinols <b>78a</b>−<b>b</b>, followed by transformation of the hydroxymethyl group into the aminomethyl moiety, under the same conditions used to prepare <b>74a</b>, to yield the desired 5-phenyl- (<b>81a</b>) and 5-(3-furyl)-4-pyridinol (<b>81b</b>) derivatives. The 6-pyridinol isomer of <b>74b</b>, namely, <b>88</b>, was obtained from 2-chloro-3-pyridinol <b>82</b>. Treatment of <b>82</b> with paraformaldehye in base<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> gave 6-hydroxymethyl-2-chloro-3-pyridinol <b>83</b>, followed by propylation of the phenolic group to give <b>84</b>. After the primary alcohol of <b>84</b> was protected as the triisopropylsilyl ether (TIPSO), it was reacted with sodium benzyloxide in benzyl alcohol under microwave conditions to give <b>85</b>. Removal of the TIPS group from the OH provided <b>86</b>, which was converted into the corresponding azide <b>87</b>. Treatment of <b>87</b> under Staudinger conditions, followed by catalytic hydrogenation, provided the desired 6-pyridinol derivative <b>88</b>.</div><figure id="sch7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0014.jpeg" id="gs7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) RBr, KI, K<sub>2</sub>CO<sub>3</sub>, DMF; (ii) SOCl<sub>2</sub>, CHCl<sub>3</sub>; (iii) NaN<sub>3</sub>, DMF, room temperature; (iv) Ph<sub>3</sub>P, THF, then H<sub>2</sub>O, room temperature; (v) conc. NH<sub>4</sub>OH or NH<sub>3</sub> in MeOH, 90 °C, sealed tube; (vi) RB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, KBr, dioxane, 60 °C; (vii) <i>n</i>-Bu<sub>4</sub>F, THF, room temperature; (viii) Ph<sub>3</sub>P, DMF, CBr<sub>4</sub>; then NaN<sub>3</sub>; (ix) (CH<sub>2</sub>O)<i>n</i>, NaHCO<sub>3</sub>; (x) <i>n</i>-Prl, K<sub>2</sub>CO<sub>3</sub>, 2-butanone; (xi) (i-Pr)<sub>3</sub>SiCl, imidazole, CH<sub>2</sub>Cl<sub>2</sub>, room temperature; NaOBz, BzOH, microwave, 120 °C; (xii) Ph<sub>3</sub>P, THF, H<sub>2</sub>O; then EtOH, Pd/C, H<sub>2</sub>.</p></p></figure><div class="NLM_p">Several analogues of <b>5e</b> were prepared with various alkyl, aryl, heteroaryl, and alkoxy substituents on the C-4 of the 3-hydroxybenzylamino headpiece. Compounds <b>89a</b>−<b>g</b> were prepared by the reaction of <b>4e</b> with the desired 3-hydroxybenzylamine hydrochloride in the presence of triethylamine and DMF at room temperature, as shown in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>. The 3-hydroxybenzylamines used included 4-methyl (<b>25</b>), 4-phenyl (<b>34</b>), 2-furyl (<b>41</b>), 3-furyl (<b>45a</b>), the three possible pyridyl isomers (<b>45b</b>−<b>d</b>), and O-<i>n</i>-Pr (<b>16b</b>).</div><figure id="sch8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0015.jpeg" id="gs8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) (For <b>89a</b>, <b>89d</b>−<b>h</b>, <b>94b</b>−<b>c</b>) DMF, Et<sub>3</sub>N, room temperature; (for <b>89b</b>−<b>c</b>, <b>90</b>, <b>92</b>, <b>93</b>) DMF, room temperature; (for <b>91</b>) THF, Et<sub>3</sub>N, room temperature; (for <b>94a</b>) THF, DMF, Et<sub>3</sub>N, room temperature.</p></p></figure><div class="NLM_p">The analogue of <b>5e</b>, wherein the benzylamine was replaced with the pyrimidinylmethylamine, namely, <b>90</b>, was prepared by treatment of <b>4e</b> with the amine <b>51</b>. Analogue <b>92</b>, bearing a 2-aminomethyl-3-propoxy-6-pyridinol headpiece, was obtained by reacting <b>4e</b> with the amine <b>88</b>. Two analogues <b>91</b> and <b>93</b>, where no hydroxyl group was present in the headpiece, were prepared by reacting <b>4d</b> with 2-methoxypyridyl derivative <b>54</b> and 5-methoxy-4-pyrone derivative <b>70a</b>, respectively. The analogue of <b>91</b>, where the methoxy was replaced with a hydroxyl, namely <b>94a</b>, was obtained by treatment of 2-pyridone <b>55</b> with the 6-Br core <b>4d</b>. Other 6-iodo compounds carrying N-substituted 2-pyridones <b>94b</b>−<b>c</b> were formed by reacting <b>4e</b> with <i>N</i>-substituted 2-pyridones <b>58</b> and <b>65</b>, respectively.</div><div class="NLM_p">Two cores <b>97</b> and <b>99</b>, carrying 6-<i>t</i>-butyl and 6-cyclopentyl substituents, respectively, were prepared, as depicted in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>. 2-Methyl-4-<i>t</i>-butylbenzoic acid <b>95</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was treated with lithium diisopropylamide at −78 °C, followed by the addition of dimethylcarbonate to yield the diacid <b>96</b>, which was then cyclized as described before<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> to yield the 6-<i>t</i>-butyl core <b>97</b>. The corresponding 6-cyclopentyl core <b>99</b> was formed by reaction of bis-TBS protected 6-bromoisoquonline-1,3-diol<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> with cyclopenyl magnesium bromide and tetrakis(triphenylphosphine)palladium under microwave conditions. Both <b>97</b> and <b>99</b> were then converted to the corresponding 4-methoxymethylene derivatives <b>4k</b> and <b>4l</b>, respectively, by treatment with trimethylorthoformate in acetic acid.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Further reaction of 6-<i>t</i>-butyl intermediate <b>4k</b> with 5-substituted 4-pyridinols <b>74b</b>, <b>81a</b>, and <b>81b</b> produced the final compounds <b>100c</b>, <b>100e</b>, and <b>100g</b>, respectively. Similary, the 6-cyclopentyl intermediate <b>4l</b> was reacted with 5-substituted 4-pyridinols <b>74b</b> and <b>81b</b> to generate the final compounds <b>100d</b> and <b>100h</b>, respectively. 4-Methoxymethylene-6-iodo intermediate <b>4e</b> was also used to couple with 5-substituted 4-pyridinols <b>74a</b>, <b>74b</b>, and <b>81b</b> to yield <b>100a</b>, <b>100b</b>, and <b>100f</b>, respectively.</div><figure id="sch9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0016.jpeg" id="gs9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) lithium diisopropylamide, (MeO)<sub>2</sub>CO, −78 °C; (ii) urea, 150 °C; (iii) HC(OMe)<sub>3</sub>, HOAc, 90 °C; (iv) cyclopentylMgBr, Pd(PPh<sub>3</sub>)<sub>4</sub>, ethyl ether, microwave, 75 °C; then THF, H<sub>2</sub>O, HCl, room temperature; (v) DMF, room temperature.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Activity, and Metabolic Stability</h3><div class="NLM_p">Our synthetic efforts on this series began with the discovery of <b>3f</b>, which carried a 4-(3,4-dihydroxyphenylethylamino)methylene headpiece and showed moderate CDK4 activity with an IC<sub>50</sub> value of 16.2 μM, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Further analogues were prepared by varying the chain length between the 3,4-dihydroxyphenyl ring and the aminomethylene moiety. When the 3,4-dihydroxyphenyl ring was directly linked to the aminomethylene moiety, as shown in <b>3a</b>, the CDK4 potency was not much improved (IC<sub>50</sub> = 7.8 μM). However, when the two groups were linked via a methylene bridge, the resulting compound <b>3b</b> showed a 10-fold enhancement in CDK4 potency. We then explored the importance of the two hydroxyl groups by preparing the two monohydroxyl isomers <b>3c</b> and <b>3d</b>. Compared to the 3,4-dihydroxy compound, <b>3b</b>, the 3-hydroxy derivative, <b>3d</b>, was equipotent and selective in inhibiting CDK4; however, the 4-hydroxy derivative, <b>3c</b>, was at least 64-fold less potent. These results clearly show that the 3-hydroxyl moiety is critical for CDK4 potency and selectivity. Markwalder et al.<a onclick="showRef(event, 'cit34a'); return false;" href="javascript:void(0);" class="ref cit34a">(34a)</a> and Rossi et al.<a onclick="showRef(event, 'cit34b'); return false;" href="javascript:void(0);" class="ref cit34b">(34b)</a> reported a similar requirement of <i>m</i>-OH moiety on the 6-arylmethyl group of pyrazolopyrimidinone, a different core from ours, for enhancing CDK4 potency; however, the improvement was not sufficient enough to render their compound selective for CDK4. Our modeling studies revealed a key hydrogen bond interaction between the 3-OH group and the side chain of His 82 of the CDK4 enzyme, which will be elaborated below. Analogues of <b>3d</b> were then prepared by introducing a variety of substituents at the C-4 position next to the 3-OH group. One of them, the 3-hydroxy-4-methoxy analogue <b>3e</b>, showed a 4-fold increase in potency over <b>3d</b>, with an IC<sub>50</sub> value of 0.19 uM in inhibiting CDK4, with 256- and 36-fold selectivity over CDK1 and CDK2, respectively.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition (IC<sub>50</sub>) of CDK4, CDK1, and CDK2 Activities</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0018.gif" alt="" id="gr11" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col width="13.857142857142858%" align="left" /></col><col width="14.428571428571429%" align="left" /></col><col width="14.285714285714285%" align="left" /></col><col width="14.428571428571429%" align="left" /></col><col width="14.285714285714285%" align="left" /></col><col width="14.428571428571429%" align="left" /></col><col width="14.285714285714285%" align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle">kinase assays IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle"><i>n</i></th><th align="center" valign="middle">R1</th><th align="center" valign="middle">R2</th><th align="center" valign="middle">CDK4</th><th align="center" valign="middle">CDK1</th><th align="center" valign="middle">CDK2</th></tr></thead><tbody><tr valign="top"><td align="left"><b>3a</b></td><td align="left">0</td><td align="left">OH</td><td align="left">OH</td><td align="left">7.8</td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>3b</b></td><td align="left">1</td><td align="left">OH</td><td align="left">OH</td><td align="left">1.2</td><td align="left">36.6</td><td align="left">12.5</td></tr><tr valign="top"><td align="left"><b>3c</b></td><td align="left">1</td><td align="left">H</td><td align="left">OH</td><td align="left"><50</td><td align="left">37.2</td><td align="left">17.3</td></tr><tr valign="top"><td align="left"><b>3d</b></td><td align="left">1</td><td align="left">OH</td><td align="left">H</td><td align="left">0.78</td><td align="left"><50</td><td align="left">16.9</td></tr><tr valign="top"><td align="left"><b>3e</b></td><td align="left">1</td><td align="left">OH</td><td align="left">OMe</td><td align="left">0.19</td><td align="left">48.7</td><td align="left">6.9</td></tr><tr valign="top"><td align="left"><b>3f</b></td><td align="left">2</td><td align="left">OH</td><td align="left">OH</td><td align="left">16.2</td><td align="left"> </td><td align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Concentration (μM) needed to inhibit the Rb phosphorylation by 50%, as determined from the dose−response curve. Determinations were done in duplicate, and repeat values agreed, on average, with a mean 2-fold difference.</p></div></div></div><div class="NLM_p">We then investigated substituent effects on the isoquinoline-1,3-dione core. Relative to <b>3e</b>, the corresponding 6-fluoro (<b>5a</b>) and 6-chloro (<b>5b</b>) derivatives showed comparable CDK4 inhibitory activity; however, the 6-bromo (<b>5d</b>) and 6-iodo (<b>5e</b>) derivatives exhibited enhanced potency in inhibiting CDK4 with IC<sub>50</sub> values of 30 nM and 10 nM, respectively, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. In addition, <b>5d</b> is over 1600-fold selective for CDK4 over CDK1 and CDK2. The position of the substituent on the core seems to be important for activity. Moving the bromo substituent from C-6 (<b>5d</b>) to C-5 (<b>5c</b>) resulted in a 30-fold loss of CDK4 inhibitory activity. Therefore, our synthetic efforts focused on C-6 substituted analogues. We found that the 6-phenyl derivative (<b>5j</b>) was as potent as the 6-iodo derivative (<b>5e</b>) in inhibiting CDK4 (IC<sub>50</sub> = 10 nM); however, the former was more selective than the latter over CDK1 (3400-fold vs 600-fold) and CDK2 (2600-fold vs 80-fold). Compared to <b>5j</b>, the corresponding 6-heteroaryl derivatives such as <i>N</i>-pyrrolyl (<b>5g</b>), 3-thienyl (<b>5h</b>), and 3-furyl (<b>5i</b>) were more potent CDK4 inhibitors with IC<sub>50</sub> values of 4, 2,and 2 nM, respectively. In particular, <b>5h</b> showed excellent selectivity for CDK4 over CDK1 and CDK2 by 11,000- and 9,000-fold, respectively.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition (IC<sub>50</sub>) of CDK4, CDK1, and CDK2 Activities</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0001.gif" alt="" id="gr12" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle">kinase assays IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R</th><th align="center" valign="middle">CDK4</th><th align="center" valign="middle">CDK1</th><th align="center" valign="middle">CDK2</th></tr></thead><tbody><tr valign="top"><td align="left"><b>3e</b></td><td align="left">H</td><td align="left">0.19</td><td align="left">48.7</td><td align="left">6.9</td></tr><tr valign="top"><td align="left"><b>5a</b></td><td align="left">6-F</td><td align="left">0.17</td><td align="left"><50</td><td align="left">6.6</td></tr><tr valign="top"><td align="left"><b>5b</b></td><td align="left">6-Cl</td><td align="left">0.23</td><td align="left"><50</td><td align="left"><50</td></tr><tr valign="top"><td align="left"><b>5c</b></td><td align="left">5-Br</td><td align="left">0.94</td><td align="left">8.1</td><td align="left">3.1</td></tr><tr valign="top"><td align="left"><b>5d</b></td><td align="left">6-Br</td><td align="left">0.03</td><td align="left"><50</td><td align="left"><50</td></tr><tr valign="top"><td align="left"><b>5e</b></td><td align="left">6-I</td><td align="left">0.01</td><td align="left">6</td><td align="left">0.87</td></tr><tr valign="top"><td align="left"><b>5f</b></td><td align="left">6-OMe</td><td align="left">0.031</td><td align="left">22.3</td><td align="left">2.9</td></tr><tr valign="top"><td align="left"><b>5g</b></td><td align="left">6-(<i>N</i>-pyrrolyl)</td><td align="left">0.004</td><td align="left">9.7</td><td align="left">3.1</td></tr><tr valign="top"><td align="left"><b>5h</b></td><td align="left">6-(3-thienyl)</td><td align="left">0.002</td><td align="left">23.3</td><td align="left">18.3</td></tr><tr valign="top"><td align="left"><b>5i</b></td><td align="left">6-(3-furyl)</td><td align="left">0.002</td><td align="left">2.5</td><td align="left">1.1</td></tr><tr valign="top"><td align="left"><b>5j</b></td><td align="left">6-phenyl</td><td align="left">0.01</td><td align="left">34.7</td><td align="left">25.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Concentration (μM) needed to inhibit the Rb phosphorylation by 50%, as determined from the dose−response curve. Determinations were done in duplicate, and repeat values agreed, on average, with a mean 2-fold difference.</p></div></div></div><div class="NLM_p">In the study of the 3-hydroxy-4-methoxybenzylamino group, shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, the α-methylbenzylamine derivative <b>11</b> was an order of magnitude less potent than <b>5d</b>, but the <i>N</i>-methylbenzylamine derivative <b>13</b> showed a dramatic loss of activity. The importance of the NH group of the benzylamine for CDK4 inhibitory activity was substantiated by our molecular modeling studies, wherein a hydrogen bond interaction between this NH and the backbone carbonyl of Val 83 was shown. A detailed discussion on the modeling will be presented later. Introduction of an additional methoxy group, as in <b>18</b>, resulted in a 4-fold increase in potency compared to <b>5d</b>. We then investigated the effect of varing the 4-methoxy substituent of <b>5d</b>. Compared to <b>5d</b>, the 4-ethoxy derivative <b>17d</b> was equi-potent, but the 4-<i>n</i>-propoxy derivative <b>17b</b> was about an order of magnitude less potent. However, the 4-methoxyethoxy derivative, <b>17c</b> was as active as <b>5d</b>. Interestingly, the 4-amino derivative <b>21</b> was 3-fold less potent than <b>5d</b>, but was much less selective versus CDK2, while selectivity over CDK1 was maintained.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition (IC<sub>50</sub>) of CDK4, CDK1, and CDK2 Activities</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0002.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle">kinase assays IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">X</th><th align="center" valign="middle">Y</th><th align="center" valign="middle">CDK4</th><th align="center" valign="middle">CDK1</th><th align="center" valign="middle">CDK2</th></tr></thead><tbody><tr valign="top"><td align="left"><b>5d</b></td><td align="left">H</td><td align="left">H</td><td align="left">0.03</td><td align="left"><50</td><td align="left"><50</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">H</td><td align="left">Me</td><td align="left">0.37</td><td align="left"><50</td><td align="left"><50</td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="left">Me</td><td align="left">H</td><td align="left"><50</td><td align="left"><50</td><td align="left">44.4</td></tr><tr valign="top"><td align="left"><b>17a</b></td><td align="left">OH</td><td align="left">OH</td><td align="left">0.04</td><td align="left"><50</td><td align="left"><50</td></tr><tr valign="top"><td align="left"><b>17b</b></td><td align="left">OH</td><td align="left">O-<i>n</i>-Pr</td><td align="left">0.35</td><td align="left">42.5</td><td align="left">34.5</td></tr><tr valign="top"><td align="left"><b>17c</b></td><td align="left">OH</td><td align="left">O-(CH<sub>2</sub>)<sub>2</sub>OMe</td><td align="left">0.04</td><td align="left"><50</td><td align="left"><50</td></tr><tr valign="top"><td align="left"><b>17d</b></td><td align="left">OH</td><td align="left">OEt</td><td align="left">0.03</td><td align="left"><50</td><td align="left">45.5</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="left"> </td><td align="left"> </td><td align="left">0.007</td><td align="left"><50</td><td align="left"><50</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="left">OH</td><td align="left">NH<sub>2</sub></td><td align="left">0.08</td><td align="left"><50</td><td align="left">6.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last"><sup></sup>Concentration (μM) needed to inhibit the Rb phosphorylation by 50%, as determined from the dose−response curve. Determinations were done in duplicate, and repeat values agreed, on average, with a mean 2-fold difference.</p></div></div></div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> shows the effect of varying the 4-methoxy substituent of <b>5e</b>. Compared to <b>5e</b>, the 4-methyl derivative <b>89a</b> was 3-fold less potent, whereas the 4-phenyl, 4-(2-furyl), and 4-(3-furyl) derivatives (<b>89b</b>, <b>89c</b>, and <b>89d</b>, respectively) were about 10-fold less potent. However, they all showed comparable selectivity for CDK4 over CDK1 and CDK2. One compound, <b>89d</b>, was further evaluated for its ability to inhibit a panel of protein kinases, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. It is clear that <b>89d</b> was highly potent in inhibiting CDK4 among the serine−threonine kinases and tyrosine kinases tested. The CDK4 inhibitory activity for the three C-4 pyridyl isomers varied depending upon the position of the pyridyl nitrogen. Although the 4-(2-pyridyl) derivative <b>89e</b> was a poor CDK4 inhibitor, the 4-(3-pyridyl) and 4-(4-pyridyl) derivatives <b>89f</b> and <b>89g</b> were as potent as <b>5e</b>. Among these three C-4 pyridyl isomers, the pyridyl nitrogen atom from <b>89e</b> could potentially form a hydrogen bond interaction with the phenolic OH group, thereby interfering with this critical OH group interaction with His 82 of the CDK4 enzyme for activity. In terms of selectivity, both <b>89f</b> and <b>89g</b> showed higher selectivity for CDK4 over CDK1 and CDK2, relative to <b>5e</b>. Analogues <b>89f</b> demonstrated better cellular activity than <b>89g</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition (IC<sub>50</sub>) of CDK4, CDK1, and CDK2 Activities and Cell Proliferation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0003.gif" alt="" id="gr14" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle">kinase assays IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></th><th colspan="2" align="center" valign="middle">cell-based assays IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">X</th><th align="center" valign="middle">Y</th><th align="center" valign="middle">Z</th><th align="center" valign="middle">R</th><th align="center" valign="middle">CDK4</th><th align="center" valign="middle">CDK1</th><th align="center" valign="middle">CDK2</th><th align="center" valign="middle">HCT116</th><th align="center" valign="middle">MCF-7</th></tr></thead><tbody><tr valign="top"><td align="left"><b>5e</b></td><td align="left">I</td><td align="left">CH</td><td align="left">CH</td><td align="left">OMe</td><td align="left">0.01</td><td align="left">6.00</td><td align="left">0.87</td><td align="left">2.00</td><td align="left">3.70</td></tr><tr valign="top"><td align="left"><b>89a</b></td><td align="left">I</td><td align="left">CH</td><td align="left">CH</td><td align="left">Me</td><td align="left">0.03</td><td align="left">>50</td><td align="left">13.6</td><td align="left">6.70</td><td align="left">8.20</td></tr><tr valign="top"><td align="left"><b>89b</b></td><td align="left">I</td><td align="left">CH</td><td align="left">CH</td><td align="left">Ph</td><td align="left">0.13</td><td align="left">47.8</td><td align="left">15.1</td><td align="left">0.42</td><td align="left">0.88</td></tr><tr valign="top"><td align="left"><b>89c</b></td><td align="left">I</td><td align="left">CH</td><td align="left">CH</td><td align="left">2-furyl</td><td align="left">0.10</td><td align="left">>50</td><td align="left">8.40</td><td align="left">0.38</td><td align="left">0.70</td></tr><tr valign="top"><td align="left"><b>89d</b></td><td align="left">I</td><td align="left">CH</td><td align="left">CH</td><td align="left">3-furyl</td><td align="left">0.06</td><td align="left">24.4</td><td align="left">4.70</td><td align="left">0.48</td><td align="left">1.13</td></tr><tr valign="top"><td align="left"><b>89e</b></td><td align="left">I</td><td align="left">CH</td><td align="left">CH</td><td align="left">2-pyridyl</td><td align="left">19.30</td><td align="left">>50</td><td align="left">>50</td><td align="left">0.25</td><td align="left">0.54</td></tr><tr valign="top"><td align="left"><b>89f</b></td><td align="left">I</td><td align="left">CH</td><td align="left">CH</td><td align="left">3-pyridyl</td><td align="left">0.01</td><td align="left">>50</td><td align="left">3.60</td><td align="left">0.44</td><td align="left">1.10</td></tr><tr valign="top"><td align="left"><b>89g</b></td><td align="left">I</td><td align="left">CH</td><td align="left">CH</td><td align="left">4-pyridyl</td><td align="left">0.008</td><td align="left">>50</td><td align="left">>50</td><td align="left">2.30</td><td align="left">1.50</td></tr><tr valign="top"><td align="left"><b>89h</b></td><td align="left">I</td><td align="left">CH</td><td align="left">CH</td><td align="left">O-<i>n</i>-Pr</td><td align="left">0.02</td><td align="left">>50</td><td align="left">2.6</td><td align="left">0.65</td><td align="left">1.8</td></tr><tr valign="top"><td align="left"><b>90</b></td><td align="left">I</td><td align="left">N</td><td align="left">N</td><td align="left">OMe</td><td align="left">0.44</td><td align="left">>50</td><td align="left">>50</td><td align="left">>50</td><td align="left">>50</td></tr><tr valign="top"><td align="left"><b>92</b></td><td align="left">I</td><td align="left">CH</td><td align="left">N</td><td align="left">O-<i>n</i>-Pr</td><td align="left">0.02</td><td align="left">10.1</td><td align="left">0.70</td><td align="left">0.67</td><td align="left">1.40</td></tr><tr valign="top"><td align="left"><b>100a</b></td><td align="left">I</td><td align="left">N</td><td align="left">CH</td><td align="left">OMe</td><td align="left">0.01</td><td align="left">14.7</td><td align="left">0.50</td><td align="left">1.30</td><td align="left">1.00</td></tr><tr valign="top"><td align="left"><b>100b</b></td><td align="left">I</td><td align="left">N</td><td align="left">CH</td><td align="left">O-<i>n</i>-Pr</td><td align="left">0.03</td><td align="left">25.3</td><td align="left">1.60</td><td align="left">0.73</td><td align="left">0.88</td></tr><tr valign="top"><td align="left"><b>100c</b></td><td align="left"><i>t</i>-Bu</td><td align="left">N</td><td align="left">CH</td><td align="left">O-<i>n</i>-Pr</td><td align="left">0.02</td><td align="left">6.20</td><td align="left">0.96</td><td align="left">0.43</td><td align="left">0.70</td></tr><tr valign="top"><td align="left"><b>100d</b></td><td align="left">cyclopentyl</td><td align="left">N</td><td align="left">CH</td><td align="left">O-<i>n</i>-Pr</td><td align="left"><0.005</td><td align="left">3.10</td><td align="left">1.20</td><td align="left">0.15</td><td align="left">0.30</td></tr><tr valign="top"><td align="left"><b>100e</b></td><td align="left"><i>t</i>-Bu</td><td align="left">N</td><td align="left">CH</td><td align="left">Ph</td><td align="left">0.03</td><td align="left">16.3</td><td align="left">2.60</td><td align="left">0.15</td><td align="left">0.70</td></tr><tr valign="top"><td align="left"><b>100f</b></td><td align="left">I</td><td align="left">N</td><td align="left">CH</td><td align="left">3-furyl</td><td align="left">0.03</td><td align="left">13.5</td><td align="left">2.30</td><td align="left">0.55</td><td align="left">2.70</td></tr><tr valign="top"><td align="left"><b>100g</b></td><td align="left"><i>t</i>-Bu</td><td align="left">N</td><td align="left">CH</td><td align="left">3-furyl</td><td align="left">0.02</td><td align="left">9.50</td><td align="left">1.90</td><td align="left">0.48</td><td align="left">1.40</td></tr><tr valign="top"><td align="left"><b>100h</b></td><td align="left">cyclpentyl</td><td align="left">N</td><td align="left">CH</td><td align="left">3-furyl</td><td align="left"><0.005</td><td align="left">3.10</td><td align="left">1.30</td><td align="left">0.81</td><td align="left">0.83</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Concentration (μM) needed to inhibit the Rb phosphorylation by 50%, as determined from the dose−response curve. Determinations were done in duplicate, and repeat values agreed, on average, with a mean 2-fold difference.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Dose−response curves were determined at five concentrations. The IC<sub>50</sub> (μM) values are the concentrations needed to inhibit cell growth by 50%, as determined from these curves.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Activity of <b>89d</b> against a Panel of Protein Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">kinase</th><th align="center" valign="middle">IC<sub>50</sub> (μM)</th><th align="center" valign="middle">kinase</th><th align="center" valign="middle">IC<sub>50</sub> (μM)</th><th align="center" valign="middle">kinase</th><th align="center" valign="middle">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left">CDK4</td><td align="left">0.06</td><td align="left">CDK1</td><td align="left">24.4</td><td align="left">CDK2</td><td align="left">4.7</td></tr><tr valign="top"><td align="left">AKT</td><td align="left">10.2</td><td align="left">Braf</td><td align="left">>10</td><td align="left">EGFR</td><td align="left">>10</td></tr><tr valign="top"><td align="left">IGFR</td><td align="left">>10</td><td align="left">IKK-2</td><td align="left">>10</td><td align="left">IR</td><td align="left">>10</td></tr><tr valign="top"><td align="left">KDR</td><td align="left">10</td><td align="left">LCK</td><td align="left">>30</td><td align="left">LYN</td><td align="left">8.5</td></tr><tr valign="top"><td align="left">MK2</td><td align="left">19</td><td align="left">mTOR</td><td align="left">18</td><td align="left">p70S6</td><td align="left">>30</td></tr><tr valign="top"><td align="left">PDK1</td><td align="left">17</td><td align="left">PKCθ</td><td align="left">25.9</td><td align="left">Src</td><td align="left">>30</td></tr><tr valign="top"><td align="left">Tpl2</td><td align="left">>4</td><td align="left">STAT3</td><td align="left">1.7</td><td align="left"> </td><td align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">Through our optimization efforts, we have synthesized selective CDK4 inhibitors with potencies as low as 2 nM. However, all of these inhibitors bear a phenolic OH group, a critical group for activity, but also a metabolic liability for the effectiveness of these inhibitors in vivo. It is well-known that phenolic OH groups<a onclick="showRef(event, 'cit34c'); return false;" href="javascript:void(0);" class="ref cit34c">(34c)</a> are prone to glucuronidation in the endoplasmic reticulum and sulfation in the liver via phase II metabolism, leading to rapid excretion from the body. The rate of glucuronidation is dependent on the lipophilicity and the nucleophilicity of the phenols.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> As the lipophilicity of phenols increases, the rate of glucuronidation increases. Electron-donating substituents (higher p<i>K</i><sub>a</sub>) facilitate the conversion of phenols to the corresponding glucuronides. As expected, 3-hydroxybenzylamine derivatives bearing 4-OMe, 4-(3-furyl), and 4-(O-<i>n</i>-Pr) substituents, namely, <b>5e</b>, <b>89d</b>. and <b>89h</b>, respectively, suffered reduced stability in phase II metabolism using rat microsomes, as depicted in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rat Microsomal Stability Studies</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0004.gif" alt="" id="gr15" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle"><i>t</i><sub>1/2</sub> (min)</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">X</th><th align="center" valign="middle">Y</th><th align="center" valign="middle">R</th><th align="center" valign="middle"><a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a>phase I</th><th align="center" valign="middle"><a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a>phaseI/II</th></tr></thead><tbody><tr valign="top"><td align="left"><b>5e</b></td><td align="left">CH</td><td align="left">CH</td><td align="left">OMe</td><td align="left">18</td><td align="left">6</td></tr><tr valign="top"><td align="left"><b>89d</b></td><td align="left">CH</td><td align="left">CH</td><td align="left">3-furyl</td><td align="left">>30</td><td align="left">18</td></tr><tr valign="top"><td align="left"><b>89h</b></td><td align="left">CH</td><td align="left">CH</td><td align="left">O-<i>n</i>-Pr</td><td align="left">>30</td><td align="left">15</td></tr><tr valign="top"><td align="left"><b>92</b></td><td align="left">CH</td><td align="left">N</td><td align="left">O-<i>n</i>-Pr</td><td align="left">>30</td><td align="left">>30</td></tr><tr valign="top"><td align="left"><b>100a</b></td><td align="left">N</td><td align="left">CH</td><td align="left">OMe</td><td align="left">>30</td><td align="left">>30</td></tr><tr valign="top"><td align="left"><b>100b</b></td><td align="left">N</td><td align="left">CH</td><td align="left">O-<i>n</i>-Pr</td><td align="left">>30</td><td align="left">>30</td></tr><tr valign="top"><td align="left"><b>100f</b></td><td align="left">N</td><td align="left">CH</td><td align="left">3-furyl</td><td align="left">>30</td><td align="left">22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Substrate half-life (min) when incubated at 37 °C for 15 min with SD rat liver microsomes (0.5 mg/mL protein) and NADPH cofactor.</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">Substrate half-life (min) when incubated at 37 °C for 15 min with SD rat liver microsomes (0.5 mg/mL protein), NADPH, and UDPGA cofactors.</p></div></div></div><div class="NLM_p">To address the phase II metabolism issue associated with the phenolic OH, we introduced one or two nitrogen atoms in the phenyl ring of the benzylamine headpiece in <b>5e</b>, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. We expect that electronic effects of the nitrogen in the dihydroxypyrimidine (<b>90</b>), 6-pyridinol (<b>92</b>), and 4-pyridinols (<b>100a</b>−<b>h</b>) would decrease the nucleophilicity of the phenols, thereby decreasing the nucleophilic attack on C-1 of the uridine diphosphate glucuronic acid to generate glucuronidate metabolites. Furthermore, the 4-pyridinols and 6-pyridinols are expected to be in equilibrium with the corresponding 4-pyridones and 6-pyridones,<a onclick="showRef(event, 'cit37a cit37b'); return false;" href="javascript:void(0);" class="ref cit37a cit37b">(37a, 37b)</a> which are devoid of the OH group, therefore reducing the extent of phase II metabolism. The keto−enol tautomeric equilibrium strongly depends on the substituent, on its ring position, and on the solvent dielectric constant.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> However, in all cases, the solvent dielectric effect tends to increase the preponderance of the keto structure. In the physiological environment where water has a high dielectric constant, the equilibrium is expected to shift more toward the keto tautomeric form, leading to metabolically more stable molecules. We were pleased to see that the 5-(3-furyl)-4-pyridinol derivative <b>100f</b> showed improved phase II metabolic stability and that the 5-(O-<i>n</i>-Pr)-6-pyridinol derivative <b>92</b>, 5-OMe-4-pyridinol derivative <b>100a</b>, and 5-(O-<i>n</i>-Pr)-4-pyridinol derivative <b>100b</b> showed good stability with <i>t</i><sub>1/2</sub> values greater than 30 min (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_p">These metabolically more stable pyridinol derivatives are also potent CDK4 inhibitors. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the 4-pyridinol derivative <b>100a</b> was equipotent with <b>5e</b>, whereas the corresponding 4-pyrimidinol derivative <b>90</b> was 44-fold less active in inhibiting the CDK4 enzyme. Varying the C-5 substituent at the 4-pyridinol headpiece of <b>100a</b> from methoxy to <i>n</i>-propoxy in <b>100b</b> and 3-furyl in <b>100f</b> resulted in a 3−4-fold decrease in potency, but a 2-fold increase in cellular activities. Comparing the two pyridine isomers, the 6-pyridinol derivative <b>92</b> was as active and selective as the corresponding 4-pyridinol derivative <b>100b</b>, with comparable cellular activities. Additional substitution effects at the C-6 of the isoquinoline-1,3-dione core were evaluated. The 6-<i>t</i>-butyl derivatives (<b>100c</b> and <b>100g</b>) were equipotent with the corresponding 6-iodo derivatives (<b>100b</b> and <b>100f</b>), whereas the corresponding 6-cyclopentyl derivatives (<b>100d</b> and <b>100h</b>) showed at least 6-fold increase in CDK4 inhibitory activity, with IC<sub>50</sub> values below 5 nM. Furthermore, <b>100d</b> and <b>100h</b> showed good selectivity for CDK4 over CDK1 and CDK2, by more than 620-fold and 240-fold, respectively. Although both <b>100d</b> and <b>100h</b> showed equivalent potency against CDK4 and selectivity vs CDK1 and CDK2, <b>100d</b> was more active than <b>100h</b> in inhibiting HCT116 and MCF7 cells, with IC<sub>50</sub> values of 0.15 μM and 0.3 μM, respectively. Among a pair of 6-iodo and 6-<i>t</i>-butyl derivatives (<b>100b</b> and <b>100c</b>, respectively) where the headpiece is 5-propoxy-4-pyridinol, both showed comparable CDK4 potency (IC<sub>50</sub> values of 20−30 nM) and selectivity, similar to the pairs of the corresponding 5-(3-furyl)-4-pyridinols (<b>100f</b> and <b>100g</b>). The three 6-<i>t</i>-butyl derivatives <b>100c</b>, <b>100e</b>, and <b>100g</b>, were equipotent against CDK4; however, <b>100e</b> was the most active one in inhibiting cells.</div><div class="NLM_p">Additional derivatives were prepared where the 3-OH group in the headpiece of the isoquinoline-1,3-dione was replaced with a methoxy or a carbonyl group. On the basis of the importance of the 3-OH group on the headpiece for activity, we expected <b>91</b> would be a poor CDK4 inhibitor (IC<sub>50</sub> value of 31.7 uM) as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> since the 3-OH was replaced with a 3-OMe group. However, the 4-pyrone derivative <b>93</b> also lacks an OH group; to our surprise, its ability to inhibit CDK4 was 30-fold better than that of <b>91</b>. We were also intrigued to observe that N-substituted 2-pyridones <b>94b</b>−<b>c</b>, bearing no OH substituent, showed reasonably good potency in inhibiting CDK4. In fact, comparable potency was observed for the pair of <i>N</i>-phenyl-2-pyridone derivative <b>94b</b> and 4-phenyl-3-hydroxyphenyl derivatives <b>89b</b>, as well as for the pair of <i>N</i>-(3-furyl)-2-pyridone derivative <b>94c</b> and 4-(3-furyl)-3-hydroxyphenyl derivatives <b>89d</b>. This unexpected result seems to contradict what we observed earlier, i.e., that a 3-OH group on the headpiece is essential for activity. However, this puzzle was unraveled by our molecular modeling, as described below in the subsequent discussions.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Inhibition (IC<sub>50</sub>) of CDK4, CDK1, and CDK2 Activities</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0005.gif" alt="" id="gr16" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle">kinase assays IC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">X</th><th align="center" valign="middle">Y</th><th align="center" valign="middle">CDK4</th><th align="center" valign="middle">CDK1</th><th align="center" valign="middle">CDK2</th></tr></thead><tbody><tr valign="top"><td align="left"><b>89b</b></td><td align="left">I</td><td align="left">Ph</td><td align="left">0.13</td><td align="left">47.8</td><td align="left">15.1</td></tr><tr valign="top"><td align="left"><b>89d</b></td><td align="left">I</td><td align="left">3-furyl</td><td align="left">0.06</td><td align="left">24.4</td><td align="left">4.7</td></tr><tr valign="top"><td align="left"><b>91</b></td><td align="left">Br</td><td align="left"> </td><td align="left">31.7</td><td align="left">>50</td><td align="left">6.1</td></tr><tr valign="top"><td align="left"><b>93</b></td><td align="left">Br</td><td align="left">OMe</td><td align="left">1.3</td><td align="left">>50</td><td align="left">16.9</td></tr><tr valign="top"><td align="left"><b>94a</b></td><td align="left">Br</td><td align="left">H</td><td align="left">0.56</td><td align="left">>5050</td><td align="left">2.7</td></tr><tr valign="top"><td align="left"><b>94b</b></td><td align="left">I</td><td align="left">Ph</td><td align="left">0.27</td><td align="left">29.6</td><td align="left">41.5</td></tr><tr valign="top"><td align="left"><b>94c</b></td><td align="left">I</td><td align="left">3-furyl</td><td align="left">0.06</td><td align="left">11.6</td><td align="left">2.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">Concentration (μM) needed to inhibit the Rb phosphorylation by 50%, as determined from the dose−response curve. Determinations were done in duplicate, and repeat values agreed, on average, with a mean 2-fold difference.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Molecular Modeling</h3><div class="NLM_p">A binding model for compound <b>5e</b> at the ATP binding site is presented in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. The protein coordinates used in this study are those reported in the X-ray crystal structure of the catalytic domain of CDK2, with three residues of the binding site mutated to mimic CDK4.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The CDK4 mimic structure of Ikuta et al. includes three mutations, at residues F82H, L83V, and K89T. The amino acid numbering of the CDK4 mimic structure will therefore be that of CDK2, which is the parent structure. The inhibitor was docked using the GLIDE docking algorithm in the XP (extra precision) mode.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The resulting model successfully identifies key hydrogen bond interactions between the ligands and residues of the protein’s ATP binding pocket. The binding model accounts for the nanomolar activity as well as the selectivity of the isoquinoline-1,3-dione inhibitor, in that significant and strong interactions with residues unique to CDK4 have been identified. The specific orientation of the ligand in the binding model exploits the range of residues unique to CDK4, namely, 82 and 83. In the most favored bound conformation, the NH of the isoquinoline-1,3-dione core is found to be 2.6 Å from the backbone carbonyl oxygen of Glu 81. The binding model places a carbonyl oxygen of the isoquinoline-1,3-dione core at 2.1 Å from the backbone NH of Val 83, a position in the binding cavity where the L83V mutation differentiates CDK4 from CDK2. Additionally, the amino NH of the benzylamino headpiece is found within 2.5 Å from the backbone carbonyl oxygen of Val 83. As the sequence of amino acids confers specific spatial features to the protein cavity, we postulate that the close proximity of these interactions lends support to the selectivity of the isoquinoline-1,3-dione core for the CDK4 binding pocket. A second carbonyl oxygen of the isoquinoline-1,3-dione core is found within 4.2−4.8 Å of the center of the phenyl ring of Phe 80, the gatekeeper residue. Short molecular dynamics runs resulted in the placement of this carbonyl oxygen within 3.5−4.0 Å of various aromatic hydrogens of the Phe 80 side chain. It is postulated here that interactions between at least two of the aromatic hydrogens of the phenyl ring and the carbonyl oxygen of the isoquinoline-1,3-dione core play a significant role in supporting inhibitor binding. These interactions of the core with Phe 80, Glu 81, and Val 83 of the CDK4 protein in the binding model are quite similar to the ones we observed in our previous series, the 4-(phenylaminomethylene)isoquinoline-1,3-diones.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, in the headpiece, the binding interactions of the current series are different from those observed for our previous series. In the binding model of our previous series, the basic nitrogen atom of the headpiece was expected to interact with the flexible side chains of Asp 84 and His 82, two CDK4-unique amino acid residues, in the solvent exposed regions. In contrast, the current series bears a 3-hydroxyl substituent in the benzylamino headpiece. In the current binding model, this 3-hydroxyl group forms an H-bond with the imidazole nitrogen of the His 82 side chain, with an interaction distance of within 2.5 Å. This key interaction is not attainable by a 4-hydroxyl compound <b>3c</b>, a poor inhibitor for CDK4, compared to the corresponding 3-hydroxyl compound <b>3d</b>. Furthermore, placement of an electron donating substituent such as methoxy (e.g., compound <b>3e</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and compound <b>5e</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) is found to enhance this interaction.</div><figure id="fig1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0006.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed binding model for <b>5e</b> in the ATP binding site of the CDK4 mimic model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In summary, our binding model identifies three key interactions with the backbone groups of hinge region residues as well as favorable, albeit supportive, electrostatic interactions with at least two of the aromatic hydrogens of the side chain of Phe 80, the gatekeeper residue. It is noted here that two of these three hydrogen bonds involve the backbone groups of Val 83, a residue unique to CDK4. Additionally, the hydrogen bond interaction between the 3-hydroxyl group on <b>5e</b> and the side chain of a CDK4-unique residue, His 82, contributes to and strengthens the cooperative hydrogen bond network between <b>5e</b> and CDK4 enzyme. Like <b>5e</b>, compound <b>5d</b> is a potent and selective CDK4 inhibitor. Addition of a methyl group at the α position of the benzylamino headpiece in <b>5d</b> would perturb the overall binding to CDK4, and the resulting compound <b>11</b> showed a 10-fold loss of CDK4 potency, though it is still selective for CDK4. However, when the NH of the benzylamino headpiece in <b>5d</b> is methylated, the resulting compound <b>13</b> can no longer interact with the backbone carbonyl oxygen of Val 83. This led to such a disruption of the cooperative hydrogen bond network with CDK4 that <b>13</b> showed a dramatic loss of potency and selectivity for CDK4. Thus, having the 3-hydroxyl group is crucial but not sufficient for CDK4 potency and selectivity, both of which also depend on the optimal and unique orientation of these inhibitors in the CDK4 binding pocket, resulting in the formation of a strong and cooperative hydrogen bond network. In comparison, modeling studies of pyrazolopyrimidinone<a onclick="showRef(event, 'cit34a cit34b'); return false;" href="javascript:void(0);" class="ref cit34a cit34b">(34a, 34b)</a> identify a hydrogen bond interaction between the meta-hydroxyl moiety of the 6-arylmethyl group and the side chain of His 82 of CDK4, in addition to interactions of the core with Val 83, a total of two hydrogen bond interactions with the backbone moieties of the hinge region of CDK4. Although improved potency for CDK4 was realized in these studies, no selectivity for CDK4 was achieved. The lack of CDK4 selectivity of the pyrazolopyrimidinone series may lie in the fact that its core is different from ours; therefore, the two series are expected to be oriented differently in the ATP-binding site of the CDK4 enzyme. In comparison to compound <b>5e</b>, the pyridone derivatives <b>94b</b>,<b>c</b> lack the critical 3-hydroxyl group. However, the pyridone moiety of <b>94b</b>,<b>c</b> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>) places the carbonyl oxygen within 3.5 Å of the flexible side chain of His 82 in the solvent exposed region. It is expected that the flexibility and the solvent exposed nature of this interaction could bring the carbonyl oxygen of pyridones closer to the NH of His 82 side chain and possibly a water-mediated interaction. There are precedents that showed H-bond interaction of NH of imidazole or His side chain with carbonyl oxygen.<a onclick="showRef(event, 'cit40a cit40b'); return false;" href="javascript:void(0);" class="ref cit40a cit40b">(40a, 40b)</a> This favorable interaction may explain why the pyridones <b>94b</b>,<b>c</b> are as potent as the corresponding phenols <b>89b</b>,<b>d</b> in inhibiting CDK4. However, the His 82 side chain may be partially protonated. The extent of the protonation depends on the p<i>K</i><sub>a</sub> of the histidine side chain, which varies according to the environment surrounding the His residue.<a onclick="showRef(event, 'cit40c'); return false;" href="javascript:void(0);" class="ref cit40c">(40c)</a> It is possible that the protonated nitrogen of imidazole could form an H-bond interaction with the carbonyl oxygen of the pyridones. But the nature of the interaction can be fully understood when X-ray crystal structure of CDK4 is available to enable cocrystal structures with our pyridone derivatives.</div><div class="NLM_p">Other researchers such as McInnes,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Honma,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and Aubry<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> carried out computational studies using a crystal structure of inhibitor bound CDK2 and a homology model of CDK4, which was built using both CDK2 and CDK6 as templates. As such, the amino acid numbering of these homology models differs from those of the CDK4 mimic models used by our group, Ikuta<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and Pratt,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> by a value of 13 for the residues of the ATP binding site. Docking studies with CDK4 selective compounds were then used to elucidate binding features of the CDK4 selective compounds in the ATP binding pockets of both the CDK2 crystal structure and the CDK4 homology model. A key finding of their study is the presence of a positively charged moiety, proximal to the Asp and Glu residues that correspond to residues numbered 86 and 131, respectively, in the CDK2 structure used in our study (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Although the 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-dione analogues of our study are not found to interact with Asp 86 (not shown) and are a little more than 4.0 Å distance from the Glu 131 side chain, our binding models place the phenol moiety of our inhibitors within 2.5 Å of the His 82 side chain, a residue unique to CDK4. The CDK4 mimic structure of Ikuta et al.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> used in this study contains a Gln residue at position 131. The corresponding residue in CDK4 is Glu. Again, it should be noted that, in a previous study,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> an in silico mutation of Gln 131 to Glu 131 with subsequent short molecular dynamics runs was carried out. Our binding models place the 6-iodo substituent of compound <b>5e</b> in close proximity to the Gln 131 residue. Specifically, Glu 131 is in a region of the binding pocket, where protein flexibility and the presence of solvent molecules are expected to be significant. Park et al.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> have shown that protein flexibility is crucial to inhibitor binding and that CDK4 undergoes significant conformational changes resulting from solvent and inhibitor interactions. We postulate that detailed molecular dynamics studies with the residue at position 131 mutated to Glu will identify the key role that Glu 131 plays in stabilizing the binding of protein to 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-dione and further enhance our understanding of the SAR of substituents at position 6 of the isoquinoline-1,3-dione core (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p last">The K89T mutation, which places a threonine at the entrance to the ATP binding cleft of CDK4, is singled out as a significant source of CDK2/CDK4 selectivity by several investigators.<a onclick="showRef(event, 'ref20 ref44'); return false;" href="javascript:void(0);" class="ref ref20 ref44">(20, 44)</a> Our binding studies, however, do not indicate any involvement of the threonine residue in ligand binding. Pratt et al.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> have pointed to the K89T mutation as being the primary source of CDK4 selectivity for the bisanilino pyrimidine analogues. We point to intrinsic differences in the shapes of the 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-dione analogues, which result in optimal orientations in the CDK4 binding cavity, that do not involve the threonine residue in question. Therefore, the 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-dione inhibitors of our study represent a class of molecules that form interactions with several CDK4 specific amino acids that are described in earlier literature as well as the side chain of His 82, a nonconserved amino acid residue proximal to the hinge region of the CDK4 catalytic domain. We believe that the protein−ligand interactions detailed in our binding models characterize the selectivity and potency of the isoquinoline-1,3-dione analogues of this study.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Inhibition of pRb Phosphorylation</h3><div class="NLM_p">The biological activity of <b>89d</b>, <b>94c</b>, and <b>100c</b> was evaluated in MCF-7 cells, which overexpress cyclin D1 due to gene amplification. We examined the phosphorylation state of pRb, the physiological substrate for CDK4/cyclin D complexes, after overnight incubation with <b>89d</b>, <b>94c</b>, or <b>100c</b>. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, treatment of MCF-7 cells with each of these compounds resulted in a reduction of phosphorylation of pRb, as indicated by the decrease of the band corresponding to ppRb in polyacrylamide-SDS gels (upper panel). The inhibition was dose-dependent and could be detected at the lowest concentration tested (0.15 μM). The resulting IC<sub>50</sub> values are in agreement with those obtained in the cellular proliferation assays. Clearly, the biological activities of these compounds are consistent with the expected effects of CDK4 inhibition.</div><figure id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0007.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of <b>89d</b>, <b>94c</b>, and <b>100c</b> on pRb phosphorylation in MCF-7 cells. MCF-7 cells were incubated in the presence of <b>89d</b>, <b>94c</b>, or <b>100c</b> at the indicated concentrations at 37 °C for 24 h. Protein extracts were analyzed by SDS−PAGE, followed by immunoblotting using either phospho-Rb antibody to probe ppRb (Ser 807/811, upper panel) or Rb antibody to probe the total pRb (lower panel). Equivalent protein loading of lanes was confirmed by Ponceau S staining. Blots were scanned and quantified using the FluorS multi-image analyzer (BioRad). The results were normalized to the amount of total pRb, and the IC<sub>50</sub> values for ppRb were determined from inhibition plots (Kaleidagraph). The cellular IC<sub>50</sub> values were determined from inhibition curves (LSW Toolbox) using data points from the SRB cell proliferation assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We report here the discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2<i>H</i>,4<i>H</i>)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4). Compared to our earlier series<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> where the headpiece is a substituted aniline, this new series carries substituted 3-hydroxybenzylamino or (hydroxypyridyl)methylamino headpieces and exhibits enhanced potency for CDK4 and higher activity in inhibiting cell proliferation. Furthermore, compounds bearing the (hydroxypyridyl)methylamino headpieces show good phase II metabolic stability. The inhibitory activity is enhanced when an iodo, aryl, heteroaryl, <i>t</i>-butyl, or cyclopentyl substituent is introduced at the C-6 position of the isoquinoline-1,3-dione core. We also present a proposed binding model for <b>5e</b> at the ATP binding site of a CDK4 mimic structure that contains three mutations at residues F82H, L83V, and K89T. This binding model shows a hydrogen bond interaction between the 3-hydroxyl group on <b>5e</b> and a CDK4-unique His 82 as well as interactions between the core and Phe 80, Glu 81, and Val 83, a residue unique to CDK4. The crucial interaction of the 3-hydroxyl group with CDK4 contributes to and strengthens the cooperative hydrogen bond network with CDK4, thus providing the potency and selectivity of this series of compounds for CDK4 over CDK2 and CDK1. In cells, selected compounds, <b>89d</b>, <b>94c</b>, and <b>100c</b>, from this series have demonstrated biological activity: they inhibit phosphorylation of pRb, the physiological substrate for CDK4/cyclin D1 at the IC<sub>50</sub> values consistent with their respective IC<sub>50</sub> values for inhibition of cell proliferation.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Chemistry</h3><div class="NLM_p last"><sup>1</sup>H NMR spectra were determined with a Bruker DRX400 spectrometer at 400 MHZ or a NT-300 WB spectrometer at 300 MHz. Chemical shifts (δ) are expressed in parts per million relative to the internal standard tetramethylsilane. Electrospray mass spectra were recorded in positive mode on a Micromass Platform spectrometer. Electron impact (EI) and high-resolution mass spectra (HRMS) were obtained on a Finnigan MAT-90 spectrometer. Some high-resolution electrospray mass spectra with higher precision were obtained on a Brucker 9.4T FTMS spectrometer. Chromatographic purifications were by flash chromatography using Baker 40 μm silica gel. Melting points were determined in open capillary tubes on a Meltemp melting point apparatus and are uncorrected. Semipreparative reverse-phase high-pressure liquid chromtography (RP-HPLC) was performed using a Gilson Preparatory HPLC. The sample was dissolved in DMSO, applied on a Phenomenex C18 Luna column (21.2 mm × 60 mm, 5 μm), and eluted at 22.5 mL/min with a 19 min of gradient, 5% B; 2.5 min, 5% B; 18 min, 95% B; 19 min, 95% B, where solvent A = water (0.02% TFA buffer), and solvent B = acetonitrile (0.02% TFA buffer). Analytical high-pressure liquid chromatograpy (HPLC) and LC-MS analyses were conducted using the following two instruments and conditions. LCMS1: Analytical HPLC was conducted on an HP 1100 liquid chromatography system over a 2.1 mm × 30 mm xterra C18 Luna column (5 μm) at 50 °C using multiple wavelength UV detection (typically 215, 254 nm) and MS detection (API-ES scanning mode positive/negative 100−1000; fragmentor, positive 140 mV; negative, 170 mV). A gradient elution of increasing concentrations of acetonitrile in water containing 0.02% formic acid (10−90% over 3.5 min and was held at 90% for an additional 1.5 min) and a flow rate of 1 mL/min were employed. LCMS2: Analytical HPLC was conducted on an Agilent LC-1100-MSD liquid chromatography system over a 50 × 2.1 mm Aquasil C18 column (Thermo Electron Corporation, 5 μm) using multiple wavelenth UV detection (typically 215, 254 nm) and MS detection (single quadrupole mass filter scanning from 100−1000 Da). A gradient elution of increasing concentrations of acetonitrile in water containing 0.1% formic acid (0−100% over 2.5 min and was held at 100% for additional 1.5 min) and a flow rate of 1 mL/min were employed.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Molecular Modeling</h3><div class="NLM_p last">The inhibitor structures were minimized using the MMFF94 force field of SYBYL.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> A public domain structure of CDK4<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> was used as the 3-D representation for molecular docking studies. The inhibitor structures were docked using the GLIDE<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> docking algorithm in the XP (extra precision) mode. Details of the algorithm are found in GLIDE documentation. Briefly, GLIDE’s proprietary conformational expansion and exhaustive search of the binding site produces a multitude of ligand poses that undergo an initial refinement, energy minimization on a precomputed grid, and a final scoring and ranking. GLIDE uses proprietary scoring functions that are variations of the ChemScore<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> empirical scoring function and the OPLS-AA<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> force field to compute van der Waals and electrostatic grids for the receptor. The final ligand binding poses are ranked according to a computed E model score that encompasses the grid score, the proprietary Glide Score, and the internal energy strain.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Preparation of the Substituted Cores</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-<i>tert</i>-Butylisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>97</b>)</h4><div class="NLM_p">To a solution of <i>N</i>,<i>N</i>-diisopropylamine (1.06 g, 10.4 mmol) in THF (10 mL) at 0 °C was added <i>n</i>-butyllithium (4.2 mL, 2.5 M, 10.5 mmol). After it was stirred for 10 min, it was cooled to −78 °C, and then a solution of 4-<i>tert</i>-butyl-2-methylbenzoic acid (<b>95</b>) (500 mg, 2.6 mmol) and dimethylcarbonate (471 mg, 5 mmol) in THF (5 mL) was added. It was warmed up to room temperature and stirred overnight. The mixture was cooled, and water was added. The organic phase was extracted with water. The combined aqueous phase was washed with hexane to remove <i>N</i>,<i>N</i>-diisopropylamine. The water solution was acidified with conc. HCl to pH 2 and extracted with ethyl acetate. The ethyl acetate layer was dried and evaporated to give 552 mg (90%) of 4-<i>tert</i>-butyl-2-(carboxymethyl)benzoic acid (<b>96</b>) as a white solid: MS (ESI) <i>m</i>/<i>z</i> 237.1 (M + 1)<sup>+1</sup>.</div><div class="NLM_p last">Compound <b>96</b> (90 mg, 0.38 mmol) and urea (46 mg, 0.76 mmol) were mixed and heated at 145 °C for 1 h. The solid was collected by filtration, washed with ethyl acetate, water, and methanol, and air-dried to give 45 mg (55%) of <b>97</b> as a solid: MS (ESI) <i>m</i>/<i>z</i> 216.1 (M − 1)<sup>−1</sup>; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>15</sub>NO<sub>2</sub> 218.11756; found, 218.11765 (M + H)<sup>+1</sup>.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (4<i>E</i>)-6-<i>tert</i>-Butyl-4-(methoxymethylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>4k</b>)</h4><div class="NLM_p last">A solution of <b>97</b> (45 mg, 0.20 mmol) in DMF (1 mL), acetic anhydride (2 mL), and trimethyl orthoformate (0.2 mL, 1.83 mmol) was heated at 120 °C for 1 h. After the solvents were evaporated, the precipitate was washed with methanol, and dried to give 44 mg (85%) of <b>4k</b> as a yellow solid: MS (ESI) <i>m</i>/<i>z</i> 260.2; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>17</sub>NO<sub>3</sub> 260.12812; found, 260.12825 (M + H)<sup>+1</sup>.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-Cyclopentyl-4<i>H</i>-isoquinoline-1,3-dione (<b>99</b>)</h4><div class="NLM_p last">To 6-Bromo-1,3-bis-(<i>tert</i>-butyl-dimethyl-silanyloxy)-isoquinoline<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (1.76 g, 3.75 mmol) was added tetrakis(triphenylphosphine)palladium (110 mg, 0.095 mmol) and 2 M cyclopentyl magnesium bromide in ether (3.0 mL, 6.0 mmol). This mixture was at 75 °C under microwave conditions for 10 min. The mixture was cooled to room temperature, transferred to a flask with THF and water, then 2 M hydrochloric acid (20 mL) was added and stirred for 4 h at room temperature. The organic solvents were removed in vacuo, the mixture extracted with ethyl acetate, the organic layer dried over sodium sulfate, filtered, evaporated, and chromatographed with hexane-ethyl acetate on silica gel to give 268 mg (31%) of <b>99</b> as a white solid: MS (ESI) <i>m</i>/<i>z</i> 230.2 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.48 − 1.60 (m, 2H), 1.60 − 1.72 (m, 2H), 1.72 − 1.84 (m, 2H), 1.98 − 2.08 (m, 2H), 2.99 − 3.09 (m, 1H), 3.99 (s, 2H), 7.26 (bs, 1H), 7.34 (dd, <i>J =</i> 8.3, 1.2 Hz, 1H), 7.92 (d, <i>J</i> = 8.3 Hz, 1H), 11.20 (s, 1H).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-Cyclopentyl-4-methoxymethylene-4<i>H</i>-isoquinoline-1,3-dione (<b>4l</b>)</h4><div class="NLM_p last">A mixture of <b>99</b> (222 mg, 0.97 mmol), 10 mL of acetic acid, and trimethyl orthoformate (212 mg, 2.0 mmol) was stirred and heated to 90 °C. After 2 h at that temperature, the reaction mixture was cooled, and the solvents were removed in vacuo, and the residue taken up in 4% methanol in dichloromethane, passed through a short pad of Florisil, and eluted with 4% methanol in dichloromethane. The eluate was evaporated, and the product was treated with 4:1 hexane-ethyl acetate and collected by filtration to give 165 mg (62%) of <b>4l</b> as a yellow solid: MS (ESI) <i>m</i>/<i>z</i> 272.2 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.48 − 1.62 (m, 2H), 1.63 − 1.73 (m, 2H), 1.73 − 1.85 (m, 2H), 1.99 − 2.11 (m, 2H), 3.00 − 3.12 (m, 1H), 4.23 (s, 3H), 7.32 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.99 (d, <i>J</i> = 8.3 Hz, 1H), 8.01 (s, 1H), 8.14 (d, <i>J</i> = 1.4 Hz, 1H), 11.18 (s, 1H).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Preparation of the Headgroups</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-Hydroxy-benzylamine Hydrogen Chloride (<b>2d</b>)</h4><div class="NLM_p last">An amount of 2 g (16.79 mmol) of 3-cyanophenol was dissolved in THF (40 mL). After cooling to 0 °C, borane tetrahydrofuran complex (32.0 mL, 2.0 M) was added dropwise to the solution. It was allowed to stir at 0 °C for 15 min, then at room temperature for 25 min. After refluxing for 3 h, it was cooled to room temperature and then evaporated to dryness. Methanol (14 mL) was added and then evaporated to dryness. Subsequently conc. hydrogen chloride (155 mL) was added and then evaporated to dryness. The residue was recrystallized from ethyl acetate to give 2.66 g (100%) of <b>2d</b> as a white solid. MS (ESI) <i>m</i>/<i>z</i> 123.15 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-Hydroxy-4-methoxy-benzylamine Hydrogen Chloride (<b>2e</b>)</h4><div class="NLM_p">An amount of 1.52 g (10.0 mmol) of 3-hydroxy-4-methoxy-benzylaldehyde was added to ethanol (20 mL) and pyridine (10 mL) at room temperature, followed by the addition of hydroxylamine hydrochloride (764.39 mg, 11.0 mmol). The mixture was stirred at ambient temperature for 24 h, and 200 mL of water was added. After the solvents were evaporated, the residue was dissolved in 400 mL of ethyl ether, washed successively with 100 mL of aqueous sodium bicarbonate, 100 mL of sodium bisulfite, and 100 mL of brine. It was dried over magnesium sulfate, filtered, and evaporated to give 1.39 g (83%) of 3-hydroxy-4-methoxy-benzylaldehyde oxime as a white solid.</div><div class="NLM_p last">A solution of 3-hydroxy-4-methoxy-benzylaldehyde oxime (1.0 g, 5.98 mmol) was dissolved in ethanol (50 mL). Then conc. hydrochloric acid (2 mL) was added, followed by 10% Pd/C (200 mg) and hydrogenated at 35 psi for 3 h. The mixture was filtered through celite and evaporated to dryness. The residue was recrystallized from ethyl acetate to give 1.13 g (91%) of <b>2e</b> as a white solid (HCl/hydrate salt): mp160−161 °C; MS (ESI) <i>m</i>/<i>z</i> 154.2(M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-(1-Amino-ethyl)-2-methoxyphenol hydrochloride (<b>10</b>)</h4><div class="NLM_p">To a solution of 3-hydroxy-4-methoxybenzaldehyde (<b>6</b>) (5.0 g, 33 mmol) in DMF (165 mL) was added benzyl bromide (4.3 mL, 36 mmol), followed by potassium carbonate (∼325 mesh, 14 g, 100 mmol). The reaction mixture was stirred for 4 h at room temperature and then partitioned between diethyl ether and water. The aqueous phase was extracted with ether (3 × 50 mL). The combined ethereal extracts were washed twice with water and once with saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give a golden oil, which was crystallized upon standing to afford 3-benzyloxy-4-methoxybenzaldehyde (<b>7</b>) as a white solid. The material was used in the following step without further purification.</div><div class="NLM_p">A solution of the crude <b>7</b> in THF (150 mL) was cooled to −78 °C. Methyllithium (1.6 M solution in diethyl ether, 31 mL, 49 mmol) was added dropwise via a syringe. Following completion of the addition, the cooling bath was removed, and the reaction mixture was allowed to warm to room temperature. After 90 min at that temperature, the mixture was cooled to 0 °C and treated with saturated aqueous sodium hydrogen carbonate. The quenched reaction mixture, after warming to room temperature, was acidified with 1 M hydrochloric acid solution to pH 1 and extracted thrice with diethyl ether. The combined extracts were washed with saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give 1-(3-benzyloxy-4-methoxy-phenyl)-ethanol (<b>8</b>).</div><div class="NLM_p">To a mixture of the crude <b>8</b> and diphenylphosphoryl azide (2.6 mL, 12 mmol) in toluene (18 mL) at 0 °C was added 1,8-diazabicyclo[5.4.0]undec-7-ene (1.6 mL, 11 mmol). The mixture was stirred at 0 °C for 2 h and then at room temperature overnight. The reaction mixture was washed with water and concentrated to give 4-(1-azido-ethyl)-2-benzyloxy-1-methoxybenzene (<b>9</b>), which was used in the next step without purification.</div><div class="NLM_p last">Crude <b>9</b> was hydrogenated at 50 psi, using 10% Pd/C in ethanolic hydrogen chloride solution to give a brown syrup, which, when was dried under vacuum, gave 0.53 g (8% over 4 steps) of 5-(1-amino-ethyl)-2-methoxyphenol hydrochloride (<b>10</b>) as a tan foam: MS (ESI) <i>m</i>/<i>z</i> 150.9 (M-NH<sub>3</sub> + 1)<sup>+1</sup>.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Methoxy-5-methylaminomethyl-phenol (<b>12</b>)</h4><div class="NLM_p last">Methylamine (40% aqueous solution, 2.2 mL, 25 mmol) was added to a solution of 3-hydroxy-4-methoxybenzaldehyde (<b>6</b>) (3.0 g, 20 mmol) in ethanol (35 mL). The resulting slurry was stirred for 30 min at room temperature. Then the solvents were evaporated under reduced pressure. The resulting solid was dissolved in methanol (300 mL), and sodium borohydride (0.90 g, 24 mmol) was added. The reaction mixture was stirred for 2 h at room temperature and then concentrated under reduced pressure. The residue was partitioned between saturated aqueous potassium carbonate solution and ethyl acetate. The aqueous phase was extracted thrice with ethyl acetate, and the combined extracts were concentrated under reduced pressure to give 2.5 g (75%) of <b>12</b> as a granular white solid: MS (ESI) <i>m</i>/<i>z</i> 168.2 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-Hydroxy-4-propoxybenzaldehyde (<b>15b</b>)</h4><div class="NLM_p last">To a solution of 1-bromopropane (1.7 mL, 18.7 mmol) in anhydrous DMF (25 mL) was added potassium carbonate (5.7 g, 41.0 mmol). The mixture was stirred at room temperature, and 1,2-dihydroxy-4-benzaldehyde (<b>14</b>) (1.0 g, 7.2 mmol) was added. After the mixture was stirred at 65 °C for 30 min, the resulting mixture was concentrated, and the residue was then partitioned between water (25 mL) and ethyl acetate (25 mL). The organic layer was then dried and purified by flash chromatography to give 0.2 g (15%) of <b>15b</b> as a brown solid: MS (ESI) <i>m</i>/<i>z</i> 181.2 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.99 (t, <i>J =</i> 7.3 Hz, 3H), 1.77 (m, 2H), 4.03 (t, <i>J =</i> 6.6 Hz, 2H), 7.11 (d, <i>J =</i> 8.3 Hz, 1H), 7.26 (d, <i>J =</i> 2.0 Hz, 1H), 7.38 (dd, <i>J =</i> 8.3, 2.0 Hz, 1H), 9.49 (s, 1H), 9.76 (s, 1H).</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-Hydroxy-4-(2-methoxyethoxy)benzaldehyde (<b>15c</b>)</h4><div class="NLM_p last">An amount of <b>14</b> (5.0 g, 36.2 mmol) in 20 mL of DMF was added to 2-bromoethyl methyl ether (3.4 mL, 36.2 mmol) and sodium carbonate (5.0 g, 72.4 mmol). The reaction mixture was stirred at room temperature for 3 days. After removal of solids by filtration, the solution was subsequently evaporated under high-pressure vacuum to give a dark brown liquid. The residue was treated with water and acidified with 12 N HCl solution to pH ∼2, then extracted with 4× 100 mL of EtOAc. The combined organic layer was washed with brine, dried over Mg<sub>2</sub>SO<sub>4</sub>, stirred in Darco, filtered, and evaporated to give a yellow liquid. Purification was performed by column chromatography over silica gel using 40% EtOAc/Hexane as eluent to give 2.13 g (30%) of <b>15c</b> as a colorless solid: mp 74−75 °C; MS (ESI) <i>m</i>/<i>z</i> 195.1 (M + H)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.32 (s, 3 H), 3.62 − 3.79 (m, 2 H), 4.03 − 4.34 (m, 2 H), 7.13 (d, <i>J</i> = 8.3 Hz, 1 H), 7.27 (d, <i>J</i> = 2.0 Hz, 1 H), 7.38 (dd, <i>J</i> = 8.3, 2.0 Hz, 1 H), 9.58 (s, 1 H), 9.77 (s, 1 H).</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-(Aminomethyl)-2-propoxyphenol Hydrochloride (<b>16b</b>)</h4><div class="NLM_p">An amount of <b>15b</b> (150 mg, 0.83 mmol) was added to pyridine (4.0 mL) at room temperature, followed by the addition of methoxylamine hydrogen chloride (101.2 mg, 1.2 mmol). The mixture was stirred at ambient temperature for 24 h, and 4 mL of water was added. After the solvents were evaporated, the residue was dissolved in 8 mL of anhydrous ether and washed successively with 2 mL of aqueous sodium bicarbonate, 2 mL of sodium bisulfite, and 2 mL of brine. It was dried over magnesium sulfate, filtered, and evaporated to give 150 mg (86%) crude 3-hydroxy-4-propoxybenzaldehyde <i>O</i>-methyloxime as a yellow solid: MS (ESI) <i>m</i>/<i>z</i> 210.5 (M + 1)<sup>+1</sup>.</div><div class="NLM_p last">An amount of 3-hydroxy-4-propoxybenzaldehyde <i>O</i>-methyloxime (150 mg, 0.83 mmol) was dissolved in ethanol (4 mL). Then 12 N HCl (0.600 mL) was added, followed by 10% Pd/C (15.0 mg). After hydrogenation at 35 psi for 3 h, the solution was filtered through Celite and evaporated to dryness. The residue was recrystallized from ethyl acetate to give 112 mg (62%) of <b>16b</b> as a white solid: MS (ESI) <i>m</i>/<i>z</i> 182.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.97 (t, <i>J =</i> 7.4 Hz, 3H), 1.53 − 1.94 (m, 2H), 3.84 (s, 2H), 3.91 (t, <i>J =</i> 6.5 Hz, 2H), 6.75 − 6.86 (m, 1H), 6.88 − 6.98 (m, 2H), 8.08 (s, 3H), 9.03 (s, 1H).</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-(Aminomethyl)-2-(2-methoxyethoxy)phenol (<b>16c</b>)</h4><div class="NLM_p last">Using the procedures described for the preparation of <b>16b</b>, <b>15c</b> (1.24 g, 6.32 mmol) was reacted to give a coloress oil, which upon recrystallization from MeOH/EtOAc yielded 0.45 g (55%) of <b>16c</b> as a colorless solid: mp: 89−90 °C; MS (ESI) <i>m</i>/<i>z</i> 198.1 (M + H)<sup>+1</sup>.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-Amino-5-(aminomethyl)phenol Hydrochloride (<b>20</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>2e</b>, 4-nitro-3-hydroxybenzadehyde <i>O</i>-methyloxime (2.2 g, 16.1 mmol) was hydrogenated to give 2.5 g (89%) of <b>20</b> as a purple solid: MS (ESI) <i>m</i>/<i>z</i> 138.9 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-Aminomethyl-2-methyl-phenol hydrogen chloride (<b>25</b>)</h4><div class="NLM_p">A solution of 3-hydroxy-4-methylbenzoic acid (<b>22</b>) (2 g, 13.14 mmol) and oxalyl chloride (10 mL) was refluxed at 60 °C until all of the solid was in solution. After cooling, the mixture was evaporated to dryness to give 3-hydroxy-4-methylbenzoyl chloride (<b>23</b>). It was cooled to 0 °C, and ammonium hydroxide (20 mL) was added within 5 min. The mixture was allowed to stir at 0 °C for 30 min, then at room temperature for an additional 30 min. Water (30 mL) was added to the mixture. After the white precipitate was filtered, the aqueous solution was adjusted to pH 3 and then extracted with ethyl acetate. The organic solution was dried over MgSO4, filtered, and dried to give 1.4 mg (70%) of 3-hydroxy-4-methylbenzamide (<b>24</b>) as a white solid.</div><div class="NLM_p last">A solution of <b>24</b> (1.4 g, 9.65 mmol) was dissolved in THF (20 mL) and cooled to 0 °C. A solution of borane tetrahydrofuran complex (25 mL, 2.0 M) was added dropwise over 15 min and maintained at 0 °C for an additional 10 min. The mixture was stirred at room temperature for 20 min, refluxed for 3 h, and then cooled to room temperature, and HCl (15 mL) was added and refluxed overnight. After cooling, the solvent was evaporated, and methanol (5 mL) was added. After evaporation to dryness, the residue was crystallized with ethyl acetate to provide 450 mg (28%) of the desired product <b>25</b> as a white solid: MS (ESI) <i>m</i>/<i>z</i> 174.1 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-Aminomethyl-biphenyl-2-ol (<b>34</b>)</h4><div class="NLM_p">(2-Methoxy-biphenyl-4-yl)-methanol (<b>31</b>) (170 mg, 0.79 mmol)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and cooled to 0 °C. Thionyl chloride (1 mL) was then added dropwise. The mixture was then allowed to stir till no starting material was left, ca. 1 h. The volatile was then removed, and the crude 4-chloromethyl-2-methoxy-biphenyl (<b>32</b>) was employed directly in the next step.</div><div class="NLM_p">The crude product <b>32</b> was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) and cooled to −78 °C. Boron tribromide (3 mL, 1 M solution in CH<sub>2</sub>Cl<sub>2</sub>, 3 mmol) was added. The cooling bath was then removed, and the mixture was allowed to stir at room temperature for 1 h. The mixture was quenched with ice water, and the methylene chloride layer was dried and concentrated. The residue was purified by column chormatography to obtain 4-chloromethyl-2-hydroxy-biphenyl. This product (170 mg) was then dissolved in DMF (5 mL) to which NaN<sub>3</sub> (100 mg, 1.53 mmol) was added at room temperature for 1 h. Ethyl ether and water were then added, and the ether layer was washed with water and dried over Na<sub>2</sub>SO<sub>4</sub>. Removal of ether provided 100 mg (53% over three steps starting from <b>31</b>) of the desired 4-azidomethyl-2-hydroxy-biphenyl (<b>33</b>).</div><div class="NLM_p last">Triphenylphosphine (100 mg, 0.38 mmol) was added to a solution of <b>33</b> (100 mg, 0.42 mmol) in THF (5 mL) and water (0.5 mL). The mixture was stirred at room temperature overnight. After the solvents were evaporated, the residue was purified by column chromatography to provide 84 mg (100%) of <b>34</b>: MS (ESI) <i>m</i>/<i>z</i> 199.10 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 5-Aminomethyl-2-furan-2-yl-phenol (<b>41</b>)</h4><div class="NLM_p">3-Hydroxy-4-iodo-benzonitrile (<b>38</b>) (120 mg, 0.49 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (35 mg, 0.049 mmol), and 2-furyltributyltin (200 g, 0.56 mmol) in DMF (5 mL) were degassed and heated at 100 °C for 30 min. After the mixture was cooled to room temperature, an aqueous work up was performed, and 80 mg (88%) of 4-furan-2-yl-3-hydroxy-benzonitrile (<b>40</b>) was isolated after column chromatography.</div><div class="NLM_p last">To a solution of <b>40</b> (180 mg, 0.97 mmol) in THF (5 mL) was added BH<sub>3</sub>·THF (5 mL, 1 M solution in THF, 5 mmol) under nitrogen. The mixture was then allowed to stir at room temperature for 24 h. The reaction was then quenched with 6 N HCl. THF was then removed, and the aqueous layer was then neutralized with ammonium hydroxide to pH 9. The mixture was then extracted with CHCl<sub>3</sub>/MeOH (9:1). The organic layer was dried and evaporated, and the residue was chromatographed to provide 60 mg (33%) of <b>41</b>: MS (ESI) <i>m</i>/<i>z</i> 190 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-Iodo-3-methoxymethoxy-benzonitrile (<b>42</b>)</h4><div class="NLM_p last">3-Hydroxy-4-iodobenzonitrile (<b>38</b>) (500 mg, 2.04 mmol) and MOMCl (350 mg, 4.37 mmol) were dissolved in anhydrous DMF (5 mL) and cooled to 0 °C. NaH (100 mg, 60% suspension in mineral oil, 2.5 mmol) was then added. The resulting mixture was allowed to stir at room temperature for 1 h. Ether was then added and washed with H<sub>2</sub>O (3 × 20 mL) and brine. After drying over Na<sub>2</sub>SO<sub>4</sub>, ether was removed, and the residue was purified by column chromatography to afford 570 mg (96%) of <b>42</b>: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.32 (d, <i>J</i> = 1.7 Hz, 1H), 7.03 (dd, <i>J</i> = 8.0 and 1.7 Hz, 1H), 5.27 (s, 2H), 3.51 (s, 3H).</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-Aminomethyl-2-furan-3-yl-phenol (<b>45a</b>)</h4><div class="NLM_p">4-Iodo-3-methoxymethoxy-benzonitrile (<b>42</b>) (150 mg, 0.52 mmol), 3-furanboronic acid (96 mg, 0.86 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (60 mg, 0.052 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (500 mg, 1.53 mmol) were mixed in DMF (10 mL), degassed, and then heated at 100 °C for 4 h. After the mixture was cooled to room temperature, an aqueous work up was performed, and the residue was purified to afford 100 mg (84%) of 4-furan-3-yl-3-methoxymethoxy-benzonitrile (<b>43a</b>).</div><div class="NLM_p">Nitrile <b>43a</b> (120 mg, 0.52 mmol) was dissolved in ether (10 mL). The resulting solution was slowly added to a suspension of LiAlH<sub>4</sub> (100 mg, 2.6 mmol) in ether. After addition, the mixture was stirred for another 10 min before quenching with water and 5 N NaOH. It was extracted with ethyl acetate, and the organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and dried to provide 90 mg (74%) of the crude 4-furan-3-yl-3-methoxymethoxy-benzylamine (<b>44a</b>).</div><div class="NLM_p last">The MOM protected amine (<b>44a</b>) (90 mg, 0.39 mmol) was then dissolved in 2 N aq HCl/MeOH (1:1). The resulting solution was heated at reflux for 15 min. After cooling to room temperature, the mixture was basified with aqueous ammonium hydroxide and extracted with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (9:1). The organic layer was dried, filtered, and evaporated to yield a crude product <b>45a</b>, which was used directly in the next step. MS (ESI) <i>m</i>/<i>z</i> 190 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-Aminomethyl-2-pyridin-2-yl-phenol (<b>45b</b>)</h4><div class="NLM_p">4-Iodo-3-methoxymethoxy-benzonitrile (42) (190 mg, 0.66 mmol), 2-pyridinyl tributyltin (370 mg, 1 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (60 mg, 0.084 mmol), and CuI (40 mg, 0.21 mmol) were mixed in DMF (10 mL). This mixture was then degassed and heated at 100 °C for 1 h. TLC suggested full conversion. After aqueous workup, the residue was purified by column chromatography to yield 162 mg (93%) of 3-methoxymethoxy-4-pyridin-2-yl-benzonitrile (<b>43b</b>): MS (ESI) <i>m</i>/<i>z</i> 241 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.74 (m, 1H), 7.26−7.91 (m, 6H), 5.22 (s, 2H), 3.48 (s, 3H).</div><div class="NLM_p last">By the procedure described above for <b>44a</b>, 160 mg (0.67 mmol) of <b>43b</b> was reacted in two steps to give 63 mg (47%) of <b>45b</b>: MS (ESI) <i>m</i>/<i>z</i> 201 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.50 (m, 1H), 7.76−7.92 (m, 3H), 7.24 (m, 1H), 6.86−6.97 (m, 2H), 3.87 (s, 2H).</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-Aminomethyl-2-pyridin-3-yl-phenol (<b>45c</b>)</h4><div class="NLM_p last">By the procedure described above for <b>45b</b>, 200 mg (0.69 mmol) of <b>42</b> was reacted in three steps to give 53 mg (33%) of <b>45c</b>: MS (ESI) <i>m</i>/<i>z</i> 201 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-Aminomethyl-2-pyridin-4-yl-phenol (<b>45d</b>)</h4><div class="NLM_p last">By the procedure described above for <b>45b</b>, 200 mg (0.69 mmol) of <b>42</b> was reacted in three steps to give 40 mg (25%) of <b>45d</b>: MS (ESI) <i>m</i>/<i>z</i> 201 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-Aminomethyl-5-methoxy-pyrimidin-4-ol (<b>51</b>)</h4><div class="NLM_p">1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-acetonitrile (<b>46</b>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (1 g, 5.34 mmol) was dissolved in 4 N HCl in dioxane (10 mL). The mixture was stirred at room temperature, and MeOH (1 mL) was added. The solution turned cloudy shortly. The precipitate was collected and washed with ether to provide 1 g (86%) of 2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-acetimidic acid methyl ester hydrochloride (<b>47</b>): MS (ESI) <i>m</i>/<i>z</i> 219 (M + 1)<sup>+1</sup>.</div><div class="NLM_p">A suspension of <b>47</b> (1 g, 4.58 mmol) in MeOH (15 mL) was added to a saturated NH<sub>3</sub>/MeOH solution. The mixture was stirred at 0 °C and then room temperature. After all the volatile was removed, the product 9b-hydroxy-2-imino-1,2,3,9b-tetrahydro-imidazo[2,1-a]isoindol-5-one (<b>48</b>) was directly employed in the next step: MS (ESI) <i>m</i>/<i>z</i> 204 (M + 1)<sup>+1</sup>.</div><div class="NLM_p">Compound <b>48</b> (500 mg, 2.09 mmol) and the sodium salt of 3-hydroxy-2-methoxy-acrylic acid methyl ester (<b>49</b>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (500 mg, 3.24 mmol) were mixed in MeOH and stirred at room temperature for 2 h, and then heated at reflux overnight. The crude mixture was filtered. After the filtrate was concentrated, the resulting residue was purified by column chromatography to afford 100 mg (16%) of 2-(4-hydroxy-5-methoxy-pyrimidin-2-ylmethyl)-isoindole-1,3-dione (<b>50</b>): MS (ESI) <i>m</i>/<i>z</i> 286 (M + 1)<sup>+1</sup>.</div><div class="NLM_p last">Hydrazine (0.5 mL) was added to a suspension of <b>50</b> (50 mg, 0.18 mmol) in EtOH (2 mL), and the mixture was stirred till no starting material was left. The precipitate was filtered and the filtrate was concentrated to provide <b>51</b>, which was used directly without further purification: MS (ESI) <i>m</i>/<i>z</i> 156 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-Aminomethyl-1<i>H</i>-pyridin-2-one hydrochloride (<b>55</b>)</h4><div class="NLM_p">2-Methoxy-4-cyanopyridine (<b>53</b>) was prepared from 2-chloro-4-cyanopyridine according to the procedure by Brown et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Reduction of <b>53</b> to 4-(2-methoxypyridyl)methylamine (<b>54</b>) was achieved through the method of Walpole et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p last">A solution of <b>54</b> (0.19 g, 1.1 mmol) in water (50 mL) and 3 N aqueous hydrochloric acid (25 mL) was heated at reflux for 5 h. The solvents were evaporated to give 0.15 g (83%) of <b>55</b> as an off-white solid: MS (ESI) <i>m</i>/<i>z</i> 125.1 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-Oxo-1-phenyl-1,2-dihydropyridin-4-ylmethylamine hydrochloride (<b>58</b>)</h4><div class="NLM_p">To a solution of <b>55</b> (3.68 g, 23 mmol) in 50% aqueous dioxane (100 mL) was added sodium hydroxide (2.8 g, 69 mmol), followed by di-<i>tert</i>-butyldicarbonate (5.0 g, 23 mmol). After stirring overnight at room temperature, the mixture was neutralized with 5% aqueous potassium hydrogen sulfate solution. The mixture was extracted four times with ethyl acetate. The combined extracts were dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. A sample of crude material was purified by reverse-phase HPLC to give <i>tert</i>-butyl (2-oxo-1,2-dihydro-pyridin-4-ylmethyl)-carbamate (<b>56</b>) as a straw colored foam: MS (ESI) <i>m</i>/<i>z</i> 225.3 (M + 1)<sup>+1</sup>.</div><div class="NLM_p">To a solution of <b>56</b> (0.13 g, 0.58 mmol) in dichloromethane (5 mL) was added trimethylphenylstannane (210 μL, 1.2 mmol), followed successively by copper (II) acetate (0.12 g, 0.64 mmol) and tetra-<i>n</i>-butylammonium fluoride (1.0 M solution in tetrahydrofuran, 1.2 mL). The reaction mixture was stirred for 2 days at room temperature and then was quenched by the addition of methanolic ammonia (2 M, 4 mL). The reaction mixture was concentrated and then purified by flash silica gel chromatography (methanol/chloroform) to give 88 mg (52%) of <b>57</b>: MS (ESI) <i>m</i>/<i>z</i> 301.3 (M + 1)<sup>+1</sup>.</div><div class="NLM_p last">Compound <b>57</b> (83 mg, 0.28 mmol) was treated with 4 N hydrogen chloride (2 mL) in dioxane to remove the Boc protecting group. The reaction solution was evaporated to dryness to give 66 mg (100%) of 4-aminomethyl-1-phenyl-1<i>H</i>-pyridin-2-one hydrochloride (<b>58</b>).</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-Furan-3-yl-4-methyl-1<i>H</i>-pyridin-2-one (<b>60</b>)</h4><div class="NLM_p last">A mixture of 2-hydroxy-4-methylpyridine (<b>59</b>) (0.66 g, 6.0 mmol), 3-bromofuran (1.7 g, 12 mmol), copper (I) iodide (0.11 g, 0.60 mmol), and potassium carbonate (0.84 g, 6.0 mmol) in DMF (12 mL) was heated at 180 °C for 2 h in a 300 W microwave reactor. The reaction mixture was then diluted with 10% aqueous ammonium hydroxide solution and extracted thrice with ethyl acetate. The combined extracts were washed with saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give 0.65 g (62%) of <b>60</b>: MS (ESI) <i>m</i>/<i>z</i> 176.1 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-Furan-3-yl-2-oxo-1,2-dihydro-pyridine-4-carbaldehyde (<b>62</b>)</h4><div class="NLM_p">A mixture of <b>60</b> (3.7 g, 21 mmol), <i>tert</i>-butoxybis(dimethylamino)methane (11 g, 63 mmol), and DMF (4 mL) was heated at 150 °C for 2.5 h and then concentrated to dryness under reduced pressure to yield crude 4-(2-dimethylamino-vinyl)-1-furan-3-yl-1<i>H</i>-pyridin-2-one (<b>61</b>), which was used without further purification: MS (ESI) <i>m</i>/<i>z</i> 231.3 (M + 1)<sup>+1</sup>.</div><div class="NLM_p last">To a solution of <b>61</b> (21 mmol) in 50% aqueous tetrahydrofuran (700 mL) was added sodium periodate (13 g, 63 mmol). After 6 h of stirring at room temperature, the reaction mixture was filtered. The filtrate was washed thrice with saturated aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to give 2.1 g (53% over 2 steps) of <b>62</b> as a yellow powder: MS (ESI) <i>m</i>/<i>z</i> 190.3 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-Aminomethyl-1-furan-3-yl-1<i>H</i>-pyridin-2-one (<b>65</b>)</h4><div class="NLM_p">A solution of <b>62</b> (1.4 g, 7.4 mmol) in pyridine (40 mL) was treated with methoxylamine hydrochloride (0.68 g, 8.1 mmol). After stirring overnight at room temperature, the reaction mixture was concentrated under reduced pressure. The residue was partitioned between ethyl acetate and water. The organic phase was washed twice with water and once with saturated aqueous sodium chloride solution, dried, and concentrated under reduced pressure to provide 1-furan-3-yl-2-oxo-1,2-dihydro-pyridine-4-carbaldehyde <i>O</i>-methyl-oxime (<b>63</b>), which was used in the next step without further purification: MS (ESI) <i>m</i>/<i>z</i> 219.3 (M + 1)<sup>+1</sup>.</div><div class="NLM_p">To a mixture of the crude <b>63</b> and glacial acetic acid (77 mL) was added zinc powder (3.1 g). The reaction mixture was heated for 45 min at 100 °C in an oil bath and then allowed to cool to room temperature. The mixture was filtered through a pad of diatomaceous earth. After the filtrate was concentrated, the residue was purified by reverse-phase HPLC to give 2.3 g of crude 4-aminomethyl-1-furan-3-yl-1<i>H</i>-pyridin-2-trifluoroacetic acid salt contaminated with zinc salt: MS (ESI) <i>m</i>/<i>z</i> 191.3 (M + 1)<sup>+1</sup>.</div><div class="NLM_p">To a solution of 2.3 g of the crude 4-aminomethyl-1-furan-3-yl-1<i>H</i>-pyridin-2-one trifluoroacetic acid salt in 50% aqueous dioxane (20 mL) was added sodium hydroxide (800 mg), followed by an additional volume of aqueous dioxane (20 mL), and then the addition of di-<i>tert</i>-butyldicarbonate (600 μL). After the reaction was completed, the reaction mixture was filtered. The filtrate was neutralized with 5% aqueous potassium hydrogen sulfate solution and extracted thrice with ethyl acetate. The combined extracts were washed with saturated aqueous sodium chloride solution, dried, and concentrated under reduced pressure to give 0.18 g (8% over 3 steps) of <i>tert</i>-butyl (1-furan-3-yl-2-oxo-1,2-dihydro-pyridin-4-ylmethyl)-carbamate (<b>64</b>): MS (ESI) <i>m</i>/<i>z</i> 291.3 (M + 1)<sup>+1</sup>.</div><div class="NLM_p last"><i>tert</i>-Butyl (1-furan-3-yl-2-oxo-1,2-dihydro-pyridin-4-ylmethyl)-carbamate (<b>64</b>) (0.20 g, 0.69 mmol) was treated with 4 N hydrogen chloride in dioxane (5 mL) at room temperature. After the deprotection was completed, the solution was concentrated to yield 43 mg (27%) of 4-aminomethyl-1-furan-3-yl-1<i>H</i>-pyridin-2-one (<b>65</b>): MS (ESI) <i>m</i>/<i>z</i> 191.2 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-Hydroxymethyl-5-propoxy-pyran-4-one (<b>67b</b>)</h4><div class="NLM_p last">A mixture of kojic acid (<b>66</b>) (28.4 g, 0.20 mol), 120 mL of DMF, potassium carbonate powder (27.6 g, 0.20 mol), potassium iodide (1.66 g, 0.01 mol), and 1-bromopropane (24.6 g, 0.20 mol) was stirred for 15 min at ambient temperature and then stirred at 90 °C for 3 h. The reaction mixture was cooled, evaporated to dryness in vacuo, and then partitioned between water and chloroform. The aqueous layer was extracted with chloroform (3 × 100 mL) and ethyl acetate (6 × 100 mL). The combined organic solution was dried with sodium sulfate and passed through a pad of magnesol and silica gel eluting with ethyl acetate. The eluate was evaporated in vacuo and crystallized with hexane/ethyl acetate (2:1) to give 22.6 g (61%) of <b>67b</b> as an off-white solid: MS (ESI) <i>m</i>/<i>z</i> 185.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.02 (t, <i>J =</i> 7.5, 3H), 1.78 − 1.89 (m, 2H), 3.57 (t, <i>J =</i> 6.5, 1H), 3.81 (t, <i>J =</i> 6.7, 2H), 4.48 (dd, <i>J =</i> 6.7, 0.7, 2H), 6.52 (m, 1H), 7.57 (s, 1H).</div></div><div id="sec4_4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-Hydroxymethyl-5-propoxy-pyridin-4-ol (<b>71b</b>)</h4><div class="NLM_p last">A mixture of <b>67b</b> (30.0 g, 0.163 mol) and ammonium hydroxide (150 mL) was stirred and heated in a sealed vessel at 90 °C for 2 h. The reaction mixture was cooled and evaporated to dryness in vacuo. The residue was taken up in 15% methanol in chloroform and passed through a pad of magnesol and silica gel eluting with the same solvent. The eluate was evaporated, and the residue was treated with acetone, filtered, washed with acetone, and air-dried to give 8.03 g (80%) of <b>71b</b> as a gray solid: mp 159−160 °C; MS (ESI) <i>m</i>/<i>z</i> 184.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.00 (t, <i>J =</i> 7.5, 3H), 1.73 − 1.83 (m, 2H), 4.08 (t, <i>J =</i> 6.6, 2H), 4.68 (s, 2H), 7.21 (s, 1H), 8.19 (s, 1H).</div></div><div id="sec4_4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-Azidomethyl-5-propoxy-pyridin-4-ol (<b>73b</b>)</h4><div class="NLM_p">To a mixture of <b>71b</b> (5.56 g, 30.3 mmol) and chloroform (30 mL) cooled in an ice bath was added 30 mL of thionyl chloride. It was stirred for 15 min at ice bath temperature and then refluxed for 1 h. The reaction mixture was cooled, evaporated to dryness in vacuo, and then treated with isopropanol. The solid was filtered, washed with fresh isopropanol, then ether, and air-dried to give 3.4 g (48%) of 2-chloromethyl-5-propoxy-pyridin-4-ol (<b>72b</b>) as an off-white solid: mp 165−167 °C; MS (ESI) <i>m</i>/<i>z</i> 202.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.99 (t, <i>J =</i> 7.5, 3H), 1.71 − 1.82 (m, 2H), 4.10 (t, <i>J =</i> 6.6, 2H), 4.95 (s, 2H), 7.83 (s, 1H), 8.34 (s, 1H).</div><div class="NLM_p last">To a suspension of sodium azide (2.82 g, 43.3 mmol) in 30 mL of DMF was added <b>72b</b> (8.74 g, 43.3 mmol). It was stirred overnight at ambient temperature and then quenched into ice water. The solid formed was filtered, washed with cold water, and dried to give 5.74 g (63%) of <b>73b</b> as an off white solid: MS (ESI) <i>m</i>/<i>z</i> 209.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.00 (t, <i>J =</i> 7.5, 3H), 1.73 − 1.83 (m, 2H), 4.09 (t, <i>J =</i> 6.6, 2H), 4.76 (s, 2H), 7.26 (s, 1H), 8.35 (s, 1H).</div></div><div id="sec4_4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-Aminomethyl-5-propoxy-pyridin-4-ol (<b>74b</b>)</h4><div class="NLM_p last">Azide <b>73b</b> (9.70 g, 46.6 mol) was suspended in 120 mL of THF and treated with triphenylphosphine (12.22 g, 46.6 mmol). After stirring for 10 min at ambient temperature, water was added (12.6 mL, 700 mmol), and the reaction mixture was stirred at ambient temperature overnight. The solid was gradually dissolved, followed by the formation of a precipitate. The resulting solid was filtered, washed with THF/water (10:1), and dried to give 5.92 g (69%) of <b>74b</b>: mp 159−160 °C; MS (ESI) <i>m</i>/<i>z</i> 183.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.00 (t, <i>J =</i> 7.5, 3H), 1.73 − 1.84 (m, 2H), 4.10 (t, <i>J =</i> 6.6, 2H), 4.24 (bs, 2H), 7.32 (s, 1H), 8.44 (s, 1H), 8.51 (bs, 3H).</div></div><div id="sec4_4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-Azidomethyl-5-methoxy-pyridin-4-ol (<b>73a</b>)</h4><div class="NLM_p last">Using the precedure described for <b>73b</b>, 2-chloromethyl-5-methoxy-pyridin-4-ol<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<b>72a</b>) (3.47 g, 20.0 mmol) and sodium azide (1.30 g, 20.0 mmol) were reacted to give 1.53 g (42%) of <b>73a</b> as a light brown solid: mp 111−114 °C (dec); MS (ESI) <i>m</i>/<i>z</i> 179.3 (M − 1)<sup>−1</sup>.</div></div><div id="sec4_4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-Aminomethyl-5-methoxy-pyridin-4-ol (<b>74a</b>)</h4><div class="NLM_p last">Using the procedure described for <b>74b</b>, <b>73a</b> (1.45 g, 8.05 mol) and triphenylphosphine (2.11 g, 8.05 mmol) were reacted to give 0.897 g (88%) of <b>74a</b>: mp 196−201 °C (dec); MS (ESI): <i>m</i>/<i>z</i> 155.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, w/TFA) δ 4.00 (s, 3H), 4.27 (s, 2H), 7.32 (s, 1H), 8.43 (s, 1H), 8.59 (bs, 3H).</div></div><div id="sec4_4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-Hydroxymethyl-5-furan-3-yl-pyran-4-one (<b>77b</b>)</h4><div class="NLM_p">A mixture of trifluoro-methanesulfonic acid 6-(<i>tert</i>-butyl-dimethyl-silanyloxymethyl)-4-oxo-4<i>H</i>-pyran-3-yl ester<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (<b>75</b>) (6.94 g, 17.8 mmol), furan-3-boronic acid (4.0 g, 35.7 mmol), tetrakistriphenylphosphine palladium (1.024 g, 0.87 mmol), cesium carbonate (16.32 g, 50.1 mmol), and potassium bromide (10.63 g, 89.3 mmol) in (250 mL) dioxane (250 mL) was heated to 60 °C and stirred overnight. The reaction mixture was cooled to room temperature and diluted with saturated aqueous ammonium chloride and extracted with ethyl acetate. The combined ethyl acetate layers were washed with water, dried over sodium sulfate, filtered, diluted with an equal volume of hexane, and passed through a short column of magnesol and silica gel eluting with 1:1 hexane/ethyl acetate. The product was eluted with 2:1 ethyl acetate/hexane, the solvents were evaporated, triturated with 1:1 hexane/ethyl acetate, filtered, washed with the same solvent, and air-dried to give 2.58 g (47%) of <b>76b</b> as an off white solid: MS (ESI) <i>m</i>/<i>z</i> 307.3 (M + 1).</div><div class="NLM_p last">Compound <b>76b</b> was dissolved in tetrahydrofuran, and tetrabutylammonium fluoride solution in tetrahydrofuran (40.0 mL, 40.0 mmol) was added and the mixture stirred at room temperature overnight. The reaction mixture was diluted with water and extracted with ethyl acetate. The ethyl acetate layers were combined and washed with water, dried over sodium sulfate, filtered, diluted with an equal volume of hexane, and passed through a short column of magnesol and silica gel eluting with 1:1 hexane/ethyl acetate. The product was eluted with 2:1 ethyl acetate/hexane, and the solvents were evaporated, triturated with 1:1 hexane/ethyl acetate, filtered, washed with the same solvent, and air-dried to give 2.06 g, (37%) of <b>77b</b> as an off white solid, MS (ESI) <i>m</i>/<i>z</i> 193.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.36(d, <i>J =</i> 5.9, 2H), 5.74 (t, <i>J =</i> 5.9, 1H), 6.39 (s, 1H), 6.93 − 6.97 (m, 1H), 7.72 − 7.56 (m, 1H), 8.40 − 8.43 (m, 1H), 8.70 (s, 1H).</div></div><div id="sec4_4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-Hydroxymethyl-5-(3-furyl)-pyridin-4-ol (<b>78b</b>)</h4><div class="NLM_p last">A mixture of 2-hydroxymethyl-5-furan-3-yl-pyran-4-one (<b>77b</b>) (1.92 g, 10.0 mmol) and 7 M ammonia in methanol (50.0 mL) was stirred and heated in a sealed vessel at 90 °C overnight. The reaction mixture was cooled, evaporated to dryness in vacuo, taken up in 15% methanol in chloroform, and passed through a pad of magnesol and silica gel eluting with the same solvent. The eluate was evaporated, treated with acetone, filtered, washed with acetone, and air-dried to give 1.21 g (63%) of <b>78b</b> as a gray solid: MS (ESI) <i>m</i>/<i>z</i> 192.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, w/TFA) δ 4.75 (s, 2H), 7.20 − 7.26 (m, 1H), 7.34 (s, 1H), 7.82 − 7.87 (m, 1H), 8.39 (s, 1H), 8.81 (s, 1H).</div></div><div id="sec4_4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-Aminomethyl-5-furan-3-yl-pyridin-4-ol (<b>81b</b>)</h4><div class="NLM_p">To a mixture of <b>78b</b> (1.148 g, 6.00 mmol) and 30 mL of <i>N</i>,<i>N</i>-dimethylformamide stirred and cooled with an ice bath to 0 °C was added triphenylphosphine (2.361 g, 9 mmol) followed by carbon tetrabromide (2.988 g, 9 mmol). This was stirred for 15 min, maintaining the temperature between 0−5 °C. Sodium azide was then added (1.172 g, 18.03 mmol) and the reaction mixture stirred for 24 h at ambient temperature. The reaction mixture was diluted with water and extracted with ethyl acetate. The combined extracts were dried over sodium sulfate, filtered, evaporated, and the residue chromatographed on silica gel eluting with ethyl acetate to give 0.417 g (32%) of 2-azidomethyl-5-furan-3-yl)-pyridin-4-ol (<b>80b</b>) as a white solid: mp 198−200 °C (dec); MS (ESI) <i>m</i>/<i>z</i> 217.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.87 (s, 2H), 7.23 − 7.25 (m, 1H), 7.40 (s, 1H), 7.81 − 7.83 (m, 1H), 8.42 (bs, 1H), 8.95 (s, 1H).</div><div class="NLM_p last">To a mixture of <b>80b</b> (216 mg, 1 mmol), 6 mL of tetrahydrofuran and triphenylphosphine (262 mg, 1 mmol) were added followed by water (270 μL, 15.0 mmol). It was stirred at ambient temperature overnight and then at 60 °C overnight. The reaction mixture was cooled, evaporated to dryness in vacuo, and then treated with warm toluene. This mixture was cooled and the solid was filtered, washed with toluene, and dried to give 0.170 g (89%) of <b>81b</b> as an off-white solid: mp 183−7 °C (dec); MS (ESI) <i>m</i>/<i>z</i> 191.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, w/TFA) δ 4.32 (s, 2H), 7.25 (s, 1H), 7.41 (s, 1H), 7.86 (s, 1H), 8.45 (s, 1H), 8.58 (bs, 3H), 9.00 (s, 1H).</div></div><div id="sec4_4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-Aminomethyl-5-phenyl-pyridin-4-ol (<b>81a</b>)</h4><div class="NLM_p">A mixture of 2-hydroxymethyl-5-phenyl-pyridin-4-ol (<b>78a</b>) (0.40 g, 2 mmol) and 5 mL of thionyl chloride was heated to a gentle reflux. After 4 h, the reaction mixture was cooled and evaporated to dryness in vacuo, and the residue was treated with water and neutralized with sodium bicarbonate. The resulting solid was collected by filtration, washed with water, and dried to give 256 mg (58%) of the 2-chloromethyl-5-phenyl-pyridin-4-ol (<b>79a</b>).</div><div class="NLM_p">Compound <b>79a</b> (252 mg, 1.15 mmol) was then stirred with 3 mL of dimethyl formamide, and sodium azide was then added (75 mg, 1.15 mmol) and the reaction mixture stirred for 24 h at ambient temperature. The solvent was removed in vacuo and the residue treated with water, filtered, washed with water, and dried to give 231 mg (88%) of 2-azidomethyl-5-phenyl-pyridin-4-ol (<b>80a</b>).</div><div class="NLM_p last">Compound <b>80a</b> (228 mg, 1.01 mmol) was then suspended in 3 mL of tetrahydrofuran and treated with triphenylphosphine (264 mg, 1.01 mmol). After stirring for 10 min at ambient temperature, water was added (272 μL, 15 equivalents) and the reaction mixture warmed with an oil bath at 60 °C, and stirred at that temperature overnight. The reaction mixture was evaporated to dryness in vacuo and treated with a 2:1 mixture of ethyl acetate and hexane. The resulting solid was filtered, washed with fresh 2:1 ethyl acetate and hexane, and dried to give 116 mg (57%) of <b>81a</b> as a gray solid: MS (ESI) <i>m</i>/<i>z</i> 201.1 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (6-Chloro-5-propoxy-pyridin-2-yl)-methanol (<b>84</b>)</h4><div class="NLM_p last">A mixture of 2-chloro-6-hydroxymethyl-pyridin-3-ol<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (<b>83</b>) (27.92 g, 0.175 mol), 120 mL of 2-butanone, potassium carbonate powder (48.37 g, 0.35 mol), and 1-iodopropane (37.19 g, 0.219 mol) was stirred for 15 min at ambient temperature and then stirred at 90 °C for 3 h. The reaction mixture was cooled, evaporated to dryness in vacuo, and then portioned between water and dichloromethane. The organic layer was dried, filtered, and crystallized with 2/1 hexane/ethyl acetate to give 5.875 g (16%) of <b>84</b> as a pale yellow solid: mp 59−60 °C; MS (ESI) <i>m</i>/<i>z</i> 160.3, 162.3 (M + 1)<sup>+1</sup>.</div></div><div id="sec4_4_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-Benzyloxy-3-propoxy-6-triisopropylsilanyloxymethyl-pyridine (<b>85</b>)</h4><div class="NLM_p last">A mixture of <b>84</b> (0.93 g, 4.61 mmol), 20 mL of dichloromethane, tri(isopropyl)silyl chloride (1.0 g, 5.19 mmol), and imidazole (0.47 g, 6.9 mmol) was stirred overnight at ambient temperature. The reaction mixture was washed with water, dried over sodium sulfate, filtered, and evaporated in vacuo to give an oil which was chromatographed on silica gel with 10:1 hexane/ethyl acetate to give 2-chloro-3-propoxy-6-triisopropylsilanyloxymethyl-pyridine as a clear liquid (1.06 g) (64%); MS (ESI): <i>m</i>/<i>z</i> 358.2, 360.2 (M + 1). A portion of this (716 mg, 2.0 mmol) and 5 mL of 1 M sodium benzyloxide in benzyl alcohol were heated at 120 °C under microwave conditions for 5 min. The reaction mixture was cooled, transferred to a separatory funnel with ethyl acetate and washed with water, and the organic layer was dried, filtered, evaporated, and chromatographed on silica gel with hexane/ethyl acetate to give 524 mg (61%) of <b>85</b> as a clear liquid; MS (ESI) <i>m</i>/<i>z</i> 430.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.02 (t, <i>J =</i> 7.4 Hz, 3H), 1.07 − 1.12 (m, 18H), 1.14 − 1.23 (m, 3H), 1.77 (m, 2H), 3.95 (t, <i>J =</i> 6.7 Hz, 2H), 4.75 (s, 2H), 5.44 (s, 2H), 7.03 (d, <i>J =</i> 7.9 Hz, 1H), 7.09 (d, <i>J</i> = 7.9 Hz, 1H), 7.26 − 7.38 (m, 3H), 7.45 − 7.50 (m, 2H).</div></div><div id="sec4_4_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (6-Benzyloxy-5-propoxy-pyridin-2-yl)-methanol (<b>86</b>)</h4><div class="NLM_p last">To a solution of <b>85</b> (860 mg, 2.0 mmol) was added 1 M tetrabutylammonium fluoride solution in tetrahydrofuran (4.0 mL, 4.0 mmol) and the mixture stirred at room temperature for 4 h. The reaction mixture was diluted with water and extracted with ether. The ether layers were combined and washed with water, dried over sodium sulfate, filtered, and chromatographed on silica gel eluting with 1:1 hexane/ether to give 355 mg (65%) of <b>86</b> as a white solid: mp 50−1 °C; MS (ESI) <i>m</i>/<i>z</i> 274.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.04 (t, <i>J =</i> 7.5 Hz, 3H), 1.79 − 1.89 (m, 2H), 2.90 (bs, 1H), 3.97 (t, <i>J =</i> 6.7 Hz, 2H), 4.57 (s, 2H), 5.48 (s, 2H), 6.74 (d, <i>J =</i> 7.8 Hz, 1H), 7.07 (d, <i>J</i> = 7.8 Hz, 1H), 7.26 − 7.31 (m, 1H), 7.33 − 7.38 (m, 2H), 7.45 − 7.49 (m, 2H).</div></div><div id="sec4_4_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 6-Azidomethyl-2-benzyloxy-3-propoxy-pyridine (<b>87</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>80b</b>, <b>86</b> (1.09 g, 4.0 mmol) was reacted with triphenylphosphine and carbon tertabromide (1.99 g, 6.0 mmol) to give 1.05 g (88%) of <b>87</b> as a clear liquid: MS (ESI) <i>m</i>/<i>z</i> 299.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.04 (t, <i>J =</i> 7.5 Hz, 3H), 1.79 − 1.90 (m, 2H), 3.96 (t, <i>J =</i> 6.7 Hz, 2H), 4.22 (s, 2H), 5.49 (s, 2H), 6.78(d, <i>J =</i> 7.8 Hz, 1H), 7.02 (d, <i>J</i> = 7.8 Hz, 1H), 7.26 − 7.31 (m, 1H), 7.32 − 7.38 (m, 2H), 7.47 − 7.52 (m, 2H).</div></div><div id="sec4_4_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 6-Aminomethyl-3-propoxy-pyridin-2-ol (<b>88</b>)</h4><div class="NLM_p last">To a mixture of <b>87</b> (544 mg, 2.00 mmol), 12 mL of tetrahydrofuran and triphenylphosphine (524 mg, 2.00 mmol) were added, followed by water (540 μL, 30.0 mmol). It was stirred at ambient temperature overnight. The reaction mixture was evaporated to dryness in vacuo and then washed with 2:1 hexane/ethyl acetate and filtered. This resulting solid was taken up in ethanol and hydrogenated over 10% palladium on carbon at 1 atm. The reaction mixture was filtered, washed with ethanol, and evaporated to give 93 mg (25%) of <b>88</b> as a brownish green solid: MS (ESI) <i>m</i>/<i>z</i> 183.3 (M + 1)<sup>+1</sup>.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Preparation of the Final Compounds</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (4<i>Z</i>)-6-Iodo-4-{[(3-hydroxy-4-methoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>5e</b>)</h4><div class="NLM_p last">A mixture of (4<i>Z</i>)-6-iodo-4-{[(4-hydroxy-3-methoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>4e</b>) (0.3 g, 0.91 mmol), 4-methoxyl-3-hydroxyl-benzylamine hydrochloride (<b>2e</b>) (0.19 g, 1 mmol), and triethylamine (0.14 mmol, 1.37 mmol) in DMF (3 mL) was stirred at room temperature overnight. The mixture was diluted with diethyl ether, and the solid was collected by filtration. The crude product was washed with water and methanol, followed by recrystallization from DMF in ether to give 0.28 g (68%) of <b>5e</b> as a tan solid: mp 209−210 °C; MS (ESI) <i>m</i>/<i>z</i> 449.0 (M − H)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.23 (s, 3H) 2.42 − 2.48 (m, 4H), 3.09 − 3.20 (m, 4H), 7.00 (d, <i>J</i> = 8.8 Hz, 2H), 7.47 (d, <i>J</i> = 8.8 Hz, 2H), 7.56 (d, <i>J</i> = 8.5 Hz, 1H), 7.72 (d, 8.5 Hz, 1H), 8.56 (s, 1H), 8.86 (d, 12.84 Hz, 1H), 11.31 (s, 1H), 12.59 (d, 12.84 Hz, 1H); Anal. (C<sub>18</sub>H<sub>15</sub>IN<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 4-[(3,4-Dihydroxy-phenylamino)-methylene]-4<i>H</i>-isoquinoline-1,3-dione (<b>3a</b>)</h4><div class="NLM_p last">The title compound was obtained by the procedure described above for <b>5e</b> except that no triethylamine was used, and the reaction was carried out at 115 °C for 1.5 h. 4-Methoxymethylene-4<i>H</i>-isoquinoline-1,3-dione (<b>1)</b> (40.6 mg, 0.2 mmol) and 3,4-dihydroxyaniline (<b>2a</b>) (25 mg, 0.2 mmol) were reacted to give 15.8 mg (27%) of <b>3a</b>; LC/MS1 R<i>t</i> 1.716 min, <i>m</i>/<i>z</i> 297.1 (M + H)<sup>+1</sup>; LC/MS2 R<i>t</i> 1.74 min, <i>m</i>/<i>z</i> 295 (M − H)<sup>−1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 6.55 (s, 1H) 6.60 (d, <i>J</i> = 8.7 Hz, 1 H) 7.24 (t, <i>J</i> = 8.3 Hz, <i>J</i> = 7.3 Hz, 1 H) 7.39 (d, <i>J</i> = 8.7 Hz, 1 H) 7.60 (t, <i>J</i> = 7.8 Hz, 1 H) 8.02 (d, <i>J</i> = 7.8 Hz, 1 H) 8.11 (d, <i>J</i> = 8.7 Hz, 1 H) 8.79 (d, <i>J</i> = 12.8 Hz, 1 H) 9.56 (br s, 2 H) 11.24 (s, 1 H) 12.41 (d, <i>J</i> = 12.8 Hz, 1 H).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4-[(3,4-Dihydroxy-benzylamino)-methylene]-4<i>H</i>-isoquinoline-1,3-dione (<b>3b</b>)</h4><div class="NLM_p last">The title compound was obtained by the procedure described above for <b>5e</b> except that the reaction was carried out at 115 °C for 1.5 h. Compound <b>1</b> (20.3 mg, 0.1 mmol), 3,4-dihydroxybenzylamine hydrobromide (<b>2b</b>) (22 mg, 0.1 mmol), and triethylamine (21 μL) were reacted to give 28.4 mg (91%) of <b>3b</b>. LC/MS1 R<i>t</i> 1.940 min, <i>m</i>/<i>z</i> 311.0 (M + H); LC/MS2 R<i>t</i> 1.67 min, <i>m</i>/<i>z</i> 311 (M + H); HRMS (ESI) <i>m</i>/<i>z</i> calcd for N<sub>17</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub> 311.1031; found, 311.1026 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.52 − 4.54 (m, 2 H), 6.63 (d, <i>J</i> = 8.0 Hz, 1H), 6.71 (s, 1H), 6.47 (d, <i>J</i> = 8.0 Hz, 1H), 7.17 (t, <i>J</i> = 7.4 Hz, <i>J</i> = 7.9 Hz, 1H), 7.55 (t, <i>J</i> = 7.4 Hz, <i>J</i> = 8.3 Hz, 1H), 7.83 (d, <i>J</i> = 8.3 Hz, 1H), 7.97 (d, <i>J</i> = 7.9 Hz, 1H), 8.61 (d, <i>J</i> = 13.2 Hz, 1H), 8.93 (s, 1H), 8.99 (s, H), 10.55 − 10.64 (m, 1H), 10.97 (s, 1H).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (4<i>Z</i>)-4-{[(4-Hydroxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>3c</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b> except without the addition of triethylamine, <b>1</b> (300 mg, 1.48 mmol) and 4-hydroxy-benzylamine (<b>2c</b>) (235 mg, 1.48 mmol) were reacted to give 200 mg (46%) of <b>3c</b> as a red-brown solid: mp 272−273 °C; MS (ESI) <i>m</i>/<i>z</i> 294.31 (M − 1)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.58 (d, <i>J</i> = 6.0 Hz, 2H), 6.76 (d, <i>J</i> = 8.3 Hz, 2H), 6.99 − 7.26 (m, 3H), 7.55 (t, <i>J</i> = 7.6 Hz, 1H), 7.83 (d, <i>J</i> = 8.3 Hz, 1H), 7.97 (d, <i>J</i> = 7.8 Hz, 1H), 8.62 (d, <i>J</i> = 13.3 Hz, 1H), 9.44 (s, 1H), 10.00 − 10.77 (m, 1H), 10.96 (s, 1H); Anal. (C<sub>17</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub>·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (4<i>Z</i>)-4-{[(3-Hydroxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>3d</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b> except without the addition of triethylamine, <b>1</b> (300 mg, 1.48 mmol) and 3-hydroxy-benzylamine (<b>2d</b>) (235 mg, 1.48 mmol) were reacted to give 200 mg (46%) of <b>3c</b> as a reddish-brown solid: mp 261−262 °C; MS (ESI) <i>m</i>/<i>z</i> 294.31 (M − 1); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.63 (d, <i>J</i> = 6.0 Hz, 2H), 6.69 (d, <i>J</i> = 8.0 Hz, 1H), 6.77 (m, 2H), 7.16 (t, <i>J</i> = 8.0 Hz, 2H), 7.56 (t, <i>J</i> = 7.3 Hz, 1H), 7.83 (d, <i>J</i> = 7.3 Hz, 1H), 7.98 (d, <i>J</i> = 7.3 Hz, 1 H), 8.63 (d, <i>J</i> = 13.3 Hz, 1H), 9.48 (s, 1H), 10.64 (m, 1H), 11.0 (s, 1 H); Anal. (C<sub>17</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub>·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (4<i>Z</i>)-4-{[(3-Hydroxy-4-methoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>3e</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>1</b> (0.2 g, 0.98 mmol) and 4-methoxyl-3-hydroxyl-benzylamine hydrochloride (<b>2e</b>) (0.2 g, 1.08 mmol) were reacted to give 0.25 g (78%) of <b>3e</b> as a red-brown solid: mp 192−193 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.75 (s, 3H), 4.56 (d, <i>J</i> = 4.5 Hz, 2H), 6.78 (m, 2H), 6.91 (d, <i>J =</i> 6 Hz, 1H), 7.17 (dd, <i>J =</i> 6, 6 Hz, 1H), 7.55 (dd, <i>J</i> = 6, 6 Hz, 1H), 7.83 (d, <i>J</i> = 6 Hz, 1H), 7.98 (d, <i>J =</i> 6 Hz, 1H), 8.62 (d, <i>J</i> = 9 Hz, 1H), 9.04 (s, 1H), 10.60 (m, 1H), 10.97 (s, 1H); MS (ESI) <i>m</i>/<i>z</i> 325.1 (M + H)<sup>+1</sup>; Anal. (C<sub>18</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-{[2-(3,4-Dihydroxy-phenyl)-ethylamino]-methylene}-4<i>H</i>-isoquinoline-1,3-dione (<b>3f</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>1</b> (20.3 mg, 0.1 mmol) and 3-hydroxytyramine hydrochloride (<b>2f</b>) (19 mg, 0.1 mmol) were reacted to give 18.1 mg (56%) of <b>3f</b> as a red-brown solid; LC/MS1 R<i>t</i> 1.748 min, <i>m</i>/<i>z</i> 325.0 (M + H)<sup>+1</sup>; LC/MS2 R<i>t</i> 1.73 min, <i>m</i>/<i>z</i> 325 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-D6) δ ppm 2.74 (t, <i>J</i> = 7.1 Hz, 2H), 3.65 (q, <i>J</i> = 7.1 Hz, <i>J</i> = 6.7 Hz, 2 H), 6.52 (dd, <i>J</i> = 9.6 Hz, <i>J</i> = 1.8 Hz, 1 H), 6.64 (d, <i>J</i> = 1.8 Hz, 1 H), 6.66 (d, <i>J</i> = 9.6 Hz, 1 H), 7.14 (t, <i>J</i> = 7.5 Hz, <i>J</i> = 7.8 Hz, 1 H), 7.51 (t, <i>J</i> = 8.4 Hz, 1 H), 7.72 (d, <i>J</i> = 8.4 Hz, 1 H), 7.95 (d, <i>J</i> = 7.8 Hz, 1 H), 8.41 (d, <i>J</i> = 13.5 Hz, 1 H), 8.77 (br s, 2 H), 10.37 − 10.45 (m, 1 H), 10.91 (s, 1 H).</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (4<i>Z</i>)-6-Fluoro-4-{[(3-hydroxy-4-methoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>5a</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, (4<i>E</i>)-6-fluoro-4-(methoxymethylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>4a</b>) (300 mg, 1.06 mmol) and 3-hydroxy-4-methoxy-benzylamine hydrogen chloride (<b>2e</b>) (201.2 mg, 1.06 mmol) were reacted to give 340 mg (94%) of <b>5a</b> as a light-brown solid: mp 200−201 °C; MS (ESI) <i>m</i>/<i>z</i> 342.33 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.75 (s, 3H), 4.56 (m, 2H), 6.77 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 6.81 (d, <i>J</i> = 2.0 Hz, 1H), 6.91 (d, <i>J</i> = 8.0 Hz, 1H), 6.95−7.0 (m, 1H), 7.68 (dd, <i>J</i> = 12, 2.0 Hz, 1H), 8.01 (m, <i>J</i> = 8.0, 1H), 8.65 (d, <i>J</i> = 12.0 Hz, 1H), 9.05 (s, 1H), 10.62 − 10.65 (m, 1H), 11.01 (s, 1H); Anal. (C<sub>18</sub>H<sub>15</sub>FN<sub>2</sub>O<sub>4</sub>·0.3 H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (4<i>Z</i>)-6-Chloro-4-{[(3-hydroxy-4-methoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>5b</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, (4<i>E</i>)-6-chloro-4-(methoxymethylene)-isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>4b</b>) (0.15 g, 0.63 mmol) and <b>2e</b> (0.114 g, 0.756 mmol) were reacted to give 0.182 g (80.2%) of <b>5b</b> as a tan solid: mp 265−266 °C; MS (ESI) <i>m</i>/<i>z</i> 357.5 (M − H)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.75 (s, 3 H), 4.57 (d, <i>J</i> = 6.0 Hz, 2 H), 6.78 (d, <i>J</i> = 8.1 Hz, 1 H), 6.82 (s, 1 H), 6.91 (d, <i>J</i> = 8.1 Hz, 1 H), 7.17 (d, <i>J</i> = 8.3 Hz, 1 H), 7.81 − 8.08 (m, 2 H), 8.71 (d, <i>J</i> = 13.4 Hz, 1 H), 9.05 (s, 1 H), 10.45 − 10.85 (m, 1 H), 11.07 (s, 1 H); Anal. (C<sub>18</sub>H<sub>15</sub>ClN<sub>2</sub>O<sub>4</sub>·0.8 H<sub>2</sub>O) C, N. H: calcd, 4.48; found, 4.06.</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (4<i>Z</i>)-5-Bromo-4-{[(3-hydroxy-4-methoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>5c</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, (4<i>E</i>)-5-bromo-4-(methoxymethylene)-isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>4c</b>) (132 mg, 0.468 mmol) and <b>2e</b> (88.5 mg, 0.468 mmol) were reacted to give 163 mg (86%) of <b>5c</b> as a pale yellow amorphous solid: mp 204−206 °C; HRMS (ESI) <i>m</i>/<i>e</i> calcd for C<sub>25</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub> 431.20886; found, 431.20820 (M − H)<sup>−1</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub><i>6</i></sub>) δ 3.75 (s, 3H), 4.49 (d, 2H, <i>J</i> = 5.4 Hz), 6.78 (m, 2H), 6.91 (d, 1H, <i>J</i> = 8.1 Hz), 7.09 (m, 1H), 7.87 (d, 1H, <i>J</i> = 6.9 Hz), 8.05 (d, 1H, <i>J</i> = 6.9 Hz), 8.93 (d, 1H, <i>J</i> = 13.6 Hz), 9.08 (s, 1H), 10.56 (m, 1H), 11.11 (s, 1H); Anal. (C<sub>18</sub>H<sub>15</sub>BrN<sub>2</sub>O<sub>4</sub>·1.25 H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (4<i>Z</i>)-6-Bromo-4-{[(3-hydroxy-4-methoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>5d</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, (4<i>E</i>)-6-bromo-4-(methoxymethylene)-isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>4d</b>) (300 mg, 1.06 mmol) and <b>2e</b> (201.2 mg, 1.06 mmol) were reacted to give 340 mg (77%) of <b>5d</b> as a light-brown solid: mp 243−244 °C; MS (ESI) <i>m</i>/<i>z</i> 413.23 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.75 (s, 3H), 4.56 (m, 2H), 6.77 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 6.81 (d, <i>J</i> = 2.0 Hz, 1H), 6.91 (d, <i>J</i> = 8.4 Hz, 1H), 7.30 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 7.87 (d, <i>J</i> = 8.4 Hz, 1H), 8.10 (d, <i>J</i> = 1.2 Hz, 1H), 8.71 (m, 1H), 9.05 (s, 1H), 10.56 − 10.75 (m, 1H), 11.07 (s, 1H); Anal. (C<sub>18</sub>H<sub>15</sub>BrN<sub>2</sub>O<sub>4</sub>·0.5 H<sub>2</sub>O) C, N. H: calcd, 3.99; found, 3.56.</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-[(3-Hydroxy-4-methoxy-benzylamino)-methylene]-6-methoxy-4<i>H</i>-isoquinoline-1,3-dione (<b>5f</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, (4<i>E</i>)-6-methoxy-4-(methoxymethylene)-isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>4d</b>) (117 mg, 0.50 mmol) and <b>2e</b> (145 mg, 0.50 mmol) were reacted to give 161 mg (91%) of <b>5f</b> as a light beige solid: mp 240−242 °C (dec); MS (ESI) <i>m</i>/<i>z</i> 355.2 (M − 1)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.75 (s, 3H), 3.88 (s, 3H), 4.58 (d, <i>J</i> = 6.0 Hz, 2H), 6.72 − 6.79 (m, 2H), 6.80 (d, <i>J</i> = 2.0 Hz, 1H), 6.91 (d, <i>J</i> = 8.2 Hz, 1H), 7.27 (d, <i>J</i> = 2.01 Hz, 1H), 7.90 (d, <i>J</i> = 9.1 Hz, 1H), 8.63 (d, <i>J</i> = 13.2 Hz, 1H), 9.07 (bs, 1H), 10.63 (dt, <i>J =</i> 13.3, 5.8 Hz, 1H), 10.78 (s, 1H); Anal. (C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>O<sub>5</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (4<i>Z</i>)-4-{[(3-hydroxy-4-methoxybenzyl)amino]methylene}-6-(1<i>H</i>-pyrrol-1-yl)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>5g</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, (4<i>E</i>)-4-(methoxymethylene)-6-(1<i>H</i>-pyrrol-1-yl)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>4g</b>) (100 mg, 0.38 mmol) and <b>2e</b> (60 mg, 0.35 mmol) were reacted to give 90 mg (66%) of <b>5g</b> as a light brown solid: mp 252−253 °C; MS (ESI) <i>m</i>/<i>z</i> 389.41 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.75 (s, 3H), 4.60 (m, 2H), 6.34 (t, <i>J</i> = 4.0, 2.0 Hz, 2H), 6.78 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 6.82 (d, <i>J</i> = 2.0 Hz, 1H), 6.92 (d, <i>J</i> = 8.4 Hz, 1H), 7.41 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 7.59 (t, <i>J</i> = 4.0, 2.0 Hz, 2H), 7.92 (d, <i>J</i> = 2.0 Hz, 1H), 8.02 (d, <i>J</i> = 8.8 Hz, 1H), 8.80 (m, 1H), 9.07 (s, 1H), 10.37 − 10.78 (m, 1H), 10.96 (s, 1H); Anal. (C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub>·0.6H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (4<i>Z</i>)-4-{[(3-Hydroxy-4-methoxybenzyl)amino]methylene}-6-thien-3-ylisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>5h</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, (4<i>E</i>)-4-(methoxymethylene)-6-(3-thienyl)-isoquinoline-1,3(2<i>H</i>,4<i>H</i>-dione (<b>4h</b>) (0.15 g, 0.53 mmol) and <b>2e</b> (0.11 g, 0.62 mmol) were reacted to give 0.18 g (86%) of <b>5h</b> as a tan solid: mp 219−220 °C, MS (ESI) <i>m</i>/<i>z</i> 407.1 (M + H)<sup>+1</sup>; Anal. (C<sub>22</sub>H<sub>18</sub>N<sub>2</sub>O<sub>4</sub>S ·0.8H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (4<i>Z</i>)-6-(3-Furyl)-4-{[(3-hydroxy-4-methoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>5i</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, (4<i>E</i>)-6-(3-furyl)-4-(methoxymethylene)-isoquinoline-1,3(2<i>H</i>,4<i>H</i>-dione (<b>4h</b>) (160 mg, 0.59 mmol) and <b>2e</b> (94.6 mg, 0.59 mmol) were reacted to give 150 mg (65%) of <b>5i</b> as a brown solid: mp 254−255 °C; MS (ESI) <i>m</i>/<i>z</i> 390.40 (M − 1)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.75 (s, 3H), 4.60 (m, 2H), 6.78 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 6.82 (d, <i>J</i> = 2.0 Hz, 1H), 6.92 (d, <i>J</i> = 8.0 Hz, 1H), 7.17 (d, <i>J</i> = 1.2 Hz, 1H), 7.44 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 7.82 (m, 1H), 7.76 (d, <i>J</i> = 8.4 Hz, 1H), 8.0 (m, 1H), 8.36 (m, 1H), 8.75 (m, 1H), 9.07 (s, 1H), 10.56 − 10.74 (m, 1H), 10.94 (s, 1H); Anal. (C<sub>22</sub>H<sub>18</sub>N<sub>2</sub>O<sub>5</sub> ·0.7H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 4-[(3-Hydroxy-4-methoxy-benzylamino)-methylene]-6-phenyl-4<i>H</i>-isoquinoline-1,3-dione (<b>5j</b>)</h4><div class="NLM_p last">To a suspension of <b>5d</b> (40 mg, 0.1 mmol) in DMF (1 mL) was added phenylboronic acid (14.6 mg, 0.12 mmol), followed by 60 μL of 2 M aqueous cesium carbonate and tetrakistriphenylphosphine palladium (6 mg, 0.005 mmol). The reaction mixture was subjected to microwave heating at 150 °C under microwave conditions for 5 min. The reaction mixture was then diluted to 2 mL with DMF and purified by C18 reverse phase HPLC. The pure fractions were combined and concentrated to yield 6.2 mg (15.5%) of <b>5j</b>; LC/MS1 R<i>t</i> 2.620 min, <i>m</i>/<i>z</i> 401.0 (M + H)<sup>+1</sup>; LC/MS2 R<i>t</i> 2.36 min, <i>m</i>/<i>z</i> 401 (M + H)<sup>+1</sup>; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub> 401.1498; found, 401.1496 (M + H)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-d6) δ ppm 3.81 (s, 3H), 4.59 − 4.62 (m, 2H), 6.78 (d, <i>J</i> = 8.13 Hz, 1H), 6.82 (s, 1H), 6.91 (d, <i>J</i> = 8.1 Hz, 1H), 7.44 − 7.55 (m, 4H), 7.82 (d, <i>J</i> = 7.2 Hz, 2H), 8.05 (d, <i>J</i> = 8.2 Hz, 1H), 8.09 (s, 1H), 8.83 (d, <i>J</i> = 13.2 Hz, 1H), 9.06 (s, 1H), 10.61 − 10.71 (m, 1H), 10.99 (s, 1H).</div></div><div id="sec4_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (4<i>Z</i>)-6-Bromo-4-({[1-(3-hydroxy-4- methoxyphenyl)ethyl]amino}methylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>11</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4d</b> (0.10 g, 0.35 mmol) and 5-(1-amino-ethyl)-2-methoxyphenol hydrochloride (<b>10</b>) (0.142, 0.70 mmol) were reacted to give 0.11 (73%) of <b>11</b> as a light tan powder: MS (ESI) <i>m</i>/<i>z</i> 417.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.59 (d, <i>J =</i> 6.8 Hz, 3H), 3.75 (s, 3H), 4.76 − 4.85 (m, 1H), 6.80 (dd, <i>J =</i> 8.4, 2.0 Hz, 1H), 6.83 (d, <i>J =</i> 2.0 Hz, 1H), 6.93 (d, <i>J =</i> 8.4 Hz, 1H), 7.30 (dd, <i>J =</i> 8.4, 1.6 Hz, 1H), 7.86 (d, <i>J =</i> 8.4 Hz, 1H), 8.09 (d, <i>J =</i> 1.6 Hz, 1H), 8.69 (d, <i>J =</i> 13.2 Hz, 1H), 9.08 (s, 1H), 10.79 (dd, <i>J =</i> 13.2, 8.4 Hz, 1H), 11.13 (s, 1H); Anal. (C<sub>19</sub>H<sub>17</sub>BrN<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (4<i>Z</i>)-6-Bromo-4-{[(3-hydroxy-4-methoxybenzyl)(methyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>13</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>3c</b>, except for replacing DMF with tetrahydrofuran, <b>4d</b> (0.15 g, 0.53 mmol) and 2-methoxy-5-methylaminomethyl-phenol (<b>12</b>) (80 mg, 0.48 mmol) were reacted to give 0.19 g (95%) of <b>13</b> as a yellow solid: MS (ESI) <i>m</i>/<i>z</i> 417.9, 419.9 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.10 (s, 3H), 3.81 (s, 3H), 4.81 (s, 2H), 6.81 (d, <i>J =</i> 2.0 Hz, 1H), 6.84 (d, <i>J =</i> 2.0 Hz, 1H), 6.93 (d, <i>J =</i> 8.8 Hz, 1H), 7.28 (dd, <i>J =</i> 8.4, 1.6 Hz, 1H), 7.83 (d, <i>J =</i> 1.6 Hz, 1H), 7.91 (d, <i>J =</i> 8.4 Hz, 1H), 8.50 (s, 1H), 9.10 (s, 1H), 10.73 (s, 1H); Anal. (C<sub>19</sub>H<sub>17</sub>BrN<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> (4<i>Z</i>)-6-Bromo-4-{[(3,4-dihydroxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>17a</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4d</b> (1.21 g, 4.3 mmol) and 3,4-dihydroxybenzylamine (<b>16a</b>) (0.596 g, 4.3 mmol) were reacted, and the crude product was purified by high performance liquid chromatography to give 910 mg (54%) of <b>17a</b> as a white solid: MS (ESI) <i>m</i>/<i>z</i> 389.7 (M + 1);<sup>1</sup>H NMR (400 MHz, DMSO-D6) δ ppm 4.53 (d, <i>J</i> = 6.3 Hz, 2H), 6.63 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 6.72 (d, <i>J</i> = 7.5 Hz, 1H), 6.76 (d, <i>J</i> = 1.7 Hz, 1H), 7.30 (dd, <i>J</i> = 8.3, 1.6 Hz, 1H), 7.87 (d, <i>J</i> = 8.3 Hz, 1H), 8.11 (d, <i>J</i> = 1.5 Hz, 1H), 8.71 (d, <i>J</i> = 13.3 Hz, 1H), 8.91 (s, 1H), 8.97 (s, 1H), 10.64 (m, 1H), 11.07 (s, 1H); Anal. (C<sub>17</sub>H<sub>13</sub>BrN<sub>2</sub>O<sub>4</sub>·0.5 H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> (4<i>Z</i>)-6-Bromo-4-{[(3-hydroxy-4 propoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>17b</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4d</b> (171 mg, 0.607 mmol) and 5-(aminomethyl)-2-propoxyphenol (<b>16b</b>) (100 mg, 0.55 mmol) were reacted, and the crude product was purified by high performance liquid chromatography to give 67 mg (28%) of <b>17b</b> as a white solid: MS (ESI) <i>m</i>/<i>z</i> 430.8 (M + 1)<sup>+1</sup>; HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>BrN<sub>2</sub>O<sub>4</sub> 431.06010; found, 431.05984 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.97 (t, <i>J =</i> 7.4 Hz, 3H), 1.56 − 1.91 (m, 2H), 3.89 (t, <i>J =</i> 6.6 Hz, 2H), 4.56 (d, <i>J =</i> 6.0 Hz, 2H), 6.64 − 6.77 (m, 1H), 6.82 (s, 1H), 6.89 (d, <i>J =</i> 8.3 Hz, 1H), 7.30 (d, <i>J =</i> 8.7 Hz, 1H), 7.87 (d, <i>J =</i> 8.7 Hz, 1H), 8.11 (s, 1H), 8.72 (d, <i>J =</i> 13.2 Hz, 1H), 8.97 (s, 1H), 10.41 − 10.89 (m, 1H), 11.10 (s, 1H); Anal. (C<sub>20</sub>H<sub>19</sub>BrN<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> (4<i>Z</i>)-6-Bromo-4-({[3-hydroxy-4-(2-methoxyethoxy)benzyl]amino}methylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>17c</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4d</b> (400 mg, 1.42 mmol) and 5-(aminomethyl)-2-(methoxyethoxy)phenol (<b>16c</b>) (330 mg, 1.67 mmol) were reacted to give 480 mg (76%) of <b>17c</b> as a tan solid: mp 179−180 °C; MS (ESI) <i>m</i>/<i>z</i> 447.0−449.0 (M + H)<sup>+1</sup>;<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.30 (s, 3 H), 3.47 − 3.69 (m, 2 H), 3.92 − 4.19 (m, 2 H), 4.57 (d, <i>J</i> = 6.3 Hz, 2 H), 6.75 (dd, <i>J</i> = 8.3, 2.0 Hz, 1 H), 6.83 (d, <i>J</i> = 2.0 Hz, 1 H), 6.92 (d, <i>J</i> = 8.3 Hz, 1 H), 7.30 (dd, <i>J</i> = 8.4, 1.7 Hz, 1 H), 7.87 (d, <i>J</i> = 8.4 Hz, 1 H), 8.11 (d, <i>J</i> = 1.7 Hz, 1 H), 8.72 (d, <i>J</i> = 13.35 Hz, 1 H), 9.06 (s, 1 H), 10.45 − 10.81 (m, 1 H), 11.09 (s, 1 H); Anal. (C<sub>20</sub>H<sub>19</sub>BrN<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> (4<i>Z</i>)-6-bromo-4-{[(4-ethoxy-3-hydroxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>17d</b>)</h4><div class="NLM_p last">To a solution of 1-iodoethane (43.3 μL, 0.28 mmol) in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (2 mL) was added potassium carbonate (207 mg, 1.5 mmol). The mixture was stirred at room temperature, and <b>17a</b> (100 mg, 0.26 mmol) was added. After the mixture was stirred at 65 °C for 30 min, the resulting mixture was concentrated, and the residue was then partitioned between water (50 mL) and ethyl acetate (50 mL). The organic layer was then dried and purified by high performance liquid chromatography to give 26 mg (24%) of <b>17d</b> as a white solid. MS (ESI) <i>m</i>/<i>z</i> 416.7 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.31 (t, <i>J =</i> 7.0 Hz, 3H), 3.99 (q, <i>J =</i> 7.0 Hz, 2H), 4.56 (d, <i>J =</i> 6.3 Hz, 2H), 6.75 (dd, <i>J =</i> 8.3, 2.0 Hz, 1H), 6.82 (d, <i>J =</i> 2.0 Hz, 1H), 6.90 (d, <i>J =</i> 8.3 Hz, 1H), 7.30 (dd, <i>J =</i> 8.5, 1.6 Hz, 1H), 7.87 (d, <i>J =</i> 8.5 Hz, 1H), 8.11 (d, <i>J =</i> 1.7 Hz, 1H), 8.71 (d, <i>J =</i> 13.3 Hz, 1H), 9.00 (s, 1H), 10.45 − 10.94 (m, 1H), 11.09 (s, 1H); Anal. (C<sub>19</sub>H<sub>17</sub>BrN<sub>2</sub>O<sub>4</sub>·0.3DMF·0.5TFA) C, H, N.</div></div><div id="sec4_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> (4<i>Z</i>)-6-Bromo-4-{[(3-hydroxy-4,5-dimethoxybenzyl)amino]methylene}isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>18</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4d</b> (400 mg, 1.42 mmol) and 3-hydroxy-4,5-dimethoxybenzylamine (272 mg, 1.15 mmol) were reacted to give 400 mg (65%) of <b>18</b> as a brown solid: mp 262−263 °C; MS (ESI) <i>m</i>/<i>z</i> 433.26 (M − 1)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.64 (s, 3H), 3.76 (s, 3H), 4.56 (m, 2H), 6.49 (d, <i>J</i> = 1.2 Hz, 1H), 6.55 (m, 1H), 7.3 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 7.87 (d, <i>J</i> = 8.4 Hz, 1H), 8.10 (m, 1H) 8.70 (m, 1H), 9.24 (s, 1H), 10.50 − 10.80 (m, 1H), 11.09 (s, 1H); Anal. (C<sub>19</sub>H<sub>17</sub>BrN<sub>2</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec4_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> (4<i>Z</i>)-4-{[(4-Amino-3-hydroxybenzyl)amino]methylene}-6-bromoisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>21</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4d</b> (500 mg, 1.77 mmol) and 2-amino-5-(aminomethyl)phenol hydrochloride (<b>20</b>) (448 mg, 2.57 mmol) were reacted to give 700 mg (100%) of <b>21</b> as a yellowish brown solid: mp 245−246 °C; MS (ESI) <i>m</i>/<i>z</i> 390 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.45 (m, 2H), 4.56 (m, 2H), 6.57 (m, 2H), 6.66 (m, 1H), 7.29 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 1H), 8.11 (d, <i>J</i> = 2.0 Hz, 1H), 8.71 (m, 1H), 9.09 (s, 1H), 10.48 − 10.75 (m, 1H), 11.07 (s, 1H); Anal. (C<sub>17</sub>H<sub>14</sub>BrN<sub>3</sub>O<sub>3</sub>·1.4 H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> (4<i>Z</i>)-4-{[(4-Methyl-3-hydroxybenzyl)amino]methylene}−6-iodoisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>89a</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4e</b> (200 mg, 0.61 mmol) and 5-aminomethyl-2-methyl-phenol hydrogen chloride (<b>25</b>) (105.64 mg, 0.61 mmol) were reacted to give 120 mg (45%) of <b>89a</b> as an orange solid: mp 312−313 °C; MS (APCI); HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>15</sub>IN<sub>2</sub>O<sub>3</sub> 435.02002; found, 435.02006 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.08 (s, 3H), 4.61 (m, 2H), 6.70 (d, <i>J</i> = 7.6 Hz, 1H), 6.75 (m, 1H), 7.1 (d, <i>J</i> = 7.6 Hz, 1H), 7.5 (dd, <i>J</i> = 8.0, 1.0 Hz, 1H), 7.70 (d, <i>J</i> = 8.0 Hz, 1H), 8.28 (d, <i>J</i> = 1.0 Hz, 1H), 8.73 (m, 1H), 9.40 (s, 1H), 10.64 − 10.68 (m, 1H), 11.08 (s, 1H); Anal. (C<sub>18</sub>H<sub>15</sub>IN<sub>2</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 4-{[(2-Hydroxy-biphenyl-4-ylmethyl)-amino]-methylene}-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>89b</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, except without the addition of triethylamine, <b>4e</b> (110 mg, 0.34 mmol) and 4-aminomethyl-biphenyl-2-ol (<b>34</b>) (80 mg, 0.4 mmol) were reacted to give 151 mg (89%) of <b>89b</b>: MS (ESI) <i>m</i>/<i>z</i> 495.1 (M − 1)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.68 (d, <i>J =</i> 6.6 Hz, 2H), 6.61 − 6.96 (m, 2H), 7.23 − 7.32 (m, 2H), 7.34 − 7.42 (m, 2H), 7.48 − 7.53 (m, 2H), 7.53 (d, <i>J =</i> 1.5 Hz, 1H), 7.69 (d, <i>J =</i> 8.3 Hz, 1H), 8.30 (d, <i>J =</i> 1.5 Hz, 1H), 8.75 (d, <i>J =</i> 13.1 Hz, 1H), 9.67 (s, 1H), 10.65 − 10.81 (m, 1H), 11.10 (s, 1H); Anal. (C<sub>23</sub>H<sub>20</sub>IN<sub>3</sub>O<sub>4</sub>·0.7H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 4-[(4-Furan-2-yl-3-hydroxy-benzylamino)-methylene]-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>89c</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4e</b> (80 mg, 0.24 mmol) and 5-aminomethyl-2-furan-3-yl-phenol (<b>41</b>) (50 mg, 0.26 mmol) were reacted to give 62 mg (53%) of <b>89c</b>: MS (ESI) <i>m</i>/<i>z</i> 485.1 (M − 1)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.67 (d, <i>J =</i> 6.3 Hz, 2H), 6.56 (dd, <i>J =</i> 3.3, 1.8 Hz, 1H), 6.88 (dd, <i>J =</i> 8.1, 1.5 Hz, 1H), 6.90 − 6.94 (m, 2H), 7.50 (dd, <i>J =</i> 8.3, 1.3 Hz, 1H), 7.57 − 7.79 (m, 3H), 8.16 − 8.35 (m, 1H), 8.73 (d, <i>J =</i> 13.4 Hz, 1H), 10.23 (s, 1H), 10.47 − 10.82 (m, 1H), 11.08 (s, 1H); Anal. (C<sub>21</sub>H<sub>15</sub>IN<sub>2</sub>O<sub>4</sub>·0.5H<sub>2</sub>O) C, H. N: calcd, 5.66; found 5.23.</div></div><div id="sec4_5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 4-[(4-Furan-3-yl-3-hydroxy-benzylamino)-methylene]-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>89d</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4e</b> (85 mg, 0.26 mmol) and 5-aminomethyl-2-furan-3-yl-phenol (<b>45a</b>) (73 mg, 0.39 mmol) were reacted to give 70 mg (56%) of <b>89d</b>: MS (ESI) <i>m</i>/<i>z</i> 487.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.66 (d, <i>J =</i>6.6 Hz, 2H), 6.85 (dd, <i>J =</i> 7.9, 1.6 Hz, 1H), 6.90 (d, <i>J =</i> 1.6 Hz, 1H), 6.99 (d, <i>J =</i> 1.3 Hz, 1H), 7.49 (dd, <i>J =</i> 8.1, 1.5 Hz, 1H), 7.54 (d, <i>J =</i> 8.1 Hz, 1H), 7.67 − 7.72 (m, 2H), 8.12 (s, 1H), 8.24 − 8.37 (m, 1H), 8.74 (d, <i>J =</i> 13.4 Hz, 1H), 10.06 (s, 1H), 10.56 − 10.78 (m, 1H), 11.08 (s, 1H); Anal. (C<sub>21</sub>H<sub>15</sub>IN<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 4-[(3-Hydroxy-4-pyridin-2-yl-benzylamino)-methylene]-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>89e</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4e</b> (98 mg, 0.30 mmol) and 5-aminomethyl-2-pyridin-2-yl-phenol (<b>45b</b>) (60 mg, 0.30 mmol) were reacted to give 85 mg (57%) of <b>89e</b>: MS (ESI) <i>m</i>/<i>z</i> 498.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.69 (d, <i>J =</i> 6.3 Hz, 2H), 6.75 − 7.02 (m, 2H), 7.43 (dd, <i>J =</i> 7.1, 5.5 Hz, 1H), 7.50 (d, <i>J =</i> 8.3 Hz, 1H), 7.69 (d, <i>J =</i> 8.3 Hz, 1H), 7.95 − 8.08 (m, 2H), 8.20 (d, <i>J =</i> 7.8 Hz, 1H), 8.28 (s, 1H), 8.61 (d, <i>J =</i> 5.0 Hz, 1H), 8.71 (d, <i>J =</i> 13.4 Hz, 1H), 10.37 − 11.03 (m, 1H), 11.07 (s, 1H), 14.27 (s, 1H); Anal. (C<sub>22</sub>H<sub>16</sub>IN<sub>3</sub>O<sub>3</sub>·0.3TFA) C, H, N.</div></div><div id="sec4_5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 4-[(3-Hydroxy-4-pyridin-3-yl-benzylamino)-methylene]-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>89f</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4e</b> (50 mg, 0.15 mmol) and 5-aminomethyl-3-pyridin-2-yl-phenol (<b>45c</b>) (53 mg, 0.27 mmol) were reacted to give 57 mg (76%) of <b>89f</b>: MS (ESI) <i>m</i>/<i>z</i> 498.0 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.68 (d, <i>J =</i> 6.3 Hz, 2H), 6.58 − 7.06 (m, 2H), 7.33 (d, <i>J =</i> 7.6 Hz, 1H), 7.42 (dd, <i>J =</i> 7.6, 4.0 Hz, 1H), 7.50 (dd, <i>J =</i> 8.3, 1.3 Hz, 1H), 7.69 (d, <i>J =</i> 8.3 Hz, 1H), 7.86 − 8.00 (m, 1H), 8.27 (d, <i>J =</i> 1.3 Hz, 1H), 8.47 (d, <i>J =</i> 4.0 Hz, 1H), 8.58 − 8.79 (m, 2H), 9.96 (s, 1H), 10.53 − 10.79 (m, 1H), 11.07 (s, 1H); Anal. (C<sub>22</sub>H<sub>16</sub>IN<sub>3</sub>O<sub>3</sub>·0.4H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 4-[(3-Hydroxy-4-pyridin-4-yl-benzylamino)-methylene]-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>89g</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4e</b> (50 mg, 0.15 mmol) and 5-aminomethyl-4-pyridin-2-yl-phenol (<b>45d</b>) (40 mg, 0.20 mmol) were reacted to give 30 mg (40%) of <b>89g</b>: MS (ESI) <i>m</i>/<i>z</i> 498.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.69 (d, <i>J =</i> 6.0 Hz, 2H), 6.88 − 7.06 (m, 2H), 7.39 (d, <i>J =</i> 7.9 Hz, 1H), 7.50 (d, <i>J =</i> 8.3 Hz, 1H), 7.58 (d, <i>J =</i> 5.7 Hz, 2H), 7.69 (d, <i>J =</i> 8.3 Hz, 1H), 8.28 (s, 1H), 8.55 (d, <i>J =</i> 5.7 Hz, 2H), 8.73 (d, <i>J =</i> 13.2 Hz, 1H), 10.07 (s, 1H), 10.71 (d, <i>J =</i> 13.2 Hz, 1H), 11.10 (s, 1H); Anal. (C<sub>22</sub>H<sub>16</sub>IN<sub>3</sub>O<sub>3</sub>·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> (4<i>Z</i>)-4-{[(3-Hydroxy-4-propoxybenzyl)amino]methylene}-6-iodoisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>89h</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4e</b> (2.5 g, 7.6 mmol) and 5-(aminomethyl)-2-propoxyphenol hydrochloride (<b>16b</b>) (1.82 g, 8.36 mmol) were reacted to give 3.0 g (83%) of <b>89h</b> as a tan solid: MS (ESI) <i>m</i>/<i>z</i> 479.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.97 (t, <i>J</i> = 6.9 Hz, 3H), 1.71 (m, 2H), 3.90 (t, <i>J</i> = 6.9 Hz, 2H), 4.57 (d, <i>J</i> = 8.6 Hz, 2H), 6.74 (d, <i>J</i> = 8.8 Hz, 1H), 6.81 (m, 1H), 6.90 (d, <i>J</i> = 7.5 Hz, 1H), 7.48 (d, <i>J</i> = 8.8 Hz, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 8.27 (s, 1H), 8.73 (m, 1H), 8.94 (s, 1H), 10.66 (m, 1H), 11.05 (s, 1H); HRMS (ESI) <i>m</i>/<i>e</i> calcd for C<sub>20</sub>H<sub>19</sub>IN<sub>2</sub>O<sub>4</sub> 479.04623; found, 479.04449 (M + H)<sup>+1</sup>; Anal. (C<sub>20</sub>H<sub>19</sub>IN<sub>2</sub>O<sub>4</sub>·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 4-{[(4-Hydroxy-5-methoxy-pyrimidin-2-ylmethyl)-amino]-methylene}-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>90</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4e</b> (50 mg, 0.15 mmol) and 2-aminomethyl-5-methoxy-pyrimidin-4-ol <b>(51)</b> (10 mg, 0.064 mmol) were reacted to give 10 mg (34%) of <b>90</b>: MS (ESI) <i>m</i>/<i>z</i> 453 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.72 (s, 3H), 4.57 (d, <i>J</i> = 6.0 Hz, 2H), 7.44 − 7.56 (m, 2H), 7.69 (d, <i>J</i> = 8.3 Hz, 1H), 7.89 (s, 1H), 8.20 (s, 1H), 10.55 (d, <i>J</i> = 13.1 Hz, 1H), 11.09 (s, 1H), 12.74 (s, 1H).</div></div><div id="sec4_5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> (4<i>Z</i>)-6-Bromo-4-({[(2-methoxypyridin-4-yl)methyl]amino}methylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>91</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4d</b> (0.15 g, 0.53 mmol) and 4-(2-methoxypyridyl)methylamine hydrochloride (<b>54</b>) (93 mg, 0.53 mmol) were reacted to give 0.13 (62%) of <b>91</b> as a golden solid: MS (ESI) <i>m</i>/<i>z</i> 388.0, 390.0 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.84 (s, 3H), 4.68 (d, <i>J =</i> 6.4 Hz, 2H), 6.76 (s, 1H), 6.98 (dd, <i>J =</i> 5.2, 1.2 Hz, 1H), 7.32 (dd, <i>J =</i> 8.4, 1.6 Hz, 1H), 7.87 (d, <i>J =</i> 8.4 Hz, 1H), 8.08 (d, <i>J =</i> 1.6 Hz, 1H), 8.15 (d, <i>J =</i> 5.2 Hz, 1H), 8.68 (d, <i>J =</i> 13.2 Hz, 1H), 10.66 (dd, <i>J =</i> 13.2, 6.4 Hz, 1H), 11.12 (s, 1H); Anal. (C<sub>17</sub>H<sub>14</sub>BrN<sub>3</sub>O<sub>3</sub>·0.2TFA) C, H, N.</div></div><div id="sec4_5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 4-{[(6-Hydroxy-5-propoxy-pyridin-2-ylmethyl)-amino]-methylene}-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>92</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4e</b> (165 mg, 0.50 mmol) and 6-aminomethyl-3-propoxy-pyridin-2-ol (<b>88</b>) (91 mg, 0.50 mmol) were reacted to give 152 mg (63%) of <b>92</b> as a beige solid: mp 275−81 °C (dec); MS (ESI) <i>m</i>/<i>z</i> 478.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.95 (t, <i>J</i> = 7.4 Hz, 3H), 1.64 − 1.76 (m, 2H), 3.81 (t, <i>J</i> = 6.6 Hz, 2H), 4.41 (d, <i>J</i> = 6.1 Hz, 2H), 6.11 (d, <i>J</i> = 6.8 Hz, 1H), 6.79 (d, <i>J</i> = 7.3 Hz, 1H), 7.50 (d, <i>J</i> = 8.1 Hz, 1H), 7.68 (d, <i>J</i> = 8.31 Hz, 1H), 8.19 (s, 1H), 8.57 (d, <i>J</i> = 13.3 Hz, 1H), 10.52 (dt, <i>J =</i> 13.0, 6.1 Hz,, 1H), 11.09 (s, 1H), 11.84 (s, 1H); Anal. (C<sub>19</sub>H<sub>18</sub>IN<sub>3</sub>O<sub>4</sub>·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 6-Bromo-4-{[(5-methoxy-4-oxo-4<i>H</i>-pyran-2-ylmethyl)-amino]-methylene}-4<i>H</i>-isoquinoline-1,3-dione (<b>93</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4d</b> (212 mg, 0.75 mmol) and 2-aminomethyl-5-methoxy-pyran-4-one<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (<b>70a</b>) (116 mg, 0.75 mmol) were reacted to give 152 mg (50%) of <b>93</b> as a light pink solid: mp 259−61 °C (dec); MS (ESI) <i>m</i>/<i>z</i> 403 (M − 1)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.65 (s, 3H), 4.59 (d, <i>J</i> = 6.3 Hz, 2H), 6.29 (s, 1H), 7.34 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.88 (d, <i>J</i> = 8.6 Hz, 1H), 8.05 (d, <i>J</i> = 1.7 Hz, 1H), 8.17 (s, 1H), 8.61 (d, <i>J</i> = 13.2 Hz, 1H), 10.47 (dt, <i>J =</i> 13.2, 6.3 Hz, 1H), 11.15 (s, 1H); Anal. (C<sub>17</sub>H<sub>13</sub> BrN<sub>2</sub>O<sub>5</sub>·0.1TFA) C, N. H: calcd, 3.18; found, 2.67.</div></div><div id="sec4_5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> (4<i>Z</i>)-6-Bromo-4-({[(2-oxo-1,2-dihydropyridin-4-yl)methyl]amino}methylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>94a</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4d</b> (0.26 g, 0.94 mmol) and 4-aminomethyl-1<i>H</i>-pyridin-2-one hydrochloride (<b>55</b>) (0.15 g, 0.94 mmol) were reacted to give 0.19 g (54%) of <b>94a</b> as a gray powder: MS (ESI) <i>m</i>/<i>z</i> 372.0, 347.0 (M − 1)<sup>−1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.51 (d, <i>J =</i> 6.4 Hz, 2H), 6.17 (dd, <i>J =</i> 6.8, 2.0 Hz, 1H), 6.20 (s, 1H), 7.32 (dd, <i>J =</i> 8.4, 2.0 Hz, 1H), 7.36 (d, <i>J =</i> 6.8 Hz, 1H), 7.87 (d, <i>J =</i> 8.4 Hz, 1H), 8.07 (d, <i>J =</i> 2.0 Hz, 1H), 8.63 (d, <i>J =</i> 13.2 Hz, 1H), 10.59 (dt, <i>J =</i> 6.4, 13.2 Hz, 1H), 11.13 (s, 1H), 11.53 (s, 1H); Anal. (C<sub>16</sub>H<sub>12</sub>BrN<sub>3</sub>O<sub>3</sub>·0.22TFA) C, H, N.</div></div><div id="sec4_5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> (4<i>Z</i>)-6-Iodo-4-({[(2-oxo-1-phenyl-1,2dihydropyridin-4-yl)methyl]amino}methylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>94b</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4e</b> (92 mg, 0.28 mmol) and 4-aminomethyl-1-phenyl-1<i>H</i>-pyridin-2-one hydrochloride (<b>58</b>) (66 mg, 0.28) were reacted to give 8.8 mg (6.3%) of <b>94b</b> as a pale yellow solid: MS (ESI) <i>m</i>/<i>z</i> 498.2 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.59 (d, <i>J =</i> 6.4 Hz, 2H), 6.35 (dd, <i>J =</i> 5.2, 1.6 Hz, 1H), 6.37 (s, 1H), 7.37 − 7.54 (m, 6 H), 7.67 (dd, <i>J =</i> 6.8, 0.4 Hz, 1H), 7.69 (d, <i>J =</i> 8.4 Hz, 1H), 8.26 (d, <i>J =</i> 1.2 Hz, 1H), 8.65 (d, <i>J =</i> 13.2 Hz, 1H), 10.62 (dt, <i>J =</i> 13.2, 6.4 Hz, 1H), 11.12 (s, 1H); Anal. (C<sub>22</sub>H<sub>16</sub>IN<sub>3</sub>O<sub>3</sub>·0.51TFA) C, H, N.</div></div><div id="sec4_5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> (4<i>Z</i>)-4-[({[1-(3-Furyl)-2-oxo-1,2-dihydropyridin-4-yl]methyl}amino)methylene]-6-iodoisoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>94c</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>5e</b>, <b>4e</b> (0.20 g, 0.62 mmol) and 4-aminomethyl-1-furan-3-yl-1<i>H</i>-pyridin-2-one hydrochloride (<b>65a</b>) (140 mg, 0.62) were reacted to give 0.12 g (40%) of <b>94c</b> as a brown powder: MS (ESI) <i>m</i>/<i>z</i> 488.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.58 (d, <i>J =</i> 6.0 Hz, 2H), 6.39 − 6.42 (m, 2H), 7.0 (d, <i>J =</i> 2.0 Hz, 1H), 7.50 (dd, <i>J =</i> 8.4, 1.6 Hz, 1H), 7.69 (d, <i>J =</i> 8.4 Hz, 1H), 7.78 (m, 1H), 7.94 (d, <i>J =</i> 8 Hz, 1H), 8.25 (d, <i>J =</i> 0.8 Hz, 1H), 8.38 (d, <i>J =</i> 0.8 Hz, 1H), 8.64 (d, <i>J =</i> 13.2 Hz, 1H), 10.60 (dt, <i>J =</i> 13.2, 6.0 Hz, 1H), 11.12 (s, 1H); Anal. (C<sub>20</sub>H<sub>14</sub>IN<sub>3</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 6-Iodo-4-{[(4-hydroxy-5-methoxy-pyridin-2-ylmethyl)-amino]-methylene}-4<i>H</i>-isoquinoline-1,3-dione (<b>100a</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4e</b> (247 mg, 0.75 mmol) and 2-aminomethyl-5-methoxy-pyridin-4-ol (<b>74a</b>) (116 mg, 0.75 mmol) were reacted to give 293 mg (87%) of <b>100a</b> as a pink solid: MS (ESI) <i>m</i>/<i>z</i> 451.9 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.97 (s, 3H), 4.89 (d, <i>J</i> = 6.0 Hz, 2H), 7.25 (s, 1H), 7.55 (dd, <i>J</i> = 8.3, 1.2 Hz, 1H), 7.73 (d, <i>J</i> = 8.3 Hz, 1H), 8.22 (s, 1H), 8.41 (s, 1H), 8.64 (d, <i>J</i> = 13.4 Hz, 1H), 10.56 (dt, <i>J =</i> 12.8, 6.0, 1H), 11.16 (s, 1H); Anal. (C<sub>17</sub>H<sub>14</sub>IN<sub>3</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 4-{[(4-Hydroxy-5-propoxy-pyridin-2-ylmethyl)-amino]-methylene}-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>100b</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4e</b> (247 mg, 0.75 mmol) and 2-aminomethyl-5-propoxy-pyridin-4-ol (<b>74b</b>) (137 mg, 0.75 mmol) were reacted to give 313 mg (87%) of <b>100b</b> as a pink solid: MS (ESI) <i>m</i>/<i>z</i> 479.9 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.01 (t, <i>J</i> = 7.3 Hz, 3H), 1.74 − 1.84 (m, 2H), 4.10 (t, <i>J</i> = 6.4 Hz, 2H), 4.86 (d, <i>J</i> = 6.8 Hz, 2H), 7.22 (s, 1H), 7.54 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 7.72 (d, <i>J</i> = 8.4 Hz, 1H), 8.20 (d, <i>J =</i> 1.2 Hz, 1H), 8.61 (d, <i>J =</i> 12.9 Hz, 1H), 10.54 (dt, <i>J =</i> 12.9, 6.8 Hz, 1H), 11.16 (s, 1H); Anal. (C<sub>19</sub>H<sub>18</sub>IN<sub>3</sub>O<sub>4</sub>·0.2TFA) C, H, N.</div></div><div id="sec4_5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 6-<i>tert</i>-Butyl-4-{[(4-hydroxy-5-propoxy-pyridin-2-ylmethyl)-amino]-methylene}-4<i>H</i>-isoquinoline-1,3-dione (<b>100c</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, (4<i>E</i>)-6-<i>tert</i>-butyl-4-(methoxymethylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-dione (<b>4k</b>) (50.0 mg, 0.193 mmol) and 2-aminomethyl-5-propoxy-pyridin-4-ol (<b>74b</b>) (35 mg, 0.193 mmol) were reacted to give 52 mg (66%) of <b>100c</b> as a light pink solid: mp 162−178 °C (dec); MS (ESI) <i>m</i>/<i>z</i> 410.4 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.02 (t, <i>J</i> = 7.4 Hz, 3H), 1.37 (s, 9H), 1.75 − 1.87 (m, 2H), 4.12 (t, <i>J</i> = 6.6 Hz, 2H), 4.95 (d, <i>J</i> = 6.1 Hz, 2H), 7.26 (s, 1H), 7.28 (dd, <i>J</i> = 8.5, 1.51 Hz, 1H), 7.76 (bs, 1H), 7.94 (d, <i>J</i> = 8.5 Hz, 1H), 8.40 (s, 1H), 8.59 (d, <i>J</i> = 12.9 Hz, 1H), 10.60 (dt, <i>J =</i> 12.9, 5.9 Hz, 1H), 11.02 (s, 1H); Anal. (C<sub>23</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub>·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> 6-Cyclopentyl-4-{[(4-hydroxy-5-propoxy-pyridin-2-ylmethyl)-amino]-methylene}-4<i>H</i>-isoquinoline-1,3-dione (<b>100d</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, 6-cyclopentyl-4-methoxymethylene-4<i>H</i>-isoquinoline-1,3-dione (<b>4l</b>) (110 mg, 0.405 mmol) and 2-aminomethyl-5-propoxy-pyridin-4-ol (<b>74b</b>) (74 mg, 0.405 mmol) were reacted to give 162 mg (94%) of <b>100d</b> as a pink solid: mp 263−6 °C (dec); MS (ESI): <i>m</i>/<i>z</i> 422.2 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.99 (t, <i>J</i> = 7.4 Hz, 3H), 1.56 − 1.72 (m, 4H), 1.72 − 1.87 (m, 4H), 1.98 − 2.10 (m, 2H), 2.96 − 3.08 (m, 1H), 4.09 (t, <i>J</i> = 6.5 Hz, 2H), 4.87 (d, <i>J</i> = 6.3 Hz, 2H), 7.12 (d, <i>J</i> = 8.0 Hz, 1H), 7.20 (bd, <i>J =</i> 1.5 Hz, 1H), 7.63 (s, 1H), 7.92 (d, <i>J</i> = 8.0 Hz, 1H), 8.39 (s, 1H), 8.56 (d, <i>J</i> = 12.8 Hz, 1H), 10.49 (dt, <i>J =</i> 12.8, 6.3 Hz, 1H), 10.99 (s, 1H); Anal. (C<sub>24</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub>·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 6-<i>tert</i>-Butyl-4-{[(4-hydroxy-5-phenyl-pyridin-2-ylmethyl)-amino]-methylene}-4<i>H</i>-isoquinoline-1,3-dione (<b>100e</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4k</b> (40.0 mg, 0.154 mmol) and 2-aminomethyl-5-phenyl-pyridin-4-ol (<b>81a</b>) (31 mg, 0.154 mmol) were reacted to give 44 mg (66%) of <b>100e</b> as a pink solid: mp 195−218 °C (dec)<b>;</b> MS (ESI) <i>m</i>/<i>z</i> 428.4 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.36 (s, 9H), 5.01 (d, <i>J</i> = 6.3 Hz, 2H), 7.26 − 7.30 (m, 2H), 7.45 − 7.56 (m, 3H), 7.65 (d, <i>J</i> = 6.8 Hz, 2H), 7.75 (s, 1H), 7.95 (d, <i>J</i> = 8.3 Hz, 1H), 8.63 (d, <i>J</i> = 12.8 Hz, 1H), 8.76 (s, 1H), 10.60 (dt, <i>J =</i> 12.7, 6.3 Hz, 1H), 11.04 (s, 1H); Anal. (C<sub>26</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> (4<i>Z</i>)-{[(5-Furan-3-yl-4-hydroxy-pyridin-2-ylmethyl)-amino]-methylene}-6-iodo-4<i>H</i>-isoquinoline-1,3-dione (<b>100f</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4e</b> (110 mg (0.33 mmol) and 2-aminomethyl-5-furan-3-yl-pyridin-4-ol (<b>81b</b>) (64 mg, 0.33 mmol) were reacted to give 109 mg (67%) of <b>100f</b> as a light beige solid: mp 213−228 °C (dec): MS (ESI) <i>m</i>/<i>z</i> 488.0 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.87 (d, <i>J</i> = 6.2 Hz, 2H), 7.11 (s, 1H), 7.18 (d, <i>J</i> = 1.3 Hz, 1H), 7.54 (dd, <i>J</i> = 8.3, 1.3 Hz, 1H), 7.71 (d, <i>J</i> = 8.3 Hz, 1H), 7.84 (t, <i>J</i> = 1.8 Hz, 1H), 7.95 (s, 1H), 8.21 (d, <i>J</i> = 1.1 Hz, 1H), 8.39 (s, 1H), 8.63 (d, <i>J</i> = 13.1 Hz, 1H), 8.82 (s, 1H), 10.56 (dt, <i>J =</i> 13.1, 6.2 Hz, 1H), 11.18 (s, 1H); Anal. (C<sub>20</sub>H<sub>14</sub>IN<sub>3</sub>O<sub>4</sub>·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> 6-<i>tert</i>-Butyl-4-{[(5-furan-3-yl-4-hydroxy-pyridin-2-ylmethyl)-amino]-methylene}-4<i>H</i>-isoquinoline-1,3-dione (<b>100g</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4k</b> (40.0 mg, 0.154 mmol) and 2-aminomethyl-5-furan-3-yl-pyridin-4-ol (<b>81b</b>) (29 mg, 0.154 mmol) were reacted to give 41 mg (64%) of <b>100g</b> as a pink solid: mp 215−230 °C (dec); MS (ESI) <i>m</i>/<i>z</i> 418.3 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.36 (s, 9H), 5.01 (d, <i>J</i> = 6.1 Hz, 2H), 7.23 (s, 1H), 7.26 − 7.34 (m, 2H), 7.76 (s, 1H), 7.85 (s, 1H), 7.96 (d, <i>J</i> = 8.3 Hz, 1H), 8.39 (s, 1H), 8.63 (d, <i>J</i> = 12.8 Hz, 1H), 8.97 (s, 1H), 10.60 (dt, <i>J =</i> 12.5, 6.4 Hz, 1H), 11.04 (s, 1H); Anal. (C<sub>24</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>·0.3TFA) C, H, N.</div></div><div id="sec4_5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 6-Cyclopentyl-4-{[(5-furan-3-yl-4-hydroxy-pyridin-2-ylmethyl)-amino]-methylene}-4<i>H</i>-isoquinoline-1,3-dione (<b>100h</b>)</h4><div class="NLM_p last">Using the procedure described for the preparation of <b>89b</b>, <b>4l</b> (110 mg, 0.405 mmol) and 2-aminomethyl-5-furan-3-yl-pyridin-4-ol (<b>81b</b>) (77 mg, 0.405 mmol) were reacted to give 152 mg (87%) of <b>100h</b> as a pink solid: mp 279−283 °C (dec); MS (ESI) <i>m</i>/<i>z</i> 430.1 (M + 1)<sup>+1</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.55 − 1.74 (m, 4H), 1.74 − 1.88 (m, 2H), 1.98 − 2.10 (m, 2H), 2.96 − 3.09 (m, 1H), 4.95 (d, <i>J</i> = 6.3 Hz, 2H), 7.13 (d, <i>J</i> = 8.6 Hz, 1H), 7.21 − 7.24 (m, 1H), 7.24 − 7.29 (bm, 1H), 7.65 (s, 1H), 7.86 (d, <i>J</i> = 1.5 Hz, 1H), 7.93 (d, <i>J</i> = 8.0 Hz, 1H), 8.39 (s, 1H), 8.59 (d, <i>J</i> = 13.2 Hz, 1H), 8.95 (s, 1H), 10.53 (dt, <i>J =</i> 13.2, 6.3 Hz, 1H), 11.02 (s, 1H); Anal. (C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> Biological Methods</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Enzyme Assay</h4><div class="NLM_p last">Cyclin D1/CDK4 and cyclin E/CDK2 were expressed in insect cells (Sf9) infected with recombinant baculovirus and partially purified using ammonium sulfate fractionation. Cyclin B1/CDC2 was purchased from New England BioLabs (Beverly, MA). Test compounds were diluted in 20% DMSO/20 mM HEPES, pH 7.5, and serial dilutions were prepared (5 concentrations; 0.005−50 μM). High-binding ELISA microtiter plates (Costar) were coated with the kinase substrate (glutathione-<i>S</i>-transferase (GST) fusion of C-terminal fragment of the retinoblastoma susceptibility gene product (Rb)). Nonspecific binding sites were blocked with Superblock in Tris-buffered saline (TBS; Pierce). Kinase reactions contained the test inhibitor, 200 μM ATP, 0.5 mg/mL bovine serum albumin (BSA; Sigma), and 0.1 μL of enzyme. Reaction volumes were adjusted to 30 μL with kinase assay buffer (50 mM HEPES, pH 7.5, 10 mM MgCl <sub>2</sub>, 5% glycerol, 10 mM 2-mercaptoethanol), and plates were incubated at 30 °C for 1 h. Reactions were terminated by aspiration, and nonspecific sites were blocked with blocking buffer (TBS containing 0.1% Tween-20 and 5% nonfat dry milk). Phoshporylation of the substrate was detected using phospho-Rb specific antibodies (ser-795) (Cell Signaling Technologies) and antirabbit IgG/horseradish peroxidase conjugates (Amersham Life Science) using TMB as substrate. Colorimetric reactions were stopped with 2 N sulfuric acid, and the absorbance was measured at 450 nm. IC<sub>50</sub> values were determined from inhibition plots.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Cell Culture and Proliferation Assay</h4><div class="NLM_p last">HCT-116, LoVo, BT-474, and MCF-7 cells were cultured in RPMI medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) and 50 μg/mL gentamicin (Invitrogen) at 37 °C in a humidified incubator under 5−7% CO<sub>2</sub>. Cells were seeded in RPMI medium supplemented with 5% fetal bovine serum in 96 well plates at a density of 5000 to 10000 cells per well depending on the cell line. The following day, 11 point serial dilutions of the test compound (3-fold increments) were added to each well. Cells were incubated with the compound for 3 days (6 days for BT-474) at 37 °C and cell growth was determined using sulforhodamine B (SRB), a protein binding dye. Briefly, the surviving cells were fixed with TCA, and rinsed extensively in water. Cells were stained with 0.4% sulforhodamine B (Sigma-Aldrich) and washed in 1% acetic acid. Protein-associated dye was solubilized in 10 mM Tris, and the absorbance was measured in a Victor fluorescence reader (Wallac/Perkin-Elmer Life Sciences, Boston, MA).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> Preparation of Cell Extracts and Protein Immunoblotting</h4><div class="NLM_p last">Cell lysates were prepared in lysis buffer (25 mM Tris-Cl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 0.5% sodium deoxycholate) supplemented with 0.2 mM PMSF, 1 mM DTT, 0.2 mM sodium fluoride, and 1 mM sodium vanadate (all chemical reagents were from Sigma-Aldrich, St Louis, MO). Protein concentrations were determined by the BioRad protein assay (BioRad, Hercules, CA). Proteins (10−20 μg) were separated by electrophoresis on 8% polyacrylamide-SDS gels (SDS−PAGE) and transferred to nitrocellulose. Blots were blocked in phosphate buffered saline (PBS) or tris-buffered saline (TBS) containing 5% skim milk (or 5% BSA) and 0.1% Tween-20 and incubated with antibodies in the same buffer. Blots were developed using enhanced chemiluminescence (ECL, Amersham/GE Healthcare, Piscataway, NJ). The antibodies used were RB (Santa Cruz Biotechnologies, Santa Cruz, CA or EMD Biosciences, Darmstadt, Germany) and phospho-RB (Ser 807/811) (Cell Signaling Technologies, Beverly, MA).</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> Metabolic Stability Assays</h4><div class="NLM_p last">Substrates were initially dissolved in HPLC grade DMSO to prepare a 0.5 mM solution, which was subsequently added to 4 equivalent volumes of acetonitrile. The resulting 0.1 mM substrate solution in DMSO/acetonitrile was added to 0.1 M potassium phosphate buffer at pH 7.4 containing 0.5 mg/mL male SD rat liver microsome protein (BD Gentest). Samples were preincubated at 37 °C for 10 min and diluted to 1 μM by the addition of 1 mM NADPH regeneration solution (BD Gentest) for phase I metabolic stability screening or 1 mM NADPH regeneration solution containing 2 mM UDPGA (BD Gentest) for phase I and II metabolic stability screening. The microsomal solution was incubated at 37 °C for 15 min followed by the addition of 2 equivalent volumes of cold acetonitrile to quench the enzyme reaction. Nonincubated samples were prepared by adding cold acetonitrile before adding the regeneration solutions without incubation. Samples were analyzed by HPLC-MS/MS with a Waters Quattro Micro mass spectrometer coupled to an Agilent 1100 HPLC. The Agilent 1100 HPLC was equipped with an Aquasil C<sub>18</sub> 2.1 × 50 mm, 5 μm column. Samples were injected with a LEAP Technologies HTS PAL autosampler at 15 μL. The mobile phase flow rate was 1.0 mL/min with a 3:1 post column split. The HPLC mobile phase gradient was initiated at 5% eluent B, held at 5% eluent B for 0.1 min, followed by a linear increase to 95% eluent B over 0.5 min, held at 95% eluent B for 0.4 min, and reconditioned at 5% eluent B for 0.5 min. Eluent A was 0.1% formic acid in water and eluent B was 0.1% formic acid in acetonitrile. HPLC column temperature was maintained at 40 °C. Compounds were detected by HPLC-MS/MS using multiple reaction monitoring (MRM) transitions. Automated determination of MRM transitions were generated using Waters QuanOptimize software. The HPLC-MS/MS substrate peak area at 15 min was compared to the nonincubated substrate providing a relative percent remaining from which an experimental half-life could be calculated assuming pseudo-first-order reaction rate kinetics.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i124"><a href="/doi/suppl/10.1021/jm801026e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elementary analysis data for compounds <b>3c</b>−<b>3e</b>, <b>5a</b>−<b>5i</b>, <b>11</b>, <b>13</b>, <b>17a</b>−<b>17d</b>, <b>18</b>, <b>21</b>, <b>89a</b>−<b>89h</b>, <b>91</b>−<b>93</b>, <b>94a</b>−<b>94c</b>, and <b>100a</b>−<b>100 h</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm801026e/suppl_file/jm801026e_si_001.pdf">jm801026e_si_001.pdf (124.43 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm801026e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13217" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13217" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hwei-Ru Tsou</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3e4a4d514b567e49475b4a56105d5153"><span class="__cf_email__" data-cfemail="80f4f3eff5e8c0f7f9e5f4e8aee3efed">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoxiang Liu</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Birnberg</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua Kaplan</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mercy Otteng</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tritin Tran</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristina Kutterer</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhilian Tang</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ron Suayan</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arie Zask</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Malini Ravi</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Bretz</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Grillo</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John P. McGinnis</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sridhar K. Rabindran</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Semiramis Ayral-Kaloustian</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tarek S. Mansour</span> - <span class="hlFld-Affiliation affiliation">Chemical and Screening Sciences, and Oncology Research, Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i123">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Drs. John Ellingboe and Philip Frost for their support and encouragement. We are grateful to Dr. Ping-Zhong Huang for scaling up key intermediates. We also would like to thank members of the Wyeth Chemical Technologies group for analytical, spectral, and metabolic stability determinations.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Massague, J.</span><span> </span><span class="NLM_article-title">G1 cell cycle and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=298-306&author=J.+Massague&title=G1+cell+cycle+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMassague%26aufirst%3DJ.%26atitle%3DG1%2520cell%2520cycle%2520and%2520cancer%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D298%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span> </span><span class="NLM_article-title">CDK inhibitors: Positive and negative regulators of G1 progression</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1501</span><span class="NLM_x">–</span> <span class="NLM_lpage">1512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1501-1512&author=C.+J.+Sherrauthor=J.+M.+Roberts&title=CDK+inhibitors%3A+Positive+and+negative+regulators+of+G1+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26atitle%3DCDK%2520inhibitors%253A%2520Positive%2520and%2520negative%2520regulators%2520of%2520G1%2520progression%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D1501%26epage%3D1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Harbour, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dei Santi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postigo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. C.</span><span> </span><span class="NLM_article-title">Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2FS0092-8674%2800%2981519-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=10499802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1GrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=859-869&author=J.+W.+Harbourauthor=R.+X.+Luoauthor=A.+Dei+Santiauthor=A.+A.+Postigoauthor=D.+C.+Dean&title=Cdk+phosphorylation+triggers+sequential+intramolecular+interactions+that+progressively+block+Rb+functions+as+cells+move+through+G1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1</span></div><div class="casAuthors">Harbour, J. William; Luo, Robin X.; Santi, Angeline Dei; Postigo, Antonio A.; Dean, Douglas C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">859-869</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We present evidence that phosphorylation of the C-terminal region of Rb by Cdk4/6 initiates successive intramol. interactions between the C-terminal region and the central pocket.  The initial interaction displaces histone deacetylase from the pocket, blocking active transcriptional repression by Rb.  This facilitates a second interaction that leads to phosphorylation of the pocket by Cdk2 and disruption of pocket structure.  These intramol. interactions provide a mol. basis for sequential phosphorylation of Rb by Cdk4/6 and Cdk2.  Cdk4/6 is activated early in G1, blocking active repression by Rb.  However, it is not until near the end of G1, when cyclin E is expressed and Cdk2 is activated, that Rb is prevented from binding and inactivating E2F.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-v_BNaykFpLVg90H21EOLACvtfcHk0liRVTDjEg9_DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1GrsL8%253D&md5=3fb5a6811033a0a1b0ba0338fa2dcad4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981519-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981519-6%26sid%3Dliteratum%253Aachs%26aulast%3DHarbour%26aufirst%3DJ.%2BW.%26aulast%3DLuo%26aufirst%3DR.%2BX.%26aulast%3DDei%2BSanti%26aufirst%3DA.%26aulast%3DPostigo%26aufirst%3DA.%2BA.%26aulast%3DDean%26aufirst%3DD.%2BC.%26atitle%3DCdk%2520phosphorylation%2520triggers%2520sequential%2520intramolecular%2520interactions%2520that%2520progressively%2520block%2520Rb%2520functions%2520as%2520cells%2520move%2520through%2520G1%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D859%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dyson, N.</span><span> </span><span class="NLM_article-title">The regulation of E2F by pRB -family proteins</span> <span class="citation_source-journal">Gene Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2245</span><span class="NLM_x">–</span> <span class="NLM_lpage">2262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1101%2Fgad.12.15.2245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=9694791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK1cXltlagu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=2245-2262&author=N.+Dyson&title=The+regulation+of+E2F+by+pRB+-family+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of E2F by pRB-family proteins</span></div><div class="casAuthors">Dyson, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2245-2262</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with over 100 refs.  Topics include: Introduction to the families of E2F and DP proteins (free E2F, complexed E2F), E2F-binding sites mediate both transcriptional activation and repression (E2F as a transcriptional activator, E2F-mediated repression), Activation of E2F-dependent transcription (phosphorylation of pRB-family members, phosphorylation of E2F-1, changes in the subcellular localization of specific E2F complexes, synthesis of new E2Fs), Inactivation of E2F (E2F/DP phosphorylation, degrdn. of free E2F, E2F-repressors), Consequences of elevated E2F activity-ectopic S-phase entry and apoptosis, Is E2F required for S-phase entry, What are the key targets of E2F activity, What is the role of pRB in E2F regulation, Is the ability of pRB to bind E2F important for pRB's role as a tumor suppressor, and How can E2F-1 be both an oncogene and a tumor suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeXAl9aLvm5bVg90H21EOLACvtfcHk0liRVTDjEg9_DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlagu74%253D&md5=755af21d258487f59a09899698e860e8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.15.2245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.15.2245%26sid%3Dliteratum%253Aachs%26aulast%3DDyson%26aufirst%3DN.%26atitle%3DThe%2520regulation%2520of%2520E2F%2520by%2520pRB%2520-family%2520proteins%26jtitle%3DGene%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D2245%26epage%3D2262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weiberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lhcEfJSIi_8Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeiberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, G.</span><span> </span><span class="NLM_article-title">Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1996&pages=67-108&author=M.+Hallauthor=G.+Peters&title=Genetic+alterations+of+cyclins%2C+cyclin-dependent+kinases%2C+and+cdk+inhibitors+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DG.%26atitle%3DGenetic%2520alterations%2520of%2520cyclins%252C%2520cyclin-dependent%2520kinases%252C%2520and%2520cdk%2520inhibitors%2520in%2520human%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D1996%26volume%3D68%26spage%3D67%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Michalides, R. J. A. M.</span><span> </span><span class="NLM_article-title">Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer</span> <span class="citation_source-journal">J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1136%2Fjcp.52.8.555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=10645224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gvFyiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=555-568&author=R.+J.+A.+M.+Michalides&title=Cell+cycle+regulators%3A+mechanisms+and+their+role+in+aetiology%2C+prognosis%2C+and+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer</span></div><div class="casAuthors">Michalides R J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">555-68</span>
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjA42MK_Y2KvSAs_PE1QvifW6udTcc2eYEdGs4HZ4UErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gvFyiuw%253D%253D&md5=7b4e025e252165b483befea270c2096b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fjcp.52.8.555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.52.8.555%26sid%3Dliteratum%253Aachs%26aulast%3DMichalides%26aufirst%3DR.%2BJ.%2BA.%2BM.%26atitle%3DCell%2520cycle%2520regulators%253A%2520mechanisms%2520and%2520their%2520role%2520in%2520aetiology%252C%2520prognosis%252C%2520and%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D1999%26volume%3D52%26spage%3D555%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Grillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bott, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyyappan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span> </span><span class="NLM_article-title">Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1007%2Fs10549-005-9066-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=16319987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVensb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=185-194&author=M.+Grilloauthor=M.+J.+Bottauthor=N.+Khandkeauthor=J.+P.+McGinnisauthor=M.+Mirandaauthor=M.+Meyyappanauthor=E.+C.+Rosfjordauthor=S.+K.+Rabindran&title=Validation+of+cyclin+D1%2FCDK4+as+an+anticancer+drug+target+in+MCF-7+breast+cancer+cells%3A+Effect+of+regulated+overexpression+of+cyclin+D1+and+siRNA-mediated+inhibition+of+endogenous+cyclin+D1+and+CDK4+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression</span></div><div class="casAuthors">Grillo, Mary; Bott, Matthew J.; Khandke, Neha; McGinnis, John P.; Miranda, Miriam; Meyyappan, Muthupalaniappan; Rosfjord, Edward C.; Rabindran, Sridhar K.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-194</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We have examd. the role of cyclin D1 and cyclin-dependent kinase-4 (CDK4) in the cell cycle progression and proliferation of MCF-7 breast cancer cells.  Forced expression of cyclin D1 using a tetracycline-regulated expression system, and suppression of endogenous cyclin D1 and CDK4 using small interfering RNA (siRNA) were used to validate this protein complex as a drug target in cancer drug discovery.  Overexpression of cyclin D1 increased both phosphorylation of the retinoblastoma gene product (RB) and passage through the G1-S phase transition, resulting in increased proliferation of cells.  When cyclin D1 expression was shut off, growth rates fell below those seen in control cell lines transfected with the vector, indicating an increased dependence on this protein for proliferation.  Inhibition of endogenous cyclin D1 or CDK4 expression by RNA interference resulted in hypophosphorylation of RB and accumulation of cells in G1.  These results support the prevailing view that pharmacol. inhibition of cyclin D1/CDK4 complexes is a useful strategy to inhibit the growth of tumors.  Furthermore, since MCF-7 cells appear to be dependent on this pathway for their continued proliferation, it is a suitable cell line to test novel cyclin D1/CDK4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYCBIsweJDwLVg90H21EOLACvtfcHk0ljvcaZ1R0jdhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVensb0%253D&md5=41ddc04bfae515f6293a728cac00bc58</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs10549-005-9066-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-005-9066-y%26sid%3Dliteratum%253Aachs%26aulast%3DGrillo%26aufirst%3DM.%26aulast%3DBott%26aufirst%3DM.%2BJ.%26aulast%3DKhandke%26aufirst%3DN.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DMiranda%26aufirst%3DM.%26aulast%3DMeyyappan%26aufirst%3DM.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26atitle%3DValidation%2520of%2520cyclin%2520D1%252FCDK4%2520as%2520an%2520anticancer%2520drug%2520target%2520in%2520MCF-7%2520breast%2520cancer%2520cells%253A%2520Effect%2520of%2520regulated%2520overexpression%2520of%2520cyclin%2520D1%2520and%2520siRNA-mediated%2520inhibition%2520of%2520endogenous%2520cyclin%2520D1%2520and%2520CDK4%2520expression%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2006%26volume%3D95%26spage%3D185%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tam, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theodoras, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shay, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span> </span><span class="NLM_article-title">Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2663</span><span class="NLM_x">–</span> <span class="NLM_lpage">2674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=2663-2674&author=S.+W.+Tamauthor=A.+M.+Theodorasauthor=J.+W.+Shayauthor=G.+F.+Draettaauthor=M.+Pagano&title=Differential+expression+and+regulation+of+cyclin+D1+protein+in+normal+and+tumor+human+cells%3A+association+with+Cdk4+is+required+for+cyclin+D1+function+in+G1+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DTheodoras%26aufirst%3DA.%2BM.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26aulast%3DDraetta%26aufirst%3DG.%2BF.%26aulast%3DPagano%26aufirst%3DM.%26atitle%3DDifferential%2520expression%2520and%2520regulation%2520of%2520cyclin%2520D1%2520protein%2520in%2520normal%2520and%2520tumor%2520human%2520cells%253A%2520association%2520with%2520Cdk4%2520is%2520required%2520for%2520cyclin%2520D1%2520function%2520in%2520G1%2520progression%26jtitle%3DOncogene%26date%3D1994%26volume%3D9%26spage%3D2663%26epage%3D2674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Arber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgambato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delohery, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, I. B.</span><span> </span><span class="NLM_article-title">Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1569</span><span class="NLM_x">–</span> <span class="NLM_lpage">1574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=1569-1574&author=N.+Arberauthor=Y.+Dokiauthor=E.+K.-H.+Hanauthor=A.+Sgambatoauthor=P.+Zhouauthor=N.-H.+Kimauthor=T.+Deloheryauthor=M.+G.+Kleinauthor=P.+R.+Holtauthor=I.+B.+Weinstein&title=Antisense+to+cyclin+D1+inhibits+the+growth+and+tumorigenicity+of+human+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArber%26aufirst%3DN.%26aulast%3DDoki%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DE.%2BK.-H.%26aulast%3DSgambato%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DN.-H.%26aulast%3DDelohery%26aufirst%3DT.%26aulast%3DKlein%26aufirst%3DM.%2BG.%26aulast%3DHolt%26aufirst%3DP.%2BR.%26aulast%3DWeinstein%26aufirst%3DI.%2BB.%26atitle%3DAntisense%2520to%2520cyclin%2520D1%2520inhibits%2520the%2520growth%2520and%2520tumorigenicity%2520of%2520human%2520colon%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D1569%26epage%3D1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bartkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutzhoft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, K.</span><span> </span><span class="NLM_article-title">Cyclin D1 protein expression and function in human breast cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1002%2Fijc.2910570311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=8168995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK2cXksl2rsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1994&pages=353-361&author=J.+Bartkovaauthor=J.+Lukasauthor=H.+Mullerauthor=D.+Lutzhoftauthor=M.+Straussauthor=K.+Bartek&title=Cyclin+D1+protein+expression+and+function+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin D1 protein expression and function in human breast cancer</span></div><div class="casAuthors">Bartkova, Jirina; Lukas, Jiri; Muller, Heiko; Lutzhoeft, Dorrit; Strauss, Michael; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-61</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Cyclin D1 is a cell-cycle regulator essential for G1 phase progression and a candidate proto-oncogene implicated in pathogenesis of several human tumor types, including breast carcinomas.  In spite of the accumulating genetic evidence, however, there are no data regarding abundance and properties of the cyclin D1 protein in breast cancer.  The authors now report aberrant nuclear overexpression/accumulation of the cyclin D1 protein in about half of the 170 primary breast carcinoma specimens analyzed by monoclonal antibody immunohistochem., indicating that the frequency of cyclin D1 abnormalities may be considerably higher than previously deduced from DNA amplification studies.  A comparison of the expression patterns in matched lesions at different stages of tumor progression revealed that the cyclin D1 protein aberration appears to reflect a relatively early event and that, when acquired by a tumor, it is maintained throughout breast cancer progression including metastatic spread.  In both tumor tissues and breast cancer cell lines, the abundance of this protein shows characteristic variations consistent with a cell-cycle oscillation and the peak levels expressed in G1.  In all 7 cell lines whose retinoblastoma (Rb) protein is mutant or complexed to SV40 T antigen, exceptionally low levels of cyclin D1 protein and mRNA were found.  Antibody-mediated and anti-sense oligonucleotide knock-out expts. demonstrate the requirement for the cell-cycle regulatory function of cyclin D1 in breast cancer lines with single or multiple copies of the gene and reveal the absence of such a requirement in the cell lines with Rb defects.  The authors' data are consistent with the notion that the emerging "Rb-cyclin D1 pathway" represents a frequent target of oncogenic abnormalities in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMe4V2DjSDIrVg90H21EOLACvtfcHk0lhRZgI8MpRK_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksl2rsbk%253D&md5=1ec224a4586b04f2585921fd0086fd65</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910570311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910570311%26sid%3Dliteratum%253Aachs%26aulast%3DBartkova%26aufirst%3DJ.%26aulast%3DLukas%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DH.%26aulast%3DLutzhoft%26aufirst%3DD.%26aulast%3DStrauss%26aufirst%3DM.%26aulast%3DBartek%26aufirst%3DK.%26atitle%3DCyclin%2520D1%2520protein%2520expression%2520and%2520function%2520in%2520human%2520breast%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1994%26volume%3D57%26spage%3D353%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Uto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ido, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubouchi, H.</span><span> </span><span class="NLM_article-title">Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4779</span><span class="NLM_x">–</span> <span class="NLM_lpage">4783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4779-4783&author=H.+Utoauthor=A.+Idoauthor=A.+Moriuchiauthor=Y.+Onagaauthor=K.+Nagataauthor=M.+Onagaauthor=Y.+Taharaauthor=T.+Horiauthor=S.+Hironoauthor=K.+Hayashiauthor=H.+Tsubouchi&title=Transduction+of+antisense+cyclin+D1+using+two-step+gene+transfer+inhibits+the+growth+of+rat+hepatoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUto%26aufirst%3DH.%26aulast%3DIdo%26aufirst%3DA.%26aulast%3DMoriuchi%26aufirst%3DA.%26aulast%3DOnaga%26aufirst%3DY.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DOnaga%26aufirst%3DM.%26aulast%3DTahara%26aufirst%3DY.%26aulast%3DHori%26aufirst%3DT.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DTsubouchi%26aufirst%3DH.%26atitle%3DTransduction%2520of%2520antisense%2520cyclin%2520D1%2520using%2520two-step%2520gene%2520transfer%2520inhibits%2520the%2520growth%2520of%2520rat%2520hepatoma%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4779%26epage%3D4783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Specific protection against breast cancers by cyclin D1 ablation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=1017-1021&author=Q.+Yuauthor=Y.+Gengauthor=P.+Sicinski&title=Specific+protection+against+breast+cancers+by+cyclin+D1+ablation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DSpecific%2520protection%2520against%2520breast%2520cancers%2520by%2520cyclin%2520D1%2520ablation%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D1017%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Requirement for CDK4 kinase function in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2Fj.ccr.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=16413469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=23-32&author=Q.+Yuauthor=E.+Sicinskaauthor=Y.+Gengauthor=M.+Ahnstromauthor=A.+Zagozdzonauthor=Y.+Kongauthor=H.+Gardnerauthor=H.+Kiyokawaauthor=L.+N.+Harrisauthor=O.+Stalauthor=P.+Sicinski&title=Requirement+for+CDK4+kinase+function+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for CDK4 kinase function in breast cancer</span></div><div class="casAuthors">Yu, Qunyan; Sicinska, Ewa; Geng, Yan; Ahnstrom, Marie; Zagozdzon, Agnieszka; Kong, Yinxin; Gardner, Humphrey; Kiyokawa, Hiroaki; Harris, Lyndsay N.; Stal, Olle; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cyclin D1 is overexpressed in the majority of human breast cancers.  The authors previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene.  In this study, the authors investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis.  The authors report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the crit. role for cyclin D1 in breast cancer formation.  The authors also found that the continued presence of CDK4-assocd. kinase activity is required to maintain breast tumorigenesis.  The authors analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors.  The authors propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XtIoi9OqULVg90H21EOLACvtfcHk0ljoTXglKiykqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D&md5=de0dbbf7f2463d60b126c201ac6bb7f6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DAhnstrom%26aufirst%3DM.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DStal%26aufirst%3DO.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DRequirement%2520for%2520CDK4%2520kinase%2520function%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Landis, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlyk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=13-22&author=M.+W.+Landisauthor=B.+S.+Pawlykauthor=T.+Liauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclin+D1-dependent+kinase+activity+in+murine+development+and+mammary+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DM.%2BW.%26aulast%3DPawlyk%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclin%2520D1-dependent%2520kinase%2520activity%2520in%2520murine%2520development%2520and%2520mammary%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D13%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, J. R.</span><span> </span><span class="NLM_article-title">CDK inhibitors in cancer therapy: What is next</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=16-21&author=M.+Malumbresauthor=P.+Pevarelloauthor=M.+Barbacidauthor=J.+R.+Bischoff&title=CDK+inhibitors+in+cancer+therapy%3A+What+is+next"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26atitle%3DCDK%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520What%2520is%2520next%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D29%26spage%3D16%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Byrdt, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas S. Lin, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker-McEldowney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broering, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaaf, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerema, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozanski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suarez, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colevas, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span> </span><span class="NLM_article-title">Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=399-404&author=J.+C.+Byrdtauthor=T.+S.+Thomas+S.+Linauthor=J.+T.+Daltonauthor=D.+Wuauthor=M.+A.+Phelpsauthor=B.+Fischerauthor=M.+Moranauthor=K.+A.+Blumauthor=B.+Rovinauthor=M.+Brooker-McEldowneyauthor=S.+Broeringauthor=L.+J.+Schaafauthor=A.+J.+Johnsonauthor=D.+M.+Lucasauthor=N.+A.+Heeremaauthor=G.+Lozanskiauthor=D.+C.+Youngauthor=J.-R.+Suarezauthor=A.+D.+Colevasauthor=M.+R.+Grever&title=Flavopiridol+administered+using+a+pharmacologically+derived+schedule+is+associated+with+marked+clinical+efficacy+in+refractory%2C+genetically+high-risk+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DByrdt%26aufirst%3DJ.%2BC.%26aulast%3DThomas%2BS.%2BLin%26aufirst%3DT.%2BS.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DM.%2BA.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DMoran%26aufirst%3DM.%26aulast%3DBlum%26aufirst%3DK.%2BA.%26aulast%3DRovin%26aufirst%3DB.%26aulast%3DBrooker-McEldowney%26aufirst%3DM.%26aulast%3DBroering%26aufirst%3DS.%26aulast%3DSchaaf%26aufirst%3DL.%2BJ.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DLucas%26aufirst%3DD.%2BM.%26aulast%3DHeerema%26aufirst%3DN.%2BA.%26aulast%3DLozanski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DD.%2BC.%26aulast%3DSuarez%26aufirst%3DJ.-R.%26aulast%3DColevas%26aufirst%3DA.%2BD.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26atitle%3DFlavopiridol%2520administered%2520using%2520a%2520pharmacologically%2520derived%2520schedule%2520is%2520associated%2520with%2520marked%2520clinical%2520efficacy%2520in%2520refractory%252C%2520genetically%2520high-risk%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D399%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinase 4/6 by PD0332991 and associated antitumor activity in human tumor xenografts</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=15542782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1427-1438&author=D.+W.+Fryauthor=P.+J.+Harveyauthor=P.+R.+Keller&title=Specific+inhibition+of+cyclin-dependent+kinase+4%2F6+by+PD0332991+and+associated+antitumor+activity+in+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts</span></div><div class="casAuthors">Fry, David W.; Harvey, Patricia J.; Keller, Paul R.; Elliott, William L.; Meade, MaryAnne; Trachet, Erin; Albassam, Mudher; Zheng, XianXian; Leopold, Wilbur R.; Pryer, Nancy K.; Toogood, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1427-1438</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PD 0332991 is a highly specific inhibitor of cyclin-dependent kinase 4 (Cdk4) (IC50, 0.011 μmol/L) and Cdk6 (IC50, 0.016 μmol/L), having no activity against a panel of 36 addnl. protein kinases.  It is a potent antiproliferative agent against retinoblastoma (Rb)-pos. tumor cells in vitro, inducing an exclusive G1 arrest, with a concomitant redn. of phospho-Ser780/Ser795 on the Rb protein.  Oral administration of PD 0332991 to mice bearing the Colo-205 human colon carcinoma produces marked tumor regression.  Therapeutic doses of PD 0332991 cause elimination of phospho-Rb and the proliferative marker Ki-67 in tumor tissue and down-regulation of genes under the transcriptional control of E2F.  The results indicate that inhibition of Cdk4/6 alone is sufficient to cause tumor regression and a net redn. in tumor burden in some tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9TOgbe4wrBLVg90H21EOLACvtfcHk0litjffhQZV3cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslCkt7c%253D&md5=70931ebc6abd1c59bf1cc29748b7945f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinase%25204%252F6%2520by%2520PD0332991%2520and%2520associated%2520antitumor%2520activity%2520in%2520human%2520tumor%2520xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1427%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kubo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">lee, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, M. J.</span><span> </span><span class="NLM_article-title">The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4279</span><span class="NLM_x">–</span> <span class="NLM_lpage">4286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=10632371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsV2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=4279-4286&author=A.+Kuboauthor=K.+Nakagawaauthor=R.+K.+Varmaauthor=N.+K.+Conradauthor=J.+Q.+Chengauthor=W.-C.+leeauthor=J.+R.+Testaauthor=B.+E.+Johnsonauthor=F.+E.+Kayeauthor=M.+J.+Kelley&title=The+p16+status+of+tumor+cell+lines+identifies+small+molecule+inhibitors+specific+for+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4</span></div><div class="casAuthors">Kubo, Akihito; Nakagawa, Kazuhiko; Varma, Ravi K.; Conrad, Nicholas K.; Cheng, Jin Quan; Lee, Wen-Ching; Testa, Joseph R.; Johnson, Bruce E.; Kaye, Frederic J.; Kelley, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4279-4286</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Loss of p16 functional activity leading to disruption of the p16/cyclin-dependent kinase (CDK) 4:cyclin D/retinoblastoma pathway is the most common event in human tumorigenesis, suggesting that compds. with CDK4 kinase inhibitory activity may be useful to regulate cancer cell growth.  To identify such inhibitors, the 60 cancer cell lines of the National Cancer Institute drug screen panel were examd. for p16 alterations (biallelic deletion, intragenic mutations, or absent p16 protein), and the growth-inhibitory activity of more than 50,000 compds. against these 60 cell lines was compared with their p16 status.  One compd., 3-amino thioacridone (3-ATA; NSC 680434), whose growth-inhibitory activity correlated with the p16 status of the cell lines had an IC50 of 3.1 μM in a CDK4 kinase assay.  In addn., four compds. structurally related to 3-ATA inhibited CDK4 kinase with IC50s ranging from 0.2-2.0 μM.  All five of these compds. were less potent inhibitors of cell division cycle 2 and CDK2 kinases, with IC50s 30- to 500-fold higher than that for CDK4.  ATP competition expts. demonstrated a noncompetitive mode of inhibition for 3-ATA (Ki = 5.5 μM) and a linear mixed mode for benzothiadiazine (NSC 645787; Ki = 0.73 μM).  The authors have successfully demonstrated a novel approach to identify specific CDK4 kinase inhibitors that may selectively induce growth inhibition of p16-altered tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBiKyx30Y91bVg90H21EOLACvtfcHk0litjffhQZV3cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsV2msw%253D%253D&md5=55b023de0e7502f35033968142c3b8d4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DK.%26aulast%3DVarma%26aufirst%3DR.%2BK.%26aulast%3DConrad%26aufirst%3DN.%2BK.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3Dlee%26aufirst%3DW.-C.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DKaye%26aufirst%3DF.%2BE.%26aulast%3DKelley%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520p16%2520status%2520of%2520tumor%2520cell%2520lines%2520identifies%2520small%2520molecule%2520inhibitors%2520specific%2520for%2520cyclin-dependent%2520kinase%25204%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1999%26volume%3D5%26spage%3D4279%26epage%3D4286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Soni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumstein-Mecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1093%2Fjnci%2F93.6.436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=11259469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislCrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=436-446&author=R.+Soniauthor=T.+O%E2%80%99Reillyauthor=P.+Furetauthor=L.+Mullerauthor=C.+Stephanauthor=S.+Zumstein-Meckerauthor=H.+Fretzauthor=D.+Fabbroauthor=B.+Chaudhuri&title=Selective+in+vivo+and+in+vitro+effects+of+a+small+molecule+inhibitor+of+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4</span></div><div class="casAuthors">Soni, Rajeev; O'Reilly, Terence; Furet, Pascal; Muller, Lionel; Stephan, Christine; Zumstein-Mecker, Sabine; Fretz, Heinz; Fabbro, Doriano; Chaudhuri, Bhabatosh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">436-446</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Cyclin-dependent kinase 4 (Cdk4) represents a prime target for the treatment of cancer because most human cancers are characterized by overexpression of its activating partner cyclin D1, loss of the natural Cdk4-specific inhibitor p16, or mutation(s) in Cdk4's catalytic subunit.  All of these can cause deregulated cell growth, resulting in tumor formation.  We sought to identify a small mol. that could inhibit the kinase activity of Cdk4 in vitro and to then ascertain the effects of that inhibitor on cell growth and tumor vol. in vivo.  Methods: A triaminopyrimidine deriv., CINK4 (a chem. inhibitor of Cdk4), was identified by screening for compds. that could inhibit Cdk4 enzyme activity in vitro.  Kinase assays were performed on diverse human Cdks and on other kinases that were expressed in and purified from insect cells to det. the specificity of CINK4.  Cell cycle effects of CINK4 on tumor and normal cells were studied by flow cytometry, and changes in phosphorylation of the retinoblastoma protein (pRb), a substrate of Cdk4, were detd. by western blotting.  The effect of the inhibitor on tumor growth in vivo was studied by use of tumors established through xenografts of HCT116 colon carcinoma cells in mice.  Statistical tests were two-sided.  Results: CINK4 specifically inhibited Cdk4/cyclin D1 in vitro.  It caused growth arrest in tumor cells and in normal cells and prevented pRb phosphorylation.  CINK4 treatment resulted in statistically significantly (P = .031) smaller mean tumor vols. in a mouse xenograft model.  Conclusions: Like p16, the natural inhibitor of Cdk4, CINK4 inhibits Cdk4 activity in vitro and slows tumor growth in vivo.  The specificity of CINK4 for Cdk4 raises the possibility that this small mol. or one with a similar structure could have therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoISmjFVy7B9rVg90H21EOLACvtfcHk0litjffhQZV3cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislCrtLg%253D&md5=86345a46a2992af68c9dd22fc2e39efe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F93.6.436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F93.6.436%26sid%3Dliteratum%253Aachs%26aulast%3DSoni%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DT.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DZumstein-Mecker%26aufirst%3DS.%26aulast%3DFretz%26aufirst%3DH.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DSelective%2520in%2520vivo%2520and%2520in%2520vitro%2520effects%2520of%2520a%2520small%2520molecule%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2001%26volume%3D93%26spage%3D436%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span> </span><span class="NLM_article-title">Crystallographic approcach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">27548</span><span class="NLM_x">–</span> <span class="NLM_lpage">27554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=27548-27554&author=M.+Ikutaauthor=K.+Kamataauthor=K.+Fukasawaauthor=T.+Honmaauthor=T.+Machidaauthor=H.+Hiraiauthor=I.+Suzuki-Takahashiauthor=T.+Hayamaauthor=S.+Nishimura&title=Crystallographic+approcach+to+identification+of+cyclin-dependent+kinase+4+%28CDK4%29-specific+inhibitors+by+using+CDK4+mimic+CDK2+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DMachida%26aufirst%3DT.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26atitle%3DCrystallographic%2520approcach%2520to%2520identification%2520of%2520cyclin-dependent%2520kinase%25204%2520%2528CDK4%2529-specific%2520inhibitors%2520by%2520using%2520CDK4%2520mimic%2520CDK2%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D27548%26epage%3D27554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Grell, W.; Walter, R.; Heckel, A.; Himmelsbach, F.; Wittneben, H.; van Meel, J.; Redemann, N.; Haigh, R.</span> Preparation of 3-(α-Heteroarylaminobenzylidene)-2-indolinones as Cyclin Dependent Kinase Inhibitors. DE 19815020 A1 19991007, 1999.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Grell%2C+W.%3B+Walter%2C+R.%3B+Heckel%2C+A.%3B+Himmelsbach%2C+F.%3B+Wittneben%2C+H.%3B+van+Meel%2C+J.%3B+Redemann%2C+N.%3B+Haigh%2C+R.+Preparation+of+3-%28%CE%B1-Heteroarylaminobenzylidene%29-2-indolinones+as+Cyclin+Dependent+Kinase+Inhibitors.+DE+19815020+A1+19991007%2C+1999."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGrell%26aufirst%3DW." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Tsou, H.. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otteng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span> </span><span class="NLM_article-title">4-(Phenylaminomethylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3507</span><span class="NLM_x">–</span> <span class="NLM_lpage">3525</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800072z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3507-3525&author=H..+R.+Tsouauthor=M.+Ottengauthor=T.+Tranauthor=M.+B.+Floydauthor=M.+Reichauthor=G.+Birnbergauthor=K.+Kuttererauthor=S.+Ayral-Kaloustianauthor=M.+Raviauthor=R.+Nilakantanauthor=M.+Grilloauthor=J.+P.+McGinnisauthor=S.+K.+Rabindran&title=4-%28Phenylaminomethylene%29isoquinoline-1%2C3%282H%2C4H%29-diones+as+potent+and+selective+inhibitors+of+the+cyclin-dependent+kinase+4+%28CDK4%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm800072z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800072z%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH..%2BR.%26aulast%3DOtteng%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DKutterer%26aufirst%3DK.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DRavi%26aufirst%3DM.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DGrillo%26aufirst%3DM.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26atitle%3D4-%2528Phenylaminomethylene%2529isoquinoline-1%252C3%25282H%252C4H%2529-diones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520cyclin-dependent%2520kinase%25204%2520%2528CDK4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3507%26epage%3D3525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">De Lombaert, S.; Fink, C. A.; Firoozina, F.; Hoyer, D. W.</span> Certain Thiol inhibitors of Endothelin-Converting Enzyme. PCT Int. Appl. WO 9955726 A1 19991104,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=De+Lombaert%2C+S.%3B+Fink%2C+C.+A.%3B+Firoozina%2C+F.%3B+Hoyer%2C+D.+W.+Certain+Thiol+inhibitors+of+Endothelin-Converting+Enzyme.+PCT+Int.+Appl.+WO+9955726+A1+19991104%2C+1999."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takehana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Rational design, synthesis, and structure-activity relationships of novel factor Xa inhibitors: (2-Substituted-4-amidinophenyl)pyruvic and -propionic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1845</span><span class="NLM_x">–</span> <span class="NLM_lpage">1857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020485x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1845-1857&author=K.+Sagiauthor=T.+Nakagawaauthor=M.+Yamanashiauthor=S.+Makinoauthor=M.+Takahashiauthor=M.+Takayanagiauthor=K.+Takenakaauthor=N.+Suzukiauthor=S.+Onoauthor=N.+Kataokaauthor=K.+Ishikawaauthor=S.+Shimaauthor=Y.+Fukudaauthor=T.+Kayaharaauthor=S.+Takehanaauthor=Y.+Shimaauthor=K.+Tashiroauthor=H.+Yamamotoauthor=R.+Yoshimotoauthor=S.+Iwataauthor=T.+Tsujiauthor=K.+Sakuraiauthor=M.+Shoji&title=Rational+design%2C+synthesis%2C+and+structure-activity+relationships+of+novel+factor+Xa+inhibitors%3A+%282-Substituted-4-amidinophenyl%29pyruvic+and+-propionic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm020485x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020485x%26sid%3Dliteratum%253Aachs%26aulast%3DSagi%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DYamanashi%26aufirst%3DM.%26aulast%3DMakino%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DTakayanagi%26aufirst%3DM.%26aulast%3DTakenaka%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DOno%26aufirst%3DS.%26aulast%3DKataoka%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DK.%26aulast%3DShima%26aufirst%3DS.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DKayahara%26aufirst%3DT.%26aulast%3DTakehana%26aufirst%3DS.%26aulast%3DShima%26aufirst%3DY.%26aulast%3DTashiro%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DIwata%26aufirst%3DS.%26aulast%3DTsuji%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DK.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DRational%2520design%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationships%2520of%2520novel%2520factor%2520Xa%2520inhibitors%253A%2520%25282-Substituted-4-amidinophenyl%2529pyruvic%2520and%2520-propionic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1845%26epage%3D1857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Imanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshio, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, S.-y.; Kazuta, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akuzawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiso, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1493-1502&author=N.+Imanishiauthor=K.+Iwaokaauthor=H.+Koshioauthor=S.-y.%3B+Kazuta%2C+K.-i.+Nagashimaauthor=M.+Ohtaauthor=S.+Sakamotoauthor=H.+Itoauthor=S.+Akuzawaauthor=T.+Kisoauthor=S.-i.+Tsukamotoauthor=T.+Mase&title=New+thiazole+derivatives+as+potent+and+selective+5-hydroxytriptamine+3+%285-HT3%29+receptor+agonists+for+the+treatment+of+constipation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImanishi%26aufirst%3DN.%26aulast%3DIwaoka%26aufirst%3DK.%26aulast%3DKoshio%26aufirst%3DH.%26aulast%3DNagashima%26aufirst%3DS.-y.%253B%2BKazuta%252C%2BK.-i.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DAkuzawa%26aufirst%3DS.%26aulast%3DKiso%26aufirst%3DT.%26aulast%3DTsukamoto%26aufirst%3DS.-i.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DNew%2520thiazole%2520derivatives%2520as%2520potent%2520and%2520selective%25205-hydroxytriptamine%25203%2520%25285-HT3%2529%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520constipation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1493%26epage%3D1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Singh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesher, G. Y.</span><span> </span><span class="NLM_article-title">Synthesis of aza analogs of Amrinone</span> <span class="citation_source-journal">Hereocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2163</span><span class="NLM_x">–</span> <span class="NLM_lpage">2172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.3987%2FCOM-90-5562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK3MXitVKqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1990&pages=2163-2172&author=B.+Singhauthor=G.+Y.+Lesher&title=Synthesis+of+aza+analogs+of+Amrinone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of aza analogs of amrinone</span></div><div class="casAuthors">Singh, Baldev; Lesher, George Y.</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2163-72</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    </div><div class="casAbstract">The aldol condensation product I of 4-acetylpyridine and CO(CO2Et)2 was converted to pyridazinecarboxylic acid hydrazide II (R = CONHNH2)(III).  Curtius reaction of III gave aminopyridazinone II (R = NH2).  The condensation of (4-pyridyl)glyoxal with aminomalonamide H2NCH(CONH2)2 yielded pyrazinecarboxamide IV (R1 = CONH2) which was transformed to aminopyrazinone IV (R1 = NH2) by the Hofmann reaction.  Curtius reaction of 1,2,4-triazinone-5-carboxylic acid V (R2 = CO2H) gave aminotriazinone V (R2 = NH2).  Demethylation of methoxypyrimidine VI (R3 = Me) gave pyrimidinol VI (R3 = H).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPWWNXR0dp6rVg90H21EOLACvtfcHk0lj9icm0Bga-MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVKqtbg%253D&md5=86e1442d56e521f4a826b10de76970d0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3987%2FCOM-90-5562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-90-5562%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DLesher%26aufirst%3DG.%2BY.%26atitle%3DSynthesis%2520of%2520aza%2520analogs%2520of%2520Amrinone%26jtitle%3DHereocycles%26date%3D1990%26volume%3D31%26spage%3D2163%26epage%3D2172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Brown, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durant, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, A. C.,zprint>; DA ]?></span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, D. A.</span><span> </span><span class="NLM_article-title">Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&F 93574) and related compounds</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1993&pages=601-608&author=T.+H.+Brownauthor=R.+C.+Blakemoreauthor=G.+J.+Durantauthor=C.+R.+Ganellinauthor=M.+E.+Parsonsauthor=A.+C.%2Czprint%3E%3B+DA+%5D%3F%3E+Rasmussenauthor=D.+A.+Rawlings&title=Isocytosine+H2-receptor+histamine+antagonists.+IV.+The+synthesis+and+biological+activity+of+donetidine+%28SK%26F+93574%29+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DT.%2BH.%26aulast%3DBlakemore%26aufirst%3DR.%2BC.%26aulast%3DDurant%26aufirst%3DG.%2BJ.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DParsons%26aufirst%3DM.%2BE.%26aulast%3DRasmussen%26aufirst%3DA.%2BC.%252Czprint%253E%253B%2BDA%2B%255D%253F%253E%26aulast%3DRawlings%26aufirst%3DD.%2BA.%26atitle%3DIsocytosine%2520H2-receptor%2520histamine%2520antagonists.%2520IV.%2520The%2520synthesis%2520and%2520biological%2520activity%2520of%2520donetidine%2520%2528SK%2526F%252093574%2529%2520and%2520related%2520compounds%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1993%26volume%3D28%26spage%3D601%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Walpole, C. S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigglesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J.</span><span> </span><span class="NLM_article-title">Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic “A-region”</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2362</span><span class="NLM_x">–</span> <span class="NLM_lpage">2372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00068a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2362-2372&issue=16&author=C.+S.+J.+Walpoleauthor=R.+Wrigglesworthauthor=S.+Bevanauthor=E.+A.+Campbellauthor=A.+Drayauthor=I.+F.+Jamesauthor=M.+N.+Perkinsauthor=D.+J.+Reidauthor=J.+Winter&title=Analogs+of+capsaicin+with+agonist+activity+as+novel+analgesic+agents%3B+structure-activity+studies.+1.+The+aromatic+%E2%80%9CA-region%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00068a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00068a014%26sid%3Dliteratum%253Aachs%26aulast%3DWalpole%26aufirst%3DC.%2BS.%2BJ.%26aulast%3DWrigglesworth%26aufirst%3DR.%26aulast%3DBevan%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DE.%2BA.%26aulast%3DDray%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DI.%2BF.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DReid%26aufirst%3DD.%2BJ.%26aulast%3DWinter%26aufirst%3DJ.%26atitle%3DAnalogs%2520of%2520capsaicin%2520with%2520agonist%2520activity%2520as%2520novel%2520analgesic%2520agents%253B%2520structure-activity%2520studies.%25201.%2520The%2520aromatic%2520%25E2%2580%259CA-region%25E2%2580%259D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D16%26spage%3D2362%26epage%3D2372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Sugahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukita, T.</span><span> </span><span class="NLM_article-title">A facile copper-catalyzed Ullmann condensation: N-Arylation of heterocyclic compounds containing an -NHCO- moiety</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=719-721&issue=4&author=M.+Sugaharaauthor=T.+Ukita&title=A+facile+copper-catalyzed+Ullmann+condensation%3A+N-Arylation+of+heterocyclic+compounds+containing+an+-NHCO-+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSugahara%26aufirst%3DM.%26aulast%3DUkita%26aufirst%3DT.%26atitle%3DA%2520facile%2520copper-catalyzed%2520Ullmann%2520condensation%253A%2520N-Arylation%2520of%2520heterocyclic%2520compounds%2520containing%2520an%2520-NHCO-%2520moiety%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1997%26volume%3D45%26issue%3D4%26spage%3D719%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Campbell, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. K.</span><span> </span><span class="NLM_article-title">Studies on g-Pyrones. I. Derivatives of Kojic Acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01147a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1950&pages=221-6&author=K.+N.+Campbellauthor=J.+F.+Ackermanauthor=B.+K.+Campbell&title=Studies+on+g-Pyrones.+I.+Derivatives+of+Kojic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo01147a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01147a034%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DK.%2BN.%26aulast%3DAckerman%26aufirst%3DJ.%2BF.%26aulast%3DCampbell%26aufirst%3DB.%2BK.%26atitle%3DStudies%2520on%2520g-Pyrones.%2520I.%2520Derivatives%2520of%2520Kojic%2520Acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1950%26volume%3D15%26spage%3D221%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Cizmaricova, Ruzena</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskikova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregan, F.</span><span> </span><span class="NLM_article-title">Derivatives of kojic acid</span> <span class="citation_source-journal">Pharmazie.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1991&pages=460&issue=6&author=Ruzena+Cizmaricovaauthor=E.+Miskikovaauthor=F.+Gregan&title=Derivatives+of+kojic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCizmaricova%26aufirst%3DRuzena%26aulast%3DMiskikova%26aufirst%3DE.%26aulast%3DGregan%26aufirst%3DF.%26atitle%3DDerivatives%2520of%2520kojic%2520acid%26jtitle%3DPharmazie.%26date%3D1991%26volume%3D46%26issue%3D6%26spage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kamino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuramochi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span> </span><span class="NLM_article-title">A concise approach to 5-substituted-4-pyrones from kojic acid</span> <span class="citation_source-journal">Tet. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">7349</span><span class="NLM_x">–</span> <span class="NLM_lpage">7351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2FS0040-4039%2803%2901836-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvV2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=7349-7351&author=T.+Kaminoauthor=K.+Kuramochiauthor=S.+Kobayashi&title=A+concise+approach+to+5-substituted-4-pyrones+from+kojic+acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A concise approach to 5-substituted-4-pyrones from kojic acid</span></div><div class="casAuthors">Kamino, Tomoyuki; Kuramochi, Kouji; Kobayashi, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">7349-7351</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A concise approach to 5-substituted-4-pyrones is described.  This approach is based on manipulation of the 5-hydroxy group of readily available kojic acid.  A no. of 5-substituted-4-pyrones were synthesized from kojic acid utilizing Heck reaction, Suzuki coupling, and Stille coupling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnble4DdJKkrVg90H21EOLACvtfcHk0lgbn9bncQQ2pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvV2mtL0%253D&md5=f80280779dec690e8e56d222000da5bc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2803%2901836-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252803%252901836-7%26sid%3Dliteratum%253Aachs%26aulast%3DKamino%26aufirst%3DT.%26aulast%3DKuramochi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26atitle%3DA%2520concise%2520approach%2520to%25205-substituted-4-pyrones%2520from%2520kojic%2520acid%26jtitle%3DTet.%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D7349%26epage%3D7351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graber, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seest, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolak, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William Watt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joel Morris, J.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis of furo[2,3-c]pyridine pyrimidine thioethers, a new class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7851</span><span class="NLM_x">–</span> <span class="NLM_lpage">7859</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9810359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=7851-7859&issue=22&author=D.+G.+Wishkaauthor=D.+R.+Graberauthor=E.+P.+Seestauthor=L.+A.+Dolakauthor=F.+Hanauthor=W.+William+Wattauthor=J.+Joel+Morris&title=Stereoselective+synthesis+of+furo%5B2%2C3-c%5Dpyridine+pyrimidine+thioethers%2C+a+new+class+of+potent+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo9810359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9810359%26sid%3Dliteratum%253Aachs%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DGraber%26aufirst%3DD.%2BR.%26aulast%3DSeest%26aufirst%3DE.%2BP.%26aulast%3DDolak%26aufirst%3DL.%2BA.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DWilliam%2BWatt%26aufirst%3DW.%26aulast%3DJoel%2BMorris%26aufirst%3DJ.%26atitle%3DStereoselective%2520synthesis%2520of%2520furo%255B2%252C3-c%255Dpyridine%2520pyrimidine%2520thioethers%252C%2520a%2520new%2520class%2520of%2520potent%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26issue%3D22%26spage%3D7851%26epage%3D7859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Nightingale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J. R.</span><span> </span><span class="NLM_article-title">The Alkylation of o- and p-Xylene</span> <span class="citation_source-journal">J. Amer. Chem, Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1944</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01229a502" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1944&pages=154-155&author=D.+Nightingaleauthor=J.+R.+Janes&title=The+Alkylation+of+o-+and+p-Xylene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja01229a502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01229a502%26sid%3Dliteratum%253Aachs%26aulast%3DNightingale%26aufirst%3DD.%26aulast%3DJanes%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Alkylation%2520of%2520o-%2520and%2520p-Xylene%26jtitle%3DJ.%2520Amer.%2520Chem%252C%2520Soc.%26date%3D1944%26volume%3D66%26spage%3D154%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Markwalder, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnone, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisclair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerniak, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doleniak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grafstrom, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaltenbach, III, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugiel, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouten, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5894</span><span class="NLM_x">–</span> <span class="NLM_lpage">5911</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020455u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5894-5911&author=J.+A.+Markwalderauthor=M.+R.+Arnoneauthor=P.+A.+Benfieldauthor=M.+Boisclairauthor=C.+R.+Burtonauthor=C.-H.+Changauthor=S.+S.+Coxauthor=P.+M.+Czerniakauthor=C.+L.+Deanauthor=D.+Doleniakauthor=R.+Grafstromauthor=B.+A.+Harrisonauthor=R.+F.+Kaltenbach%2C+IIIauthor=D.+A.+Nugielauthor=K.+A.+Rossiauthor=S.+R.+Sherkauthor=L.+M.+Siskauthor=P.+Stoutenauthor=G.+L.+Trainorauthor=P.+Worlandauthor=S.+P.+Seitz&title=Synthesis+and+biological+evaluation+of+1-aryl-4%2C5-dihydro-1H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1021%2Fjm020455u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020455u%26sid%3Dliteratum%253Aachs%26aulast%3DMarkwalder%26aufirst%3DJ.%2BA.%26aulast%3DArnone%26aufirst%3DM.%2BR.%26aulast%3DBenfield%26aufirst%3DP.%2BA.%26aulast%3DBoisclair%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DCox%26aufirst%3DS.%2BS.%26aulast%3DCzerniak%26aufirst%3DP.%2BM.%26aulast%3DDean%26aufirst%3DC.%2BL.%26aulast%3DDoleniak%26aufirst%3DD.%26aulast%3DGrafstrom%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DKaltenbach%252C%2BIII%26aufirst%3DR.%2BF.%26aulast%3DNugiel%26aufirst%3DD.%2BA.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DSherk%26aufirst%3DS.%2BR.%26aulast%3DSisk%26aufirst%3DL.%2BM.%26aulast%3DStouten%26aufirst%3DP.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWorland%26aufirst%3DP.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25201-aryl-4%252C5-dihydro-1H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5894%26epage%3D5911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markwalder, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisclair, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brizuela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouten, P. F. W.</span><span> </span><span class="NLM_article-title">Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=111-122&author=K.+A.+Rossiauthor=J.+A.+Markwalderauthor=S.+P.+Seitzauthor=C.-H.+Changauthor=S.+Coxauthor=M.+D.+Boisclairauthor=L.+Brizuelaauthor=S.+L.+Brennerauthor=P.+F.+W.+Stouten&title=Understanding+and+modulating+cyclin-dependent+kinase+inhibitor+specificity%3A+molecular+modeling+and+biochemical+evaluation+of+pyrazolopyrimidinones+as+CDK2%2Fcyclin+A+and+CDK4%2Fcyclin+D1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DMarkwalder%26aufirst%3DJ.%2BA.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DCox%26aufirst%3DS.%26aulast%3DBoisclair%26aufirst%3DM.%2BD.%26aulast%3DBrizuela%26aufirst%3DL.%26aulast%3DBrenner%26aufirst%3DS.%2BL.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26atitle%3DUnderstanding%2520and%2520modulating%2520cyclin-dependent%2520kinase%2520inhibitor%2520specificity%253A%2520molecular%2520modeling%2520and%2520biochemical%2520evaluation%2520of%2520pyrazolopyrimidinones%2520as%2520CDK2%252Fcyclin%2520A%2520and%2520CDK4%252Fcyclin%2520D1%2520inhibitors%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2005%26volume%3D19%26spage%3D111%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shangari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, P. J.</span><span> </span><span class="NLM_article-title">Sulfation and glucuronidation of phenols: Implications in coenyzme Q metabolism</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2005&pages=342-259&author=N.+Shangariauthor=T.+S.+Chanauthor=P.+J.+O%E2%80%99Brien&title=Sulfation+and+glucuronidation+of+phenols%3A+Implications+in+coenyzme+Q+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShangari%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DT.%2BS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%2BJ.%26atitle%3DSulfation%2520and%2520glucuronidation%2520of%2520phenols%253A%2520Implications%2520in%2520coenyzme%2520Q%2520metabolism%26jtitle%3DMethods%2520Enzymol.%26date%3D2005%26volume%3D400%26spage%3D342%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kim, K. H.</span><span> </span><span class="NLM_article-title">Quantitative structure-activity relationships of the metabolism of drugs by uridine diphosphate glucuronosyltransferase</span> <span class="citation_source-journal">J. Phamacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">966</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1002%2Fjps.2600801013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK38XhsFWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1991&pages=966-970&issue=10&author=K.+H.+Kim&title=Quantitative+structure-activity+relationships+of+the+metabolism+of+drugs+by+uridine+diphosphate+glucuronosyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative structure-activity relationships of the metabolism of drugs by uridine diphosphate glucuronosyltransferase</span></div><div class="casAuthors">Kim, Ki H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">966-70</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A review with 14 refs. discussing the quant. structure-activity relationships of the metab. of drugs by uridine diphosphate (UDP)-glucuronosyltransferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGAWIs-LrLmrVg90H21EOLACvtfcHk0ljINrqIAnUi4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFWksg%253D%253D&md5=ee322f5223021e2145a75334a0d65a2f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600801013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600801013%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BH.%26atitle%3DQuantitative%2520structure-activity%2520relationships%2520of%2520the%2520metabolism%2520of%2520drugs%2520by%2520uridine%2520diphosphate%2520glucuronosyltransferase%26jtitle%3DJ.%2520Phamacol.%2520Sci.%26date%3D1991%26volume%3D80%26issue%3D10%26spage%3D966%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Mechanistic studies of uridine diphosphate glucuronosyltransferase</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2F0009-2797%2894%2990110-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=8131219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK2cXkslOjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1994&pages=47-58&author=H.+Yinauthor=G.+Bennettauthor=J.+P.+Jones&title=Mechanistic+studies+of+uridine+diphosphate+glucuronosyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic studies of uridine diphosphate glucuronosyltransferase</span></div><div class="casAuthors">Yin, Hequn; Bennett, Grace; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-58</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    </div><div class="casAbstract">Bisubstrate reaction kinetics and product inhibition studies were used to characterize the kinetic mechanism of a partially purified uridine diphosphate glucuronosyltransferase (UDPGT).  These studies indicate that the reaction must likely occurs via a random order sequential mechanism.  The effect on electron withdrawing and donating groups on the rate of reaction was also detd.  It was found that electron donating groups increased the rate of glucuronide conjugation.  This result is consistent with nucleophilic attack of the C-1 carbon of the UDP-glucuronic acid (UDPGA) by an SN2 mechanism.  This is the first direct evidence for a SN2 mechanism in UDPGT catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovvAs7ylh6PrVg90H21EOLACvtfcHk0lh2UgNCtw_btw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslOjsLw%253D&md5=3c2f2f01d69c341e8c2bcb908024856a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2F0009-2797%2894%2990110-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-2797%252894%252990110-4%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DBennett%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DMechanistic%2520studies%2520of%2520uridine%2520diphosphate%2520glucuronosyltransferase%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D1994%26volume%3D90%26spage%3D47%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Katritzky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagowski, J. M.</span><span> </span><span class="NLM_article-title">Prototropic tautomerism of heteroaromatic compounds: I. General discussion and methods of study</span> <span class="citation_source-journal">Adv. Heterocyclic Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2FS0065-2725%2808%2960528-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaF3sXkt1Wks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1963&pages=311-38&author=A.+R.+Katritzkyauthor=J.+M.+Lagowski&title=Prototropic+tautomerism+of+heteroaromatic+compounds%3A+I.+General+discussion+and+methods+of+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Prototropic tautomerism of heteroaromatic compounds: I. General discussion and methods of study</span></div><div class="casAuthors">Katritzky, A. R.; Lagowski, J. M.</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">311-38</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQZtPm7PqQ7Vg90H21EOLACvtfcHk0lh2UgNCtw_btw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXkt1Wks7s%253D&md5=3cfe46a93bed1eef9d192de793f41b82</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1016%2FS0065-2725%2808%2960528-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-2725%252808%252960528-0%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DLagowski%26aufirst%3DJ.%2BM.%26atitle%3DPrototropic%2520tautomerism%2520of%2520heteroaromatic%2520compounds%253A%2520I.%2520General%2520discussion%2520and%2520methods%2520of%2520study%26jtitle%3DAdv.%2520Heterocyclic%2520Chem.%26date%3D1963%26volume%3D1%26spage%3D311%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, R. J.</span><span> </span><span class="NLM_article-title">Tautomeric equilibria of hydroxypyridines in different solvents: An ab initio study</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">16141</span><span class="NLM_x">–</span> <span class="NLM_lpage">16146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp961295z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1996&pages=16141-16146&author=J.+Wangauthor=R.+J.+Boyd&title=Tautomeric+equilibria+of+hydroxypyridines+in+different+solvents%3A+An+ab+initio+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1021%2Fjp961295z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp961295z%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DR.%2BJ.%26atitle%3DTautomeric%2520equilibria%2520of%2520hydroxypyridines%2520in%2520different%2520solvents%253A%2520An%2520ab%2520initio%2520study%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1996%26volume%3D100%26spage%3D16141%26epage%3D16146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">De Kowaleski, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">diez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, A.</span><span> </span><span class="NLM_article-title">NMR J(C, C) scalar coupling analysis of the effects of substituents on the keto-enol tautomeric equilibrium in 2-OH-n-X-pyridines. An experimental and DFT study</span> <span class="citation_source-journal">Mol. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23−24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2607</span><span class="NLM_x">–</span> <span class="NLM_lpage">2615</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23%E2%88%9224&publication_year=2004&pages=2607-2615&author=D.+G.+De+Kowaleskiauthor=R.+H.+Contrerasauthor=E.+diezauthor=A.+Esteban&title=NMR+J%28C%2C+C%29+scalar+coupling+analysis+of+the+effects+of+substituents+on+the+keto-enol+tautomeric+equilibrium+in+2-OH-n-X-pyridines.+An+experimental+and+DFT+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BKowaleski%26aufirst%3DD.%2BG.%26aulast%3DContreras%26aufirst%3DR.%2BH.%26aulast%3Ddiez%26aufirst%3DE.%26aulast%3DEsteban%26aufirst%3DA.%26atitle%3DNMR%2520J%2528C%252C%2520C%2529%2520scalar%2520coupling%2520analysis%2520of%2520the%2520effects%2520of%2520substituents%2520on%2520the%2520keto-enol%2520tautomeric%2520equilibrium%2520in%25202-OH-n-X-pyridines.%2520An%2520experimental%2520and%2520DFT%2520study%26jtitle%3DMol.%2520Phys.%26date%3D2004%26volume%3D23%25E2%2588%259224%26spage%3D2607%26epage%3D2615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span>GLIDE; <span class="NLM_publisher-name">Schrodinger Software</span>: <span class="NLM_publisher-loc">Portland, OR</span> (<a href="http://www.schrodinger.com" class="extLink">www.schrodinger.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GLIDE%3B+Schrodinger+Software%3A+Portland%2C+OR+%28www.schrodinger.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGLIDE%26pub%3DSchrodinger%2520Software" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thompson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, K. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winborne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomszek, T. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Meguid, S. S.</span><span> </span><span class="NLM_article-title">Rational design, syntheis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1′-P2′ amide bond isostere</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3100</span><span class="NLM_x">–</span> <span class="NLM_lpage">3107</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00045a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3100-3107&author=S.+K.+Thompsonauthor=K.+H.+M.+Murthyauthor=B.+Zhaoauthor=E.+Winborneauthor=D.+W.+Greenauthor=S.+M.+Fisherauthor=R.+L.+DesJarlaisauthor=T.+A.+Thomszekauthor=T.+D.+Meekauthor=J.+G.+Gleasonauthor=S.+S.+Abdel-Meguid&title=Rational+design%2C+syntheis%2C+and+crystallographic+analysis+of+a+hydroxyethylene-based+HIV-1+protease+inhibitor+containing+a+heterocyclic+P1%E2%80%B2-P2%E2%80%B2+amide+bond+isostere"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1021%2Fjm00045a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00045a015%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DS.%2BK.%26aulast%3DMurthy%26aufirst%3DK.%2BH.%2BM.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DWinborne%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DD.%2BW.%26aulast%3DFisher%26aufirst%3DS.%2BM.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DThomszek%26aufirst%3DT.%2BA.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DAbdel-Meguid%26aufirst%3DS.%2BS.%26atitle%3DRational%2520design%252C%2520syntheis%252C%2520and%2520crystallographic%2520analysis%2520of%2520a%2520hydroxyethylene-based%2520HIV-1%2520protease%2520inhibitor%2520containing%2520a%2520heterocyclic%2520P1%25E2%2580%25B2-P2%25E2%2580%25B2%2520amide%2520bond%2520isostere%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3100%26epage%3D3107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.-S.</span><span> </span><span class="NLM_article-title">Hydrogen bonding interaction between the primary quinone acceptor Q<sub>A</sub> and a histidine side chain in photosystem II as revealed by fourier transform infrared spectroscopy</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi982294v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=399-403&author=T.+Noguchiauthor=Y.+Inoueauthor=X.-S.+Tang&title=Hydrogen+bonding+interaction+between+the+primary+quinone+acceptor+QA+and+a+histidine+side+chain+in+photosystem+II+as+revealed+by+fourier+transform+infrared+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Fbi982294v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi982294v%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DX.-S.%26atitle%3DHydrogen%2520bonding%2520interaction%2520between%2520the%2520primary%2520quinone%2520acceptor%2520QA%2520and%2520a%2520histidine%2520side%2520chain%2520in%2520photosystem%2520II%2520as%2520revealed%2520by%2520fourier%2520transform%2520infrared%2520spectroscopy%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D399%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Edgcomb, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. P.</span><span> </span><span class="NLM_article-title">Variability in the pKa of histidine side-chains correlates with burial within proteins</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=1-6&author=S.+P.+Edgcombauthor=K.+P.+Murphy&title=Variability+in+the+pKa+of+histidine+side-chains+correlates+with+burial+within+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdgcomb%26aufirst%3DS.%2BP.%26aulast%3DMurphy%26aufirst%3DK.%2BP.%26atitle%3DVariability%2520in%2520the%2520pKa%2520of%2520histidine%2520side-chains%2520correlates%2520with%2520burial%2520within%2520proteins%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2002%26volume%3D49%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">McInnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontopidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meades, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2Fj.chembiol.2004.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=15123247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1Cms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=525-534&author=C.+McInnesauthor=S.+Wangauthor=S.+Andersonauthor=J.+O%E2%80%99Boyleauthor=W.+Jacksonauthor=G.+Kontopidisauthor=C.+Meadesauthor=M.+Meznaauthor=M.+Thomasauthor=G.+Woodauthor=D.+P.+Laneauthor=P.+M.+Fischer&title=Structural+determinants+of+CDK4+inhibition+and+design+of+selective+ATP+competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants of CDK4 Inhibition and Design of Selective ATP Competitive Inhibitors</span></div><div class="casAuthors">McInnes, Campbell; Wang, Shudong; Anderson, Sian; O'Boyle, Janice; Jackson, Wayne; Kontopidis, George; Meades, Christopher; Mezna, Mokdad; Thomas, Mark; Wood, Gavin; Lane, David P.; Fischer, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">525-534</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A no. of selective inhibitors of the CDK4/cyclin D1 complex have been reported recently.  Due to the absence of an exptl. CDK4 structure, the ligand and protein determinants contributing to CDK4 selectivity are poorly understood at present.  Here, we report the use of computational methods to elucidate the characteristics of selectivity and to derive the structural basis for specific, high-affinity binding of inhibitors to the CDK4 active site.  From these data, the hypothesis emerged that appropriate incorporation of an ionizable function into a CDK2 inhibitor results in more favorable binding to CDK4.  This knowledge was applied to the design of compds. in the otherwise CDK2-selective 2-anilino-4-(thiazol-5-yl)pyrimidine pharmacophore that are potent and highly selective ATP antagonists of CDK4/cyclin D1.  The findings of this study also have significant implications in the design of CDK4 mimic structures based on CDK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU07M2Ugw65bVg90H21EOLACvtfcHk0lgFs7r14X44fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1Cms74%253D&md5=94d613c28266a51507bf63d34965d792</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DW.%26aulast%3DKontopidis%26aufirst%3DG.%26aulast%3DMeades%26aufirst%3DC.%26aulast%3DMezna%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DG.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DStructural%2520determinants%2520of%2520CDK4%2520inhibition%2520and%2520design%2520of%2520selective%2520ATP%2520competitive%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D525%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iduta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, H.</span><span> </span><span class="NLM_article-title">Structure-based generation of a new class of potent cdk4 inhibitors: New de novo design strategy and library design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4615</span><span class="NLM_x">–</span> <span class="NLM_lpage">4627</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0103256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFagtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4615-4627&author=T.+Honmaauthor=K.+Hayashiauthor=T.+Aoyamaauthor=N.+Hashimotoauthor=T.+Machidaauthor=K.+Fukasawaauthor=T.+Iwamaauthor=C.+Ikeuraauthor=M.+Idutaauthor=I.+Suzuki-Takahashiauthor=Y.+Iwasawaauthor=T.+Hayamaauthor=S.+Nishimuraauthor=H.+Morishima&title=Structure-based+generation+of+a+new+class+of+potent+cdk4+inhibitors%3A+New+de+novo+design+strategy+and+library+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Generation of a New Class of Potent Cdk4 Inhibitors: New de Novo Design Strategy and Library Design</span></div><div class="casAuthors">Honma, Teruki; Hayashi, Kyoko; Aoyama, Tetsuya; Hashimoto, Noriaki; Machida, Takumitsu; Fukasawa, Kazuhiro; Iwama, Toshiharu; Ikeura, Chinatsu; Ikuta, Mari; Suzuki-Takahashi, Ikuko; Iwasawa, Yoshikazu; Hayama, Takashi; Nishimura, Susumu; Morishima, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4615-4627</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a first step in structure-based design of highly selective and potent Cdk4 inhibitors, we performed structure-based generation of a novel series of Cdk4 inhibitors.  A Cdk4 homol. model was constructed according to x-ray anal. of an activated form of Cdk2.  Using this model, we applied a new de novo design strategy which combined the de novo design program LEGEND with our inhouse structure selection supporting system SEEDS to generate new scaffold candidates.  In this way, four classes of scaffold candidates including diarylurea were identified.  By constructing diarylurea informer libraries based on the structural requirements of Cdk inhibitors in the ATP binding pocket of the Cdk4 model, we were able to identify a potent Cdk4 inhibitor N-(9-oxo-9H-fluoren-4-yl)-N'-pyridin-2-ylurea (I) with IC50 = 0.10 μM, together with preliminary SAR.  We performed a docking study between I and the Cdk4 model and selected a reasonable binding mode which is consistent with the SAR.  Further modification based on the proposed binding mode provided a more potent compd., N-[(9bR)-5-oxo- 2,3,5,9b-tetrahydro-1H-pyrrolo[2,1-a]isoindol-9-yl]-N'-pyridin-2-ylurea (II) with IC50 = 0.042 μM, x-ray anal. of which was accomplished by the soaking method.  The predicted binding mode of I in Cdk4 was validated by x-ray anal. of the Cdk2-II complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvx3J3Bqyg9LVg90H21EOLACvtfcHk0lgFs7r14X44fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFagtrs%253D&md5=0c4458fa88d41c148a672863b3a6daa0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm0103256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0103256%26sid%3Dliteratum%253Aachs%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DAoyama%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DMachida%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DIwama%26aufirst%3DT.%26aulast%3DIkeura%26aufirst%3DC.%26aulast%3DIduta%26aufirst%3DM.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DH.%26atitle%3DStructure-based%2520generation%2520of%2520a%2520new%2520class%2520of%2520potent%2520cdk4%2520inhibitors%253A%2520New%2520de%2520novo%2520design%2520strategy%2520and%2520library%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4615%26epage%3D4627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=787-801&author=C.+Aubryauthor=A.+J.+Wilsonauthor=P.+R.+Jenkinsauthor=S.+Mahaleauthor=B.+Chaudhuriauthor=J.+Marechalauthor=M.+J.+Sutcliffe&title=Design%2C+synthesis+and+biological+activity+of+new+CDK4-specific+inhibitors%2C+based+on+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DMarechal%26aufirst%3DJ.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%2520new%2520CDK4-specific%2520inhibitors%252C%2520based%2520on%2520fascaplysin%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D787%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span> </span><span class="NLM_article-title">Dissecting the determinants of cyclin-dependent kinase 2 and cyclin-dependent kinase 4 inhibitor selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5470</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060216x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5470-5477&author=D.+J.+Prattauthor=J.+Bentleyauthor=F.+Jewsburyauthor=T.+Boyleauthor=J.+A.+Endicottauthor=M.+E.+M.+Noble&title=Dissecting+the+determinants+of+cyclin-dependent+kinase+2+and+cyclin-dependent+kinase+4+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm060216x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060216x%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DJewsbury%26aufirst%3DF.%26aulast%3DBoyle%26aufirst%3DT.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26atitle%3DDissecting%2520the%2520determinants%2520of%2520cyclin-dependent%2520kinase%25202%2520and%2520cyclin-dependent%2520kinase%25204%2520inhibitor%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5470%26epage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span> </span><span class="NLM_article-title">Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: Comparative molecular dynamics simulation studies of CDK2 and CDK4</span> <span class="citation_source-journal">ChemBioChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1662</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1662-1672&author=H.+Parkauthor=M.+S.+Yeomauthor=S.+Lee&title=Loop+flexibility+and+solvent+dynamics+as+determinants+for+the+selective+inhibition+of+cyclin-dependent+kinase+4%3A+Comparative+molecular+dynamics+simulation+studies+of+CDK2+and+CDK4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%26aulast%3DYeom%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DLoop%2520flexibility%2520and%2520solvent%2520dynamics%2520as%2520determinants%2520for%2520the%2520selective%2520inhibition%2520of%2520cyclin-dependent%2520kinase%25204%253A%2520Comparative%2520molecular%2520dynamics%2520simulation%2520studies%2520of%2520CDK2%2520and%2520CDK4%26jtitle%3DChemBioChem.%26date%3D2004%26volume%3D5%26spage%3D1662%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span>SYBYL, version 7.2; <span class="NLM_publisher-name">Tripos, Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SYBYL%2C+version+7.2%3B+Tripos%2C+Inc.%3A+St.+Louis%2C+MO%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSYBYL%26pub%3DTripos%252C%2520Inc%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Eldridge, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auton, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolini, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, R. P.</span><span> </span><span class="NLM_article-title">Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1023%2FA%3A1007996124545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=9385547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK2sXnsV2it7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=425-445&author=M.+D.+Eldridgeauthor=C.+W.+Murrayauthor=T.+R.+Autonauthor=G.+V.+Paoliniauthor=R.+P.+Mee&title=Empirical+scoring+functions%3A+I.+The+development+of+a+fast+empirical+scoring+function+to+estimate+the+binding+affinity+of+ligands+in+receptor+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes</span></div><div class="casAuthors">Eldridge, Matthew D.; Murray, Christopher W.; Auton, Timothy R.; Paolini, Gaia V.; Mee, Roger P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">425-445</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">This paper describes the development of a simple empirical scoring function designed to est. the free energy of binding for a protein-ligand complex when the 3D structure of the complex is known or can be approximated.  The function uses simple contact terms to est. lipophilic and metal-ligand binding contributions, a simple explicit form for hydrogen bonds and a term which penalizes flexibility.  The coeffs. of each term are obtained using a regression based on 82 ligand-receptor complexes for which the binding affinity is known.  The function reproduces the binding affinity of the complexes with a cross-validated error of 8.68 kJ/mol.  Tests on internal consistency indicate that the coeffs. obtained are stable to changes in the compn. of the training set.  The function is also tested on two test sets contg. a further 20 and 10 complexes, resp.  The deficiencies of this type of function are discussed and it is compared to approaches by other workers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJZ-k95NG1LVg90H21EOLACvtfcHk0lj2SCBt__7Jrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsV2it7o%253D&md5=ece4b881e181f3d5c1287af55efaf6b4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1023%2FA%3A1007996124545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1007996124545%26sid%3Dliteratum%253Aachs%26aulast%3DEldridge%26aufirst%3DM.%2BD.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DAuton%26aufirst%3DT.%2BR.%26aulast%3DPaolini%26aufirst%3DG.%2BV.%26aulast%3DMee%26aufirst%3DR.%2BP.%26atitle%3DEmpirical%2520scoring%2520functions%253A%2520I.%2520The%2520development%2520of%2520a%2520fast%2520empirical%2520scoring%2520function%2520to%2520estimate%2520the%2520binding%2520affinity%2520of%2520ligands%2520in%2520receptor%2520complexes%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D425%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triado-Rives, J.</span><span> </span><span class="NLM_article-title">Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">11225</span><span class="NLM_x">–</span> <span class="NLM_lpage">11236</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9621760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK28XmtlOitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=11225-11236&issue=45&author=W.+L.+Jorgensenauthor=D.+S.+Maxwellauthor=J.+Triado-Rives&title=Development+and+testing+of+the+OPLS+all-atom+force+field+on+conformational+energetics+and+properties+of+organic+liquids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids</span></div><div class="casAuthors">Jorgensen, William L.; Maxwell, David S.; Tirado-Rives, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11225-11236</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and testing of the OPLS all-atom force field for org. mols. and peptides are described.  Parameters for both torsional and nonbonded energetics have been derived, while the bond stretching and angle bending parameters have been adopted mostly from the AMBER all-atom force field.  The torsional parameters were detd. by fitting to rotational energy profiles obtained from ab initio MO calcns. at the RHF/6-31G*//RHF/6-31G* level for more than 50 org. mols. and ions.  The quality of the fits was high with av. errors for conformational energies of less than 0.2 kcal/mol.  The force-field results for mol. structures are also demonstrated to closely match the ab initio predictions.  The nonbonded parameters were developed in conjunction with Monte Carlo statistical mechanics simulations by computing thermodn. and structural properties for 34 pure org. liqs. including alkanes, alkenes, alcs., ethers, acetals, thiols, sulfides, disulfides, aldehydes, ketones, and amides.  Av. errors in comparison with exptl. data are 2% for heats of vaporization and densities.  The Monte Carlo simulations included sampling all internal and intermol. degrees of freedom.  It is found that such non-polar and monofunctional systems do not show significant condensed-phase effects on internal energies in going from the gas phase to the pure liqs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhGotSev_b1LVg90H21EOLACvtfcHk0lgPsGLm0mQ1UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtlOitrs%253D&md5=fef2924a69421881390282aa309ae91b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fja9621760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9621760%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMaxwell%26aufirst%3DD.%2BS.%26aulast%3DTriado-Rives%26aufirst%3DJ.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520the%2520OPLS%2520all-atom%2520force%2520field%2520on%2520conformational%2520energetics%2520and%2520properties%2520of%2520organic%2520liquids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26issue%3D45%26spage%3D11225%26epage%3D11236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34a','cit34b','cit34c'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37a','cit37b'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a','cit40b','cit40c'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 49 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Pete Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Novel Route for Incorporation of Carbon-14 into the Pyridine Ring of Rinskor Active. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2019,</strong> <em>23 </em>
                                    (10)
                                     , 2243-2252. <a href="https://doi.org/10.1021/acs.oprd.9b00302" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00302%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BNovel%252BRoute%252Bfor%252BIncorporation%252Bof%252BCarbon-14%252Binto%252Bthe%252BPyridine%252BRing%252Bof%252BRinskor%252BActive%26aulast%3DJohnson%26aufirst%3DPete%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01072019%26date%3D07102019%26volume%3D23%26issue%3D10%26spage%3D2243%26epage%3D2252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radek Jorda, Denisa Hendrychová, Jiří Voller, Eva Řezníčková, Tomáš Gucký, <span class="NLM_string-name hlFld-ContribAuthor">Vladimír Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9105-9120. <a href="https://doi.org/10.1021/acs.jmedchem.8b00049" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BSelective%252BAre%252BPharmacological%252BInhibitors%252Bof%252BCell-Cycle-Regulating%252BCyclin-Dependent%252BKinases%25253F%26aulast%3DJorda%26aufirst%3DRadek%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31012018%26date%3D05102018%26date%3D20092018%26volume%3D61%26issue%3D20%26spage%3D9105%26epage%3D9120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keshab  Mondal</span> and <span class="hlFld-ContribAuthor ">Subhas Chandra  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2,5-Disubstituted Furans from Sc(OTf)3 Catalyzed Reaction of Aryl Oxiranediesters with γ-Hydroxyenones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (8)
                                     , 4415-4421. <a href="https://doi.org/10.1021/acs.joc.7b00133" title="DOI URL">https://doi.org/10.1021/acs.joc.7b00133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b00133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b00133%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2%25252C5-Disubstituted%252BFurans%252Bfrom%252BSc%252528OTf%2525293%252BCatalyzed%252BReaction%252Bof%252BAryl%252BOxiranediesters%252Bwith%252B%2525CE%2525B3-Hydroxyenones%26aulast%3DMondal%26aufirst%3DKeshab%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19012017%26date%3D31032017%26date%3D21042017%26date%3D23032017%26volume%3D82%26issue%3D8%26spage%3D4415%26epage%3D4421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seo-Hee  Jung</span>, <span class="hlFld-ContribAuthor ">Dan-Bi  Sung</span>, <span class="hlFld-ContribAuthor ">Cho-Hee  Park</span>, and <span class="hlFld-ContribAuthor ">Won-Suk  Kim</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed N-Arylation of 2-Pyridones Employing Diaryliodonium Salts at Room Temperature. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (17)
                                     , 7717-7724. <a href="https://doi.org/10.1021/acs.joc.6b01415" title="DOI URL">https://doi.org/10.1021/acs.joc.6b01415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b01415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b01415%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper-Catalyzed%252BN-Arylation%252Bof%252B2-Pyridones%252BEmploying%252BDiaryliodonium%252BSalts%252Bat%252BRoom%252BTemperature%26aulast%3DJung%26aufirst%3DSeo-Hee%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13062016%26date%3D09082016%26date%3D02092016%26date%3D02082016%26volume%3D81%26issue%3D17%26spage%3D7717%26epage%3D7724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuequan  Zhu</span>, <span class="hlFld-ContribAuthor ">Panpan  Xu</span>, and <span class="hlFld-ContribAuthor ">Yuefa  Gong</span>  . </span><span class="cited-content_cbyCitation_article-title">Triflic Acid-Catalyzed Cycloisomerization Reactions of Donor–Acceptor Cyclopropanes: Access to Alkyl 5-Arylfuran-2-carboxylates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (11)
                                     , 4829-4834. <a href="https://doi.org/10.1021/acs.joc.6b00161" title="DOI URL">https://doi.org/10.1021/acs.joc.6b00161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b00161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b00161%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTriflic%252BAcid-Catalyzed%252BCycloisomerization%252BReactions%252Bof%252BDonor%2525E2%252580%252593Acceptor%252BCyclopropanes%25253A%252BAccess%252Bto%252BAlkyl%252B5-Arylfuran-2-carboxylates%26aulast%3DZhu%26aufirst%3DYuequan%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D24012016%26date%3D17052016%26date%3D03062016%26date%3D08052016%26volume%3D81%26issue%3D11%26spage%3D4829%26epage%3D4834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atanu  Bhaumik</span> and <span class="hlFld-ContribAuthor ">Tanmaya  Pathak</span>  . </span><span class="cited-content_cbyCitation_article-title">Methyl-α-d-2-selenonyl Pent-2-enofuranoside: A Reactive Selenosugar for the Diversity Oriented Synthesis of Enantiomerically Pure Heterocycles, Carbocycles, and Isonucleosides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (21)
                                     , 11057-11064. <a href="https://doi.org/10.1021/acs.joc.5b01192" title="DOI URL">https://doi.org/10.1021/acs.joc.5b01192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b01192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b01192%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMethyl-%2525CE%2525B1-d-2-selenonyl%252BPent-2-enofuranoside%25253A%252BA%252BReactive%252BSelenosugar%252Bfor%252Bthe%252BDiversity%252BOriented%252BSynthesis%252Bof%252BEnantiomerically%252BPure%252BHeterocycles%25252C%252BCarbocycles%25252C%252Band%252BIsonucleosides%26aulast%3DBhaumik%26aufirst%3DAtanu%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27052015%26date%3D28102015%26date%3D06112015%26volume%3D80%26issue%3D21%26spage%3D11057%26epage%3D11064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominik  Nitsch</span> and <span class="hlFld-ContribAuthor ">Thorsten  Bach</span>  . </span><span class="cited-content_cbyCitation_article-title">Bismuth(III) Triflate-Catalyzed Synthesis of Substituted 2-Alkenylfurans. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (13)
                                     , 6372-6379. <a href="https://doi.org/10.1021/jo5009993" title="DOI URL">https://doi.org/10.1021/jo5009993</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo5009993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo5009993%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DBismuth%252528III%252529%252BTriflate-Catalyzed%252BSynthesis%252Bof%252BSubstituted%252B2-Alkenylfurans%26aulast%3DNitsch%26aufirst%3DDominik%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08052014%26date%3D19062014%26date%3D03072014%26volume%3D79%26issue%3D13%26spage%3D6372%26epage%3D6379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José  Vicente</span>, <span class="hlFld-ContribAuthor ">Pablo  González-Herrero</span>, <span class="hlFld-ContribAuthor ">Roberto  Frutos-Pedreño</span>, and <span class="hlFld-ContribAuthor ">María-Teresa  Chicote</span>  , <span class="hlFld-ContribAuthor ">Peter G.  Jones</span>  , <span class="hlFld-ContribAuthor ">Delia  Bautista</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Reactivity of Ortho-Palladated Phenylacetamides. Intramolecular C−N vs C−O Reductive Coupling after CO or XyNC Insertion into the Pd−C Bond. Synthesis of Isoquinoline- and Isocoumarin-Based Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2011,</strong> <em>30 </em>
                                    (5)
                                     , 1079-1093. <a href="https://doi.org/10.1021/om101110s" title="DOI URL">https://doi.org/10.1021/om101110s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/om101110s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fom101110s%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DSynthesis%252Band%252BReactivity%252Bof%252BOrtho-Palladated%252BPhenylacetamides.%252BIntramolecular%252BC%2525E2%252588%252592N%252Bvs%252BC%2525E2%252588%252592O%252BReductive%252BCoupling%252Bafter%252BCO%252Bor%252BXyNC%252BInsertion%252Binto%252Bthe%252BPd%2525E2%252588%252592C%252BBond.%252BSynthesis%252Bof%252BIsoquinoline-%252Band%252BIsocoumarin-Based%252BHeterocycles%26aulast%3DVicente%26aufirst%3DJos%25C3%25A9%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D26112010%26date%3D02022011%26date%3D14032011%26volume%3D30%26issue%3D5%26spage%3D1079%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Shin  Cho</span>, <span class="hlFld-ContribAuthor ">Maria  Borland</span>, <span class="hlFld-ContribAuthor ">Christopher  Brain</span>, <span class="hlFld-ContribAuthor ">Christine H.-T.  Chen</span>, <span class="hlFld-ContribAuthor ">Hong  Cheng</span>, <span class="hlFld-ContribAuthor ">Rajiv  Chopra</span>, <span class="hlFld-ContribAuthor ">Kristy  Chung</span>, <span class="hlFld-ContribAuthor ">James  Groarke</span>, <span class="hlFld-ContribAuthor ">Guo  He</span>, <span class="hlFld-ContribAuthor ">Ying  Hou</span>, <span class="hlFld-ContribAuthor ">Sunkyu  Kim</span>, <span class="hlFld-ContribAuthor ">Steven  Kovats</span>, <span class="hlFld-ContribAuthor ">Yipin  Lu</span>, <span class="hlFld-ContribAuthor ">Marc  O’Reilly</span>, <span class="hlFld-ContribAuthor ">Junqing  Shen</span>, <span class="hlFld-ContribAuthor ">Troy  Smith</span>, <span class="hlFld-ContribAuthor ">Gary  Trakshel</span>, <span class="hlFld-ContribAuthor ">Markus  Vögtle</span>, <span class="hlFld-ContribAuthor ">Mei  Xu</span>, <span class="hlFld-ContribAuthor ">Ming  Xu</span>, and <span class="hlFld-ContribAuthor ">Moo Je  Sung</span>  . </span><span class="cited-content_cbyCitation_article-title">4-(Pyrazol-4-yl)-pyrimidines as Selective Inhibitors of Cyclin-Dependent Kinase 4/6. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (22)
                                     , 7938-7957. <a href="https://doi.org/10.1021/jm100571n" title="DOI URL">https://doi.org/10.1021/jm100571n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100571n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100571n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-%252528Pyrazol-4-yl%252529-pyrimidines%252Bas%252BSelective%252BInhibitors%252Bof%252BCyclin-Dependent%252BKinase%252B4%25252F6%26aulast%3DCho%26aufirst%3DYoung%2BShin%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D11052010%26date%3D01112010%26date%3D25112010%26volume%3D53%26issue%3D22%26spage%3D7938%26epage%3D7957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph M.  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Aranapakam M.  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Zecheng  Chen</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Osvaldo  Dos Santos</span>, <span class="hlFld-ContribAuthor ">Efren  Delos Santos</span>, <span class="hlFld-ContribAuthor ">Kevin  Curran</span>, <span class="hlFld-ContribAuthor ">Max T.  Follettie</span>, <span class="hlFld-ContribAuthor ">Veronica  Diesl</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Yi  Geng</span>, <span class="hlFld-ContribAuthor ">Susan Quinn  DeJoy</span>, <span class="hlFld-ContribAuthor ">Rosanne  Petersen</span>, <span class="hlFld-ContribAuthor ">Inder  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Tarek S.  Mansour</span>, <span class="hlFld-ContribAuthor ">Kim  Arndt</span> and <span class="hlFld-ContribAuthor ">Lei  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel Diaminoquinazolines with in Vivo Efficacy for β-Catenin/T-Cell Transcriptional Factor 4 Pathway Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (2)
                                     , 897-910. <a href="https://doi.org/10.1021/jm901370m" title="DOI URL">https://doi.org/10.1021/jm901370m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901370m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901370m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252BDiaminoquinazolines%252Bwith%252Bin%252BVivo%252BEfficacy%252Bfor%252B%2525CE%2525B2-Catenin%25252FT-Cell%252BTranscriptional%252BFactor%252B4%252BPathway%252BInhibition%26aulast%3DDehnhardt%26aufirst%3DChristoph%2BM.%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D15092009%26date%3D21122009%26date%3D28012010%26volume%3D53%26issue%3D2%26spage%3D897%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">David J.  Richard</span>, <span class="hlFld-ContribAuthor ">Kevin  Curran</span>, <span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Mark  Lefever</span>, <span class="hlFld-ContribAuthor ">Pawel  Nowak</span>, <span class="hlFld-ContribAuthor ">David J.  Malwitz</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Wei-Guo  Zhang</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Tarek S.  Mansour</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span> and <span class="hlFld-ContribAuthor ">Arie  Zask</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-Morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (24)
                                     , 8010-8024. <a href="https://doi.org/10.1021/jm9013828" title="DOI URL">https://doi.org/10.1021/jm9013828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9013828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9013828%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-Morpholino-6-aryl-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252Bas%252BHighly%252BPotent%252Band%252BSelective%252BATP-Competitive%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%25253A%252BOptimization%252Bof%252Bthe%252B6-Aryl%252BSubstituent%26aulast%3DVerheijen%26aufirst%3DJeroen%2BC.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D23072009%26date%3D06112009%26date%3D24122009%26volume%3D52%26issue%3D24%26spage%3D8010%26epage%3D8024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh R.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Nitin P.  Lad</span>, <span class="hlFld-ContribAuthor ">Vijay M.  Khedkar</span>, <span class="hlFld-ContribAuthor ">Nitin D.  Gaikwad</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, in vitro cytotoxicity, and molecular docking study of novel 3,
              4‐dihydroisoquinolin
              ‐1(
              
                2
                H
              
              )‐one based piperlongumine analogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>58 </em>
                                    (6)
                                     , 1359-1370. <a href="https://doi.org/10.1002/jhet.4264" title="DOI URL">https://doi.org/10.1002/jhet.4264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4264%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bin%252Bvitro%252Bcytotoxicity%25252C%252Band%252Bmolecular%252Bdocking%252Bstudy%252Bof%252Bnovel%252B3%25252C%252B4%2525E2%252580%252590dihydroisoquinolin%252B%2525E2%252580%2525901%252528%252B2%252BH%252B%252529%2525E2%252580%252590one%252Bbased%252Bpiperlongumine%252Banalogues%26aulast%3DKulkarni%26aufirst%3DMahesh%2BR.%26date%3D2021%26date%3D2021%26volume%3D58%26issue%3D6%26spage%3D1359%26epage%3D1370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sameera  Senaweera</span>, <span class="hlFld-ContribAuthor ">Tianyu  He</span>, <span class="hlFld-ContribAuthor ">Haixi  Cui</span>, <span class="hlFld-ContribAuthor ">Hideki  Aihara</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">4-benzylideneisoquinoline-1,3(2H,4H)-diones as tyrosyl DNA phosphodiesterase 2 (TDP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 371-386. <a href="https://doi.org/10.1007/s00044-020-02662-w" title="DOI URL">https://doi.org/10.1007/s00044-020-02662-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02662-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02662-w%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3D4-benzylideneisoquinoline-1%25252C3%2525282H%25252C4H%252529-diones%252Bas%252Btyrosyl%252BDNA%252Bphosphodiesterase%252B2%252B%252528TDP2%252529%252Binhibitors%26aulast%3DSenaweera%26aufirst%3DSameera%26date%3D2021%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D371%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojiao  Luo</span>, <span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Pan  Tang</span>, <span class="hlFld-ContribAuthor ">Xingkai  Du</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Qingying  Wang</span>, <span class="hlFld-ContribAuthor ">Rong  Li</span>, <span class="hlFld-ContribAuthor ">Jun  He</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>25 </em>
                                    (1)
                                     , 367-382. <a href="https://doi.org/10.1007/s11030-020-10120-3" title="DOI URL">https://doi.org/10.1007/s11030-020-10120-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10120-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10120-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDiscovery%252Bof%252Bnew%252Bsmall-molecule%252Bcyclin-dependent%252Bkinase%252B6%252Binhibitors%252Bthrough%252Bcomputational%252Bapproaches%26aulast%3DLuo%26aufirst%3DXiaojiao%26date%3D2021%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D367%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheau Ling  Ho</span>, <span class="hlFld-ContribAuthor ">Ching‐Ting  Lin</span>, <span class="hlFld-ContribAuthor ">Shoei‐Sheng  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">In silico design and synthesis of N‐arylalkanyl 2‐naphthamides as a new class of non‐purine xanthine oxidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2021,</strong> <em>23 </em><a href="https://doi.org/10.1002/ddr.21782" title="DOI URL">https://doi.org/10.1002/ddr.21782</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21782%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DIn%252Bsilico%252Bdesign%252Band%252Bsynthesis%252Bof%252BN%2525E2%252580%252590arylalkanyl%252B2%2525E2%252580%252590naphthamides%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Bnon%2525E2%252580%252590purine%252Bxanthine%252Boxidase%252Binhibitors%26aulast%3DHo%26aufirst%3DSheau%2BLing%26date%3D2021%26date%3D2021%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaxuan  Shao</span>, <span class="hlFld-ContribAuthor ">Youjia  Wang</span>, <span class="hlFld-ContribAuthor ">Silu  Chen</span>, <span class="hlFld-ContribAuthor ">Shaowei  Wang</span>, <span class="hlFld-ContribAuthor ">Yanhui  Wu</span>, <span class="hlFld-ContribAuthor ">Xulian  Li</span>, <span class="hlFld-ContribAuthor ">Weihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Chao  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of CF2H-containing isoquinoline-1,3-diones through metal-free, visible-light and air-promoted radical difluoromethylation/cyclization of N-benzamides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>79 </em>, 131822. <a href="https://doi.org/10.1016/j.tet.2020.131822" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131822%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252BCF2H-containing%252Bisoquinoline-1%25252C3-diones%252Bthrough%252Bmetal-free%25252C%252Bvisible-light%252Band%252Bair-promoted%252Bradical%252Bdifluoromethylation%25252Fcyclization%252Bof%252BN-benzamides%26aulast%3DShao%26aufirst%3DJiaxuan%26date%3D2021%26volume%3D79%26spage%3D131822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Xu</span>, <span class="hlFld-ContribAuthor ">Zhao  Yang</span>, <span class="hlFld-ContribAuthor ">Jiawei  Hua</span>, <span class="hlFld-ContribAuthor ">Yang  Lin</span>, <span class="hlFld-ContribAuthor ">Mixue  Bian</span>, <span class="hlFld-ContribAuthor ">Yuguang  Li</span>, <span class="hlFld-ContribAuthor ">Chengkou  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Zheng  Fang</span>, <span class="hlFld-ContribAuthor ">Kai  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">The continuous-flow electrosynthesis of 4-(sulfonylmethyl)isoquinoline-1,3(2
              H
              ,4
              H
              )-diones from
              N
              -alkyl-
              N
              -methacryloyl benzamides under metal-free and oxidant-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (20)
                                     , 3223-3228. <a href="https://doi.org/10.1039/D0QO00909A" title="DOI URL">https://doi.org/10.1039/D0QO00909A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00909A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00909A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DThe%252Bcontinuous-flow%252Belectrosynthesis%252Bof%252B4-%252528sulfonylmethyl%252529isoquinoline-1%25252C3%2525282%252BH%252B%25252C4%252BH%252B%252529-diones%252Bfrom%252BN%252B-alkyl-%252BN%252B-methacryloyl%252Bbenzamides%252Bunder%252Bmetal-free%252Band%252Boxidant-free%252Bconditions%26aulast%3DXu%26aufirst%3DJia%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D20%26spage%3D3223%26epage%3D3228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh R.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Nitin D.  Gaikwad</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Synthesis of 3,4‐Dihydroisoquinolin‐1(2
              H
              )‐one. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (27)
                                     , 8157-8184. <a href="https://doi.org/10.1002/slct.202002131" title="DOI URL">https://doi.org/10.1002/slct.202002131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002131%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DRecent%252BAdvances%252Bin%252BSynthesis%252Bof%252B3%25252C4%2525E2%252580%252590Dihydroisoquinolin%2525E2%252580%2525901%2525282%252BH%252B%252529%2525E2%252580%252590one%26aulast%3DKulkarni%26aufirst%3DMahesh%2BR.%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D27%26spage%3D8157%26epage%3D8184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingpeng  Su</span>, <span class="hlFld-ContribAuthor ">Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenxuan  Xue</span>, <span class="hlFld-ContribAuthor ">Xuan  Liu</span>, <span class="hlFld-ContribAuthor ">Yanan  Zhao</span>, <span class="hlFld-ContribAuthor ">Ke-Hu  Wang</span>, <span class="hlFld-ContribAuthor ">Danfeng  Huang</span>, <span class="hlFld-ContribAuthor ">Congde  Huo</span>, <span class="hlFld-ContribAuthor ">Yulai  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-light-promoted acyl radical cascade reaction for accessing acylated isoquinoline-1,3(2
              H
              ,4
              H
              )-dione derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (10)
                                     , 1940-1948. <a href="https://doi.org/10.1039/D0OB00086H" title="DOI URL">https://doi.org/10.1039/D0OB00086H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00086H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00086H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DVisible-light-promoted%252Bacyl%252Bradical%252Bcascade%252Breaction%252Bfor%252Baccessing%252Bacylated%252Bisoquinoline-1%25252C3%2525282%252BH%252B%25252C4%252BH%252B%252529-dione%252Bderivatives%26aulast%3DSu%26aufirst%3DYingpeng%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D10%26spage%3D1940%26epage%3D1948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  González-Zamora</span>, <span class="hlFld-ContribAuthor ">A.  Islas-Jácome</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5–5 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: One Extra Heteroatom 1:0. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00029-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00029-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00029-9%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525935%252BSystems%252BWith%252BOne%252BBridgehead%252B%252528Ring%252BJunction%252529%252BNitrogen%252BAtom%25253A%252BOne%252BExtra%252BHeteroatom%252B1%25253A0%26aulast%3DGonz%25C3%25A1lez-Zamora%26aufirst%3DE.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pingping  Chen</span>, <span class="hlFld-ContribAuthor ">Yinqiu  Xu</span>, <span class="hlFld-ContribAuthor ">Xuanyi  Li</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and strategies of CDK4/6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (2)
                                     , 127-145. <a href="https://doi.org/10.4155/fmc-2019-0062" title="DOI URL">https://doi.org/10.4155/fmc-2019-0062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0062%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bstrategies%252Bof%252BCDK4%25252F6%252Binhibitors%26aulast%3DChen%26aufirst%3DPingping%26date%3D2020%26volume%3D12%26issue%3D2%26spage%3D127%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanfei  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaping  Wu</span>, <span class="hlFld-ContribAuthor ">Baiyang  Qian</span>, <span class="hlFld-ContribAuthor ">Yongjia  Shang</span>. </span><span class="cited-content_cbyCitation_article-title">Controllable construction of isoquinolinedione and isocoumarin scaffolds
              via
              Rh
              III
              -catalyzed C–H annulation of
              N
              -tosylbenzamides with diazo compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (38)
                                     , 8768-8777. <a href="https://doi.org/10.1039/C9OB01789E" title="DOI URL">https://doi.org/10.1039/C9OB01789E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01789E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01789E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DControllable%252Bconstruction%252Bof%252Bisoquinolinedione%252Band%252Bisocoumarin%252Bscaffolds%252Bvia%252BRh%252BIII%252B-catalyzed%252BC%2525E2%252580%252593H%252Bannulation%252Bof%252BN%252B-tosylbenzamides%252Bwith%252Bdiazo%252Bcompounds%26aulast%3DLiu%26aufirst%3DYanfei%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D38%26spage%3D8768%26epage%3D8777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaowei  Wang</span>, <span class="hlFld-ContribAuthor ">Peng  Dai</span>, <span class="hlFld-ContribAuthor ">Zhichao  Yan</span>, <span class="hlFld-ContribAuthor ">Youjia  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Shao</span>, <span class="hlFld-ContribAuthor ">Yanhui  Wu</span>, <span class="hlFld-ContribAuthor ">Chao  Deng</span>, <span class="hlFld-ContribAuthor ">Weihua  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Metal‐free, Visible‐Light‐Induced Radical Trifluoromethylation/Cyclization of N‐benzamides with CF
              3
              SO
              2
              Na to Synthesize CF
              3
              ‐Containing Isoquinoline‐1,3‐diones. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (35)
                                     , 10329-10333. <a href="https://doi.org/10.1002/slct.201902545" title="DOI URL">https://doi.org/10.1002/slct.201902545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902545%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DMetal%2525E2%252580%252590free%25252C%252BVisible%2525E2%252580%252590Light%2525E2%252580%252590Induced%252BRadical%252BTrifluoromethylation%25252FCyclization%252Bof%252BN%2525E2%252580%252590benzamides%252Bwith%252BCF%252B3%252BSO%252B2%252BNa%252Bto%252BSynthesize%252BCF%252B3%252B%2525E2%252580%252590Containing%252BIsoquinoline%2525E2%252580%2525901%25252C3%2525E2%252580%252590diones%26aulast%3DWang%26aufirst%3DShaowei%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D35%26spage%3D10329%26epage%3D10333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Jue  Chen</span>, <span class="hlFld-ContribAuthor ">Yan-Hong  He</span>, <span class="hlFld-ContribAuthor ">Zhi  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free visible-light-promoted thiocyanation/cyclization cascade for the synthesis of thiocyanato-containing isoquinolinediones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (22)
                                     , 3053-3061. <a href="https://doi.org/10.1016/j.tet.2019.04.053" title="DOI URL">https://doi.org/10.1016/j.tet.2019.04.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.04.053%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DMetal-free%252Bvisible-light-promoted%252Bthiocyanation%25252Fcyclization%252Bcascade%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bthiocyanato-containing%252Bisoquinolinediones%26aulast%3DChen%26aufirst%3DYu-Jue%26date%3D2019%26volume%3D75%26issue%3D22%26spage%3D3053%26epage%3D3061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Li  Zuo</span>, <span class="hlFld-ContribAuthor ">Yan-Hong  He</span>, <span class="hlFld-ContribAuthor ">Zhi  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free Visible-Light Photocatalytic Tandem Radical Addition-Cyclization Strategy for the Synthesis of Sulfonyl-Containing Isoquinolinediones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (5)
                                     , 939-948. <a href="https://doi.org/10.1002/ejoc.201801519" title="DOI URL">https://doi.org/10.1002/ejoc.201801519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801519%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free%252BVisible-Light%252BPhotocatalytic%252BTandem%252BRadical%252BAddition-Cyclization%252BStrategy%252Bfor%252Bthe%252BSynthesis%252Bof%252BSulfonyl-Containing%252BIsoquinolinediones%26aulast%3DZuo%26aufirst%3DKai-Li%26date%3D2019%26date%3D2018%26volume%3D2019%26issue%3D5%26spage%3D939%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Songhai  Huang</span>, <span class="hlFld-ContribAuthor ">Pengfei  Niu</span>, <span class="hlFld-ContribAuthor ">Yingpeng  Su</span>, <span class="hlFld-ContribAuthor ">Dongcheng  Hu</span>, <span class="hlFld-ContribAuthor ">Congde  Huo</span>. </span><span class="cited-content_cbyCitation_article-title">Tandem radical cyclization of
              N
              -methacryloyl benzamides with CBr
              4
              to construct brominated isoquinolinediones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (41)
                                     , 7748-7752. <a href="https://doi.org/10.1039/C8OB01964A" title="DOI URL">https://doi.org/10.1039/C8OB01964A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB01964A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB01964A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DTandem%252Bradical%252Bcyclization%252Bof%252BN%252B-methacryloyl%252Bbenzamides%252Bwith%252BCBr%252B4%252Bto%252Bconstruct%252Bbrominated%252Bisoquinolinediones%26aulast%3DHuang%26aufirst%3DSonghai%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D41%26spage%3D7748%26epage%3D7752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liu-Jun  He</span>, <span class="hlFld-ContribAuthor ">Dong-Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Shi-Qiang  Li</span>, <span class="hlFld-ContribAuthor ">Ya-Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Tang</span>, <span class="hlFld-ContribAuthor ">Jie  Lei</span>, <span class="hlFld-ContribAuthor ">Brendan  Frett</span>, <span class="hlFld-ContribAuthor ">Hui-kuan  Lin</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-Gang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (14)
                                     , 3899-3908. <a href="https://doi.org/10.1016/j.bmc.2018.06.010" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFacile%252Bconstruction%252Bof%252Bfused%252Bbenzimidazole-isoquinolinones%252Bthat%252Binduce%252Bcell-cycle%252Barrest%252Band%252Bapoptosis%252Bin%252Bcolorectal%252Bcancer%252Bcells%26aulast%3DHe%26aufirst%3DLiu-Jun%26date%3D2018%26volume%3D26%26issue%3D14%26spage%3D3899%26epage%3D3908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiujie  Tang</span>, <span class="hlFld-ContribAuthor ">Ping  Xie</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Jiajun  Lin</span>, <span class="hlFld-ContribAuthor ">Chunlai  Feng</span>, <span class="hlFld-ContribAuthor ">Charles U.  Pittman</span>, <span class="hlFld-ContribAuthor ">Aihua  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">“One-pot” sequential preparation of isoquinoline-1,3(2H,4H)-dione derivatives by reacting N-alkyl(aryl)-N-methacryloyl benzamides with benzyl alcohols and sodium benzenesulfinates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (36)
                                     , 5436-5443. <a href="https://doi.org/10.1016/j.tet.2017.07.055" title="DOI URL">https://doi.org/10.1016/j.tet.2017.07.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.07.055%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D%2525E2%252580%25259COne-pot%2525E2%252580%25259D%252Bsequential%252Bpreparation%252Bof%252Bisoquinoline-1%25252C3%2525282H%25252C4H%252529-dione%252Bderivatives%252Bby%252Breacting%252BN-alkyl%252528aryl%252529-N-methacryloyl%252Bbenzamides%252Bwith%252Bbenzyl%252Balcohols%252Band%252Bsodium%252Bbenzenesulfinates%26aulast%3DTang%26aufirst%3DQiujie%26date%3D2017%26volume%3D73%26issue%3D36%26spage%3D5436%26epage%3D5443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuanxuan  Li</span>, <span class="hlFld-ContribAuthor ">Shengyi  Zhuang</span>, <span class="hlFld-ContribAuthor ">Xinxin  Fang</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Peipei  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Addition of nitrogen dioxide to carbon–carbon double bond followed by a cyclization to construct nitromethylated isoquinolinediones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (8)
                                     , 1821-1827. <a href="https://doi.org/10.1039/C6OB02797K" title="DOI URL">https://doi.org/10.1039/C6OB02797K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB02797K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB02797K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAddition%252Bof%252Bnitrogen%252Bdioxide%252Bto%252Bcarbon%2525E2%252580%252593carbon%252Bdouble%252Bbond%252Bfollowed%252Bby%252Ba%252Bcyclization%252Bto%252Bconstruct%252Bnitromethylated%252Bisoquinolinediones%26aulast%3DLi%26aufirst%3DXuanxuan%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D8%26spage%3D1821%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanglong  Zou</span>, <span class="hlFld-ContribAuthor ">Xuelin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-light induced di- and trifluoromethylation of N-benzamides with fluorinated sulfones for the synthesis of CF
              2
              H/CF
              3
              -containing isoquinolinediones. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2017,</strong> <em>15 </em>
                                    (41)
                                     , 8748-8754. <a href="https://doi.org/10.1039/C7OB02226C" title="DOI URL">https://doi.org/10.1039/C7OB02226C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02226C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02226C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DVisible-light%252Binduced%252Bdi-%252Band%252Btrifluoromethylation%252Bof%252BN-benzamides%252Bwith%252Bfluorinated%252Bsulfones%252Bfor%252Bthe%252Bsynthesis%252Bof%252BCF%252B2%252BH%25252FCF%252B3%252B-containing%252Bisoquinolinediones%26aulast%3DZou%26aufirst%3DGuanglong%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D41%26spage%3D8748%26epage%3D8754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiro  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Yuuya  Honda</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient One-Pot Synthesis of 4-Hydroxyisoquinoline-1,3(2H,4H)-diones from N-Alkylbenzamides and α-Keto Esters. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2017,</strong> <em>94 </em>
                                    (6)
                                     , 1099. <a href="https://doi.org/10.3987/COM-17-13666" title="DOI URL">https://doi.org/10.3987/COM-17-13666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-17-13666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-17-13666%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DAn%252BEfficient%252BOne-Pot%252BSynthesis%252Bof%252B4-Hydroxyisoquinoline-1%25252C3%2525282H%25252C4H%252529-diones%252Bfrom%252BN-Alkylbenzamides%252Band%252B%2525CE%2525B1-Keto%252BEsters%26aulast%3DKobayashi%26aufirst%3DKazuhiro%26date%3D2017%26volume%3D94%26issue%3D6%26spage%3D1099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pratik P.  Goswami</span>, <span class="hlFld-ContribAuthor ">Victoria P.  Suding</span>, <span class="hlFld-ContribAuthor ">Angela S.  Carlson</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Topczewski</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Conversion of Aldehydes and Ketones into Azides by Sequential Nucleophilic Addition and Substitution. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (28)
                                     , 4805-4809. <a href="https://doi.org/10.1002/ejoc.201600856" title="DOI URL">https://doi.org/10.1002/ejoc.201600856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600856%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BConversion%252Bof%252BAldehydes%252Band%252BKetones%252Binto%252BAzides%252Bby%252BSequential%252BNucleophilic%252BAddition%252Band%252BSubstitution%26aulast%3DGoswami%26aufirst%3DPratik%2BP.%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D28%26spage%3D4805%26epage%3D4809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ding  Yuan</span>, <span class="hlFld-ContribAuthor ">Zhuan  Duan</span>, <span class="hlFld-ContribAuthor ">Yong  Rao</span>, <span class="hlFld-ContribAuthor ">Ming-Wu  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">New efficient synthesis of isoquinoline-1,3(2H,4H)-diones and isoindolin-1-ones via sequential Ugi/cyclization reaction. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (2)
                                     , 338-346. <a href="https://doi.org/10.1016/j.tet.2015.11.051" title="DOI URL">https://doi.org/10.1016/j.tet.2015.11.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.11.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.11.051%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DNew%252Befficient%252Bsynthesis%252Bof%252Bisoquinoline-1%25252C3%2525282H%25252C4H%252529-diones%252Band%252Bisoindolin-1-ones%252Bvia%252Bsequential%252BUgi%25252Fcyclization%252Breaction%26aulast%3DYuan%26aufirst%3DDing%26date%3D2016%26volume%3D72%26issue%3D2%26spage%3D338%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Yecheng  Li</span>, <span class="hlFld-ContribAuthor ">Mengyan  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoqian  Pang</span>, <span class="hlFld-ContribAuthor ">Zhihong  Liu</span>, <span class="hlFld-ContribAuthor ">Wen  Tan</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical fragment-based CDK4/6 inhibitors prediction and web server. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (21)
                                     , 16972-16981. <a href="https://doi.org/10.1039/C5RA23289A" title="DOI URL">https://doi.org/10.1039/C5RA23289A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA23289A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA23289A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DChemical%252Bfragment-based%252BCDK4%25252F6%252Binhibitors%252Bprediction%252Band%252Bweb%252Bserver%26aulast%3DWang%26aufirst%3DLing%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D21%26spage%3D16972%26epage%3D16981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Liu</span>, <span class="hlFld-ContribAuthor ">Tiantian  Cong</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Peipei  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Visible light-promoted synthesis of 4-(sulfonylmethyl)isoquinoline-1,3(2H,4H)-diones via a tandem radical cyclization and sulfonylation reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (39)
                                     , 9416-9422. <a href="https://doi.org/10.1039/C6OB01569G" title="DOI URL">https://doi.org/10.1039/C6OB01569G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB01569G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB01569G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DVisible%252Blight-promoted%252Bsynthesis%252Bof%252B4-%252528sulfonylmethyl%252529isoquinoline-1%25252C3%2525282H%25252C4H%252529-diones%252Bvia%252Ba%252Btandem%252Bradical%252Bcyclization%252Band%252Bsulfonylation%252Breaction%26aulast%3DLiu%26aufirst%3DXu%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D39%26spage%3D9416%26epage%3D9422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S  Mahale</span>, <span class="hlFld-ContribAuthor ">S B  Bharate</span>, <span class="hlFld-ContribAuthor ">S  Manda</span>, <span class="hlFld-ContribAuthor ">P  Joshi</span>, <span class="hlFld-ContribAuthor ">P R  Jenkins</span>, <span class="hlFld-ContribAuthor ">R A  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">B  Chaudhuri</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2015,</strong> <em>6 </em>
                                    (5)
                                     , e1743-e1743. <a href="https://doi.org/10.1038/cddis.2015.96" title="DOI URL">https://doi.org/10.1038/cddis.2015.96</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/cddis.2015.96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fcddis.2015.96%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DAntitumour%252Bpotential%252Bof%252BBPT%25253A%252Ba%252Bdual%252Binhibitor%252Bof%252Bcdk4%252Band%252Btubulin%252Bpolymerization%26aulast%3DMahale%26aufirst%3DS%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3De1743%26epage%3De1743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Xin-Yan  Wu</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Suzuki–Miyaura cross-coupling reaction of 1,2-oxaborol-2(5H)-ols with carboxylic anhydrides: a new method to furans. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (30)
                                     , 4071-4074. <a href="https://doi.org/10.1016/j.tetlet.2014.05.106" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.05.106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.05.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.05.106%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSuzuki%2525E2%252580%252593Miyaura%252Bcross-coupling%252Breaction%252Bof%252B1%25252C2-oxaborol-2%2525285H%252529-ols%252Bwith%252Bcarboxylic%252Banhydrides%25253A%252Ba%252Bnew%252Bmethod%252Bto%252Bfurans%26aulast%3DYu%26aufirst%3DTao%26date%3D2014%26volume%3D55%26issue%3D30%26spage%3D4071%26epage%3D4074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junxia  Zheng</span>, <span class="hlFld-ContribAuthor ">Hao  Kong</span>, <span class="hlFld-ContribAuthor ">James M.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jialiang  Guo</span>, <span class="hlFld-ContribAuthor ">Yiqun  Chang</span>, <span class="hlFld-ContribAuthor ">Mengjia  Yang</span>, <span class="hlFld-ContribAuthor ">Gaokeng  Xiao</span>, <span class="hlFld-ContribAuthor ">Pinghua  Sun</span>, . </span><span class="cited-content_cbyCitation_article-title">Insight into the Interactions between Novel Isoquinolin-1,3-Dione Derivatives and Cyclin-Dependent Kinase 4 Combining QSAR and Molecular Docking. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (4)
                                     , e93704. <a href="https://doi.org/10.1371/journal.pone.0093704" title="DOI URL">https://doi.org/10.1371/journal.pone.0093704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0093704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0093704%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DInsight%252Binto%252Bthe%252BInteractions%252Bbetween%252BNovel%252BIsoquinolin-1%25252C3-Dione%252BDerivatives%252Band%252BCyclin-Dependent%252BKinase%252B4%252BCombining%252BQSAR%252Band%252BMolecular%252BDocking%26aulast%3DZheng%26aufirst%3DJunxia%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3De93704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia  Bensulong</span>, <span class="hlFld-ContribAuthor ">Jutatip  Boonsombat</span>, <span class="hlFld-ContribAuthor ">Somsak  Ruchirawat</span>. </span><span class="cited-content_cbyCitation_article-title">DBU-mediated regioselective intramolecular cyclization/dehydration of ortho diketo phenoxyethers: a synthesis of 2,3-substituted γ-benzopyranones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (44)
                                     , 9335-9348. <a href="https://doi.org/10.1016/j.tet.2013.07.104" title="DOI URL">https://doi.org/10.1016/j.tet.2013.07.104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.07.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.07.104%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDBU-mediated%252Bregioselective%252Bintramolecular%252Bcyclization%25252Fdehydration%252Bof%252Bortho%252Bdiketo%252Bphenoxyethers%25253A%252Ba%252Bsynthesis%252Bof%252B2%25252C3-substituted%252B%2525CE%2525B3-benzopyranones%26aulast%3DBensulong%26aufirst%3DSofia%26date%3D2013%26volume%3D69%26issue%3D44%26spage%3D9335%26epage%3D9348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Cao</span>, <span class="hlFld-ContribAuthor ">Haiying  Zhan</span>, <span class="hlFld-ContribAuthor ">Jianyong  Wu</span>, <span class="hlFld-ContribAuthor ">Haiping  Zhong</span>, <span class="hlFld-ContribAuthor ">Yuanguang  Lin</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient and General Iron-Catalyzed One-Pot Synthesis of Furans via α-Hydroxy Ketones and Activated Alkynes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>2012 </em>
                                    (12)
                                     , 2318-2322. <a href="https://doi.org/10.1002/ejoc.201200163" title="DOI URL">https://doi.org/10.1002/ejoc.201200163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201200163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201200163%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAn%252BEfficient%252Band%252BGeneral%252BIron-Catalyzed%252BOne-Pot%252BSynthesis%252Bof%252BFurans%252Bvia%252B%2525CE%2525B1-Hydroxy%252BKetones%252Band%252BActivated%252BAlkynes%26aulast%3DCao%26aufirst%3DHua%26date%3D2012%26date%3D2012%26volume%3D2012%26issue%3D12%26spage%3D2318%26epage%3D2322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Cao</span>, <span class="hlFld-ContribAuthor ">Huan-Feng  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiao-Song  Zhou</span>, <span class="hlFld-ContribAuthor ">Chao-Rong  Qi</span>, <span class="hlFld-ContribAuthor ">Yuan-Guang  Lin</span>, <span class="hlFld-ContribAuthor ">Jian-Yong  Wu</span>, <span class="hlFld-ContribAuthor ">Qi-Mei  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">CuO/CNTs-catalyzed heterogeneous process: a convenient strategy to prepare furan derivatives from electron-deficient alkynes and α-hydroxy ketones. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2012,</strong> <em>14 </em>
                                    (10)
                                     , 2710. <a href="https://doi.org/10.1039/c2gc35697j" title="DOI URL">https://doi.org/10.1039/c2gc35697j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2gc35697j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2gc35697j%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DCuO%25252FCNTs-catalyzed%252Bheterogeneous%252Bprocess%25253A%252Ba%252Bconvenient%252Bstrategy%252Bto%252Bprepare%252Bfuran%252Bderivatives%252Bfrom%252Belectron-deficient%252Balkynes%252Band%252B%2525CE%2525B1-hydroxy%252Bketones%26aulast%3DCao%26aufirst%3DHua%26date%3D2012%26volume%3D14%26issue%3D10%26spage%3D2710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Aude  Hiebel</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclopentylmagnesium Bromide. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,<a href="https://doi.org/10.1002/047084289X.rn01235" title="DOI URL">https://doi.org/10.1002/047084289X.rn01235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn01235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn01235%26sid%3Dliteratum%253Aachs%26atitle%3DCyclopentylmagnesium%252BBromide%26aulast%3DHiebel%26aufirst%3DMarie-Aude%26date%3D2011%26date%3D2011%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Lan</span>, <span class="hlFld-ContribAuthor ">Wan-Na  Chen</span>, <span class="hlFld-ContribAuthor ">Gao-Keng  Xiao</span>, <span class="hlFld-ContribAuthor ">Ping-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and docking studies on pyrazolo[4,3-h]qinazoline-3-carboxamides as cyclin-dependent kinase 2 (CDK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (22)
                                     , 6764-6772. <a href="https://doi.org/10.1016/j.bmcl.2010.08.131" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.08.131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.08.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.08.131%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3D-QSAR%252Band%252Bdocking%252Bstudies%252Bon%252Bpyrazolo%25255B4%25252C3-h%25255Dqinazoline-3-carboxamides%252Bas%252Bcyclin-dependent%252Bkinase%252B2%252B%252528CDK2%252529%252Binhibitors%26aulast%3DLan%26aufirst%3DPing%26date%3D2010%26volume%3D20%26issue%3D22%26spage%3D6764%26epage%3D6772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James E. H.  Day</span>, <span class="hlFld-ContribAuthor ">Swee Y.  Sharp</span>, <span class="hlFld-ContribAuthor ">Martin G.  Rowlands</span>, <span class="hlFld-ContribAuthor ">Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">William  Lewis</span>, <span class="hlFld-ContribAuthor ">S. Mark  Roe</span>, <span class="hlFld-ContribAuthor ">Chrisostomos  Prodromou</span>, <span class="hlFld-ContribAuthor ">Laurence H.  Pearl</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Moody</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Hsp90 with Resorcylic Acid Macrolactones: Synthesis and Binding Studies. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2010,</strong> <em>16 </em>
                                    (34)
                                     , 10366-10372. <a href="https://doi.org/10.1002/chem.201001119" title="DOI URL">https://doi.org/10.1002/chem.201001119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201001119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201001119%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DInhibition%252Bof%252BHsp90%252Bwith%252BResorcylic%252BAcid%252BMacrolactones%25253A%252BSynthesis%252Band%252BBinding%252BStudies%26aulast%3DDay%26aufirst%3DJames%25E2%2580%2585E.%25E2%2580%2585H.%26date%3D2010%26date%3D2010%26volume%3D16%26issue%3D34%26spage%3D10366%26epage%3D10372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jérémie  Mortier</span>, <span class="hlFld-ContribAuthor ">Bernard  Masereel</span>, <span class="hlFld-ContribAuthor ">Caroline  Remouchamps</span>, <span class="hlFld-ContribAuthor ">Corinne  Ganeff</span>, <span class="hlFld-ContribAuthor ">Jacques  Piette</span>, <span class="hlFld-ContribAuthor ">Raphaël  frederick</span>. </span><span class="cited-content_cbyCitation_article-title">NF-κB inducing kinase (NIK) inhibitors: Identification of new scaffolds using virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (15)
                                     , 4515-4520. <a href="https://doi.org/10.1016/j.bmcl.2010.06.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.06.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.06.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNF-%2525CE%2525BAB%252Binducing%252Bkinase%252B%252528NIK%252529%252Binhibitors%25253A%252BIdentification%252Bof%252Bnew%252Bscaffolds%252Busing%252Bvirtual%252Bscreening%26aulast%3DMortier%26aufirst%3DJ%25C3%25A9r%25C3%25A9mie%26date%3D2010%26volume%3D20%26issue%3D15%26spage%3D4515%26epage%3D4520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sham M.  Sondhi</span>, <span class="hlFld-ContribAuthor ">Reshma  Rani</span>, <span class="hlFld-ContribAuthor ">Jaiveer  Singh</span>, <span class="hlFld-ContribAuthor ">Partha  Roy</span>, <span class="hlFld-ContribAuthor ">S.K.  Agrawal</span>, <span class="hlFld-ContribAuthor ">A.K.  Saxena</span>. </span><span class="cited-content_cbyCitation_article-title">Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (7)
                                     , 2306-2310. <a href="https://doi.org/10.1016/j.bmcl.2010.01.147" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.147%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSolvent%252Bfree%252Bsynthesis%25252C%252Banti-inflammatory%252Band%252Banticancer%252Bactivity%252Bevaluation%252Bof%252Btricyclic%252Band%252Btetracyclic%252Bbenzimidazole%252Bderivatives%26aulast%3DSondhi%26aufirst%3DSham%2BM.%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2306%26epage%3D2310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">David J.  Richard</span>, <span class="hlFld-ContribAuthor ">Kevin  Curran</span>, <span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines as highly potent and selective ATP competitive mTOR inhibitors: Optimization of human microsomal stability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (8)
                                     , 2648-2653. <a href="https://doi.org/10.1016/j.bmcl.2010.02.031" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.02.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.02.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.02.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2-Arylureidophenyl-4-%2525283-oxa-8-azabicyclo%25255B3.2.1%25255Doctan-8-yl%252529triazines%252Bas%252Bhighly%252Bpotent%252Band%252Bselective%252BATP%252Bcompetitive%252BmTOR%252Binhibitors%25253A%252BOptimization%252Bof%252Bhuman%252Bmicrosomal%252Bstability%26aulast%3DVerheijen%26aufirst%3DJeroen%2BC.%26date%3D2010%26volume%3D20%26issue%3D8%26spage%3D2648%26epage%3D2653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin J.  Curran</span>, <span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">David J.  Richard</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): Optimization of the 1-substituent. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (4)
                                     , 1440-1444. <a href="https://doi.org/10.1016/j.bmcl.2009.12.086" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.12.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.12.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.12.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyrazolopyrimidines%252Bas%252Bhighly%252Bpotent%252Band%252Bselective%25252C%252BATP-competitive%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%25253A%252BOptimization%252Bof%252Bthe%252B1-substituent%26aulast%3DCurran%26aufirst%3DKevin%2BJ.%26date%3D2010%26volume%3D20%26issue%3D4%26spage%3D1440%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (2)
                                     , 640-643. <a href="https://doi.org/10.1016/j.bmcl.2009.11.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3%25252C6-dihydro-2H-pyran%252Bas%252Ba%252Bmorpholine%252Breplacement%252Bin%252B6-aryl-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252Band%252B2-arylthieno%25255B3%25252C2-d%25255Dpyrimidines%25253A%252BATP-competitive%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%26aulast%3DKaplan%26aufirst%3DJoshua%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D640%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0008.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0009.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) <b>2e</b>, DMF, Et<sub>3</sub>N, room temperature; (ii) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DMF, microwave, 150 °C.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0010.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) PhCH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, room temperature; (ii) THF, MeLi in ethyl ether, −78 °C; (iii) (PhO)<sub>2</sub>P(O)N<sub>3</sub>, toluene, DBU, 0 °C; (iv) Pd/C, H<sub>2</sub>, EtOH, HCl; (v) <b>4d</b>, DMF, Et<sub>3</sub>N, room temperature; (vi) MeNH<sub>2</sub>, EtOH, room temperature; then NaBH<sub>4</sub>, MeOH; (vii) <b>4d</b>, THF, room temperature.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0011.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) RBr, K<sub>2</sub>CO<sub>3</sub>, or Na<sub>2</sub>CO<sub>3</sub>, DMF, room temperature or 65 °C; (ii) MeONH<sub>2</sub> · HCl, pyridine, room temperature; then Pd/C, H<sub>2</sub>, EtOH, HCl; (iii) <b>4d</b>, DMF, room temperature; (iv) EtI, K<sub>2</sub>CO<sub>3</sub>, DMF, 65 °C.</p></p></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0012.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) (COCl)<sub>2</sub>, 60 °C; (ii) NH<sub>4</sub>OH, 0 °C to room temperature; (iii) BH<sub>3</sub>, THF, 0 °C; (iv) HCl, MeOH, reflux; (v) H<sub>2</sub>O, HCl, NaNO<sub>2</sub>, 0 °C; then KI, H<sub>2</sub>O, room temperature; (vi) NaH, DMF, then Mel, 0 °C; (vii) PhB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (viii) LiAlH<sub>4</sub>, Et<sub>2</sub>O; (ix) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (x) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C; then NaN<sub>3</sub>, DMF, room temperature; (xi) PPh<sub>3</sub>, THF, H<sub>2</sub>O, room temperature; (xii) NH<sub>4</sub>OH, then I<sub>2</sub>, KI, H<sub>2</sub>O; (xiii) Et<sub>3</sub>N, THF, isobutylchloroformate, 0 °C; then NH<sub>3</sub> in THF, room temperature; (xiv) SOCl<sub>2</sub>, toluene, reflux; (xv) BH<sub>3</sub>, THF, room temperature; (xvi) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, 2-furylSnBu<sub>3</sub>, CuI, DMF, 100 °C; (xvii) NaH, MOMCl, DMF, 0 °C; (xviii) (for <b>43a</b>) 3-furanboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (for <b>43b</b>−<b>d</b>) XSnBu<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, DMF, 100 °C.</p></p></figure><figure data-id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0013.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) HCl, dioxane, MeOH, room temperature; (ii) NH<sub>3</sub> in MeOH, 0 °C; (iii) MeOH, reflux; (iv) EtOH, NH<sub>2</sub>NH<sub>2</sub>; (v) NaOMe, MeOH, dioxane; (vi) RaNi, H<sub>2</sub>, NH<sub>3</sub>, MeOH; (vii) aq. HCl, reflux; (viii) O(CO<sub>2</sub>-<i>t</i>-Bu)<sub>2</sub>, dioxane, NaOH, room temperature; (ix) Me<sub>3</sub>SnPh, Cu(OAc)<sub>2</sub>, <i>n</i>-Bu<sub>4</sub>NF in THF, CH<sub>2</sub>Cl<sub>2</sub>, room temperature; (x) 4 N HCl in dioxane; (xi) (3-furyl)Br, Cul, K<sub>2</sub>CO<sub>3</sub>, DMF, 180 °C, microwave, or 150 °C; (xii) (Me<sub>2</sub>N)<sub>2</sub>CH(O-<i>t</i>-Bu), DMF, 100−150 °C; (xiii) NaIO<sub>4</sub>, aq. THF, room temperature; (xiv) MeONH<sub>2</sub> HCl, pyridine, room temperature; (xv) Zn, HOAc,100 °C.</p></p></figure><figure data-id="sch7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0014.jpeg" id="rightTab-gs7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) RBr, KI, K<sub>2</sub>CO<sub>3</sub>, DMF; (ii) SOCl<sub>2</sub>, CHCl<sub>3</sub>; (iii) NaN<sub>3</sub>, DMF, room temperature; (iv) Ph<sub>3</sub>P, THF, then H<sub>2</sub>O, room temperature; (v) conc. NH<sub>4</sub>OH or NH<sub>3</sub> in MeOH, 90 °C, sealed tube; (vi) RB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, KBr, dioxane, 60 °C; (vii) <i>n</i>-Bu<sub>4</sub>F, THF, room temperature; (viii) Ph<sub>3</sub>P, DMF, CBr<sub>4</sub>; then NaN<sub>3</sub>; (ix) (CH<sub>2</sub>O)<i>n</i>, NaHCO<sub>3</sub>; (x) <i>n</i>-Prl, K<sub>2</sub>CO<sub>3</sub>, 2-butanone; (xi) (i-Pr)<sub>3</sub>SiCl, imidazole, CH<sub>2</sub>Cl<sub>2</sub>, room temperature; NaOBz, BzOH, microwave, 120 °C; (xii) Ph<sub>3</sub>P, THF, H<sub>2</sub>O; then EtOH, Pd/C, H<sub>2</sub>.</p></p></figure><figure data-id="sch8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0015.jpeg" id="rightTab-gs8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) (For <b>89a</b>, <b>89d</b>−<b>h</b>, <b>94b</b>−<b>c</b>) DMF, Et<sub>3</sub>N, room temperature; (for <b>89b</b>−<b>c</b>, <b>90</b>, <b>92</b>, <b>93</b>) DMF, room temperature; (for <b>91</b>) THF, Et<sub>3</sub>N, room temperature; (for <b>94a</b>) THF, DMF, Et<sub>3</sub>N, room temperature.</p></p></figure><figure data-id="sch9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0016.jpeg" id="rightTab-gs9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) lithium diisopropylamide, (MeO)<sub>2</sub>CO, −78 °C; (ii) urea, 150 °C; (iii) HC(OMe)<sub>3</sub>, HOAc, 90 °C; (iv) cyclopentylMgBr, Pd(PPh<sub>3</sub>)<sub>4</sub>, ethyl ether, microwave, 75 °C; then THF, H<sub>2</sub>O, HCl, room temperature; (v) DMF, room temperature.</p></p></figure><figure data-id="fig1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0006.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed binding model for <b>5e</b> in the ATP binding site of the CDK4 mimic model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/medium/jm-2008-01026e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0007.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of <b>89d</b>, <b>94c</b>, and <b>100c</b> on pRb phosphorylation in MCF-7 cells. MCF-7 cells were incubated in the presence of <b>89d</b>, <b>94c</b>, or <b>100c</b> at the indicated concentrations at 37 °C for 24 h. Protein extracts were analyzed by SDS−PAGE, followed by immunoblotting using either phospho-Rb antibody to probe ppRb (Ser 807/811, upper panel) or Rb antibody to probe the total pRb (lower panel). Equivalent protein loading of lanes was confirmed by Ponceau S staining. Blots were scanned and quantified using the FluorS multi-image analyzer (BioRad). The results were normalized to the amount of total pRb, and the IC<sub>50</sub> values for ppRb were determined from inhibition plots (Kaleidagraph). The cellular IC<sub>50</sub> values were determined from inhibition curves (LSW Toolbox) using data points from the SRB cell proliferation assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801026e/production/images/large/jm-2008-01026e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801026e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Massague, J.</span><span> </span><span class="NLM_article-title">G1 cell cycle and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=298-306&author=J.+Massague&title=G1+cell+cycle+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMassague%26aufirst%3DJ.%26atitle%3DG1%2520cell%2520cycle%2520and%2520cancer%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D298%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span> </span><span class="NLM_article-title">CDK inhibitors: Positive and negative regulators of G1 progression</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1501</span><span class="NLM_x">–</span> <span class="NLM_lpage">1512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1501-1512&author=C.+J.+Sherrauthor=J.+M.+Roberts&title=CDK+inhibitors%3A+Positive+and+negative+regulators+of+G1+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26atitle%3DCDK%2520inhibitors%253A%2520Positive%2520and%2520negative%2520regulators%2520of%2520G1%2520progression%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26spage%3D1501%26epage%3D1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Harbour, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dei Santi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postigo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. C.</span><span> </span><span class="NLM_article-title">Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2FS0092-8674%2800%2981519-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=10499802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1GrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=859-869&author=J.+W.+Harbourauthor=R.+X.+Luoauthor=A.+Dei+Santiauthor=A.+A.+Postigoauthor=D.+C.+Dean&title=Cdk+phosphorylation+triggers+sequential+intramolecular+interactions+that+progressively+block+Rb+functions+as+cells+move+through+G1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1</span></div><div class="casAuthors">Harbour, J. William; Luo, Robin X.; Santi, Angeline Dei; Postigo, Antonio A.; Dean, Douglas C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">859-869</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We present evidence that phosphorylation of the C-terminal region of Rb by Cdk4/6 initiates successive intramol. interactions between the C-terminal region and the central pocket.  The initial interaction displaces histone deacetylase from the pocket, blocking active transcriptional repression by Rb.  This facilitates a second interaction that leads to phosphorylation of the pocket by Cdk2 and disruption of pocket structure.  These intramol. interactions provide a mol. basis for sequential phosphorylation of Rb by Cdk4/6 and Cdk2.  Cdk4/6 is activated early in G1, blocking active repression by Rb.  However, it is not until near the end of G1, when cyclin E is expressed and Cdk2 is activated, that Rb is prevented from binding and inactivating E2F.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-v_BNaykFpLVg90H21EOLACvtfcHk0lhvDxup-KRk3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1GrsL8%253D&md5=3fb5a6811033a0a1b0ba0338fa2dcad4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981519-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981519-6%26sid%3Dliteratum%253Aachs%26aulast%3DHarbour%26aufirst%3DJ.%2BW.%26aulast%3DLuo%26aufirst%3DR.%2BX.%26aulast%3DDei%2BSanti%26aufirst%3DA.%26aulast%3DPostigo%26aufirst%3DA.%2BA.%26aulast%3DDean%26aufirst%3DD.%2BC.%26atitle%3DCdk%2520phosphorylation%2520triggers%2520sequential%2520intramolecular%2520interactions%2520that%2520progressively%2520block%2520Rb%2520functions%2520as%2520cells%2520move%2520through%2520G1%26jtitle%3DCell%26date%3D1999%26volume%3D98%26spage%3D859%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dyson, N.</span><span> </span><span class="NLM_article-title">The regulation of E2F by pRB -family proteins</span> <span class="citation_source-journal">Gene Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2245</span><span class="NLM_x">–</span> <span class="NLM_lpage">2262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1101%2Fgad.12.15.2245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=9694791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK1cXltlagu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=2245-2262&author=N.+Dyson&title=The+regulation+of+E2F+by+pRB+-family+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of E2F by pRB-family proteins</span></div><div class="casAuthors">Dyson, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2245-2262</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with over 100 refs.  Topics include: Introduction to the families of E2F and DP proteins (free E2F, complexed E2F), E2F-binding sites mediate both transcriptional activation and repression (E2F as a transcriptional activator, E2F-mediated repression), Activation of E2F-dependent transcription (phosphorylation of pRB-family members, phosphorylation of E2F-1, changes in the subcellular localization of specific E2F complexes, synthesis of new E2Fs), Inactivation of E2F (E2F/DP phosphorylation, degrdn. of free E2F, E2F-repressors), Consequences of elevated E2F activity-ectopic S-phase entry and apoptosis, Is E2F required for S-phase entry, What are the key targets of E2F activity, What is the role of pRB in E2F regulation, Is the ability of pRB to bind E2F important for pRB's role as a tumor suppressor, and How can E2F-1 be both an oncogene and a tumor suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeXAl9aLvm5bVg90H21EOLACvtfcHk0lhDn-IkfpZ_5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlagu74%253D&md5=755af21d258487f59a09899698e860e8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.15.2245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.15.2245%26sid%3Dliteratum%253Aachs%26aulast%3DDyson%26aufirst%3DN.%26atitle%3DThe%2520regulation%2520of%2520E2F%2520by%2520pRB%2520-family%2520proteins%26jtitle%3DGene%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D2245%26epage%3D2262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weiberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lhDn-IkfpZ_5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeiberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, G.</span><span> </span><span class="NLM_article-title">Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1996&pages=67-108&author=M.+Hallauthor=G.+Peters&title=Genetic+alterations+of+cyclins%2C+cyclin-dependent+kinases%2C+and+cdk+inhibitors+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DG.%26atitle%3DGenetic%2520alterations%2520of%2520cyclins%252C%2520cyclin-dependent%2520kinases%252C%2520and%2520cdk%2520inhibitors%2520in%2520human%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D1996%26volume%3D68%26spage%3D67%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Michalides, R. J. A. M.</span><span> </span><span class="NLM_article-title">Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer</span> <span class="citation_source-journal">J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1136%2Fjcp.52.8.555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=10645224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gvFyiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=555-568&author=R.+J.+A.+M.+Michalides&title=Cell+cycle+regulators%3A+mechanisms+and+their+role+in+aetiology%2C+prognosis%2C+and+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer</span></div><div class="casAuthors">Michalides R J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">555-68</span>
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjA42MK_Y2KvSAs_PE1QvifW6udTcc2ebUJ6Lc4S3Vcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gvFyiuw%253D%253D&md5=7b4e025e252165b483befea270c2096b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fjcp.52.8.555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.52.8.555%26sid%3Dliteratum%253Aachs%26aulast%3DMichalides%26aufirst%3DR.%2BJ.%2BA.%2BM.%26atitle%3DCell%2520cycle%2520regulators%253A%2520mechanisms%2520and%2520their%2520role%2520in%2520aetiology%252C%2520prognosis%252C%2520and%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D1999%26volume%3D52%26spage%3D555%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Grillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bott, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyyappan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosfjord, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span> </span><span class="NLM_article-title">Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1007%2Fs10549-005-9066-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=16319987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVensb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=185-194&author=M.+Grilloauthor=M.+J.+Bottauthor=N.+Khandkeauthor=J.+P.+McGinnisauthor=M.+Mirandaauthor=M.+Meyyappanauthor=E.+C.+Rosfjordauthor=S.+K.+Rabindran&title=Validation+of+cyclin+D1%2FCDK4+as+an+anticancer+drug+target+in+MCF-7+breast+cancer+cells%3A+Effect+of+regulated+overexpression+of+cyclin+D1+and+siRNA-mediated+inhibition+of+endogenous+cyclin+D1+and+CDK4+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression</span></div><div class="casAuthors">Grillo, Mary; Bott, Matthew J.; Khandke, Neha; McGinnis, John P.; Miranda, Miriam; Meyyappan, Muthupalaniappan; Rosfjord, Edward C.; Rabindran, Sridhar K.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-194</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We have examd. the role of cyclin D1 and cyclin-dependent kinase-4 (CDK4) in the cell cycle progression and proliferation of MCF-7 breast cancer cells.  Forced expression of cyclin D1 using a tetracycline-regulated expression system, and suppression of endogenous cyclin D1 and CDK4 using small interfering RNA (siRNA) were used to validate this protein complex as a drug target in cancer drug discovery.  Overexpression of cyclin D1 increased both phosphorylation of the retinoblastoma gene product (RB) and passage through the G1-S phase transition, resulting in increased proliferation of cells.  When cyclin D1 expression was shut off, growth rates fell below those seen in control cell lines transfected with the vector, indicating an increased dependence on this protein for proliferation.  Inhibition of endogenous cyclin D1 or CDK4 expression by RNA interference resulted in hypophosphorylation of RB and accumulation of cells in G1.  These results support the prevailing view that pharmacol. inhibition of cyclin D1/CDK4 complexes is a useful strategy to inhibit the growth of tumors.  Furthermore, since MCF-7 cells appear to be dependent on this pathway for their continued proliferation, it is a suitable cell line to test novel cyclin D1/CDK4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYCBIsweJDwLVg90H21EOLACvtfcHk0liEbTKwzhz20g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVensb0%253D&md5=41ddc04bfae515f6293a728cac00bc58</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs10549-005-9066-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-005-9066-y%26sid%3Dliteratum%253Aachs%26aulast%3DGrillo%26aufirst%3DM.%26aulast%3DBott%26aufirst%3DM.%2BJ.%26aulast%3DKhandke%26aufirst%3DN.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DMiranda%26aufirst%3DM.%26aulast%3DMeyyappan%26aufirst%3DM.%26aulast%3DRosfjord%26aufirst%3DE.%2BC.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26atitle%3DValidation%2520of%2520cyclin%2520D1%252FCDK4%2520as%2520an%2520anticancer%2520drug%2520target%2520in%2520MCF-7%2520breast%2520cancer%2520cells%253A%2520Effect%2520of%2520regulated%2520overexpression%2520of%2520cyclin%2520D1%2520and%2520siRNA-mediated%2520inhibition%2520of%2520endogenous%2520cyclin%2520D1%2520and%2520CDK4%2520expression%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2006%26volume%3D95%26spage%3D185%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tam, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theodoras, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shay, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, M.</span><span> </span><span class="NLM_article-title">Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2663</span><span class="NLM_x">–</span> <span class="NLM_lpage">2674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=2663-2674&author=S.+W.+Tamauthor=A.+M.+Theodorasauthor=J.+W.+Shayauthor=G.+F.+Draettaauthor=M.+Pagano&title=Differential+expression+and+regulation+of+cyclin+D1+protein+in+normal+and+tumor+human+cells%3A+association+with+Cdk4+is+required+for+cyclin+D1+function+in+G1+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DTheodoras%26aufirst%3DA.%2BM.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26aulast%3DDraetta%26aufirst%3DG.%2BF.%26aulast%3DPagano%26aufirst%3DM.%26atitle%3DDifferential%2520expression%2520and%2520regulation%2520of%2520cyclin%2520D1%2520protein%2520in%2520normal%2520and%2520tumor%2520human%2520cells%253A%2520association%2520with%2520Cdk4%2520is%2520required%2520for%2520cyclin%2520D1%2520function%2520in%2520G1%2520progression%26jtitle%3DOncogene%26date%3D1994%26volume%3D9%26spage%3D2663%26epage%3D2674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Arber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, E. K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgambato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delohery, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, I. B.</span><span> </span><span class="NLM_article-title">Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1569</span><span class="NLM_x">–</span> <span class="NLM_lpage">1574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=1569-1574&author=N.+Arberauthor=Y.+Dokiauthor=E.+K.-H.+Hanauthor=A.+Sgambatoauthor=P.+Zhouauthor=N.-H.+Kimauthor=T.+Deloheryauthor=M.+G.+Kleinauthor=P.+R.+Holtauthor=I.+B.+Weinstein&title=Antisense+to+cyclin+D1+inhibits+the+growth+and+tumorigenicity+of+human+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArber%26aufirst%3DN.%26aulast%3DDoki%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DE.%2BK.-H.%26aulast%3DSgambato%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DN.-H.%26aulast%3DDelohery%26aufirst%3DT.%26aulast%3DKlein%26aufirst%3DM.%2BG.%26aulast%3DHolt%26aufirst%3DP.%2BR.%26aulast%3DWeinstein%26aufirst%3DI.%2BB.%26atitle%3DAntisense%2520to%2520cyclin%2520D1%2520inhibits%2520the%2520growth%2520and%2520tumorigenicity%2520of%2520human%2520colon%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D1569%26epage%3D1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bartkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutzhoft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, K.</span><span> </span><span class="NLM_article-title">Cyclin D1 protein expression and function in human breast cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1002%2Fijc.2910570311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=8168995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK2cXksl2rsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1994&pages=353-361&author=J.+Bartkovaauthor=J.+Lukasauthor=H.+Mullerauthor=D.+Lutzhoftauthor=M.+Straussauthor=K.+Bartek&title=Cyclin+D1+protein+expression+and+function+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin D1 protein expression and function in human breast cancer</span></div><div class="casAuthors">Bartkova, Jirina; Lukas, Jiri; Muller, Heiko; Lutzhoeft, Dorrit; Strauss, Michael; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-61</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Cyclin D1 is a cell-cycle regulator essential for G1 phase progression and a candidate proto-oncogene implicated in pathogenesis of several human tumor types, including breast carcinomas.  In spite of the accumulating genetic evidence, however, there are no data regarding abundance and properties of the cyclin D1 protein in breast cancer.  The authors now report aberrant nuclear overexpression/accumulation of the cyclin D1 protein in about half of the 170 primary breast carcinoma specimens analyzed by monoclonal antibody immunohistochem., indicating that the frequency of cyclin D1 abnormalities may be considerably higher than previously deduced from DNA amplification studies.  A comparison of the expression patterns in matched lesions at different stages of tumor progression revealed that the cyclin D1 protein aberration appears to reflect a relatively early event and that, when acquired by a tumor, it is maintained throughout breast cancer progression including metastatic spread.  In both tumor tissues and breast cancer cell lines, the abundance of this protein shows characteristic variations consistent with a cell-cycle oscillation and the peak levels expressed in G1.  In all 7 cell lines whose retinoblastoma (Rb) protein is mutant or complexed to SV40 T antigen, exceptionally low levels of cyclin D1 protein and mRNA were found.  Antibody-mediated and anti-sense oligonucleotide knock-out expts. demonstrate the requirement for the cell-cycle regulatory function of cyclin D1 in breast cancer lines with single or multiple copies of the gene and reveal the absence of such a requirement in the cell lines with Rb defects.  The authors' data are consistent with the notion that the emerging "Rb-cyclin D1 pathway" represents a frequent target of oncogenic abnormalities in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMe4V2DjSDIrVg90H21EOLACvtfcHk0ljtnJUcCs8hKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksl2rsbk%253D&md5=1ec224a4586b04f2585921fd0086fd65</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910570311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910570311%26sid%3Dliteratum%253Aachs%26aulast%3DBartkova%26aufirst%3DJ.%26aulast%3DLukas%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DH.%26aulast%3DLutzhoft%26aufirst%3DD.%26aulast%3DStrauss%26aufirst%3DM.%26aulast%3DBartek%26aufirst%3DK.%26atitle%3DCyclin%2520D1%2520protein%2520expression%2520and%2520function%2520in%2520human%2520breast%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1994%26volume%3D57%26spage%3D353%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Uto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ido, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubouchi, H.</span><span> </span><span class="NLM_article-title">Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4779</span><span class="NLM_x">–</span> <span class="NLM_lpage">4783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4779-4783&author=H.+Utoauthor=A.+Idoauthor=A.+Moriuchiauthor=Y.+Onagaauthor=K.+Nagataauthor=M.+Onagaauthor=Y.+Taharaauthor=T.+Horiauthor=S.+Hironoauthor=K.+Hayashiauthor=H.+Tsubouchi&title=Transduction+of+antisense+cyclin+D1+using+two-step+gene+transfer+inhibits+the+growth+of+rat+hepatoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUto%26aufirst%3DH.%26aulast%3DIdo%26aufirst%3DA.%26aulast%3DMoriuchi%26aufirst%3DA.%26aulast%3DOnaga%26aufirst%3DY.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DOnaga%26aufirst%3DM.%26aulast%3DTahara%26aufirst%3DY.%26aulast%3DHori%26aufirst%3DT.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DTsubouchi%26aufirst%3DH.%26atitle%3DTransduction%2520of%2520antisense%2520cyclin%2520D1%2520using%2520two-step%2520gene%2520transfer%2520inhibits%2520the%2520growth%2520of%2520rat%2520hepatoma%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4779%26epage%3D4783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Specific protection against breast cancers by cyclin D1 ablation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=1017-1021&author=Q.+Yuauthor=Y.+Gengauthor=P.+Sicinski&title=Specific+protection+against+breast+cancers+by+cyclin+D1+ablation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DSpecific%2520protection%2520against%2520breast%2520cancers%2520by%2520cyclin%2520D1%2520ablation%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D1017%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagozdzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span> </span><span class="NLM_article-title">Requirement for CDK4 kinase function in breast cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2Fj.ccr.2005.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=16413469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=23-32&author=Q.+Yuauthor=E.+Sicinskaauthor=Y.+Gengauthor=M.+Ahnstromauthor=A.+Zagozdzonauthor=Y.+Kongauthor=H.+Gardnerauthor=H.+Kiyokawaauthor=L.+N.+Harrisauthor=O.+Stalauthor=P.+Sicinski&title=Requirement+for+CDK4+kinase+function+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for CDK4 kinase function in breast cancer</span></div><div class="casAuthors">Yu, Qunyan; Sicinska, Ewa; Geng, Yan; Ahnstrom, Marie; Zagozdzon, Agnieszka; Kong, Yinxin; Gardner, Humphrey; Kiyokawa, Hiroaki; Harris, Lyndsay N.; Stal, Olle; Sicinski, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cyclin D1 is overexpressed in the majority of human breast cancers.  The authors previously found that mice lacking cyclin D1 are resistant to mammary carcinomas triggered by the ErbB-2 oncogene.  In this study, the authors investigated which function of cyclin D1 is required for ErbB-2-driven mammary oncogenesis.  The authors report that the ability of cyclin D1 to activate cyclin-dependent kinase CDK4 underlies the crit. role for cyclin D1 in breast cancer formation.  The authors also found that the continued presence of CDK4-assocd. kinase activity is required to maintain breast tumorigenesis.  The authors analyzed primary human breast cancers and found high cyclin D1 levels in a subset (∼25%) of ErbB-2-overexpressing tumors.  The authors propose that this subset of breast cancer patients might benefit from inhibiting CDK4 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XtIoi9OqULVg90H21EOLACvtfcHk0lidGheeD0B9-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosFersw%253D%253D&md5=de0dbbf7f2463d60b126c201ac6bb7f6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2005.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2005.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DSicinska%26aufirst%3DE.%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DAhnstrom%26aufirst%3DM.%26aulast%3DZagozdzon%26aufirst%3DA.%26aulast%3DKong%26aufirst%3DY.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DKiyokawa%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DStal%26aufirst%3DO.%26aulast%3DSicinski%26aufirst%3DP.%26atitle%3DRequirement%2520for%2520CDK4%2520kinase%2520function%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D23%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Landis, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlyk, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicinski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, P. W.</span><span> </span><span class="NLM_article-title">Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=13-22&author=M.+W.+Landisauthor=B.+S.+Pawlykauthor=T.+Liauthor=P.+Sicinskiauthor=P.+W.+Hinds&title=Cyclin+D1-dependent+kinase+activity+in+murine+development+and+mammary+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DM.%2BW.%26aulast%3DPawlyk%26aufirst%3DB.%2BS.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSicinski%26aufirst%3DP.%26aulast%3DHinds%26aufirst%3DP.%2BW.%26atitle%3DCyclin%2520D1-dependent%2520kinase%2520activity%2520in%2520murine%2520development%2520and%2520mammary%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D13%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, J. R.</span><span> </span><span class="NLM_article-title">CDK inhibitors in cancer therapy: What is next</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=16-21&author=M.+Malumbresauthor=P.+Pevarelloauthor=M.+Barbacidauthor=J.+R.+Bischoff&title=CDK+inhibitors+in+cancer+therapy%3A+What+is+next"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26atitle%3DCDK%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520What%2520is%2520next%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D29%26spage%3D16%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Byrdt, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas S. Lin, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker-McEldowney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broering, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaaf, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerema, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozanski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suarez, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colevas, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M. R.</span><span> </span><span class="NLM_article-title">Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=399-404&author=J.+C.+Byrdtauthor=T.+S.+Thomas+S.+Linauthor=J.+T.+Daltonauthor=D.+Wuauthor=M.+A.+Phelpsauthor=B.+Fischerauthor=M.+Moranauthor=K.+A.+Blumauthor=B.+Rovinauthor=M.+Brooker-McEldowneyauthor=S.+Broeringauthor=L.+J.+Schaafauthor=A.+J.+Johnsonauthor=D.+M.+Lucasauthor=N.+A.+Heeremaauthor=G.+Lozanskiauthor=D.+C.+Youngauthor=J.-R.+Suarezauthor=A.+D.+Colevasauthor=M.+R.+Grever&title=Flavopiridol+administered+using+a+pharmacologically+derived+schedule+is+associated+with+marked+clinical+efficacy+in+refractory%2C+genetically+high-risk+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DByrdt%26aufirst%3DJ.%2BC.%26aulast%3DThomas%2BS.%2BLin%26aufirst%3DT.%2BS.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DPhelps%26aufirst%3DM.%2BA.%26aulast%3DFischer%26aufirst%3DB.%26aulast%3DMoran%26aufirst%3DM.%26aulast%3DBlum%26aufirst%3DK.%2BA.%26aulast%3DRovin%26aufirst%3DB.%26aulast%3DBrooker-McEldowney%26aufirst%3DM.%26aulast%3DBroering%26aufirst%3DS.%26aulast%3DSchaaf%26aufirst%3DL.%2BJ.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DLucas%26aufirst%3DD.%2BM.%26aulast%3DHeerema%26aufirst%3DN.%2BA.%26aulast%3DLozanski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DD.%2BC.%26aulast%3DSuarez%26aufirst%3DJ.-R.%26aulast%3DColevas%26aufirst%3DA.%2BD.%26aulast%3DGrever%26aufirst%3DM.%2BR.%26atitle%3DFlavopiridol%2520administered%2520using%2520a%2520pharmacologically%2520derived%2520schedule%2520is%2520associated%2520with%2520marked%2520clinical%2520efficacy%2520in%2520refractory%252C%2520genetically%2520high-risk%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D399%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinase 4/6 by PD0332991 and associated antitumor activity in human tumor xenografts</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=15542782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1427-1438&author=D.+W.+Fryauthor=P.+J.+Harveyauthor=P.+R.+Keller&title=Specific+inhibition+of+cyclin-dependent+kinase+4%2F6+by+PD0332991+and+associated+antitumor+activity+in+human+tumor+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts</span></div><div class="casAuthors">Fry, David W.; Harvey, Patricia J.; Keller, Paul R.; Elliott, William L.; Meade, MaryAnne; Trachet, Erin; Albassam, Mudher; Zheng, XianXian; Leopold, Wilbur R.; Pryer, Nancy K.; Toogood, Peter L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1427-1438</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PD 0332991 is a highly specific inhibitor of cyclin-dependent kinase 4 (Cdk4) (IC50, 0.011 μmol/L) and Cdk6 (IC50, 0.016 μmol/L), having no activity against a panel of 36 addnl. protein kinases.  It is a potent antiproliferative agent against retinoblastoma (Rb)-pos. tumor cells in vitro, inducing an exclusive G1 arrest, with a concomitant redn. of phospho-Ser780/Ser795 on the Rb protein.  Oral administration of PD 0332991 to mice bearing the Colo-205 human colon carcinoma produces marked tumor regression.  Therapeutic doses of PD 0332991 cause elimination of phospho-Rb and the proliferative marker Ki-67 in tumor tissue and down-regulation of genes under the transcriptional control of E2F.  The results indicate that inhibition of Cdk4/6 alone is sufficient to cause tumor regression and a net redn. in tumor burden in some tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9TOgbe4wrBLVg90H21EOLACvtfcHk0lh3RwyDchREHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslCkt7c%253D&md5=70931ebc6abd1c59bf1cc29748b7945f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinase%25204%252F6%2520by%2520PD0332991%2520and%2520associated%2520antitumor%2520activity%2520in%2520human%2520tumor%2520xenografts%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1427%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kubo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">lee, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, M. J.</span><span> </span><span class="NLM_article-title">The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">4279</span><span class="NLM_x">–</span> <span class="NLM_lpage">4286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=10632371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsV2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=4279-4286&author=A.+Kuboauthor=K.+Nakagawaauthor=R.+K.+Varmaauthor=N.+K.+Conradauthor=J.+Q.+Chengauthor=W.-C.+leeauthor=J.+R.+Testaauthor=B.+E.+Johnsonauthor=F.+E.+Kayeauthor=M.+J.+Kelley&title=The+p16+status+of+tumor+cell+lines+identifies+small+molecule+inhibitors+specific+for+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4</span></div><div class="casAuthors">Kubo, Akihito; Nakagawa, Kazuhiko; Varma, Ravi K.; Conrad, Nicholas K.; Cheng, Jin Quan; Lee, Wen-Ching; Testa, Joseph R.; Johnson, Bruce E.; Kaye, Frederic J.; Kelley, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4279-4286</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Loss of p16 functional activity leading to disruption of the p16/cyclin-dependent kinase (CDK) 4:cyclin D/retinoblastoma pathway is the most common event in human tumorigenesis, suggesting that compds. with CDK4 kinase inhibitory activity may be useful to regulate cancer cell growth.  To identify such inhibitors, the 60 cancer cell lines of the National Cancer Institute drug screen panel were examd. for p16 alterations (biallelic deletion, intragenic mutations, or absent p16 protein), and the growth-inhibitory activity of more than 50,000 compds. against these 60 cell lines was compared with their p16 status.  One compd., 3-amino thioacridone (3-ATA; NSC 680434), whose growth-inhibitory activity correlated with the p16 status of the cell lines had an IC50 of 3.1 μM in a CDK4 kinase assay.  In addn., four compds. structurally related to 3-ATA inhibited CDK4 kinase with IC50s ranging from 0.2-2.0 μM.  All five of these compds. were less potent inhibitors of cell division cycle 2 and CDK2 kinases, with IC50s 30- to 500-fold higher than that for CDK4.  ATP competition expts. demonstrated a noncompetitive mode of inhibition for 3-ATA (Ki = 5.5 μM) and a linear mixed mode for benzothiadiazine (NSC 645787; Ki = 0.73 μM).  The authors have successfully demonstrated a novel approach to identify specific CDK4 kinase inhibitors that may selectively induce growth inhibition of p16-altered tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBiKyx30Y91bVg90H21EOLACvtfcHk0ljQO7qcIM1Lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsV2msw%253D%253D&md5=55b023de0e7502f35033968142c3b8d4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DK.%26aulast%3DVarma%26aufirst%3DR.%2BK.%26aulast%3DConrad%26aufirst%3DN.%2BK.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3Dlee%26aufirst%3DW.-C.%26aulast%3DTesta%26aufirst%3DJ.%2BR.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DKaye%26aufirst%3DF.%2BE.%26aulast%3DKelley%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520p16%2520status%2520of%2520tumor%2520cell%2520lines%2520identifies%2520small%2520molecule%2520inhibitors%2520specific%2520for%2520cyclin-dependent%2520kinase%25204%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1999%26volume%3D5%26spage%3D4279%26epage%3D4286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Soni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumstein-Mecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span> </span><span class="NLM_article-title">Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">436</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1093%2Fjnci%2F93.6.436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=11259469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislCrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2001&pages=436-446&author=R.+Soniauthor=T.+O%E2%80%99Reillyauthor=P.+Furetauthor=L.+Mullerauthor=C.+Stephanauthor=S.+Zumstein-Meckerauthor=H.+Fretzauthor=D.+Fabbroauthor=B.+Chaudhuri&title=Selective+in+vivo+and+in+vitro+effects+of+a+small+molecule+inhibitor+of+cyclin-dependent+kinase+4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4</span></div><div class="casAuthors">Soni, Rajeev; O'Reilly, Terence; Furet, Pascal; Muller, Lionel; Stephan, Christine; Zumstein-Mecker, Sabine; Fretz, Heinz; Fabbro, Doriano; Chaudhuri, Bhabatosh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">436-446</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Cyclin-dependent kinase 4 (Cdk4) represents a prime target for the treatment of cancer because most human cancers are characterized by overexpression of its activating partner cyclin D1, loss of the natural Cdk4-specific inhibitor p16, or mutation(s) in Cdk4's catalytic subunit.  All of these can cause deregulated cell growth, resulting in tumor formation.  We sought to identify a small mol. that could inhibit the kinase activity of Cdk4 in vitro and to then ascertain the effects of that inhibitor on cell growth and tumor vol. in vivo.  Methods: A triaminopyrimidine deriv., CINK4 (a chem. inhibitor of Cdk4), was identified by screening for compds. that could inhibit Cdk4 enzyme activity in vitro.  Kinase assays were performed on diverse human Cdks and on other kinases that were expressed in and purified from insect cells to det. the specificity of CINK4.  Cell cycle effects of CINK4 on tumor and normal cells were studied by flow cytometry, and changes in phosphorylation of the retinoblastoma protein (pRb), a substrate of Cdk4, were detd. by western blotting.  The effect of the inhibitor on tumor growth in vivo was studied by use of tumors established through xenografts of HCT116 colon carcinoma cells in mice.  Statistical tests were two-sided.  Results: CINK4 specifically inhibited Cdk4/cyclin D1 in vitro.  It caused growth arrest in tumor cells and in normal cells and prevented pRb phosphorylation.  CINK4 treatment resulted in statistically significantly (P = .031) smaller mean tumor vols. in a mouse xenograft model.  Conclusions: Like p16, the natural inhibitor of Cdk4, CINK4 inhibits Cdk4 activity in vitro and slows tumor growth in vivo.  The specificity of CINK4 for Cdk4 raises the possibility that this small mol. or one with a similar structure could have therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoISmjFVy7B9rVg90H21EOLACvtfcHk0ljQO7qcIM1Lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislCrtLg%253D&md5=86345a46a2992af68c9dd22fc2e39efe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F93.6.436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F93.6.436%26sid%3Dliteratum%253Aachs%26aulast%3DSoni%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DT.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DZumstein-Mecker%26aufirst%3DS.%26aulast%3DFretz%26aufirst%3DH.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DChaudhuri%26aufirst%3DB.%26atitle%3DSelective%2520in%2520vivo%2520and%2520in%2520vitro%2520effects%2520of%2520a%2520small%2520molecule%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2001%26volume%3D93%26spage%3D436%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ikuta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span> </span><span class="NLM_article-title">Crystallographic approcach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">27548</span><span class="NLM_x">–</span> <span class="NLM_lpage">27554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=27548-27554&author=M.+Ikutaauthor=K.+Kamataauthor=K.+Fukasawaauthor=T.+Honmaauthor=T.+Machidaauthor=H.+Hiraiauthor=I.+Suzuki-Takahashiauthor=T.+Hayamaauthor=S.+Nishimura&title=Crystallographic+approcach+to+identification+of+cyclin-dependent+kinase+4+%28CDK4%29-specific+inhibitors+by+using+CDK4+mimic+CDK2+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DKamata%26aufirst%3DK.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DMachida%26aufirst%3DT.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26atitle%3DCrystallographic%2520approcach%2520to%2520identification%2520of%2520cyclin-dependent%2520kinase%25204%2520%2528CDK4%2529-specific%2520inhibitors%2520by%2520using%2520CDK4%2520mimic%2520CDK2%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D27548%26epage%3D27554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Grell, W.; Walter, R.; Heckel, A.; Himmelsbach, F.; Wittneben, H.; van Meel, J.; Redemann, N.; Haigh, R.</span> Preparation of 3-(α-Heteroarylaminobenzylidene)-2-indolinones as Cyclin Dependent Kinase Inhibitors. DE 19815020 A1 19991007, 1999.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Grell%2C+W.%3B+Walter%2C+R.%3B+Heckel%2C+A.%3B+Himmelsbach%2C+F.%3B+Wittneben%2C+H.%3B+van+Meel%2C+J.%3B+Redemann%2C+N.%3B+Haigh%2C+R.+Preparation+of+3-%28%CE%B1-Heteroarylaminobenzylidene%29-2-indolinones+as+Cyclin+Dependent+Kinase+Inhibitors.+DE+19815020+A1+19991007%2C+1999."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGrell%26aufirst%3DW." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Tsou, H.. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otteng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilakantan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span> </span><span class="NLM_article-title">4-(Phenylaminomethylene)isoquinoline-1,3(2<i>H</i>,4<i>H</i>)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3507</span><span class="NLM_x">–</span> <span class="NLM_lpage">3525</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800072z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3507-3525&author=H..+R.+Tsouauthor=M.+Ottengauthor=T.+Tranauthor=M.+B.+Floydauthor=M.+Reichauthor=G.+Birnbergauthor=K.+Kuttererauthor=S.+Ayral-Kaloustianauthor=M.+Raviauthor=R.+Nilakantanauthor=M.+Grilloauthor=J.+P.+McGinnisauthor=S.+K.+Rabindran&title=4-%28Phenylaminomethylene%29isoquinoline-1%2C3%282H%2C4H%29-diones+as+potent+and+selective+inhibitors+of+the+cyclin-dependent+kinase+4+%28CDK4%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm800072z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800072z%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH..%2BR.%26aulast%3DOtteng%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DFloyd%26aufirst%3DM.%2BB.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DKutterer%26aufirst%3DK.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DRavi%26aufirst%3DM.%26aulast%3DNilakantan%26aufirst%3DR.%26aulast%3DGrillo%26aufirst%3DM.%26aulast%3DMcGinnis%26aufirst%3DJ.%2BP.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26atitle%3D4-%2528Phenylaminomethylene%2529isoquinoline-1%252C3%25282H%252C4H%2529-diones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520cyclin-dependent%2520kinase%25204%2520%2528CDK4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3507%26epage%3D3525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">De Lombaert, S.; Fink, C. A.; Firoozina, F.; Hoyer, D. W.</span> Certain Thiol inhibitors of Endothelin-Converting Enzyme. PCT Int. Appl. WO 9955726 A1 19991104,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=De+Lombaert%2C+S.%3B+Fink%2C+C.+A.%3B+Firoozina%2C+F.%3B+Hoyer%2C+D.+W.+Certain+Thiol+inhibitors+of+Endothelin-Converting+Enzyme.+PCT+Int.+Appl.+WO+9955726+A1+19991104%2C+1999."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLombaert%26aufirst%3DS.%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takehana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Rational design, synthesis, and structure-activity relationships of novel factor Xa inhibitors: (2-Substituted-4-amidinophenyl)pyruvic and -propionic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1845</span><span class="NLM_x">–</span> <span class="NLM_lpage">1857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020485x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1845-1857&author=K.+Sagiauthor=T.+Nakagawaauthor=M.+Yamanashiauthor=S.+Makinoauthor=M.+Takahashiauthor=M.+Takayanagiauthor=K.+Takenakaauthor=N.+Suzukiauthor=S.+Onoauthor=N.+Kataokaauthor=K.+Ishikawaauthor=S.+Shimaauthor=Y.+Fukudaauthor=T.+Kayaharaauthor=S.+Takehanaauthor=Y.+Shimaauthor=K.+Tashiroauthor=H.+Yamamotoauthor=R.+Yoshimotoauthor=S.+Iwataauthor=T.+Tsujiauthor=K.+Sakuraiauthor=M.+Shoji&title=Rational+design%2C+synthesis%2C+and+structure-activity+relationships+of+novel+factor+Xa+inhibitors%3A+%282-Substituted-4-amidinophenyl%29pyruvic+and+-propionic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm020485x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020485x%26sid%3Dliteratum%253Aachs%26aulast%3DSagi%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DYamanashi%26aufirst%3DM.%26aulast%3DMakino%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DTakayanagi%26aufirst%3DM.%26aulast%3DTakenaka%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DOno%26aufirst%3DS.%26aulast%3DKataoka%26aufirst%3DN.%26aulast%3DIshikawa%26aufirst%3DK.%26aulast%3DShima%26aufirst%3DS.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DKayahara%26aufirst%3DT.%26aulast%3DTakehana%26aufirst%3DS.%26aulast%3DShima%26aufirst%3DY.%26aulast%3DTashiro%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DIwata%26aufirst%3DS.%26aulast%3DTsuji%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DK.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DRational%2520design%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationships%2520of%2520novel%2520factor%2520Xa%2520inhibitors%253A%2520%25282-Substituted-4-amidinophenyl%2529pyruvic%2520and%2520-propionic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1845%26epage%3D1857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Imanishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koshio, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, S.-y.; Kazuta, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akuzawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiso, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1493-1502&author=N.+Imanishiauthor=K.+Iwaokaauthor=H.+Koshioauthor=S.-y.%3B+Kazuta%2C+K.-i.+Nagashimaauthor=M.+Ohtaauthor=S.+Sakamotoauthor=H.+Itoauthor=S.+Akuzawaauthor=T.+Kisoauthor=S.-i.+Tsukamotoauthor=T.+Mase&title=New+thiazole+derivatives+as+potent+and+selective+5-hydroxytriptamine+3+%285-HT3%29+receptor+agonists+for+the+treatment+of+constipation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImanishi%26aufirst%3DN.%26aulast%3DIwaoka%26aufirst%3DK.%26aulast%3DKoshio%26aufirst%3DH.%26aulast%3DNagashima%26aufirst%3DS.-y.%253B%2BKazuta%252C%2BK.-i.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DAkuzawa%26aufirst%3DS.%26aulast%3DKiso%26aufirst%3DT.%26aulast%3DTsukamoto%26aufirst%3DS.-i.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DNew%2520thiazole%2520derivatives%2520as%2520potent%2520and%2520selective%25205-hydroxytriptamine%25203%2520%25285-HT3%2529%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520constipation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1493%26epage%3D1502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Singh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesher, G. Y.</span><span> </span><span class="NLM_article-title">Synthesis of aza analogs of Amrinone</span> <span class="citation_source-journal">Hereocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2163</span><span class="NLM_x">–</span> <span class="NLM_lpage">2172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.3987%2FCOM-90-5562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK3MXitVKqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1990&pages=2163-2172&author=B.+Singhauthor=G.+Y.+Lesher&title=Synthesis+of+aza+analogs+of+Amrinone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of aza analogs of amrinone</span></div><div class="casAuthors">Singh, Baldev; Lesher, George Y.</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2163-72</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    </div><div class="casAbstract">The aldol condensation product I of 4-acetylpyridine and CO(CO2Et)2 was converted to pyridazinecarboxylic acid hydrazide II (R = CONHNH2)(III).  Curtius reaction of III gave aminopyridazinone II (R = NH2).  The condensation of (4-pyridyl)glyoxal with aminomalonamide H2NCH(CONH2)2 yielded pyrazinecarboxamide IV (R1 = CONH2) which was transformed to aminopyrazinone IV (R1 = NH2) by the Hofmann reaction.  Curtius reaction of 1,2,4-triazinone-5-carboxylic acid V (R2 = CO2H) gave aminotriazinone V (R2 = NH2).  Demethylation of methoxypyrimidine VI (R3 = Me) gave pyrimidinol VI (R3 = H).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPWWNXR0dp6rVg90H21EOLACvtfcHk0lgW3Q03-hin3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVKqtbg%253D&md5=86e1442d56e521f4a826b10de76970d0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.3987%2FCOM-90-5562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-90-5562%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DLesher%26aufirst%3DG.%2BY.%26atitle%3DSynthesis%2520of%2520aza%2520analogs%2520of%2520Amrinone%26jtitle%3DHereocycles%26date%3D1990%26volume%3D31%26spage%3D2163%26epage%3D2172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Brown, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durant, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, A. C.,zprint>; DA ]?></span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, D. A.</span><span> </span><span class="NLM_article-title">Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&F 93574) and related compounds</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1993&pages=601-608&author=T.+H.+Brownauthor=R.+C.+Blakemoreauthor=G.+J.+Durantauthor=C.+R.+Ganellinauthor=M.+E.+Parsonsauthor=A.+C.%2Czprint%3E%3B+DA+%5D%3F%3E+Rasmussenauthor=D.+A.+Rawlings&title=Isocytosine+H2-receptor+histamine+antagonists.+IV.+The+synthesis+and+biological+activity+of+donetidine+%28SK%26F+93574%29+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DT.%2BH.%26aulast%3DBlakemore%26aufirst%3DR.%2BC.%26aulast%3DDurant%26aufirst%3DG.%2BJ.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DParsons%26aufirst%3DM.%2BE.%26aulast%3DRasmussen%26aufirst%3DA.%2BC.%252Czprint%253E%253B%2BDA%2B%255D%253F%253E%26aulast%3DRawlings%26aufirst%3DD.%2BA.%26atitle%3DIsocytosine%2520H2-receptor%2520histamine%2520antagonists.%2520IV.%2520The%2520synthesis%2520and%2520biological%2520activity%2520of%2520donetidine%2520%2528SK%2526F%252093574%2529%2520and%2520related%2520compounds%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1993%26volume%3D28%26spage%3D601%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Walpole, C. S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigglesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J.</span><span> </span><span class="NLM_article-title">Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic “A-region”</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">2362</span><span class="NLM_x">–</span> <span class="NLM_lpage">2372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00068a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2362-2372&issue=16&author=C.+S.+J.+Walpoleauthor=R.+Wrigglesworthauthor=S.+Bevanauthor=E.+A.+Campbellauthor=A.+Drayauthor=I.+F.+Jamesauthor=M.+N.+Perkinsauthor=D.+J.+Reidauthor=J.+Winter&title=Analogs+of+capsaicin+with+agonist+activity+as+novel+analgesic+agents%3B+structure-activity+studies.+1.+The+aromatic+%E2%80%9CA-region%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00068a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00068a014%26sid%3Dliteratum%253Aachs%26aulast%3DWalpole%26aufirst%3DC.%2BS.%2BJ.%26aulast%3DWrigglesworth%26aufirst%3DR.%26aulast%3DBevan%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DE.%2BA.%26aulast%3DDray%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DI.%2BF.%26aulast%3DPerkins%26aufirst%3DM.%2BN.%26aulast%3DReid%26aufirst%3DD.%2BJ.%26aulast%3DWinter%26aufirst%3DJ.%26atitle%3DAnalogs%2520of%2520capsaicin%2520with%2520agonist%2520activity%2520as%2520novel%2520analgesic%2520agents%253B%2520structure-activity%2520studies.%25201.%2520The%2520aromatic%2520%25E2%2580%259CA-region%25E2%2580%259D%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D16%26spage%3D2362%26epage%3D2372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Sugahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukita, T.</span><span> </span><span class="NLM_article-title">A facile copper-catalyzed Ullmann condensation: N-Arylation of heterocyclic compounds containing an -NHCO- moiety</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=719-721&issue=4&author=M.+Sugaharaauthor=T.+Ukita&title=A+facile+copper-catalyzed+Ullmann+condensation%3A+N-Arylation+of+heterocyclic+compounds+containing+an+-NHCO-+moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSugahara%26aufirst%3DM.%26aulast%3DUkita%26aufirst%3DT.%26atitle%3DA%2520facile%2520copper-catalyzed%2520Ullmann%2520condensation%253A%2520N-Arylation%2520of%2520heterocyclic%2520compounds%2520containing%2520an%2520-NHCO-%2520moiety%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1997%26volume%3D45%26issue%3D4%26spage%3D719%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Campbell, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. K.</span><span> </span><span class="NLM_article-title">Studies on g-Pyrones. I. Derivatives of Kojic Acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01147a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1950&pages=221-6&author=K.+N.+Campbellauthor=J.+F.+Ackermanauthor=B.+K.+Campbell&title=Studies+on+g-Pyrones.+I.+Derivatives+of+Kojic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo01147a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01147a034%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DK.%2BN.%26aulast%3DAckerman%26aufirst%3DJ.%2BF.%26aulast%3DCampbell%26aufirst%3DB.%2BK.%26atitle%3DStudies%2520on%2520g-Pyrones.%2520I.%2520Derivatives%2520of%2520Kojic%2520Acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1950%26volume%3D15%26spage%3D221%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Cizmaricova, Ruzena</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskikova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregan, F.</span><span> </span><span class="NLM_article-title">Derivatives of kojic acid</span> <span class="citation_source-journal">Pharmazie.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">460</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1991&pages=460&issue=6&author=Ruzena+Cizmaricovaauthor=E.+Miskikovaauthor=F.+Gregan&title=Derivatives+of+kojic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCizmaricova%26aufirst%3DRuzena%26aulast%3DMiskikova%26aufirst%3DE.%26aulast%3DGregan%26aufirst%3DF.%26atitle%3DDerivatives%2520of%2520kojic%2520acid%26jtitle%3DPharmazie.%26date%3D1991%26volume%3D46%26issue%3D6%26spage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kamino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuramochi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span> </span><span class="NLM_article-title">A concise approach to 5-substituted-4-pyrones from kojic acid</span> <span class="citation_source-journal">Tet. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">7349</span><span class="NLM_x">–</span> <span class="NLM_lpage">7351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2FS0040-4039%2803%2901836-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvV2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=7349-7351&author=T.+Kaminoauthor=K.+Kuramochiauthor=S.+Kobayashi&title=A+concise+approach+to+5-substituted-4-pyrones+from+kojic+acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">A concise approach to 5-substituted-4-pyrones from kojic acid</span></div><div class="casAuthors">Kamino, Tomoyuki; Kuramochi, Kouji; Kobayashi, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">7349-7351</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A concise approach to 5-substituted-4-pyrones is described.  This approach is based on manipulation of the 5-hydroxy group of readily available kojic acid.  A no. of 5-substituted-4-pyrones were synthesized from kojic acid utilizing Heck reaction, Suzuki coupling, and Stille coupling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnble4DdJKkrVg90H21EOLACvtfcHk0lg3lf289ACrRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvV2mtL0%253D&md5=f80280779dec690e8e56d222000da5bc</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2803%2901836-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252803%252901836-7%26sid%3Dliteratum%253Aachs%26aulast%3DKamino%26aufirst%3DT.%26aulast%3DKuramochi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26atitle%3DA%2520concise%2520approach%2520to%25205-substituted-4-pyrones%2520from%2520kojic%2520acid%26jtitle%3DTet.%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D7349%26epage%3D7351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graber, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seest, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolak, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William Watt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joel Morris, J.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis of furo[2,3-c]pyridine pyrimidine thioethers, a new class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7851</span><span class="NLM_x">–</span> <span class="NLM_lpage">7859</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9810359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=7851-7859&issue=22&author=D.+G.+Wishkaauthor=D.+R.+Graberauthor=E.+P.+Seestauthor=L.+A.+Dolakauthor=F.+Hanauthor=W.+William+Wattauthor=J.+Joel+Morris&title=Stereoselective+synthesis+of+furo%5B2%2C3-c%5Dpyridine+pyrimidine+thioethers%2C+a+new+class+of+potent+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo9810359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9810359%26sid%3Dliteratum%253Aachs%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DGraber%26aufirst%3DD.%2BR.%26aulast%3DSeest%26aufirst%3DE.%2BP.%26aulast%3DDolak%26aufirst%3DL.%2BA.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DWilliam%2BWatt%26aufirst%3DW.%26aulast%3DJoel%2BMorris%26aufirst%3DJ.%26atitle%3DStereoselective%2520synthesis%2520of%2520furo%255B2%252C3-c%255Dpyridine%2520pyrimidine%2520thioethers%252C%2520a%2520new%2520class%2520of%2520potent%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26issue%3D22%26spage%3D7851%26epage%3D7859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Nightingale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J. R.</span><span> </span><span class="NLM_article-title">The Alkylation of o- and p-Xylene</span> <span class="citation_source-journal">J. Amer. Chem, Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1944</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01229a502" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1944&pages=154-155&author=D.+Nightingaleauthor=J.+R.+Janes&title=The+Alkylation+of+o-+and+p-Xylene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fja01229a502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01229a502%26sid%3Dliteratum%253Aachs%26aulast%3DNightingale%26aufirst%3DD.%26aulast%3DJanes%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520Alkylation%2520of%2520o-%2520and%2520p-Xylene%26jtitle%3DJ.%2520Amer.%2520Chem%252C%2520Soc.%26date%3D1944%26volume%3D66%26spage%3D154%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Markwalder, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnone, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benfield, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisclair, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerniak, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doleniak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grafstrom, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaltenbach, III, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugiel, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouten, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5894</span><span class="NLM_x">–</span> <span class="NLM_lpage">5911</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020455u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5894-5911&author=J.+A.+Markwalderauthor=M.+R.+Arnoneauthor=P.+A.+Benfieldauthor=M.+Boisclairauthor=C.+R.+Burtonauthor=C.-H.+Changauthor=S.+S.+Coxauthor=P.+M.+Czerniakauthor=C.+L.+Deanauthor=D.+Doleniakauthor=R.+Grafstromauthor=B.+A.+Harrisonauthor=R.+F.+Kaltenbach%2C+IIIauthor=D.+A.+Nugielauthor=K.+A.+Rossiauthor=S.+R.+Sherkauthor=L.+M.+Siskauthor=P.+Stoutenauthor=G.+L.+Trainorauthor=P.+Worlandauthor=S.+P.+Seitz&title=Synthesis+and+biological+evaluation+of+1-aryl-4%2C5-dihydro-1H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1021%2Fjm020455u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020455u%26sid%3Dliteratum%253Aachs%26aulast%3DMarkwalder%26aufirst%3DJ.%2BA.%26aulast%3DArnone%26aufirst%3DM.%2BR.%26aulast%3DBenfield%26aufirst%3DP.%2BA.%26aulast%3DBoisclair%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DCox%26aufirst%3DS.%2BS.%26aulast%3DCzerniak%26aufirst%3DP.%2BM.%26aulast%3DDean%26aufirst%3DC.%2BL.%26aulast%3DDoleniak%26aufirst%3DD.%26aulast%3DGrafstrom%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DKaltenbach%252C%2BIII%26aufirst%3DR.%2BF.%26aulast%3DNugiel%26aufirst%3DD.%2BA.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DSherk%26aufirst%3DS.%2BR.%26aulast%3DSisk%26aufirst%3DL.%2BM.%26aulast%3DStouten%26aufirst%3DP.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWorland%26aufirst%3DP.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25201-aryl-4%252C5-dihydro-1H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5894%26epage%3D5911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markwalder, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisclair, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brizuela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouten, P. F. W.</span><span> </span><span class="NLM_article-title">Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=111-122&author=K.+A.+Rossiauthor=J.+A.+Markwalderauthor=S.+P.+Seitzauthor=C.-H.+Changauthor=S.+Coxauthor=M.+D.+Boisclairauthor=L.+Brizuelaauthor=S.+L.+Brennerauthor=P.+F.+W.+Stouten&title=Understanding+and+modulating+cyclin-dependent+kinase+inhibitor+specificity%3A+molecular+modeling+and+biochemical+evaluation+of+pyrazolopyrimidinones+as+CDK2%2Fcyclin+A+and+CDK4%2Fcyclin+D1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DMarkwalder%26aufirst%3DJ.%2BA.%26aulast%3DSeitz%26aufirst%3DS.%2BP.%26aulast%3DChang%26aufirst%3DC.-H.%26aulast%3DCox%26aufirst%3DS.%26aulast%3DBoisclair%26aufirst%3DM.%2BD.%26aulast%3DBrizuela%26aufirst%3DL.%26aulast%3DBrenner%26aufirst%3DS.%2BL.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26atitle%3DUnderstanding%2520and%2520modulating%2520cyclin-dependent%2520kinase%2520inhibitor%2520specificity%253A%2520molecular%2520modeling%2520and%2520biochemical%2520evaluation%2520of%2520pyrazolopyrimidinones%2520as%2520CDK2%252Fcyclin%2520A%2520and%2520CDK4%252Fcyclin%2520D1%2520inhibitors%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2005%26volume%3D19%26spage%3D111%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shangari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, P. J.</span><span> </span><span class="NLM_article-title">Sulfation and glucuronidation of phenols: Implications in coenyzme Q metabolism</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2005&pages=342-259&author=N.+Shangariauthor=T.+S.+Chanauthor=P.+J.+O%E2%80%99Brien&title=Sulfation+and+glucuronidation+of+phenols%3A+Implications+in+coenyzme+Q+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShangari%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DT.%2BS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%2BJ.%26atitle%3DSulfation%2520and%2520glucuronidation%2520of%2520phenols%253A%2520Implications%2520in%2520coenyzme%2520Q%2520metabolism%26jtitle%3DMethods%2520Enzymol.%26date%3D2005%26volume%3D400%26spage%3D342%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kim, K. H.</span><span> </span><span class="NLM_article-title">Quantitative structure-activity relationships of the metabolism of drugs by uridine diphosphate glucuronosyltransferase</span> <span class="citation_source-journal">J. Phamacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">966</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1002%2Fjps.2600801013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK38XhsFWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1991&pages=966-970&issue=10&author=K.+H.+Kim&title=Quantitative+structure-activity+relationships+of+the+metabolism+of+drugs+by+uridine+diphosphate+glucuronosyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative structure-activity relationships of the metabolism of drugs by uridine diphosphate glucuronosyltransferase</span></div><div class="casAuthors">Kim, Ki H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">966-70</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A review with 14 refs. discussing the quant. structure-activity relationships of the metab. of drugs by uridine diphosphate (UDP)-glucuronosyltransferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGAWIs-LrLmrVg90H21EOLACvtfcHk0lhm3_xXQy4KYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFWksg%253D%253D&md5=ee322f5223021e2145a75334a0d65a2f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600801013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600801013%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BH.%26atitle%3DQuantitative%2520structure-activity%2520relationships%2520of%2520the%2520metabolism%2520of%2520drugs%2520by%2520uridine%2520diphosphate%2520glucuronosyltransferase%26jtitle%3DJ.%2520Phamacol.%2520Sci.%26date%3D1991%26volume%3D80%26issue%3D10%26spage%3D966%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Mechanistic studies of uridine diphosphate glucuronosyltransferase</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2F0009-2797%2894%2990110-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=8131219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK2cXkslOjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1994&pages=47-58&author=H.+Yinauthor=G.+Bennettauthor=J.+P.+Jones&title=Mechanistic+studies+of+uridine+diphosphate+glucuronosyltransferase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic studies of uridine diphosphate glucuronosyltransferase</span></div><div class="casAuthors">Yin, Hequn; Bennett, Grace; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-58</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    </div><div class="casAbstract">Bisubstrate reaction kinetics and product inhibition studies were used to characterize the kinetic mechanism of a partially purified uridine diphosphate glucuronosyltransferase (UDPGT).  These studies indicate that the reaction must likely occurs via a random order sequential mechanism.  The effect on electron withdrawing and donating groups on the rate of reaction was also detd.  It was found that electron donating groups increased the rate of glucuronide conjugation.  This result is consistent with nucleophilic attack of the C-1 carbon of the UDP-glucuronic acid (UDPGA) by an SN2 mechanism.  This is the first direct evidence for a SN2 mechanism in UDPGT catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovvAs7ylh6PrVg90H21EOLACvtfcHk0lhm3_xXQy4KYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslOjsLw%253D&md5=3c2f2f01d69c341e8c2bcb908024856a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2F0009-2797%2894%2990110-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0009-2797%252894%252990110-4%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DBennett%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DMechanistic%2520studies%2520of%2520uridine%2520diphosphate%2520glucuronosyltransferase%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D1994%26volume%3D90%26spage%3D47%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Katritzky, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagowski, J. M.</span><span> </span><span class="NLM_article-title">Prototropic tautomerism of heteroaromatic compounds: I. General discussion and methods of study</span> <span class="citation_source-journal">Adv. Heterocyclic Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2FS0065-2725%2808%2960528-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaF3sXkt1Wks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1963&pages=311-38&author=A.+R.+Katritzkyauthor=J.+M.+Lagowski&title=Prototropic+tautomerism+of+heteroaromatic+compounds%3A+I.+General+discussion+and+methods+of+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Prototropic tautomerism of heteroaromatic compounds: I. General discussion and methods of study</span></div><div class="casAuthors">Katritzky, A. R.; Lagowski, J. M.</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">311-38</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQZtPm7PqQ7Vg90H21EOLACvtfcHk0lh83Z7TW6wP_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXkt1Wks7s%253D&md5=3cfe46a93bed1eef9d192de793f41b82</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1016%2FS0065-2725%2808%2960528-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-2725%252808%252960528-0%26sid%3Dliteratum%253Aachs%26aulast%3DKatritzky%26aufirst%3DA.%2BR.%26aulast%3DLagowski%26aufirst%3DJ.%2BM.%26atitle%3DPrototropic%2520tautomerism%2520of%2520heteroaromatic%2520compounds%253A%2520I.%2520General%2520discussion%2520and%2520methods%2520of%2520study%26jtitle%3DAdv.%2520Heterocyclic%2520Chem.%26date%3D1963%26volume%3D1%26spage%3D311%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, R. J.</span><span> </span><span class="NLM_article-title">Tautomeric equilibria of hydroxypyridines in different solvents: An ab initio study</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">16141</span><span class="NLM_x">–</span> <span class="NLM_lpage">16146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp961295z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1996&pages=16141-16146&author=J.+Wangauthor=R.+J.+Boyd&title=Tautomeric+equilibria+of+hydroxypyridines+in+different+solvents%3A+An+ab+initio+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1021%2Fjp961295z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp961295z%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DR.%2BJ.%26atitle%3DTautomeric%2520equilibria%2520of%2520hydroxypyridines%2520in%2520different%2520solvents%253A%2520An%2520ab%2520initio%2520study%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1996%26volume%3D100%26spage%3D16141%26epage%3D16146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">De Kowaleski, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">diez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, A.</span><span> </span><span class="NLM_article-title">NMR J(C, C) scalar coupling analysis of the effects of substituents on the keto-enol tautomeric equilibrium in 2-OH-n-X-pyridines. An experimental and DFT study</span> <span class="citation_source-journal">Mol. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23−24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2607</span><span class="NLM_x">–</span> <span class="NLM_lpage">2615</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23%E2%88%9224&publication_year=2004&pages=2607-2615&author=D.+G.+De+Kowaleskiauthor=R.+H.+Contrerasauthor=E.+diezauthor=A.+Esteban&title=NMR+J%28C%2C+C%29+scalar+coupling+analysis+of+the+effects+of+substituents+on+the+keto-enol+tautomeric+equilibrium+in+2-OH-n-X-pyridines.+An+experimental+and+DFT+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BKowaleski%26aufirst%3DD.%2BG.%26aulast%3DContreras%26aufirst%3DR.%2BH.%26aulast%3Ddiez%26aufirst%3DE.%26aulast%3DEsteban%26aufirst%3DA.%26atitle%3DNMR%2520J%2528C%252C%2520C%2529%2520scalar%2520coupling%2520analysis%2520of%2520the%2520effects%2520of%2520substituents%2520on%2520the%2520keto-enol%2520tautomeric%2520equilibrium%2520in%25202-OH-n-X-pyridines.%2520An%2520experimental%2520and%2520DFT%2520study%26jtitle%3DMol.%2520Phys.%26date%3D2004%26volume%3D23%25E2%2588%259224%26spage%3D2607%26epage%3D2615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span>GLIDE; <span class="NLM_publisher-name">Schrodinger Software</span>: <span class="NLM_publisher-loc">Portland, OR</span> (<a href="http://www.schrodinger.com" class="extLink">www.schrodinger.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GLIDE%3B+Schrodinger+Software%3A+Portland%2C+OR+%28www.schrodinger.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGLIDE%26pub%3DSchrodinger%2520Software" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thompson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, K. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winborne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomszek, T. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Meguid, S. S.</span><span> </span><span class="NLM_article-title">Rational design, syntheis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1′-P2′ amide bond isostere</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3100</span><span class="NLM_x">–</span> <span class="NLM_lpage">3107</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00045a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3100-3107&author=S.+K.+Thompsonauthor=K.+H.+M.+Murthyauthor=B.+Zhaoauthor=E.+Winborneauthor=D.+W.+Greenauthor=S.+M.+Fisherauthor=R.+L.+DesJarlaisauthor=T.+A.+Thomszekauthor=T.+D.+Meekauthor=J.+G.+Gleasonauthor=S.+S.+Abdel-Meguid&title=Rational+design%2C+syntheis%2C+and+crystallographic+analysis+of+a+hydroxyethylene-based+HIV-1+protease+inhibitor+containing+a+heterocyclic+P1%E2%80%B2-P2%E2%80%B2+amide+bond+isostere"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1021%2Fjm00045a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00045a015%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DS.%2BK.%26aulast%3DMurthy%26aufirst%3DK.%2BH.%2BM.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DWinborne%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DD.%2BW.%26aulast%3DFisher%26aufirst%3DS.%2BM.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DThomszek%26aufirst%3DT.%2BA.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DAbdel-Meguid%26aufirst%3DS.%2BS.%26atitle%3DRational%2520design%252C%2520syntheis%252C%2520and%2520crystallographic%2520analysis%2520of%2520a%2520hydroxyethylene-based%2520HIV-1%2520protease%2520inhibitor%2520containing%2520a%2520heterocyclic%2520P1%25E2%2580%25B2-P2%25E2%2580%25B2%2520amide%2520bond%2520isostere%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3100%26epage%3D3107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, X.-S.</span><span> </span><span class="NLM_article-title">Hydrogen bonding interaction between the primary quinone acceptor Q<sub>A</sub> and a histidine side chain in photosystem II as revealed by fourier transform infrared spectroscopy</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi982294v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=399-403&author=T.+Noguchiauthor=Y.+Inoueauthor=X.-S.+Tang&title=Hydrogen+bonding+interaction+between+the+primary+quinone+acceptor+QA+and+a+histidine+side+chain+in+photosystem+II+as+revealed+by+fourier+transform+infrared+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Fbi982294v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi982294v%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DX.-S.%26atitle%3DHydrogen%2520bonding%2520interaction%2520between%2520the%2520primary%2520quinone%2520acceptor%2520QA%2520and%2520a%2520histidine%2520side%2520chain%2520in%2520photosystem%2520II%2520as%2520revealed%2520by%2520fourier%2520transform%2520infrared%2520spectroscopy%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D399%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Edgcomb, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. P.</span><span> </span><span class="NLM_article-title">Variability in the pKa of histidine side-chains correlates with burial within proteins</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=1-6&author=S.+P.+Edgcombauthor=K.+P.+Murphy&title=Variability+in+the+pKa+of+histidine+side-chains+correlates+with+burial+within+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdgcomb%26aufirst%3DS.%2BP.%26aulast%3DMurphy%26aufirst%3DK.%2BP.%26atitle%3DVariability%2520in%2520the%2520pKa%2520of%2520histidine%2520side-chains%2520correlates%2520with%2520burial%2520within%2520proteins%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2002%26volume%3D49%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">McInnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kontopidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meades, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1016%2Fj.chembiol.2004.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=15123247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1Cms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=525-534&author=C.+McInnesauthor=S.+Wangauthor=S.+Andersonauthor=J.+O%E2%80%99Boyleauthor=W.+Jacksonauthor=G.+Kontopidisauthor=C.+Meadesauthor=M.+Meznaauthor=M.+Thomasauthor=G.+Woodauthor=D.+P.+Laneauthor=P.+M.+Fischer&title=Structural+determinants+of+CDK4+inhibition+and+design+of+selective+ATP+competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants of CDK4 Inhibition and Design of Selective ATP Competitive Inhibitors</span></div><div class="casAuthors">McInnes, Campbell; Wang, Shudong; Anderson, Sian; O'Boyle, Janice; Jackson, Wayne; Kontopidis, George; Meades, Christopher; Mezna, Mokdad; Thomas, Mark; Wood, Gavin; Lane, David P.; Fischer, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">525-534</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A no. of selective inhibitors of the CDK4/cyclin D1 complex have been reported recently.  Due to the absence of an exptl. CDK4 structure, the ligand and protein determinants contributing to CDK4 selectivity are poorly understood at present.  Here, we report the use of computational methods to elucidate the characteristics of selectivity and to derive the structural basis for specific, high-affinity binding of inhibitors to the CDK4 active site.  From these data, the hypothesis emerged that appropriate incorporation of an ionizable function into a CDK2 inhibitor results in more favorable binding to CDK4.  This knowledge was applied to the design of compds. in the otherwise CDK2-selective 2-anilino-4-(thiazol-5-yl)pyrimidine pharmacophore that are potent and highly selective ATP antagonists of CDK4/cyclin D1.  The findings of this study also have significant implications in the design of CDK4 mimic structures based on CDK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU07M2Ugw65bVg90H21EOLACvtfcHk0lisdDOLSCAv_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1Cms74%253D&md5=94d613c28266a51507bf63d34965d792</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DW.%26aulast%3DKontopidis%26aufirst%3DG.%26aulast%3DMeades%26aufirst%3DC.%26aulast%3DMezna%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DG.%26aulast%3DLane%26aufirst%3DD.%2BP.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DStructural%2520determinants%2520of%2520CDK4%2520inhibition%2520and%2520design%2520of%2520selective%2520ATP%2520competitive%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D525%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Honma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukasawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iduta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki-Takahashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishima, H.</span><span> </span><span class="NLM_article-title">Structure-based generation of a new class of potent cdk4 inhibitors: New de novo design strategy and library design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4615</span><span class="NLM_x">–</span> <span class="NLM_lpage">4627</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0103256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFagtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4615-4627&author=T.+Honmaauthor=K.+Hayashiauthor=T.+Aoyamaauthor=N.+Hashimotoauthor=T.+Machidaauthor=K.+Fukasawaauthor=T.+Iwamaauthor=C.+Ikeuraauthor=M.+Idutaauthor=I.+Suzuki-Takahashiauthor=Y.+Iwasawaauthor=T.+Hayamaauthor=S.+Nishimuraauthor=H.+Morishima&title=Structure-based+generation+of+a+new+class+of+potent+cdk4+inhibitors%3A+New+de+novo+design+strategy+and+library+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Generation of a New Class of Potent Cdk4 Inhibitors: New de Novo Design Strategy and Library Design</span></div><div class="casAuthors">Honma, Teruki; Hayashi, Kyoko; Aoyama, Tetsuya; Hashimoto, Noriaki; Machida, Takumitsu; Fukasawa, Kazuhiro; Iwama, Toshiharu; Ikeura, Chinatsu; Ikuta, Mari; Suzuki-Takahashi, Ikuko; Iwasawa, Yoshikazu; Hayama, Takashi; Nishimura, Susumu; Morishima, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4615-4627</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a first step in structure-based design of highly selective and potent Cdk4 inhibitors, we performed structure-based generation of a novel series of Cdk4 inhibitors.  A Cdk4 homol. model was constructed according to x-ray anal. of an activated form of Cdk2.  Using this model, we applied a new de novo design strategy which combined the de novo design program LEGEND with our inhouse structure selection supporting system SEEDS to generate new scaffold candidates.  In this way, four classes of scaffold candidates including diarylurea were identified.  By constructing diarylurea informer libraries based on the structural requirements of Cdk inhibitors in the ATP binding pocket of the Cdk4 model, we were able to identify a potent Cdk4 inhibitor N-(9-oxo-9H-fluoren-4-yl)-N'-pyridin-2-ylurea (I) with IC50 = 0.10 μM, together with preliminary SAR.  We performed a docking study between I and the Cdk4 model and selected a reasonable binding mode which is consistent with the SAR.  Further modification based on the proposed binding mode provided a more potent compd., N-[(9bR)-5-oxo- 2,3,5,9b-tetrahydro-1H-pyrrolo[2,1-a]isoindol-9-yl]-N'-pyridin-2-ylurea (II) with IC50 = 0.042 μM, x-ray anal. of which was accomplished by the soaking method.  The predicted binding mode of I in Cdk4 was validated by x-ray anal. of the Cdk2-II complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvx3J3Bqyg9LVg90H21EOLACvtfcHk0lje_01xZJ1qZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFagtrs%253D&md5=0c4458fa88d41c148a672863b3a6daa0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm0103256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0103256%26sid%3Dliteratum%253Aachs%26aulast%3DHonma%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DAoyama%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DMachida%26aufirst%3DT.%26aulast%3DFukasawa%26aufirst%3DK.%26aulast%3DIwama%26aufirst%3DT.%26aulast%3DIkeura%26aufirst%3DC.%26aulast%3DIduta%26aufirst%3DM.%26aulast%3DSuzuki-Takahashi%26aufirst%3DI.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DHayama%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMorishima%26aufirst%3DH.%26atitle%3DStructure-based%2520generation%2520of%2520a%2520new%2520class%2520of%2520potent%2520cdk4%2520inhibitors%253A%2520New%2520de%2520novo%2520design%2520strategy%2520and%2520library%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4615%26epage%3D4627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Aubry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marechal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=787-801&author=C.+Aubryauthor=A.+J.+Wilsonauthor=P.+R.+Jenkinsauthor=S.+Mahaleauthor=B.+Chaudhuriauthor=J.+Marechalauthor=M.+J.+Sutcliffe&title=Design%2C+synthesis+and+biological+activity+of+new+CDK4-specific+inhibitors%2C+based+on+fascaplysin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAubry%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DJenkins%26aufirst%3DP.%2BR.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DChaudhuri%26aufirst%3DB.%26aulast%3DMarechal%26aufirst%3DJ.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%2520new%2520CDK4-specific%2520inhibitors%252C%2520based%2520on%2520fascaplysin%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D787%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span> </span><span class="NLM_article-title">Dissecting the determinants of cyclin-dependent kinase 2 and cyclin-dependent kinase 4 inhibitor selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5470</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060216x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5470-5477&author=D.+J.+Prattauthor=J.+Bentleyauthor=F.+Jewsburyauthor=T.+Boyleauthor=J.+A.+Endicottauthor=M.+E.+M.+Noble&title=Dissecting+the+determinants+of+cyclin-dependent+kinase+2+and+cyclin-dependent+kinase+4+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm060216x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060216x%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DJewsbury%26aufirst%3DF.%26aulast%3DBoyle%26aufirst%3DT.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26atitle%3DDissecting%2520the%2520determinants%2520of%2520cyclin-dependent%2520kinase%25202%2520and%2520cyclin-dependent%2520kinase%25204%2520inhibitor%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5470%26epage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span> </span><span class="NLM_article-title">Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: Comparative molecular dynamics simulation studies of CDK2 and CDK4</span> <span class="citation_source-journal">ChemBioChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1662</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1662-1672&author=H.+Parkauthor=M.+S.+Yeomauthor=S.+Lee&title=Loop+flexibility+and+solvent+dynamics+as+determinants+for+the+selective+inhibition+of+cyclin-dependent+kinase+4%3A+Comparative+molecular+dynamics+simulation+studies+of+CDK2+and+CDK4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%26aulast%3DYeom%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DS.%26atitle%3DLoop%2520flexibility%2520and%2520solvent%2520dynamics%2520as%2520determinants%2520for%2520the%2520selective%2520inhibition%2520of%2520cyclin-dependent%2520kinase%25204%253A%2520Comparative%2520molecular%2520dynamics%2520simulation%2520studies%2520of%2520CDK2%2520and%2520CDK4%26jtitle%3DChemBioChem.%26date%3D2004%26volume%3D5%26spage%3D1662%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span>SYBYL, version 7.2; <span class="NLM_publisher-name">Tripos, Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SYBYL%2C+version+7.2%3B+Tripos%2C+Inc.%3A+St.+Louis%2C+MO%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSYBYL%26pub%3DTripos%252C%2520Inc%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Eldridge, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auton, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paolini, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, R. P.</span><span> </span><span class="NLM_article-title">Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm801026e&amp;key=10.1023%2FA%3A1007996124545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm801026e&amp;key=9385547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK2sXnsV2it7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=425-445&author=M.+D.+Eldridgeauthor=C.+W.+Murrayauthor=T.+R.+Autonauthor=G.+V.+Paoliniauthor=R.+P.+Mee&title=Empirical+scoring+functions%3A+I.+The+development+of+a+fast+empirical+scoring+function+to+estimate+the+binding+affinity+of+ligands+in+receptor+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes</span></div><div class="casAuthors">Eldridge, Matthew D.; Murray, Christopher W.; Auton, Timothy R.; Paolini, Gaia V.; Mee, Roger P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">425-445</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">This paper describes the development of a simple empirical scoring function designed to est. the free energy of binding for a protein-ligand complex when the 3D structure of the complex is known or can be approximated.  The function uses simple contact terms to est. lipophilic and metal-ligand binding contributions, a simple explicit form for hydrogen bonds and a term which penalizes flexibility.  The coeffs. of each term are obtained using a regression based on 82 ligand-receptor complexes for which the binding affinity is known.  The function reproduces the binding affinity of the complexes with a cross-validated error of 8.68 kJ/mol.  Tests on internal consistency indicate that the coeffs. obtained are stable to changes in the compn. of the training set.  The function is also tested on two test sets contg. a further 20 and 10 complexes, resp.  The deficiencies of this type of function are discussed and it is compared to approaches by other workers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJZ-k95NG1LVg90H21EOLACvtfcHk0liCGHqxUGdATw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsV2it7o%253D&md5=ece4b881e181f3d5c1287af55efaf6b4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1023%2FA%3A1007996124545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1007996124545%26sid%3Dliteratum%253Aachs%26aulast%3DEldridge%26aufirst%3DM.%2BD.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DAuton%26aufirst%3DT.%2BR.%26aulast%3DPaolini%26aufirst%3DG.%2BV.%26aulast%3DMee%26aufirst%3DR.%2BP.%26atitle%3DEmpirical%2520scoring%2520functions%253A%2520I.%2520The%2520development%2520of%2520a%2520fast%2520empirical%2520scoring%2520function%2520to%2520estimate%2520the%2520binding%2520affinity%2520of%2520ligands%2520in%2520receptor%2520complexes%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1997%26volume%3D11%26spage%3D425%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triado-Rives, J.</span><span> </span><span class="NLM_article-title">Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">11225</span><span class="NLM_x">–</span> <span class="NLM_lpage">11236</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9621760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm801026e&amp;key=1%3ACAS%3A528%3ADyaK28XmtlOitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=11225-11236&issue=45&author=W.+L.+Jorgensenauthor=D.+S.+Maxwellauthor=J.+Triado-Rives&title=Development+and+testing+of+the+OPLS+all-atom+force+field+on+conformational+energetics+and+properties+of+organic+liquids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids</span></div><div class="casAuthors">Jorgensen, William L.; Maxwell, David S.; Tirado-Rives, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11225-11236</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and testing of the OPLS all-atom force field for org. mols. and peptides are described.  Parameters for both torsional and nonbonded energetics have been derived, while the bond stretching and angle bending parameters have been adopted mostly from the AMBER all-atom force field.  The torsional parameters were detd. by fitting to rotational energy profiles obtained from ab initio MO calcns. at the RHF/6-31G*//RHF/6-31G* level for more than 50 org. mols. and ions.  The quality of the fits was high with av. errors for conformational energies of less than 0.2 kcal/mol.  The force-field results for mol. structures are also demonstrated to closely match the ab initio predictions.  The nonbonded parameters were developed in conjunction with Monte Carlo statistical mechanics simulations by computing thermodn. and structural properties for 34 pure org. liqs. including alkanes, alkenes, alcs., ethers, acetals, thiols, sulfides, disulfides, aldehydes, ketones, and amides.  Av. errors in comparison with exptl. data are 2% for heats of vaporization and densities.  The Monte Carlo simulations included sampling all internal and intermol. degrees of freedom.  It is found that such non-polar and monofunctional systems do not show significant condensed-phase effects on internal energies in going from the gas phase to the pure liqs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhGotSev_b1LVg90H21EOLACvtfcHk0lgyDB3xBxssIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtlOitrs%253D&md5=fef2924a69421881390282aa309ae91b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fja9621760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9621760%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMaxwell%26aufirst%3DD.%2BS.%26aulast%3DTriado-Rives%26aufirst%3DJ.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520the%2520OPLS%2520all-atom%2520force%2520field%2520on%2520conformational%2520energetics%2520and%2520properties%2520of%2520organic%2520liquids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26issue%3D45%26spage%3D11225%26epage%3D11236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i124"><a href="/doi/suppl/10.1021/jm801026e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61883"></div></div></div></div></div><hr /></hr><p class="last">Elementary analysis data for compounds <b>3c</b>−<b>3e</b>, <b>5a</b>−<b>5i</b>, <b>11</b>, <b>13</b>, <b>17a</b>−<b>17d</b>, <b>18</b>, <b>21</b>, <b>89a</b>−<b>89h</b>, <b>91</b>−<b>93</b>, <b>94a</b>−<b>94c</b>, and <b>100a</b>−<b>100 h</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm801026e/suppl_file/jm801026e_si_001.pdf">jm801026e_si_001.pdf (124.43 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm801026e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm801026e%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-8%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm801026e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                614KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b82a738dd24cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
